0001201800-14-000018.txt : 20141113 0001201800-14-000018.hdr.sgml : 20141113 20141113164243 ACCESSION NUMBER: 0001201800-14-000018 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20140930 FILED AS OF DATE: 20141113 DATE AS OF CHANGE: 20141113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VASOMEDICAL, INC CENTRAL INDEX KEY: 0000839087 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 112871434 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-18105 FILM NUMBER: 141218938 BUSINESS ADDRESS: STREET 1: 180 LINDEN AVENUE CITY: WESTBURY STATE: NY ZIP: 11590 BUSINESS PHONE: 516-997-4600 MAIL ADDRESS: STREET 1: 180 LINDEN AVENUE CITY: WESTBURY STATE: NY ZIP: 11590 FORMER COMPANY: FORMER CONFORMED NAME: VASOMEDICAL INC DATE OF NAME CHANGE: 19950517 FORMER COMPANY: FORMER CONFORMED NAME: FUTURE MEDICAL PRODUCTS INC /DE/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FUTURE MEDICAL PRODUCTS INC /NY/ DATE OF NAME CHANGE: 19920506 10-Q 1 vaso10q-sept2014.htm vaso10q-sept2014.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549


FORM 10-Q


[X] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended September 30, 2014

[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from _______________ to ______________

Commission File Number: 0-18105


VASOMEDICAL, INC.

(Exact name of registrant as specified in its charter)
 
Delaware
11-2871434
(State or other jurisdiction of
(IRS Employer Identification Number)
incorporation or organization)
  

180 Linden Ave., Westbury, New York 11590
(Address of principal executive offices)

Registrant’s Telephone Number
(516) 997-4600

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer.
 
Large Accelerated Filer o
Accelerated Filer o
Non-Accelerated Filer o
Smaller Reporting Company x
 
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yeso No x
 
Number of Shares Outstanding of Common Stock, $.001 Par Value, at November 9, 2014 – 155,677,283
 
Page 1
 

Vasomedical, Inc. and Subsidiaries

INDEX


 
 
Page 2
 
 

Vasomedical, Inc. and Subsidiaries
 
(in thousands, except share data)
   
September 30, 2014
    
December 31, 2013
  
ASSETS
  
(unaudited)
        
CURRENT ASSETS
            
Cash and cash equivalents
   $ 9,054     $ 7,961  
Short-term investments
     111       111  
Accounts and other receivables, net of an allowance for doubtful
                
accounts and commission adjustments of $3,689 at September 30,
                
2014 and $3,764 at December 31, 2013
     7,167       13,570  
Receivables due from related parties
     21       21  
Inventories, net
     1,937       1,618  
Deferred commission expense
     2,388       2,312  
Other current assets
     504       338  
 Total current assets
     21,182       25,931  
                 
PROPERTY AND EQUIPMENT, net of accumulated depreciation of
                
$1,362 at September, 2014 and $1,281 at December 31, 2013
     272       365  
GOODWILL
     3,280       3,303  
OTHER ASSETS, net
     7,585       3,918  
    $ 32,319     $ 33,517  
LIABILITIES AND STOCKHOLDERS' EQUITY
                
CURRENT LIABILITIES
                
Accounts payable
   $ 525     $ 597  
Accrued commissions
     2,106       2,161  
Accrued expenses and other liabilities
     4,351       5,571  
Sales tax payable
     191       230  
Deferred revenue - current portion
     9,158       10,541  
Deferred tax liability, net
     112       112  
Notes payable due to related party
     1,019       3  
Total current liabilities
     17,462       19,215  
                 
LONG-TERM LIABILITIES
                
Deferred revenue
     9,078       7,478  
Other long-term liabilities
     573       359  
Total long-term liabilities
     9,651       7,837  
                 
COMMITMENTS AND CONTINGENCIES (NOTE N)
                
                 
STOCKHOLDERS' EQUITY
                
Preferred stock, $.01 par value; 1,000,000 shares authorized; no shares
                
issued and outstanding at September 30, 2014, and December 31, 2013
     -       -  
Common stock, $.001 par value; 250,000,000 shares authorized;
                
165,985,370 and 164,705,382 shares issued at September 30, 2014
                
and December 31, 2013, respectively; 155,677,283 and
                
155,223,981 shares outstanding at September 30, 2014 and
                
December 31, 2013, respectively
     166       165  
Additional paid-in capital
     61,864       61,508  
Accumulated deficit
     (54,904 )     (53,561 )
Accumulated other comprehensive income
     80       108  
Treasury stock, at cost, 10,308,087 and 9,481,101 shares at September 30, 2014 and
December 31, 2013, respectively
     (2,000 )     (1,755 )
Total stockholders’ equity
     5,206       6,465  
    $ 32,319     $ 33,517  
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
Page 3
 

Vasomedical, Inc. and Subsidiaries

(Unaudited)
(in thousands, except per share data)

    Three months ended September 30     Nine months ended September 30,
   
2014
    
2013
    
2014
    
2013
  
Revenues
                        
Equipment sales
   $ 903     $ 1,353     $ 2,157     $ 3,320  
Equipment rentals and services
     331       391       1,107       1,213  
Commissions
     6,409       5,862       19,335       18,262  
Total revenues
     7,643       7,606       22,599       22,795  
                                 
Cost of revenues
                                
Cost of sales, equipment
     251       381       745       1,015  
Cost of equipment rentals and services
     189       207       549       665  
Cost of commissions
     1,828       1,831       5,282       5,502  
Total cost of revenues
     2,268       2,419       6,576       7,182  
Gross profit
     5,375       5,187       16,023       15,613  
                                 
Operating expenses
                                
Selling, general and administrative
     5,344       5,507       16,867       16,843  
Research and development
     180       172       599       474  
Total operating expenses
     5,524       5,679       17,466       17,317  
Operating loss
     (149 )     (492 )     (1,443 )     (1,704 )
                                 
Other income (expense)
                                
Interest and other income, net
     52       (63 )     150       20  
Total other income, net
     52       (63 )     150       20  
                                 
Loss before income taxes
     (97 )     (555 )     (1,293 )     (1,684 )
Income tax (expense) benefit
     (26 )     91       (50 )     35  
Net loss
     (123 )     (464 )     (1,343 )     (1,649 )
                                 
Other comprehensive loss
                                
Foreign currency translation gain (loss)
     2       29       (28 )     64  
Comprehensive loss
   $ (121 )   $ (435 )   $ (1,371 )   $ (1,585 )
                                 
Loss per common share
                                
- basic and diluted
   $ (0.00 )   $ (0.00 )   $ (0.01 )   $ (0.01 )
                                 
Weighted average common shares outstanding
                          
- basic and diluted
     155,186       157,864       155,319       160,796  
                                 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
Page 4
 

Vasomedical, Inc. and Subsidiaries

(Unaudited)
(in thousands)
      Nine months ended  
   
September 30, 2014
    
September 30, 2013
  
Cash flows from operating activities
            
Net  loss
   $ (1,343 )   $ (1,649 )
Adjustments to reconcile net loss to net cash
                
 provided by (used in) operating activities
                
Depreciation and amortization
     290       266  
Loss on disposal of fixed assets
     39       -  
Provision for doubtful accounts and commission adjustments
     (1 )     23  
Share-based compensation and arrangements
     320       300  
Amortization of deferred consulting expense
     -       87  
Changes in operating assets and liabilities:
                
Accounts and other receivables
     6,396       4,304  
Receivables due from related parties
     -       6  
Inventories, net
     (332 )     71  
Deferred commission expense
     (75 )     521  
Other current assets
     (123 )     (138 )
Other assets
     (1,639 )     (349 )
Accounts payable
     (72 )     99  
Accrued commissions
     (55 )     (746 )
Accrued expenses and other liabilities
     (1,203 )     (678 )
Sales tax payable
     (48 )     (13 )
Deferred revenue
     218       (2,875 )
Other long-term liabilities
     214       195  
Net cash provided by (used in) operating activities
     2,586       (576 )
                 
Purchases of property, equipment and software
     (227 )     (126 )
Purchases of short-term investments
     (40 )     (111 )
Redemption of short-term investments
     40       111  
Acquisition of Genwell
     (1,136 )        
Cash acquired through purchase of Genwell
     113       -  
Net cash used in investing activities
     (1,250 )     (126 )
                 
Cash flows from financing activities
                
Repurchase of common stock
     (244 )     (1,602 )
Net cash used in financing activities
     (244 )     (1,602 )
                 
Effect of exchange rate differences on cash and cash equivalents
     1       (18 )
                 
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
     1,093       (2,322 )
Cash and cash equivalents - beginning of period
     7,961       11,469  
Cash and cash equivalents - end of period
   $ 9,054     $ 9,147  
                 
SUPPLEMENTAL DISCLOSURE OF CASH INFORMATION
                
Interest paid
   $ -     $ -  
Income taxes paid
   $ 48     $ 61  
                 
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
          
Inventories transferred to property and equipment,
                
attributable to operating leases, net
   $ 5     $ 57  
Note issued for acquisition
   $ 1,017     $ -  
The accompanying notes are an integral part of these condensed consolidated financial statements.

 
 
Page 5

 
NOTE A - ORGANIZATION AND PLAN OF OPERATIONS

Vasomedical, Inc. was incorporated in Delaware in July 1987. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Vasomedical” or “management” refer to Vasomedical, Inc. and its subsidiaries. The Company until July 2014 had been operating in two distinct business segments, the Sales Representation segment and the Equipment segment. In May 2010, the Company, through its wholly-owned subsidiary Vaso Diagnostics, Inc. d/b/a VasoHealthcare, expanded into the sales representation business via its agreement with GE Healthcare (“GEHC”), the healthcare business unit of General Electric Company (NYSE: GE), to be GEHC’s exclusive sales representative for the sale of select GEHC diagnostic imaging products in specific market segments in the 48 contiguous states of the United States and the District of Columbia.   In June 2012, the Company entered into an amendment, effective July 1, 2012, of the sales representative agreement (“GEHC Agreement”) extending the initial term of three years commencing July 1, 2010 to five years through June 30, 2015, subject to earlier termination under certain circumstances.  In the Equipment segment we design, manufacture, market and support certain medical devices.  Our principal products in this segment are Enhanced External Counterpulsation (EECP®) systems, which are non-invasive therapy devices based on our proprietary technology, and currently indicated in the United States for the treatment of refractory angina and  used for other ischemic diseases overseas.  In addition we develop, manufacture and market certain ambulatory patient monitoring systems including recorders and analysis software.

In September 2011, the Company acquired Fast Growth Enterprises Limited (FGE), a British Virgin Islands company which owns and controls two Chinese operating companies - Life Enhancement Technologies Ltd. (“LET”) and Biox Instruments Co. Ltd. (“Biox”), respectively – to expand its technical and manufacturing capabilities and to enhance its distribution network, technology, and product portfolio.  Also in September 2011, the Company restructured to further align its business management structure and long-term growth strategy and started to operate through three wholly-owned subsidiaries.  Vaso Diagnostics d/b/a VasoHealthcare continues as the operating subsidiary for the sales representation of GE Healthcare diagnostic imaging products; Vasomedical Global Corp. operates the Company’s Chinese companies; and Vasomedical Solutions, Inc. manages and coordinates our EECP® therapy business as well as other medical equipment operations.

In April 2014, the Company announced that it entered into an agreement with Chongqing PSK-Health Sci-Tech Development Co., Ltd. ("PSK") of Chongqing, China, the leading manufacturer of ECP therapy systems in China, to form a joint venture company, VSK Medical Limited ("VSK"), for the global marketing, sale and advancement of ECP therapy technology.  The joint venture is in the early implementation phase and had not begun operations as of September 30, 2014.
 
In June 2014, the Company entered into a Value Added Reseller Agreement (“VAR Agreement”) with GEHC to become a national value added reseller of GE Healthcare IT's Radiology PACS (Picture Archiving and Communication System) software solutions and related services, including implementation, management and support.  This multiyear VAR Agreement focuses primarily on existing customer segments currently served by Vaso Diagnostics on behalf of GEHC.  A new wholly owned subsidiary, VasoHealthcare IT Corp., was formed to conduct the healthcare IT business.
 
In August 2014, the Company acquired all of the outstanding shares of Genwell Instruments Co. Ltd. (“Genwell”), located in Wuxi, China, through its wholly owned subsidiary Wuxi Gentone Instruments Co. Ltd. (“Gentone”).  Genwell was formed in China in 2010 with the assistance of a government grant to develop the MobiCareTM  wireless multi-parameter patient monitoring system and holds the patents and intellectual property rights for this system.  See Note K.

We report the operations of Vasomedical Global Corp. and Vasomedical Solutions, Inc. under our Equipment segment.  Vaso Diagnostics activities are included under our Sales Representation segment.  VasoHealthcare IT operations report under the IT segment (See Note C).
 
 
Page 6
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)

 
NOTE B - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES

Basis of Presentation and Use of Estimates

The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and disclosures normally included in the condensed consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in connection with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013, as filed with the SEC. These condensed consolidated financial statements include the accounts of the companies over which we exercise control. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of interim results for the Company. The results of operations for any interim period are not necessarily indicative of results to be expected for any other interim period or the full year.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company's management. The Company evaluates its estimates and assumptions on an ongoing basis.

Significant Accounting Policies

Note B of the Notes to Consolidated Financial Statements, included in the Annual Report on Form 10-K for the year ended December 31, 2013, includes a summary of the significant accounting policies used in the preparation of the condensed consolidated financial statements.

Revenue and Expense Recognition for VasoHealthcare

The Company recognizes commission revenue, net of the medical device tax reimbursement to GEHC, in its Sales Representation segment (see Note C) when persuasive evidence of an arrangement exists, service has been rendered, the price is fixed or determinable and collectability is reasonably assured.  These conditions are deemed to be met when the underlying equipment has been accepted at the customer site in accordance with the specific terms of the sales agreement.  Consequently, amounts billable under the agreement with GE Healthcare in advance of the customer acceptance of the equipment are recorded as accounts receivable and deferred revenue in the condensed consolidated balance sheets.  Similarly, commissions payable to our sales force related to such billings are recorded as deferred commission expense when the associated deferred revenue is recorded.  Commission expense is recognized when the corresponding commission revenue is recognized.
 
Reclassifications
 
Certain reclassifications have been made to prior period amounts to conform with current period presentation.

NOTE C – SEGMENT REPORTING AND CONCENTRATIONS
 
The Company views its business in three segments – the Sales Representation segment, the Equipment segment, and the IT segment.  The Sales Representation segment operates through the VasoHealthcare subsidiary and is currently engaged solely in the fulfillment of the Company’s responsibilities under our agreement with GEHC.  The Equipment segment is engaged in designing, manufacturing, marketing and supporting EECP® enhanced external counterpulsation systems both domestically and internationally, as well as the development, production, marketing and supporting of other medical devices.  The Company’s new subsidiary, VasoHealthcare IT Corp., formed to conduct its healthcare IT operations, reports through the IT segment.  Operations in the IT segment began in the third quarter of 2014.  The Company evaluates segment performance based on operating income.  Administrative functions such as finance, human resources, and information technology are centralized and related expenses allocated to each segment.  Other costs not directly attributable to operating segments, such as audit, legal, director fees, investor relations, and others, as well as certain assets – primarily cash balances – are reported in the Corporate entity below.  There are no intersegment revenues.  Summary financial information for the segments is set forth below:

Page 7
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)

 
    (in thousands)  
    As of or for the three months ended September 30, 2014  
   
Sales Representation Segment
  
Equipment Segment
  
IT Segment
  
Corporate
    
Consolidated
  
                               
Revenues from external customers
   $ 6,409     $ 1,234     $ -     $ -     $ 7,643  
Operating (loss) income
   $ 723     $ (405 )   $ (82 )   $ (385 )   $ (149 )
Total assets
   $ 13,341     $ 9,909     $ 2     $ 9,067     $ 32,319  
Accounts and other receivables, net
   $ 6,376     $ 791     $ -     $ -     $ 7,167  
Deferred commission expense
   $ 4,763     $ -     $ -     $ -     $ 4,763  
                                         
                                         
        As of or for the three months ended September 30, 2013  
   
Sales Representation Segment
  
Equipment Segment
  
IT Segment
  
Corporate
    
Consolidated
  
                                         
Revenues from external customers
   $ 5,862     $ 1,744     $ -     $ -     $ 7,606  
Operating (loss) income
   $ 199     $ (364 )   $ -     $ (327 )   $ (492 )
Total assets
   $ 8,040     $ 8,398     $ -     $ 8,972     $ 25,410  
Accounts and other receivables, net
   $ 3,510     $ 1,229     $ -     $ -     $ 4,739  
Deferred commission expense
   $ 4,145     $ -     $ -     $ -     $ 4,145  
                                         
                                         
        As of or for the nine months ended September 30, 2014  
   
Sales Representation Segment
  
Equipment Segment
  
IT Segment
  
Corporate
    
Consolidated
  
                                         
Revenues from external customers
   $ 19,335     $ 3,264     $ -     $ -     $ 22,599  
Operating (loss) income
   $ 2,267     $ (2,361 )   $ (82 )   $ (1,267 )   $ (1,443 )
Total assets
   $ 13,341     $ 9,909     $ 2     $ 9,067     $ 32,319  
Accounts and other receivables, net
   $ 6,376     $ 791     $ -     $ -     $ 7,167  
Deferred commission expense
   $ 4,763     $ -     $ -     $ -     $ 4,763  
                                         
                                         
        As of or for the nine months ended September 30, 2013
   
Sales Representation Segment
  
Equipment Segment
  
IT Segment
  
Corporate
    
Consolidated
  
                                         
Revenues from external customers
   $ 18,262     $ 4,533     $ -     $ -     $ 22,795  
Operating (loss) income
   $ 870     $ (1,489 )   $ -     $ (1,085 )   $ (1,704 )
Total assets
   $ 8,040     $ 8,398     $ -     $ 8,972     $ 25,410  
Accounts and other receivables, net
   $ 3,510     $ 1,229     $ -     $ -     $ 4,739  
Deferred commission expense
   $ 4,145     $ -     $ -     $ -     $ 4,145  
 
 
 
                                        
 
Page 8
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)

 
For the three months ended September 30, 2014 and 2013, GE Healthcare accounted for 84% and 77% of revenue, respectively.  For the nine months ended September 30, 2014 and 2013, GE Healthcare accounted for 86% and 80% of revenue, respectively.  Also, GE Healthcare accounted for $6.2 million, or 87%, and $8.1 million, or 89%, of accounts and other receivables at September 30, 2014 and December 31, 2013, respectively.

NOTE D – SHARE-BASED COMPENSATION
 
The Company complies with ASC Topic 718 “Compensation – Stock Compensation” (“ASC 718”), which requires all share-based awards to employees, including grants of employee stock options, to be recognized in the condensed consolidated financial statements based on their estimated fair values.

During the nine months ended September 30, 2014, the Company granted 450,000 restricted shares of common stock valued at $157,500 to officers and 140,000 restricted shares of common stock valued at $31,100 to employees.  Of the 450,000 shares granted to officers, 100,000 shares vested immediately and the remainder vest at various times through February 2016.  Of the 140,000 shares granted to employees, 50,000 shares vested immediately and 90,000 shares vest over a three year period.  In the first nine months of 2014, the Company also granted 500,000 restricted shares of common stock to directors.  The shares were valued at $175,000 and vested immediately.

During the nine month period ended September 30, 2013, the Company granted 400,000 restricted shares of common stock valued at $74,000.  100,000 of such shares were granted to an officer and 300,000 shares were granted to employees.  Shares valued at $3,600 and $38,000 vested over six month and two year periods, respectively, with the remainder vesting immediately.

During the nine month periods ended September 30, 2014 and 2013, the Company did not grant any stock options.

Share-based compensation expense recognized for the three and nine month periods ended September 30, 2014 was $32,000 and $189,000, respectively, and $29,000 and $300,000 for the three and nine month periods ended September 30, 2013, respectively.  These expenses are included in selling, general, and administrative expenses in the condensed consolidated statements of operations in 2014, and in cost of revenues; selling, general, and administrative expenses; and research and development expenses in the condensed consolidated statements of operations in 2013.  Expense for share-based arrangements with directors and non-employees was $43,000 and $131,000 for the three and nine months ended September 30, 2014, respectively, and $0 and $87,000 for the three and nine months ended September 30, 2013, respectively.  Unrecognized expense related to share-based compensation and arrangements is approximately $130,000 at September 30, 2014 and will be recognized through September 2017.

NOTE E – LOSS PER COMMON SHARE

Basic loss per common share is computed as earnings applicable to common stockholders divided by the weighted-average number of common shares outstanding for the period.  Diluted loss per common share reflects the potential dilution that could occur if securities or other contracts to issue common shares were exercised or converted to common stock.

The following table represents common stock equivalents that were excluded from the computation of diluted earnings per share for the three and nine months ended September 30, 2014 and 2013, because the effect of their inclusion would be anti-dilutive.
                               
     (in thousands)  
      For the three months ended     For the nine months ended  
   
September 30, 2014
    
September 30, 2013
    
September 30, 2014
    
September 30, 2013
  
Stock options
     1,402       1,780       1,402       1,780  
Common stock grants
     490       585       490       585  
      1,892       2,365       1,892       2,365  
                                 

 
Page 9
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)
 
NOTE F – FAIR VALUE MEASUREMENTS

The Company complies with the provisions of ASC 820 “Fair Value Measurements and Disclosures” (“ASC 820”).  Under ASC 820, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.

The following tables present information about the Company’s assets measured at fair value as of September 30, 2014 and December 31, 2013:        
      (in thousands)  
   
Quoted Prices
in Active
Markets for
Identical Assets
 (Level 1)
    
Significant
Other
Observable
Inputs
(Level 2)
    
Significant
Unobservable
Inputs
(Level 3)
    
Balance
as of
September 30,
2014
  
Assets
                    
(unaudited)
  
Cash equivalents invested in money market funds (included
in cash and cash equivalents)
   $ 8,384     $ -     $ -     $ 8,384  
Investment in certificates of deposit (included in
short-term investments)
     111                       111  
    $ 8,495     $ -     $ -     $ 8,495  
                                 
   
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
    
 
Significant
Other
Observable
Inputs
(Level 2)
    
Significant
Observable
Inputs
(Level 3)
      
Balance
as of
December 31,
2013
  
Assets
                                
Cash equivalents invested in money market funds (included in
cash and cash equivalents)
   $ 6,883     $ -     $ -     $ 6,883  
Investment in certificates of deposit (included in
short-term investments)
     111                       111  
    $ 6,994     $ -     $ -     $ 6,994  
                                 
 
The fair values of the Company’s cash equivalents invested in money market funds are determined through market, observable and corroborated sources.

NOTE G – ACCOUNTS AND OTHER RECEIVABLES, NET

The following table presents information regarding the Company’s accounts and other receivables as of September 30, 2014 and December 31, 2013:
      (in thousands)  
   
September 30, 2014
    
December 31, 2013
  
   
(unaudited)
        
Trade receivables
   $ 10,716     $ 17,173  
Due from employees
     140       161  
Allowance for doubtful accounts and
                
commission adjustments
     (3,689 )     (3,764 )
Accounts and other receivables, net
   $ 7,167     $ 13,570  

 
Page 10
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)

 
Trade receivables include amounts due for shipped products and services rendered.  Amounts currently due under the GEHC Agreement are subject to adjustment in subsequent periods should the underlying sales order amount, upon which the receivable is based, change.

Allowance for doubtful accounts and commission adjustments include estimated losses resulting from the inability of our customers to make required payments, and adjustments arising from subsequent changes in sales order amounts that may reduce the amount the Company will ultimately receive under the GEHC Agreement.  Due from employees is primarily commission advances made to sales personnel.

NOTE H – INVENTORIES, NET

Inventories, net of reserves, consist of the following:                            
 
      (in thousands)  
   
September 30, 2014
    
December 31, 2013
  
   
(unaudited)
        
Raw materials
   $ 651     $ 790  
Work in process
     678       291  
Finished goods
     608       537  
    $ 1,937     $ 1,618  
                 

At September 30, 2014 and December 31, 2013, the Company maintained reserves for excess and obsolete inventory of $829,000 and $803,000, respectively.

NOTE I – GOODWILL AND OTHER INTANGIBLES

Goodwill aggregating $3,280,000 and $3,303,000 was recorded on the Company’s condensed consolidated balance sheets at September 30, 2014 and December 31, 2013, respectively, pursuant to the acquisition of FGE in September 2011.  All of the goodwill was allocated to the Company’s Equipment segment.  The components of the change in goodwill are as follows:         

      (in thousands)  
   
Carrying Amount
  
       
Balance at December 31, 2013
   $ 3,303  
Foreign currency translation
     (23 )
Balance at September 30, 2014 (unaudited)
   $ 3,280  

The Company’s other intangible assets consist of capitalized patent and technology costs, customer lists and software costs, as follows:
 
 
Page 11
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)
 

      (in thousands)  
   
September 30, 2014
    
December 31, 2013
  
   
(unaudited)
        
Patents and Technology
            
Costs
   $ 2,500     $ 469  
Accumulated amortization
     (462 )     (454 )
      2,038       15  
                 
Customer lists
                
Costs
     800       800  
Accumulated amortization
     (352 )     (267 )
      448       533  
                 
Software
                
Costs
     871       696  
Accumulated amortization
     (476 )     (424 )
      395       272  
                 
    $ 2,881     $ 820  
                 

Patents and technology, customer lists, and software are included in other assets in the accompanying condensed consolidated balance sheets and are amortized on a straight line basis over their estimated useful lives of ten, seven, and five years, respectively.  Amortization expense amounted to $50,000 and $146,000 for the three and nine months ended September 30, 2014, respectively, and $41,000 and $126,000 for the three and nine months ended September 30, 2013, respectively.

NOTE J - DEFERRED REVENUE

The changes in the Company’s deferred revenues are as follows:

     (in thousands)
      For the three months ended September 30,       For the nine months ended September 30,  
   
2014
    
2013
    
2014
    
2013
  
   
(unaudited)
    
(unaudited)
    
(unaudited)
    
(unaudited)
  
Deferred revenue at the beginning of the period
   $ 17,712     $ 13,270     $ 18,019     $ 15,602  
Additions:
                                
Deferred extended service contracts
     244       410       791       848  
Deferred in-service and training
     13       8       28       23  
Deferred service arrangements
     28       30       58       60  
Deferred commission revenues
     3,457       2,076       8,840       5,355  
Recognized as revenue:
                                
Deferred extended service contracts
     (207 )     (245 )     (654 )     (755 )
Deferred in-service and training
     (10 )     (10 )     (25 )     (20 )
Deferred service arrangements
     (26 )     (16 )     (72 )     (54 )
Deferred commission revenues
     (2,975 )     (2,796 )     (8,749 )     (8,332 )
Deferred revenue at end of period
     18,236       12,727       18,236       12,727  
Less: current portion
     9,158       7,684       9,158       7,684  
Long-term deferred revenue at end of period
   $ 9,078     $ 5,043     $ 9,078     $ 5,043  

 
Page 12
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)

 
NOTE K – RELATED-PARTY TRANSACTIONS

On February 28, 2011, David Lieberman and Edgar Rios were appointed by the Board of Directors as directors of the Company.  Mr. Lieberman, a practicing attorney in the State of New York, was also appointed to serve as the Vice Chairman of the Board.  He is currently a senior partner at the law firm of Beckman, Lieberman & Barandes, LLP, which performs certain legal services for the Company.  Fees of approximately $60,000 and $180,000 were billed by the firm through the three and nine months ended September 30, 2014, respectively, and fees of approximately $66,000 and $187,000 were billed through the three and nine months ended September 30, 2013, respectively, at which dates no amounts were outstanding.

Mr. Rios currently is President of Edgary Consultants, LLC, and was appointed a director in conjunction with the Company’s consulting agreement with Edgary Consultants, LLC.  The consulting agreement (the “Agreement”) between the Company and Edgary Consultants, LLC (“Consultant”) commenced on March 1, 2011 and was for a two-year term and expired on February 28, 2013.  The Agreement provided for the engagement of Consultant to assist the Company in seeking broader reimbursement coverage of EECP® therapy.  

In consideration for the services to be provided by Consultant under the Agreement, the Company agreed to issue to Consultant or its designees, up to 18,500,000 shares of restricted common stock of the Company, 3,000,000 of which were issued in March 2011 and the balance was to be earned on performance. Mr. Lieberman received 600,000 of these restricted shares.  The Company recorded the fair value of the shares issued to Consultant as a prepaid expense and amortized the cost ratably over the two year agreement.  No performance-based shares were issued and no further compensation is expected to be paid in conjunction with the agreement.

Receivables due from FGE management aggregating $8,000 and $6,000 were collected during the three and nine months ended September 30, 2013, respectively.

On August 6, 2014 the Company acquired all of the outstanding shares of Genwell Instruments Co. Ltd. (“Genwell”), located in Wuxi, China, through its wholly owned subsidiary Wuxi Gentone Instruments Co. Ltd. (“Gentone”) for cash and notes of Chinese Yuan RMB13,250,000 (approximately $2,151,000 at the acquisition date – see Note P).  Genwell was formed in China in 2010 with the assistance of a government grant to develop the MobiCareTM  wireless multi-parameter patient monitoring system and holds the patents and intellectual property rights for this system.  The president of our subsidiary Life Enhancement Technologies Ltd. and the president and vice-president of our subsidiary Biox Instruments Company Ltd. together owned 80.9% of Genwell at the time of acquisition.  The President and CEO of the Company was appointed the nominee Chairman of Genwell at its formation for the sole purpose of applying for the government grant available only to overseas Chinese persons.  He has never received any compensation from Genwell nor held any ownership interest in Genwell.  The Company has received a fairness opinion for this transaction from an independent certified appraisal firm and a legal opinion from Chinese counsel.
 
NOTE L – STOCKHOLDERS’ EQUITY
 
Common Stock

On June 17, 2010 the Board of Directors approved the 2010 Stock Plan (the “2010 Plan”) for officers, directors, employees and consultants of the Company.  The stock issuable under the 2010 Plan shall be shares of the Company’s authorized but unissued or reacquired common stock.  The maximum number of shares of common stock which may be issued under the 2010 Plan is 5,000,000 shares.

The 2010 Plan is comprised of two separate equity programs, the Options Grant Program, under which eligible persons may be granted options to purchase shares of common stock, and the Stock Issuance Program, under which eligible persons may be issued shares of common stock directly, either through the immediate purchase of such shares or as compensation for services rendered to the Company.  The 2010 Plan provides that the Board of Directors, or a committee of the Board of Directors, will administer it with full authority to determine the identity of the recipients of the options or shares and the number of options or shares.
 
 
Page 13
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)

 
During the nine months ended September 30, 2014 the Company issued, under the 2010 Plan, 710,000 shares of common stock to employees and officers, and 500,000 shares of common stock to directors.  As of September 30, 2014, 1,222 shares were available for grant under the 2010 Plan.

On October 30, 2013 the Board of Directors approved the 2013 Stock Plan (the “2013 Plan”) for officers, directors, employees and consultants of the Company.  The stock issuable under the 2013 Plan shall be shares of the Company’s authorized but unissued or reacquired common stock.  The maximum number of shares of common stock which may be issued under the 2013 Plan is 7,500,000 shares.

The 2013 Plan is comprised of two separate equity programs, the Options Grant Program, under which eligible persons may be granted options to purchase shares of common stock, and the Stock Issuance Program, under which eligible persons may be issued shares of common stock directly, either through the immediate purchase of such shares or as compensation for services rendered to the Company.  The 2013 Plan provides that the Board of Directors, or a committee of the Board of Directors, will administer the Plan with full authority to determine the identity of the recipients of the options or shares and the number of options or shares.

During the nine months ended September 30, 2014 the Company issued, under the 2013 Plan, 69,988 shares of common stock to employees.  As of September 30, 2014, 7,330,012 shares were available for grant under the 2013 Plan.

No options were issued under the 2010 Plan or 2013 Plan during the nine-month period ended September 30, 2014.

In April 2013, the Company’s Board of Directors authorized a share repurchase program of up to $1.5 million, which was subsequently increased in July 2013 to $2.0 million, of the Company’s common stock.  As of September 30, 2014, 10,308,087 shares had been repurchased at a cost of $2,000,000, which cost has been recorded as treasury stock in the accompanying condensed consolidated balance sheet as of September 30, 2014.

NOTE M – INCOME TAXES

The Company’s provision for income taxes consists of state and local, and foreign taxes, as applicable, in amounts necessary to align the Company’s year-to-date tax provision with the effective rate that it expects to achieve for the full year.  For the three and nine months ended September 30, 2014, the Company recorded an income tax provision of $26,000 and $50,000, respectively, consisting primarily of state and local minimum taxes and foreign taxes related to the Chinese subsidiary.  For the three and nine months ended September 30, 2013, the Company recorded a tax benefit of $91,000 and $35,000, respectively, consisting of a tax refund on a previous period return, partially offset by state and local minimum taxes and foreign taxes related to the Chinese subsidiary.  Our domestic deferred tax assets are not realizable on a more-likely-than-not basis and, therefore, we have recorded a full valuation allowance against our domestic deferred tax assets.

NOTE N – COMMITMENTS AND CONTINGENCIES
 
Sales representation agreement

In June 2012, the Company concluded an amendment of the GEHC Agreement with GE Healthcare, originally signed on May 19, 2010.  The amendment, effective July 1, 2012, extended the initial term of three years commencing July 1, 2010 to five years through June 30, 2015, subject to earlier termination under certain circumstances.  These circumstances include not materially achieving certain sales goals, not maintaining a minimum number of sales representatives, and various legal and GEHC policy requirements.  Under the terms of the agreement, the Company is required to lease dedicated computer equipment from GEHC for connectivity to their network.

Value Added Reseller agreement

In June 2014, the Company entered into an agreement with GE Healthcare for the purchase of certain GEHC IT professional services in conjunction with the execution of its VAR Agreement, as described in Note A.

 
Page 14
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)
 
 
NOTE O - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

Standards issued but not yet effective

In May 2014, the FASB issued a comprehensive new revenue recognition standard which will supersede previous existing revenue recognition guidance. The standard creates a five-step model for revenue recognition that requires companies to exercise judgment when considering contract terms and relevant facts and circumstances. The five-step model includes (1) identifying the contract, (2) identifying the separate performance obligations in the contract, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations and (5) recognizing revenue when each performance obligation has been satisfied. The standard also requires expanded disclosures surrounding revenue recognition. The standard is effective for fiscal periods beginning after December 15, 2016 and allows for either full retrospective or modified retrospective adoption. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements.

NOTE P – BUSINESS COMBINATION

On August 6, 2014 the Company acquired all of the outstanding shares of Genwell Instruments Co. Ltd. (“Genwell”), located in Wuxi, China, through its wholly owned subsidiary Wuxi Gentone Instruments Co. Ltd. (“Gentone”) for cash and notes of Chinese Yuan RMB13,250,000 (approximately $2,151,000 at the acquisition date).  The notes totaling RMB6,250,000 (approximately $1,015,000) are payable one year from the closing date with interest at the rate of 5% per annum.  Genwell was formed in China in 2010 with the assistance of a government grant to develop the MobiCareTM  wireless multi-parameter patient monitoring system and holds the patents and intellectual property rights for this system.  The primary purpose of the acquisition was to acquire ownership of these patents and intellectual property.

The operating results of Genwell from August 6, 2014 to September 30, 2014 are included in the accompanying condensed consolidated statements of operations and comprehensive loss for the three and nine month periods ended September 30, 2014.  The accompanying condensed consolidated balance sheet at September 30, 2014 reflects the acquisition of Genwell effective August 6, 2014.

In accordance with Accounting Standards Codification 805, Business Combinations, the total purchase consideration is allocated to the net tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at August 6, 2014 (the acquisition date).  The purchase price was allocated based on the information currently available, and may be adjusted after obtaining more information regarding, among other things, asset valuations, liabilities assumed, and revisions of preliminary estimates.  The following table summarizes the estimated fair values of the net assets acquired:

      (in thousands)  
Cash and cash equivalents
   $ 113  
Accounts receivable and other current assets
     2  
Property and equipment
     3  
Intangible assets
     2,033  
Net assets acquired
   $ 2,151  
         
 
 
Page 15
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)
 
 

During the three and nine month periods ended September 30, 2014, the Company expensed $8,000 of acquisition-related legal costs.  The costs are included in the line item Selling, General & Administrative costs in the accompanying condensed consolidated statements of operations and comprehensive loss.  The amounts of revenue and net loss of Genwell included in the Company’s condensed consolidated statements of operations and comprehensive loss for the three months ended September 30, 2014 was $0 and $10,000, respectively.  Genwell is not expected to report future revenue as the sales of its principal product, MobiCareTM , will be through the Biox subsidiary.  The following unaudited supplemental pro forma information presents the financial results as if the acquisition of Genwell had occurred January 1, 2013:
   
    (in thousands)  
    Three months ended September 30,     Nine months ended September 30,  
   
2014
    
2013
    
2014
    
2013
  
Revenue
   $ 7,643     $ 7,606     $ 22,626     $ 22,795  
                                 
Net loss
     (136 )     (551 )     (1,420 )     (1,930 )
                                 
Basic and diluted loss per share
   $ (0.00 )   $ (0.00 )   $ (0.01 )   $ (0.01 )
                                 

An adjustment was made to the unaudited pro forma financial information to reflect the acquisition-related costs in the nine months ended September 30, 2013.



 

 
Page 16
 
Vasomedical, Inc. and Subsidiaries



 
Except for historical information contained in this report, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this report, words such as “anticipates”, “believes”, “could”, “estimates”, “expects”, “may”, “plans”, “potential” and “intends” and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the effect of the dramatic changes taking place in the healthcare environment; the impact of competitive procedures and products and their pricing; medical insurance reimbursement policies; unexpected manufacturing or supplier problems; unforeseen difficulties and delays in the conduct of clinical trials and other product development programs; the actions of regulatory authorities and third-party payers in the United States and overseas; uncertainties about the acceptance of a novel therapeutic modality by the medical community; continuation of the GEHC Agreement and the risk factors reported from time to time in the Company’s SEC reports, including its recent report on Form 10-K.  The Company undertakes no obligation to update forward-looking statements as a result of future events or developments.

General Overview

Vasomedical, Inc. was incorporated in Delaware in July 1987.  Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Vasomedical” or “management” refer to Vasomedical, Inc. and its subsidiaries.  Until 2010, we were primarily engaged in designing, manufacturing, marketing and supporting Enhanced External Counterpulsation (EECP®) systems, based on our proprietary technology, to physicians and hospitals throughout the United States and in select international markets.

In May 2010, the Company, through its wholly-owned subsidiary Vaso Diagnostics, Inc. d/b/a VasoHealthcare, expanded into the sales representation business via its agreement with GE Healthcare (“GEHC”), the healthcare business unit of General Electric Company (NYSE: GE), to be GEHC’s exclusive sales representative for the sale of select GEHC diagnostic imaging products in specific market segments in the 48 contiguous states of the United States and the District of Columbia.   In June 2012, the Company entered into an amendment, effective July 1, 2012, of the sales representative agreement (“GEHC Agreement”) extending the initial term of three years commencing July 1, 2010 to five years through June 30, 2015, subject to earlier termination under certain circumstances.

In September 2011, the Company acquired Fast Growth Enterprises Limited (FGE), a British Virgin Islands company, which owns and controls two Chinese operating companies - Life Enhancement Technology Ltd. and Biox Instruments Co. Ltd., respectively - to expand its technical and manufacturing capabilities and to enhance its distribution network, technology, and product portfolio.  Also in September 2011, the Company restructured to further align its business management structure and long-term growth strategy, and started to operate through three wholly-owned subsidiaries.  Vaso Diagnostics d/b/a VasoHealthcare continues as the operating subsidiary for the sales representation of GE diagnostic imaging products; Vasomedical Global Corp. operates the Company’s Chinese companies; and Vasomedical Solutions, Inc. was formed to manage and coordinate our EECP® therapy business as well as other medical equipment operations.

In April 2014, the Company announced that it entered into an agreement with Chongqing PSK-Health Sci-Tech Development Co., Ltd. ("PSK") of Chongqing, China, the leading manufacturer of ECP therapy systems in China, to form a joint venture company, VSK Medical Limited ("VSK"), for the global marketing, sale and advancement of ECP therapy technology.  The joint venture is in the early implementation phase and had not begun operations as of September 30, 2014.

In June 2014, the Company entered into a Value Added Reseller Agreement (“VAR Agreement”) with GEHC to become a national value added reseller of GE Healthcare IT's Radiology PACS (Picture Archiving and Communication System) software solutions and related services, including implementation, management and support.  This multiyear VAR Agreement focuses primarily on existing customer segments currently served by Vaso Diagnostics on behalf of GEHC.  A new wholly owned subsidiary, VasoHealthcare IT Corp., was formed to conduct the healthcare IT business.
 
 
Page 17
 
Vasomedical, Inc. and Subsidiaries

In August 2014, the Company acquired all of the outstanding shares of Genwell Instruments Co. Ltd. (“Genwell”), located in Wuxi, China, through its wholly owned subsidiary Wuxi Gentone Instruments Co. Ltd. (“Gentone”).  Genwell was formed in China in 2010 with the assistance of a government grant to develop the MobiCareTM  wireless multi-parameter patient monitoring system and holds the patents and intellectual property rights for this system.

We report the operations of Vasomedical Global Corp. and Vasomedical Solutions, Inc. under our Equipment segment.  Vaso Diagnostics activities are included under our Sales Representation segment.  VasoHealthcare IT operations report under the IT segment.

The Company expects to achieve profitability through its sales representation operations and its China operations, as well as by expanding its market presence and product portfolio.  In addition, the Company continues to pursue acquisitions or partnership opportunities in the international and domestic markets and to expand its sales representation business.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon the accompanying unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Although these estimates are based on our knowledge of current events, our actual amounts and results could differ from those estimates. The estimates made are based on historical factors, current circumstances, and the experience and judgment of our management, who continually evaluate the judgments, estimates and assumptions and may employ outside experts to assist in the evaluations.

Certain of our accounting policies are deemed “critical”, as they are both most important to the financial statement presentation and require management’s most difficult, subjective or complex judgments as a result of the need to make estimates about the effect of matters that are inherently uncertain. For a discussion of our critical accounting policies, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2013.

Results of Operations – For the Three Months Ended September 30, 2014 and 2013

Total revenue for the three months ended September 30, 2014 and 2013 was $7,643,000 and $7,606,000, respectively, an increase of $37,000, or less than 1%. Net loss for the three months ended September 30, 2014 was $123,000 compared to a net loss of $464,000 for the three months ended September 30, 2013, an improvement of $341,000.  The decrease in net loss was primarily attributable to an increase in gross profit from our Sales Representation segment of $550,000 and a $163,000 decrease in selling, general and administrative costs, offset by a decrease in gross profit of $362,000 in our Equipment segment.  Our total net loss was $0.00 per basic and diluted common share for the three months ended September 30, 2014 and 2013. We have implemented changes in our Equipment segment operations to reduce sales, marketing and other operating costs and the effect of these changes are reflected in the reduction in selling, general and administrative expenses during the third quarter.  We anticipate that the positive effects of these changes will continue to be reflected in subsequent periods.

Revenues

Commission revenues in the Sales Representation segment were $6,409,000 in the third quarter of 2014, as compared to $5,862,000 in the third quarter of 2013, an increase of $547,000, or 9%.  The increase in commission revenue in the third quarter of 2014 is due primarily to an increase in the commission rate on equipment delivered, as well as an increase in the volume of equipment delivered by GEHC.  The Company recognizes revenue when the underlying equipment has been accepted at the customer site in accordance with the specific terms of the sales agreement.  Consequently, amounts billable under the GEHC Agreement prior to customer acceptance of the equipment are recorded as deferred revenue in the condensed consolidated balance sheet.  As of September 30, 2014, $16,760,000 in deferred commission revenue was recorded in the Company’s condensed consolidated balance sheet, of which $8,359,000 was long-term.  At September 30, 2013, $11,357,000 in deferred commission revenue was recorded in the Company’s condensed consolidated balance sheet, of which $4,443,000 was long-term.
 
 
Page 18
 
Vasomedical, Inc. and Subsidiaries

Revenue in our Equipment segment decreased by $510,000, or 29%, to $1,234,000 for the three-month period ended September 30, 2014 from $1,744,000 for the same period of the prior year.  Equipment segment revenue from equipment sales decreased by $450,000, or 33%, to $903,000 for the three-month period ended September 30, 2014 as compared to $1,353,000 for the same period in the prior year primarily due to lower EECP® revenues as a result of lower sales volume.

We anticipate that demand for EECP® systems will remain soft unless there is greater clinical acceptance for the use of EECP® therapy or a favorable change in current reimbursement policies by CMS or third party payers.  We will continue to cost effectively pursue strategies to increase and expand reimbursement for EECP® therapy.

Equipment segment revenue from equipment rental and services decreased 15% to $331,000 in the third quarter of 2014 from $391,000 in the third quarter of 2013. Revenue from equipment rental and services represented 27% and 22% of total Equipment segment revenue in the third quarters of fiscal 2014 and fiscal 2013, respectively.  The decrease in revenue generated from equipment rentals and services is due primarily to decreased service contract revenues.

Gross Profit

The Company had a gross profit of $5,375,000 in the third quarter of 2014 compared to $5,187,000 in the third quarter of the prior year, an increase of 4%.  The increase is principally due to higher commission rates in our Sales Representation segment on equipment orders booked in 2013, and delivered in the third quarter of 2014.  Equipment segment gross profit decreased to $794,000, or 64% of Equipment segment revenues, for the third quarter of 2014 compared to $1,156,000, or 66% of Equipment segment revenues, for the same quarter of 2013.  Equipment segment gross profit decreased due to lower sales volume in the third quarter of 2014.  Gross profit margin in the Equipment segment decreased due to lower mix of higher margin equipment sales in the third quarter of 2014 as compared to the prior year period.

Sales Representation segment gross profit was $4,581,000, or 71%, for the three months ended September 30, 2014, as compared to $4,031,000, or 69%, for the three months ended September 30, 2013.  The increase was due to higher commission rates the Company received on equipment booked in 2013, coupled with commission expense which is at the same rate as in 2013 and higher equipment delivery volume by GEHC in the third quarter of 2014.  Cost of commissions of $1,828,000 and $1,831,000, for the three months ended September 30, 2014 and 2013, respectively, reflects commission expense associated with recognized commission revenues.  Commission expense associated with deferred revenue is recorded as deferred commission expense until the related commission revenue is earned.

Operating Loss

Operating loss was $149,000 for the three months ended September 30, 2014 as compared to an operating loss of $492,000 for the three months ended September 30, 2013, a decrease of $343,000.  The decrease in operating loss was primarily attributable to the increase in gross profit in the Sales Representation segment as described above, where operating income was $723,000 for the third quarter of 2014 compared to operating income of $199,000 in the same quarter of the prior year.  Equipment segment operating loss increased by $41,000 to $405,000 in the third quarter of 2014 from $364,000 in the same period of the prior year, primarily due to lower equipment sales partially offset by a decrease in selling, general, and administrative expense.  As noted above, we have taken steps to reduce costs in our Equipment segment.

Selling, general and administrative (“SG&A”) expenses for the third quarter of 2014 and 2013 were $5,344,000, or 70% of revenues, and $5,507,000, or 72% of revenues, respectively, reflecting a decrease of $163,000 or approximately 3%. The decrease in SG&A expenditures in the third quarter of 2014 resulted from $266,000 lower EECP-related sales and marketing costs – mainly consulting and personnel-related expenses - in the Equipment segment, partially offset by increased staffing costs associated with initial operations of the IT segment.

Research and development (“R&D”) expenses of $180,000, or 2% of revenues (15% of Equipment segment revenues), for the third quarter of 2014 increased by $8,000, or 5%, from $172,000, or 2% of revenues (13% of Equipment segment revenues), for the third quarter of 2013. The increase is primarily attributable to an increase in product development and clinical research expenses.
 
 
Page 19
 
Vasomedical, Inc. and Subsidiaries

Interest and Other Income, Net
 
Interest and other income (expense), net for the third quarters of 2014 and 2013 was $52,000 and ($63,000), respectively.  The change from expense to income reflected a $130,000 settlement charge associated with a workers’ compensation fund in the third quarter of 2013.

Income Tax Expense
 
During the third quarter of 2014 we recorded an income tax expense of $26,000 as compared to an income tax benefit of $91,000 for the third quarter of 2013.  The change from benefit to expense arose primarily from a tax refund recognized in 2013.  Our domestic deferred tax assets are not realizable on a more-likely-than-not basis and, therefore, we have recorded a full valuation allowance against our domestic deferred tax assets.
 
Results of Operations – For the Nine Months Ended September 30, 2014 and 2013

Total revenue for the nine months ended September 30, 2014 and 2013 was $22,599,000 and $22,795,000, respectively, a decrease of $196,000, or 1%. Net loss for the nine months ended September 30, 2014 was $1,343,000 compared to a net loss of $1,649,000 for the nine months ended September 30, 2013.  The decrease in net loss was primarily attributable to an increase of $410,000 in gross profit, partially offset by a $125,000 increase in research and development costs.  Our total net loss was $0.01 per basic and diluted common share for the nine months ended September 30, 2014 and 2013, respectively.

Revenues

Commission revenues in the Sales Representation segment were $19,335,000 in the first nine months of 2014, as compared to $18,262,000 in the same period of 2013, an increase of 6%.  The increase in commission revenue in the first nine months of 2014 is due primarily to an increase in the commission rate on equipment delivered, partially offset by a decreased volume of equipment delivered by GEHC.  The Company recognizes revenue when the underlying equipment has been accepted at the customer site in accordance with the specific terms of the sales agreement.  Consequently, amounts billable under the GEHC Agreement prior to customer acceptance of the equipment are recorded as deferred revenue in the condensed consolidated balance sheet.

Revenue in our Equipment segment decreased by $1,269,000, or 28%, to $3,264,000 for the nine-month period ended September 30, 2014 from $4,533,000 for the same period of the prior year.  Equipment segment revenue from equipment sales decreased by $1,163,000, or 35%, to $2,157,000 for the nine-month period ended September 30, 2014 as compared to $3,320,000 for the same period in the prior year, primarily due to a decrease of $797,000 in EECP® revenues and a decrease in sales at our China subsidiaries of $369,000 as a result of lower sales volume.  We anticipate an increase in revenue from our China operations as we expand our geographic penetration in China and internationally, and as the newly introduced MobiCareTM product gains market acceptance.

We anticipate that demand for EECP® systems will remain soft unless there is greater clinical acceptance for the use of EECP® therapy or a favorable change in current reimbursement policies by CMS or third party payers.  We will continue to cost effectively pursue strategies to increase and expand reimbursement for EECP® therapy.

Equipment segment revenue from equipment rental and services decreased 9% to $1,107,000 in the first nine months of 2014 from $1,213,000 in the first nine months of 2013. Revenue from equipment rental and services represented 34% and 27% of total Equipment segment revenue in the first nine months of fiscal 2014 and fiscal 2013, respectively.  The decrease in revenue generated from equipment rentals and services is due primarily to decreased service contract revenues, partially offset by higher field service revenues.

Gross Profit

The Company had a gross profit of $16,023,000 in the first nine months of 2014 compared to $15,613,000 in the same period of the prior year, an increase of 3%.  The increase is principally due to the increase in commission revenue discussed above.  Equipment segment gross profit decreased to $1,970,000, or 60% of Equipment segment revenues, for the first nine months of 2014 compared to $2,853,000, or 63% of Equipment segment revenues, for the same period of 2013.  Equipment segment gross profit declined due to lower equipment sales in the first three quarters of 2014, partially offset by higher gross profit on equipment rentals and services.  Gross profit margin on EECP® equipment decreased as a result of lower shipment volume and an increase in severance costs incurred in conjunction with our efforts to reduce costs in our EECP operations.
 
 
Page 20
 
Vasomedical, Inc. and Subsidiaries

Sales Representation segment gross profit was $14,053,000, or 73%, for the nine months ended September 30, 2014 as compared to $12,760,000, or 70%, for the nine months ended September 30, 2013.  The increase was due to higher commission rates in this segment, as explained above, partially offset by lower delivery volume in the first nine months of 2014.  Cost of commissions of $5,282,000 and $5,502,000, for the nine months ended September 30, 2014 and 2013, respectively, reflects commission expense associated with recognized commission revenues.  Commission expense associated with deferred revenue is recorded as deferred commission expense until the related commission revenue is earned.

Operating Loss
 
Operating loss was $1,443,000 for the nine months ended September 30, 2014 as compared to an operating loss of $1,704,000 for the nine months ended September 30, 2013, an improvement of $261,000.  The decrease in operating loss was primarily attributable to improved operating performance in the Sales Representation segment, where operating income was $2,267,000 for the first nine months of 2014 compared to operating income of $870,000 in the same period of the prior year, partially offset by an increase in operating loss of $872,000 in the Equipment segment to $2,361,000 in the first nine months of 2014 from an operating loss of $1,489,000 in the same period of the prior year, and a $182,000 increase in Corporate expenses during the same period.  As noted previously, we have taken steps to reduce sales, marketing and other operating costs in our Equipment segment.

Selling, general and administrative (“SG&A”) expenses for the first nine months of 2014 and 2013 were $16,867,000, or 75% of revenues, and $16,843,000, or 74% of revenues, respectively, reflecting an increase of $24,000 or less than 1%. The increase in SG&A expenditures in the first nine months of 2014 resulted primarily from increased staffing costs associated with initial operations of the IT segment and higher corporate expenses, primarily directors’ fees, partially offset by lower expenditures in the Equipment and Sales Representation segments reflecting lower sales and marketing costs.

Research and development (“R&D”) expenses of $599,000, or 3% of revenues (18% of Equipment segment revenues), for the first nine months of 2014 increased by $125,000, or 26%, from $474,000, or 2% of revenues (10% of Equipment segment revenues), for the first nine months of 2013. The increase is primarily attributable to costs associated with the preparation of an FDA required pre-market approval of our EECP® therapy system for the treatment of congestive heart failure, as well as an increase in product development and clinical research expenses.

Interest and Other Income, Net

Interest and other income, net for the first nine months of 2014 was $150,000 as compared to $20,000 for the same period of 2013. The increase was due primarily to a $130,000 settlement charge associated with a workers’ compensation fund in 2013.

Income Tax (Expense) Benefit

During the first nine months of 2014 we recorded income tax expense of $50,000 as compared to income tax benefit of $35,000 for the first nine months of 2013.  The change from benefit to expense resulted mainly from a tax refund recognized in 2013.  Our domestic deferred tax assets are not realizable on a more-likely-than-not basis and, therefore, we have recorded a full valuation allowance against our domestic deferred tax assets.
 
 
Page 21
 
Vasomedical, Inc. and Subsidiaries

Liquidity and Capital Resources
 
Cash and Cash Flow

We have financed our operations from working capital.  At September 30, 2014, we had cash and cash equivalents of $9,054,000, short-term investments of $111,000 and working capital of $3,720,000 compared to cash and cash equivalents of $7,961,000, short-term investments of $111,000 and working capital of $6,716,000 at December 31, 2013.

Cash provided by operating activities was $2,586,000 during the first nine months of 2014, which consisted of a net loss after adjustments to reconcile net loss to net cash of $695,000, offset by cash provided by operating assets and liabilities of $3,281,000. The changes in the account balances primarily reflect a decrease in accounts and other receivables of $6,396,000, partially offset by increases in other assets of $1,639,000 and decreases in accrued expenses of $1,203,000.  Under the GEHC Agreement the Company earns progressively higher commission rates as calendar year targets are met, and this commission structure has a significant impact on our cash flows. As we achieve these targets, the higher commission rates are retroactively applied to all orders booked in the calendar year, and therefore, significantly higher commission billings and recognized revenue were generated in the fourth quarter of 2013, resulting in significant cash inflows in the first quarter of 2014.  As we previously reported in our Annual Report on Form 10-K for the year ended December 31, 2013, higher commission rates were earned in 2013 than in 2012, resulting in higher cash inflows in 2014.

Cash used in investing activities during the nine-month period ended September 30, 2014 was $1,023,000, net of cash acquired, for the acquisition of Genwell and $227,000 for the purchase of equipment and software.

Cash used in financing activities during the nine-month period ended September 30, 2014 was $244,000 for the repurchase of common stock.

Liquidity

The Company expects to achieve profitability through its sales representation operations and its China operations, as well as by expanding its market presence and product portfolio.  In addition, the Company continues to pursue acquisitions or partnership opportunities in the international and domestic markets and to expand its sales representation business.

Based on our operations through September 30, 2014 and our current business outlook for the ensuing year, we believe internally generated funds from our business segments will be sufficient for the Company to continue operations through at least October 1, 2015.
 
 

 

 
Page 22
 
Vasomedical, Inc. and Subsidiaries




 
Evaluation of Disclosure Controls and Procedures
 
Disclosure controls and procedures reporting as promulgated under the Exchange Act is defined as controls and procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms.  Disclosure controls and procedures include without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Our CEO and our CFO have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2014 and have concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2014.

Changes in Internal Control Over Financial Reporting

There was no change in the Company’s internal control over financial reporting during the Company’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
 
 




 

 
Page 23
 
Vasomedical, Inc. and Subsidiaries





 

 
Exhibits

31
Certifications of the Chief Executive Officer and the Chief Financial Officer pursuant to Rules 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32
Certifications of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.






 

 
Page 24
 
Vasomedical, Inc. and Subsidiaries



In accordance with the requirements of the Exchange Act, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


VASOMEDICAL, INC.

By:           /s/ Jun Ma                                           
Jun Ma
 
President and Chief Executive Officer
 
(Principal Executive Officer)

/s/ Michael J. Beecher   .
Michael J. Beecher
 
Chief Financial Officer and Principal Accounting Officer

Date:  November 13, 2014



 

 
Page 25
 






EX-31 2 vaso10q-sept2014ex31.htm CERTIFICATION vaso10q-sept2014ex31.htm
EXHIBIT 31.1
CERTIFICATION PURSUANT TO RULE 13a/15d OF THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jun Ma, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Vasomedical, Inc. and subsidiaries (the “registrant”);

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):

a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
/s/ Jun Ma .
Jun Ma
President and Chief Executive Officer

Date: November 13, 2014

 
 
 


EXHIBIT 31.2
CERTIFICATION PURSUANT TO RULE 13a/15d OF THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael J. Beecher, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Vasomedical, Inc. and subsidiaries (the “registrant”);

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):

a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
/s/ Michael J. Beecher .
Michael J. Beecher
Chief Financial Officer

Date: November 13, 2014
 EX-32 3 vaso10q-sept2014ex32.htm CERTIFICATION vaso10q-sept2014ex32.htm


EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Vasomedical, Inc. and subsidiaries (the “Company”) on Form 10-Q for the period ending September 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jun Ma, as President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Jun Ma .
Jun Ma
President and Chief Executive Officer

Dated: November 13, 2014
 
 
 

 





EXHIBIT 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Vasomedical, Inc. and subsidiaries (the “Company”) on Form 10-Q for the period ending September 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael J. Beecher, as Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Michael J. Beecher             .
Michael J. Beecher
Chief Financial Officer
 
Dated: November 13, 2014                   
 
 
 
GRAPHIC 4 vasojune2014.jpg begin 644 vasojune2014.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4` M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@`` M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`"L! M$`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_ MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($ M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B M7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X MN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`,`P$` M`A$#$0`_`/[^**_FM_X+3?\`!4[]J7_@G[\9_AKX3^$EEX'N/"7CKP3>^(U? MQ'HLVI7AN["_@TVXC25;B!(D68RN`!*7!`(3;D]I_P`$2_\`@J+^T!_P4!\8 M?&7P[\:K+P?;V_@3PUH^M:+-X8TR3397GO\`5([2:&YC>:?>B0OE)`Z[FS^[ M&*_1*GAAQ/3X,CQVUE\LAE0AB%*&-C+%J$\7]2L\-R74XU[QG'FTBN;8_/X> M)7#<^,)<#IX^.>1KSP[C+!M85SAA/KMXXCGLX2H:QERZO2U]OZ'JHZCJFFZ1 M:R7VK:A9:99PJSRW5_=06EO&B`LS/-(XO@!\0--URW\+>'K>^EM;6?4/"NJ6VE:I?7,5ML\_P"W MS/YT<,C,HCW*Z.#Q^/\`%>;8GAGAK%\3?V9B+QRJO# M0K5Y*2ASJC4=HPG*R^%73/ZO^CAX.4OI!^,&1^$E/B[+>$L?G&59SG<,7CL- M6Q^(K8#(:-*OCZ>7X"A.D\5C'3JITH5<1AJ/NSXL?$_QS\(/JUN7232=*N9-1O1)'D,F((S#G*D9$I''N*^+?%O\`P7B_8X\. MRR0:78^/O%$JLRQOIVE6T%M*1T*W-S`_B5\1K];?POX M:\4>*;^>98FCT;2=2U.?S9`"%E^QV\@0D$-F9T4`Y+`&OOCX:_\`!(_]M[XD MI9WMC\*-2TG2[E8Y#?\`B2]L]'2-'SC]S/<-<%Q_%&T2<=&R<5^%KQ0XZSB; MCDF34.6]DL+@,7CY+;XJLI*E?S<8Q[KM_K;6_9Z_1`\+<)"MXM>+.;*O&,95 M9<0<8\-<&4JDK)OV&6TJ%7,N23ORQAB,1/5+G;U?[A:Q_P`'"7P93=_8/PF\ M57)`R/[0U#3(AR>.8+L@G&O'^KN#^ M)XKY<\&?\&^G[0NK1V\WB3XB^`_"H?!N()8=1U.>(-C*J;6?RV9>%W*A5SQ9]6I74OJ.<>(. M=*JM[E6W5:,J+_P<):C(^(O@3HI7N7\1W(YSQTE/YX]/6NFT MO_@OXEPR_P!H_!.QA4XW?9==FD89]/,F"GCU(]`2>OI^D?\`!`/X%6RK_:?Q M1\9SO@;S:6.CH"V.2HEM#WY'L:[NR_X(/_LO6P7[1XV^)%R5ZE;C3;:<3_LLZ2G3PO"7%>(TLJF# MPO&Z;VUC+%YU2\]91_R.5T#_`(+M?"R[V_VW\+?$5L2,G^S]0T^49XR%\^Z7 MGTSCT([U[CX:_P""SW[+^NE$O=&\>:)*Q4-]ITVUN8%SU/GV]QM(!XX!/?IS M7/6W_!#W]E2W`'_"0_$:0C`W-JMIG`X_Y]C_`)]3DG6A_P""*O[+]NH$/B+X MC(0W_D(!_GVXKJI4O'VA_R_X7Q2O\.(]BM/\5&G2?X[GY;G6,_9NYAS M?V?EWB[E$G\,\#]=E&-^U/'XO&Q:7FKGTQX:_P""D7[(_B)(F?XG6&B/*0!' MK,,UNRLW16*)(`>N1VQ7T+X;_:+^!OB_RQX;^*/A'53*`4$&IHA(.,<3K%CK MT./T-?GC%_P1O_9[M_\`CU\9?$.+C@27EC<`'CD+-"R@X&.`./>M*V_X)+?" MK3\?V;\1?&L)4D@O#I).<="PM"Q'8@D\5[.&S7QIP[BL;PMPGCXJW-+"YQ5P ME1][>T=6"^<.NETC\=SWAGZ'&,YY<-^)?BID\VWR4\XX3PV94(;6YGAJ>%K. MW;VE]]=%?]4[76M'OD62RU73;M'^X]M>VTZMGT,4K`]:T@P)V9QTZUZ;I/[.?[1_AV96 MT?\`:4U">U7&++5;.>X@.WINVQEC[\\^W2OH\+Q)Q>K+,N`<;2?6>79WE&.C MTUY:U7!2[Z:O3K<_*,TX'\-DY/(/&#+<9%*\89SPKQ%E%26ND>;#T,TIIVZR M<5Z'W=17SUH6C_M%:*BQ:KXG\$>)HU(4R_V=?6MR5Y^8LS+EOKQSSP*]9T:] M\4L`FMZ7;HW`,EG,#&.<$A7._'!(!YP17U&$S5XCE57+Q^>YADD<$Y.AG&39G33TJ8#%SO)=U2Q=#"UEZ.G?NCK**!GN,?K1 M7JGAA1110`45\^?M5?&^S_9Q_9Z^*_QJO3;@>`?".IZS:+=_\>TFI)%Y6FQS M#(W1/>R0B11RR;@.37\D7[)?_!=__@H!^TO^TC\)_@M8:)\+Y+;QSXWTG2M4 M%IX:N8;BUT&:[1]5F2X%Y*4>TT_SF24Q,&D1-R1*2R?><+>'7$?%^5YOG65K M`T\NR12>.KXW%QPR7L\//%5/9)PE[3V=&'-/:W-!:N1\1Q-X@\/<*9IE.3YI M+&3S#.7%8*A@\++$M\^(IX:G[5J453]I5J';+4=8^'7B#5;J_P!4LX$75KQ;VW"1 M2VQNRZ6ZH"-J;E?YL#^B3]@SXE_&;XQ?LK_"KXG?'W3+'1OB=XRT>36=;TG3 M["?3+>PBGN)%L(38W&9;>8VJI++&Q;:9``S8W&.(/#WB#AG(= M>P>"HTL;"MC;8C#?6XNMAHQ4J7)2Y?::2YI=%=] M#CS#'8;+,#C,QQDW3PN!PU;%XB:7,XT:%.52HU'[4N6+Y8KXG9=3[6HK^/#_ M`()U?\%JOV[OVR/VMOA9\$=4TKX;?\(?KFM2R>-;[3/#=U:7ECX:M;>5[J[A MG%W<".43>0BAEVD2'YU(57_K`T?XM^$];\;:A\/[4ZDOB+39)UFCFTZYCM'B M@BFE:>.\9!"R,L+A/FR6VCJ0*^FXOX#S_@K,(99G$<)/%2P*S&<$9+B[_9K\:B/]W9:1XF\/O+CO/?/? M+'G'JN['X_3Q+_@UMU;ROV@OV@=()(-U\,-'N-N>HBUX\D9R?]4,9'T)QQ^E MO_!RY\.=0\6?LI_#'Q#I-FMS=Z#\3([2X6>EZ#X=^"%Y-!#-,BR:EJT>HRR:;I\0+[W:ZN%6' M"!F7S-V,#!_IGAK"8[/_`*-N-PN!P>(Q5:E];R^E"A2G4E4Q"SW#5:5**BG[ M\Y8B"4=_>3ZW/YJXES+*^'_I&X*MF&88/!1K+"9A5>(KPI1XB%:M)3:M M",,-4RN#'>Z-X M*W+);6!,;;E;7RLT4J$H?LZENH`;X/\`^"=_@[]G3XC_`/!.VW^+/[:-QKWA MCX1?LM^//$7_``CTEHTUK-\1)/$EW-JEUX=T5U*OJ4XOU@T][*$,Q,N"-B.X M_*9?AG^T=_P5,_;HNKV^MKBY\0?%GQK)>7$?#NDV=SI7PY7 M3X-5USQ3K5G`!J/B1=,)11=7=X9KC[1(W$7C]P7QU1X%P_"F4YQPWPYQ1+'+"X?!?VM@YX#V7UI3A[*53#X MF6)Q;H3ABO;8FA1HN,^5P_GB'_!<;XB:;XIB^&W_``3T_9)\!>`-.CEGT[0H MX/"+^+/&/B"S@/_!,PZW\0==@;36US68GE*QI<+)%Y#Z2EVFCRRS^4 M[".6&=ES&Q=!)7Y%_P#!6'XZ?MU?M*_$?PIH/[4WPTT;X7:CX4T[^T=`\"V- MO`MWI5MK8<+]MO!)-*ACQ]UPSX>Y&\WP7#L/!K(>'\HC@9 MU9T?L$?L^QZM'9/4NU6)E#*?$_V7_P#@G-\;OBK_ M`,$6_BI:_"VQN9?B;\3_`(K:?XI_X16.1H)?%'AGP'?_`+JQMOF7SKB]B"]?\`>*=2TUM!\06WB/PDUW M;7NEK.MTUE7OA35_AXVB:G M>::\O^ML)X!<2/!,JLJ3V_FB,D;MK8`_IU_9X_X*0?"+XJ_L7VO[8WQ*$OP? M\+Z7%>V/C/3_`!$&ADT[Q%I:HMWIVD"X\F35/MDKA=*5`'NB<#`5F'\UGPI_ MX+K?%K4O&FAG]J/]EGX)?$^VBEM]-U/QC=>'[2?QAI&EB=#<'3EO;":V<1J9 M)5MVD"EP%1CZ):P:% M::GXG\3QRRR-JNF:<+>SDN-)2U$<8DB8QRN)%^;FN?.O"/'\19OP[PYBO#+# M\%8BK.KB\PXCR#&O%X#$X+!4X_7<+0P2I?N\16G5PZPOUJ2JTI2E+][34T;9 M-XQY+P_E/$7$.%\4O]5"G&EB'B? MJT94JBC&*]E4<&_IS]H[_@Y<^)/B#Q?>^%?V0OA/91:9#?/:Z/XB\6V,VN:O MK\(;"7"^'8K9S:!NJPDF4<[P%PS?,_@O_@Y)_;B\#^,(K7XN^#_`?B'2[2]7 M^UO#I\+'PMJPB+*9+=;E4:>V8ICRRZ)@,&Q@@U^J_P#P;Y?\$^OAOX)_9Z/[ M2OQ&\(:'XG^)?Q%U74;30)M>TVTU./PUX:TN:6T5;&WO(IX$GU-F6X>XV^:A M1A&5!!K\K_\`@XZ^'W@JY_:T\$0?"SPSX=TK5[;X>HGCP:':6FGBXUF?4`^G M->6]FD,8NTL<*S%=[(5+9+"NCAW*_#',^.L=X899X=T\>LLH8VEC,\Q%2MB, M:\7ET;8MS=U6ITXU7*@J].K2_?6<*,:=D\^(\Y\1,JX#P/B?FGB+_9T,SKX" MM@\GHPP^&P/U3,9)X-4Y-.C4G.C;$.C4I5?W'-SU934F?THM_P`%4_ACXM_X M)V>,?VYOA];*?^$8T62UO_"NI.K2Z)XZ;R8$T&[?Y5N%2XN8620!%FB)P.#G M\)/V>/\`@Y1^*FM_$FTA^/.A^#]&^&MAIFJ:EK,OA_1S)K-]-9HKV6F:>@5) M#<7SL85,6YE*Y"GDU^;8N?B?\+/^"3,?PR-K/:Q_';XZW.HRV$K%%ET+PQIE MG<0:DB%AO@N;FU:.-P-KX7DD`5]*?\$"?^"=7A/]H7XV>+OB?\<_"]IXD\$? M"6PLY=/\.:BGF:7JOB?5'D-A)=QG*W*:8+=;DV[9C?S/FZ4UX7<#\(<+%674 MJ.*]E2G!RA5E3C)*:DNN^.G_```O!<5W*NFV?B+1X MO$VKW%I%*RP37=S*(5BEN(0DDL<6](W'?"_A:V:S\/>+HI+*.==6O;I1Y>@6UO'/!\GAOP3:6_C6'P[9VVF6-]K&H2V]U82 MFSM4A@BEALQ)$X5>2Q)QTK]/?^"`_P#P37^$L7P.US]I+X]?#[0_%WBOQ3J5 M[IWA2#Q/:1:GHVE>$K."(W%]%972R6YNKJY24O.4.R--N6VJ5.(^'/"[!>&. M1\9YAP)B.>75\!A,)6E1S7&U*\I^RPE?,Y/,'FF.P"S&EF%?$TH5LNP-.@J4:V+HY9#E="OA:] M6%"E14U35>].K*I!._YMZK_P$;K3 M;J/7;.]E22X;Q'I;FUO=*T2$NCZC<7=W&XL;>$EG!QNPN:_@8_;U^&>FZI^V MA\>8O@]X4L])\#3?$S6[3POI&F!?LR6\=X;58K**/$:QR7`80QQJ$`*X`SS] M%_\`!0#5_B7X=^&?[.7[&OAT7%I\/O@]\/M-\4:CIZ3O%#JGC7QU;V^LZE/? MPJZK-/I;--#;M,C%%N#@[AQ[O$O@MPYQ-1X*PV3<-2X9K9E*.:8Z>$H3CBZ> M14\!2KXNC5A*4Z=;%?6,5@L/2K33<*M:'?&_-N&ZO&F)SGBS#\2 M4,KOE>$CBL52>$EGE7'5*&%J4Y14)T'?VAOAGX51K:2&[U+PIK/@F?P9K4UC,V0 M(IWA-Q$CH&"3*C@'T^[7G7_!*_\`:=\9_L'>`=?U71OV+=0^*GC?QIJ:7VO[*.O_``XO?"_AYM'O;BWT+6)[S5U-Q+,KW<[VH>40&4K&TC%E154< M5M@O#C(%J3 MITW&JVW4I2C^[!_`_AZWO+7QKI M>I2QR:AHOB;3@J7&@6B;D;4+B[N&$6EE`#=Y)7(1FK^:?]HK_@YC_:!\0^-+ MVR_9F\"^%_!_@ZVNY+;3Y_%FE)XDUO5K:.1EAO9[>1(TLI+I0'^RQ.[1A@C# M=N%?D1\2O#O[0OPL_90\"_`?69-3\/:5XM\6ZYXS\2>!KX36#_`()T?#V]\#^+OVG?C5X)T?Q7XCGUQ_#G MP\L])\->!/#3)>(> M-^(#\3>,?$K/,@X(X=SO#9!F4,GH8[B'&X91^M^UCAZ5?$UW27[W#T(PK8 M>,,/3=&<\37<*E2%-1BOSF_:F_X+J?$7]K+]BGQ=^SM\4O!MEI7Q*\1ZY8KJ MOB?P]"=/T?4_#]H\=PUE+I8P+2']OA'2?^$XL=`@MK"Q'BJ66X:9_L%HL5O;3-;-!YL<:* MN[!VKD`>J_!+P=K7[,'_``1+^-OC"WA_LCXH?M1_$33O`^E`MY4UWX-TNY6. M[E0G:TD+PF20;205)/3`K[:668"/AGEM#A?A_$Y!0\3,RRO"X?+;5*CI3S^M M1IX_V4GJZ4,JPF)G3Y;1C2M.,8)\J^+CG=9^)>9U.)N)<%GE?PSRS-,7B\>Y MTJ=Z>0TJD\%+$0O:-5YIC,-"HY^\ZUX2E*6K]%^$7_!>']H3X]_'SP5\,M%^ M!?P9O+SXC^/],\/6#77A.SN-4>#5M1CA5KBXDA_>745L6GFE9V.49OFQ@_NG M_P`%"O\`@L5\#OV`-+L?``L;/XB?'C^R+*2?X=^'[F.VTCPY))`HD_MV_MA* MFFJLVY[>Q6/SI(`"OS';7\C/_!)WX:ZWX(^-GCC]I#Q%H4=S8?L[?"OQC\2= M%:4!K=_&5E:QQ^'(=QROF&0W3`<'N.E>$?!_X)_%C]O']M[PQH_CR^O+S5/C M1\4Y+KQ-JUU)K3J5)TL/A,MPT:]54G"I4>(A M"$HJ3D=^2^,_$.$X>P=*EQ#ALUXGXUSIX'(ZF*GA)QP>$P]6E@IU,)1A"$*] M?%YEB)8>G[55*=/V$YRC-I1?Z?:__P`'$7_!1/Q;_:OB3X?^"?!NE>#M/N'E MD>W\!S:]#80`EA#>ZJ85C&Q/ON[*<#+**^M?V%O^#D#QWXU^*OA3X;?M5>$/ M#9T;QAK%CH,7CGPG:_V0=!OM2N8+*QFO=+6,PS63W,ZKOA1\)].^$'ACX5^![+P5I_A_^P;JVG\/Z3<37]L]F;6\N=1OKFT> MXN+FY5I))+B:0LC/E-FT`?`GAK_@B)_P3<\.^(KKQQ_PK)=4NX=4F\01->^* M[W^R-*=)S>!HK:"Y2WAM[67,B'*)&JKP`BX_&Y<<>#&9X+-L!C/#BIE4%&5' M*,;E"A5S";DI0IUZ]6=;#^PK0E&G4Y)3Q<*G-*G-2LW+]FAP7XPY9C,JQN$\ M0Z6:2YU5S7!YMSTL#%1<)5*%&C&AB%7I3BZE-3C'"SIM*<7&Z4(O@+:?M'^.= M/MK3PU^%_V(/\`@GAHOPL^#_AC0]1\KQ7J-O$` MR2&ZD:XFF#*66<,9=B:GA'+%9ABY498C/?$',\)D^4UH5K2 M3P%"O7I5TFI0C0HPPLZTU+GE4J2<8+Y7B7CJGF?$^886CXO4*&"P<:T:&0^' M^`Q.<9M1G1?+-8ZOAZ-:CHX5'7K3Q,*5-QY5"FDYGR?\#/\`@Y0_:C\/_$O2 M=`_:*\!^#]?\-G6K71_$-MH^B'PMKFE)+>Q6=[=;%C8FXT]7>8VTFWS#$8R, ML,_7_P#PWFTPW,0.=K MRWVW:<@2@@C%?R^_#WX5_%;]IK]JGPK'XEL8+KQ!\5?BOHK^('L8$@B#:[X@ MM)=4EBM[?]W#%';23N%4;55/7K^BW_!=._U_QK^UUIGPM\*2IJ/@?X"?#GPC M\,?#ZB7>(KO3-.A.M`8.%_TF&,$+SN5L]./U"MX79'@O$O@>>3\.0RK'8/+< MUS[-<%@:=9X5QP:PN%P-6-.>D91S+%N-.HH0]K3HMR@Y1LOS*EXL9CC/#7C9 MYMQ53S3+\3F>59!E>.QM>@L2IXQ8C%XVE.K"S?/EN%4YTY3J>RG45I.,_>^U MO^#7OX%2:M\3?C5\?;VV$MCX5T.W\#:9)+&"(M5UC[)J<\L3$'Y_L8V<8*E< MYR,5_:2MC9)=/>I:6Z7CIY;W*PQB=DSG:TH7>1GL37XP?\$%_P!GM_@7^P;X M1U+4;`Z?XC^*FJWWC/6H73;-L$LUEIAE[[OLB\`G@$`<8K]JJ_D_QASN6=^( MG$==2DZ.#Q2RF@KO2EEL8X62WM9UZ=6>FCYK[ZG]6^$63PR?P^X7=Z7K.GVFJ M:==)_)X:JYTJF;5\RHUX9A#"PIJ MO2P\?92IRPU9MQJ4'/G4E\2LDXW/R#QH^C=6\5N+0E;KPSX1DC\VRLU251-:WVH&:22_0A&VJB%=I7'\\/_!6VR^- M6K?MG_%&_P#B#HVOK##J5O9^'7:TU!]+?P[#;QC2_P"S9Q$;5HGB4/,+=L^< M#Y@)"FO[W(HHX(XX88TAAB18XHHD6...-`%1(T0!415`"JH"J```!7G_`(U^ M$?PH^)+P2?$7X8?#SQ]):KLM7\:^"O#?BI[9#_#`VNZ;?M"O^S&5'M7E<&>/ M>.R+Q)X@\0L_RB.>5\_PE7!.A3Q'L*N5X9UJ-3#8?+JM2G5A&A1I4*>&E2<8 M^TIWESJ3ES^MQQ]'?`<0>%_#GAMPYG+R##\.XNACO;U,,\11S;%*A6I8O$9E M2IU*4Y5\16KU,5&JI2]E4:@HN"CR_P`OW["7_!2BP^#W[.W@?X$_"#]CSQCX ML^-<2S:5_P`)!I&GVHT/7M?NGN);;7-:N4M6U&&)=Z).))52..+(`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`L?)]Q_X*R_\`!/+Q MQ^SYX^\*^)?AQX9USQ#\)9O!WA[0;/6=/LKO49;/7-'AG74H=46SCG:T2X>= M);:615B*@J6!Q7]K>@^&_#OA73X])\+Z!HOAO2H3F+3-!TJQT?3XC@#,=EIT M%O;(<`#Y8QP`.U6-7T?2-?T^YTG7=*TW6]*O$\N[TS5[&UU+3[J/.?+N;*\B MFMITR`=LL;+D9Q7O?\32Y]0XIR/,(<5B^+>(, MSHYS7XHA@,/AJ&%QE"=>JL+A_MXH\W4 M5O*28%5"Q&$==N17G'P-_8T_:T_X*6_M":G\2_B+I^NZ/H^O^(8]4\<^/O$N MF7NF6-EI[2IFUT:VNU@FNVCMHUMK"*U22*$@.6)!4_V@1_LM_LR0W0OH?V=/ M@3%?!_-%Y'\(OA^ET),Y\P7"^'A-OSSOW[L\YKVC3=,TW1K*WTW1].L=*TZT M01VNGZ;:6]C96T8Z1V]K:QQ00H.RQQJOM5XSZ1>0934SW-O#_P`.L%P[Q7Q) M[1YCQ%C<8\=6A4K3]K5JX?#*"I*2,%G@OHS<1YQ3 MX>R?Q'\3&XN9"(MTZL/WW_P"")'P>;X._L7IXQ\2:9<:/KOCC7=<\ M1:HMU;2072Z+IY)TUI(Y%64XMFD*C;_"0`2:_5G5_@W\(?$&H76KZ_\`"KX; MZWJM\Y>]U/5_`WAC4M0O'889[J]O=+FN;AV`P6FEWKXFK."H4W"IB\PQ-3&3(KA=;\=ZGIU@Z:3J3L] MGIMV='L-F+9E_>+:*T85L%75N]?V7:+9VG[&O_!-NTLOL=P;CP'\$WB\BRMI M9KR36=0S6DL:%5*I)$RK@8`P*T\0O&O`<;Y;P+D-#ANM ME>0<(8G"UL3@?K\*T\QHX.AA<)1I0G'#TH4''"T<1!2<*EI8ERM:-GGX;>!. M8:'X4UK4OAGXO MTS2KCPUJ^FV-Y?V=FVGV$-K>Z5>O:PR+9RVLBL8?.")+&#M(VJ&_LVT/X1?" M?PQJ4&L^&_AA\//#VL6JNEMJNA^"O#>DZE;K(,.L%]8:9;W42N``ZQRJ&`Y! MKJ/$/AGPWXMTR;1?%?A_1/$VCW!!GTGQ#I-AK6F3E<[3-8:E;W-K(5R<%XFQ MDXZU]OC?I48RIQQDO$V"X9]AD^79)B\DQ61U/P6!^B+@:7`.>\*X_BEXC.LSS_!9]A<^I9;R0PU3 M`8.MA*>%Q&$GB9SQ%&NL7C)UG&O3DIU*4X>]2M/^1K]DK_@LK)^S_P#LX^%O M@MXB_9WO/%OBGP1I-QH_AOQ!9QV-K:7,1EGFMI-3:5H>A>'Y)T M-PT.L7!MI+V>*T^6%88+AYIV4N(@Q8?O^G[*O[+\4PN8_P!F_P"`L=P&W"=/ M@_\`#U)@P.0PE7PZ'#9YR&SGFO8]$T#0?#.GQ:3X;T32/#^E0$F#3-$TVSTK M3X20`3%96$-O;1DA0#LC&0`.PKY#/O%CPTQ,,\Q>2>$>">>Y]6KXBMF'$6;8 MK,\-@L5B)2J5<3@L#!TXTYNK.=54XU*5-U&G-2IKV1]KP[X/>*6%GD&#S[QD MQW]@G?M'Z!\5/["OM1\*>*/`/A_2UU31]-N6T>VU?P]"+?4;9(RQ9FKR#]@#]O#]MOX/^![C]G;X#_#B'QT?$>I74GAR7 M4=`U:]N/#6H7\#/!_CK2GT+ MQOX4\->,M$EUO+1W&>&:$D=C7/>"_@]\(_AO- M/OEGTA,G7A MQEG`W$O`&"XFJ9+0HT<#/&8R5/+*E3!2F\OQ.)PU.FL0JF'A-TZD*-:,:\%* M+E"-6:/%S/Z-V=?\10S7Q`X6\1<=PK3SS$5JV80P6"C5S6G3QL:2S'"87%5: MCPSI8B=)5*4Z]"<\/-PDHSE1A)_YVWQF\'?'GQK\>?%4GQ'@\0^*/B#K/B[R MM>UEK#4+F.[UNZDMHGCBE6W\LPV\LB6<04J@2#`/!:OU+_X*L66M^`O@Y^Q[ M^R3X?T#699_A;\*=,\5>)_L&FWK)YHNS=G23.;H2_O!<>9YHD^ MUF_%M",16XO-1TZYN! M!$`!'")/+0#"J*]S%_2?P6,S?@G'5.#9T\%P?3Q]6&7X?,*5"CB,RQ.6PRO" MXFC"&%5/"X?!8>>,]CAE"HHNO34)15*[\#`_10QV`R;CO+Z?&\:N/XUJY=1J M9GB,MK5Z^'RO"YI/-L9AJ\YXSVN+Q./Q-/!>VQ4IP:WNK M68O;JES:3QNRB:%Y$92DR[@NT_Z-&@>&_#OA/38M&\+:!HOAK2(&=X=*T#2K M'1M-A>0YD:*QTZ"VM8V<\NR1`L>6)-^(5T+WQ]\*/AKXXO0JH+O MQAX$\+^);H(@PBBXUK2KV7:HX5=^`.`!7!D?TFZN#SOCFOG?"\,XX>XTQOUF M>5O&\E?`T5@*65?4G6E1E2Q6&K8"C2IU8.%%J<93IM>TDCT,^^BI2QF0<`8? M(.+*F2<2\"X+ZM#-XX#GPV/KRS&IF[QJH0KQJX7$T77@6;78(;;Q!K'A2PUG4?$=T`4$UII M;VL,S6EM=L661EC,VTA`.04[KX.?LJ?\%`-#_9&^+_QR\7>/OBEI/E^";^U\ M)_"E]2O9]6U_1]0B=-4UB[L7:2ZMS9PD&QM5"W3,LCYYV1?U,^&_V?/@)X,O MXM4\'_!#X0^%-3@=7AU'PW\-?!FA7\+JBVMQ&ZD`JR2`@C(->N.B2 M(\RO+&C7A25"5=5:E6E1E*-!4FW)^Y@/H^ M<29KFN)S_P`1O%+/N)(H5*5/%U,-AJ].GBI8>I5>( MAAG2I4JM91EB)5E%17^;E^SCXIA^#/[0_P`/_B'\3OAIK'Q`T'PCXKM]5USP M??6=PEQK$<,CDP2)?PJGG^:PE(N!AFSO#$XK]Y?VRO\`@HI^T!^TQ^S?X[T' M]G']FOQS\*_A!;VMCIGC_P`9:W8+:7UQIUTUN;?3O#L>G0VL7V21S&ES+;1R MM'"IB*$,0O\`1W>?LR_LVZCJ,NKZA^SY\$+_`%:>8W$VJ7GPG\!W6HS3LVYI MI;V?0'N9)F;YC(\IE2PU;&J7-]6Q.)BXTY*E.K1K*E""\#@_P"C9QGP MGP]Q)PK@_$ZC@9XBO4POU6E'$9IB*U3%4,"X*/UK"X22 ME4BZL*->@ZTZC_AZ_P""/WPWO;/]K*W^(WC7P_JL>C?"OP3XN\?O'>:7>*MQ MJ&BZ7,]A&AG@0-*'4O'&NYG;9@9Q7QOXR\.?$7]I/]IO6]9A\.^)'N?BG\3; MVXM9+G2]2#+#XAUZ5;?)>`*GDV,\;!=V$5/FZ&O]#32/A'\*/#TES+H'PQ^' MNARWEM)9W"_#>FR75G,GERVER]EIL+3VTJ?))!*6B=/E92.*IV'P4^#6 ME7MKJ>E_"3X8Z;J-C,MQ9:A8>`O"MG>V=PA)6>UNK?2HY[>9225EBD1P2<-7 MJ4_I3X6EQ-GW$ZX0Q,L9F619;DF74YYM3<,MI8&>.Q-2;?U/]\L3CL73KU$H MTWRT(PN])1\FK]$?%5>%.'>$Y<9X:."RKB'-,_S.I#)ZBGFE7,(9?A:=.SQG M[IX7`8.KAZ;E*HN:O*:4=8NQ\(/!EI\._A;\/_!%C;K;0>&O".@Z4854*%N+ M;3K=+HD``!FN?-8^YKT:BBOY`Q%>IBL17Q-:3G5Q%:I7JR;; EX-101.INS 5 vaso-20140930.xml INSTANCE DOCUMENT 0000839087 2014-01-01 2014-09-30 0000839087 2014-11-09 0000839087 2014-09-30 0000839087 2013-12-31 0000839087 2013-07-01 2013-09-30 0000839087 2013-01-01 2013-09-30 0000839087 2014-07-01 2014-09-30 0000839087 2012-12-31 0000839087 2013-09-30 0000839087 2010-01-01 2010-12-31 0000839087 us-gaap:CorporateNonSegmentMember 2014-07-01 2014-09-30 0000839087 us-gaap:CorporateNonSegmentMember 2013-07-01 2013-09-30 0000839087 us-gaap:OperatingSegmentsMember vaso:SalesRepresentationSegmentMember 2013-07-01 2013-09-30 0000839087 vaso:InformationTechnologySegmentMember us-gaap:OperatingSegmentsMember 2013-01-01 2013-09-30 0000839087 us-gaap:OperatingSegmentsMember vaso:SalesRepresentationSegmentMember 2014-01-01 2014-09-30 0000839087 us-gaap:OperatingSegmentsMember vaso:InformationTechnologySegmentMember 2014-07-01 2014-09-30 0000839087 us-gaap:OperatingSegmentsMember vaso:InformationTechnologySegmentMember 2013-07-01 2013-09-30 0000839087 us-gaap:OperatingSegmentsMember vaso:EquipmentSegmentMember 2013-01-01 2013-09-30 0000839087 us-gaap:CorporateNonSegmentMember 2013-01-01 2013-09-30 0000839087 us-gaap:OperatingSegmentsMember vaso:InformationTechnologySegmentMember 2014-01-01 2014-09-30 0000839087 us-gaap:OperatingSegmentsMember vaso:EquipmentSegmentMember 2013-07-01 2013-09-30 0000839087 us-gaap:OperatingSegmentsMember vaso:SalesRepresentationSegmentMember 2014-07-01 2014-09-30 0000839087 us-gaap:OperatingSegmentsMember vaso:SalesRepresentationSegmentMember 2013-01-01 2013-09-30 0000839087 us-gaap:OperatingSegmentsMember vaso:EquipmentSegmentMember 2014-07-01 2014-09-30 0000839087 us-gaap:OperatingSegmentsMember vaso:EquipmentSegmentMember 2014-01-01 2014-09-30 0000839087 us-gaap:CorporateNonSegmentMember 2014-01-01 2014-09-30 0000839087 vaso:SalesRepresentationSegmentMember us-gaap:OperatingSegmentsMember 2014-09-30 0000839087 vaso:InformationTechnologySegmentMember us-gaap:OperatingSegmentsMember 2013-09-30 0000839087 vaso:SalesRepresentationSegmentMember us-gaap:OperatingSegmentsMember 2013-09-30 0000839087 us-gaap:CorporateNonSegmentMember 2013-09-30 0000839087 vaso:EquipmentSegmentMember us-gaap:OperatingSegmentsMember 2014-09-30 0000839087 us-gaap:CorporateNonSegmentMember 2014-09-30 0000839087 vaso:EquipmentSegmentMember us-gaap:OperatingSegmentsMember 2013-09-30 0000839087 vaso:InformationTechnologySegmentMember us-gaap:OperatingSegmentsMember 2014-09-30 0000839087 vaso:GeHealthcareMember 2013-01-01 2013-09-30 0000839087 vaso:GeHealthcareMember 2013-07-01 2013-09-30 0000839087 vaso:GeHealthcareMember 2014-07-01 2014-09-30 0000839087 vaso:GeHealthcareMember 2014-01-01 2014-09-30 0000839087 vaso:GeHealthcareMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2014-09-30 0000839087 vaso:GeHealthcareMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2013-12-31 0000839087 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember vaso:GeHealthcareMember 2014-01-01 2014-09-30 0000839087 us-gaap:CreditConcentrationRiskMember vaso:GeHealthcareMember us-gaap:AccountsReceivableMember 2013-01-01 2013-12-31 0000839087 us-gaap:RestrictedStockMember vaso:EmployeesMember 2013-01-01 2013-09-30 0000839087 us-gaap:RestrictedStockMember us-gaap:OfficerMember 2013-01-01 2013-09-30 0000839087 us-gaap:DirectorMember us-gaap:RestrictedStockMember 2014-01-01 2014-09-30 0000839087 us-gaap:OfficerMember us-gaap:RestrictedStockMember 2014-01-01 2014-09-30 0000839087 us-gaap:EmployeeStockOptionMember 2013-01-01 2013-09-30 0000839087 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-09-30 0000839087 us-gaap:RestrictedStockMember 2013-01-01 2013-09-30 0000839087 vaso:EmployeesMember us-gaap:RestrictedStockMember 2014-01-01 2014-09-30 0000839087 us-gaap:RestrictedStockMember vaso:EmployeesMember 2014-09-30 0000839087 us-gaap:StockCompensationPlanMember 2014-07-01 2014-09-30 0000839087 us-gaap:StockCompensationPlanMember 2013-01-01 2013-09-30 0000839087 us-gaap:StockCompensationPlanMember 2014-01-01 2014-09-30 0000839087 us-gaap:StockCompensationPlanMember 2013-07-01 2013-09-30 0000839087 us-gaap:RestrictedStockMember 2013-09-30 0000839087 us-gaap:CommonStockMember 2013-01-01 2013-09-30 0000839087 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-09-30 0000839087 us-gaap:EmployeeStockOptionMember 2013-01-01 2013-09-30 0000839087 us-gaap:CommonStockMember 2014-01-01 2014-09-30 0000839087 us-gaap:CommonStockMember 2014-07-01 2014-09-30 0000839087 us-gaap:CommonStockMember 2013-07-01 2013-09-30 0000839087 us-gaap:EmployeeStockOptionMember 2014-07-01 2014-09-30 0000839087 us-gaap:EmployeeStockOptionMember 2013-07-01 2013-09-30 0000839087 us-gaap:FairValueInputsLevel2Member 2014-09-30 0000839087 us-gaap:FairValueInputsLevel3Member 2014-09-30 0000839087 us-gaap:FairValueInputsLevel3Member 2013-12-31 0000839087 us-gaap:FairValueInputsLevel2Member 2013-12-31 0000839087 us-gaap:FairValueInputsLevel1Member 2014-09-30 0000839087 us-gaap:FairValueInputsLevel1Member 2013-12-31 0000839087 us-gaap:CustomerListsMember 2013-12-31 0000839087 us-gaap:CustomerListsMember 2014-09-30 0000839087 us-gaap:PatentsMember 2014-09-30 0000839087 us-gaap:ComputerSoftwareIntangibleAssetMember 2013-12-31 0000839087 us-gaap:PatentsMember 2013-12-31 0000839087 us-gaap:ComputerSoftwareIntangibleAssetMember 2014-09-30 0000839087 us-gaap:PatentsMember 2014-01-01 2014-09-30 0000839087 us-gaap:CustomerListsMember 2014-01-01 2014-09-30 0000839087 us-gaap:ComputerSoftwareIntangibleAssetMember 2014-01-01 2014-09-30 0000839087 2013-06-30 0000839087 2014-06-30 0000839087 vaso:ServiceArrangementsMember 2013-07-01 2013-09-30 0000839087 vaso:ExtendedServiceContractsMember 2014-01-01 2014-09-30 0000839087 vaso:ServiceArrangementsMember 2014-01-01 2014-09-30 0000839087 vaso:CommissionRevenuesMember 2013-07-01 2013-09-30 0000839087 vaso:InServiceAndTrainingMember 2013-01-01 2013-09-30 0000839087 vaso:ExtendedServiceContractsMember 2013-07-01 2013-09-30 0000839087 vaso:CommissionRevenuesMember 2014-07-01 2014-09-30 0000839087 vaso:ExtendedServiceContractsMember 2014-07-01 2014-09-30 0000839087 vaso:InServiceAndTrainingMember 2014-07-01 2014-09-30 0000839087 vaso:ServiceArrangementsMember 2013-01-01 2013-09-30 0000839087 vaso:ExtendedServiceContractsMember 2013-01-01 2013-09-30 0000839087 vaso:InServiceAndTrainingMember 2014-01-01 2014-09-30 0000839087 vaso:CommissionRevenuesMember 2013-01-01 2013-09-30 0000839087 vaso:InServiceAndTrainingMember 2013-07-01 2013-09-30 0000839087 vaso:CommissionRevenuesMember 2014-01-01 2014-09-30 0000839087 vaso:ServiceArrangementsMember 2014-07-01 2014-09-30 0000839087 vaso:DirectorDavidLiebermanMember 2014-01-01 2014-09-30 0000839087 vaso:DirectorDavidLiebermanMember 2013-07-01 2013-09-30 0000839087 vaso:DirectorDavidLiebermanMember 2014-07-01 2014-09-30 0000839087 vaso:DirectorDavidLiebermanMember 2013-01-01 2013-09-30 0000839087 us-gaap:DirectorMember 2014-01-01 2014-09-30 0000839087 vaso:ConsultantMember 2011-01-01 2011-03-31 0000839087 2011-01-01 2011-03-31 0000839087 vaso:DirectorDavidLiebermanMember 2011-01-01 2011-03-31 0000839087 us-gaap:SubsidiaryOfCommonParentMember 2013-07-01 2013-09-30 0000839087 us-gaap:SubsidiaryOfCommonParentMember 2013-01-01 2013-09-30 0000839087 vaso:GenwellInstrumentsCoLtdMember 2014-07-01 2014-09-30 0000839087 vaso:GenwellInstrumentsCoLtdMember 2014-09-30 0000839087 vaso:Plan2013Member 2014-09-30 0000839087 vaso:Plan2010Member 2010-06-17 0000839087 vaso:Plan2010Member 2014-09-30 0000839087 vaso:Plan2013Member 2014-01-01 2014-09-30 0000839087 vaso:Plan2010Member us-gaap:DirectorMember 2014-01-01 2014-09-30 0000839087 vaso:EmployeesAndOfficersMember vaso:Plan2010Member 2014-01-01 2014-09-30 0000839087 us-gaap:EmployeeStockOptionMember vaso:Plan2013Member 2014-01-01 2014-09-30 0000839087 vaso:Plan2010Member us-gaap:EmployeeStockOptionMember 2014-01-01 2014-09-30 0000839087 us-gaap:CommonStockMember 2013-04-30 0000839087 us-gaap:CommonStockMember 2013-07-31 0000839087 us-gaap:CommonStockMember 2014-01-01 2014-09-30 0000839087 2012-06-01 2012-06-30 0000839087 vaso:GenwellInstrumentsCoLtdMember 2014-08-06 2014-08-06 0000839087 vaso:GenwellInstrumentsCoLtdMember us-gaap:NotesPayableOtherPayablesMember 2014-08-06 2014-08-06 0000839087 vaso:GenwellInstrumentsCoLtdMember us-gaap:NotesPayableOtherPayablesMember 2014-08-06 0000839087 vaso:GenwellInstrumentsCoLtdMember 2014-01-01 2014-09-30 0000839087 vaso:GenwellInstrumentsCoLtdMember 2013-07-01 2013-09-30 0000839087 vaso:GenwellInstrumentsCoLtdMember 2013-01-01 2013-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares vaso:Segment vaso:State vaso:Company vaso:Subsidiary xbrli:pure iso4217:CNY vaso:EquityProgram false --12-31 2014-09-30 No No Yes Smaller Reporting Company VASOMEDICAL, INC 0000839087 155677283 2014 Q3 10-Q 21000 21000 13570000 7167000 1229000 0 3510000 0 0 4739000 6376000 791000 0 6200000 8100000 10716000 17173000 597000 525000 2161000 2106000 5571000 4361000 1362000 1281000 108000 80000 61864000 61508000 43000 87000 131000 0 3689000 3764000 126000 41000 146000 50000 1892000 585000 1402000 2365000 1780000 490000 490000 585000 1402000 2365000 1892000 1780000 32319000 33517000 13341000 0 8040000 25410000 8972000 9909000 9067000 8398000 2000 6994000 6994000 0 8495000 0 8495000 0 0 21182000 25931000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">NOTE B - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES</div><div><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt; font-weight: bold;">Basis of Presentation and Use of Estimates</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and disclosures normally included in the condensed consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in connection with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013, as filed with the SEC. These condensed consolidated financial statements include the accounts of the companies over which we exercise control. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of interim results for the Company. The results of operations for any interim period are not necessarily indicative of results to be expected for any other interim period or the full year.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company's management. The Company evaluates its estimates and assumptions on an ongoing basis.</div><div><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt; font-weight: bold;">Significant Accounting Policies</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Note B of the Notes to Consolidated Financial Statements, included in the Annual Report on Form 10-K for the year ended December 31, 2013, includes a summary of the significant accounting policies used in the preparation of the condensed consolidated financial statements.</div><div><br /></div><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Revenue and Expense Recognition for VasoHealthcare</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The Company recognizes commission revenue, net of the medical device tax reimbursement to GEHC,&#160;in its Sales Representation segment (see Note C) when persuasive evidence of an arrangement exists, service has been rendered, the price is fixed or determinable and collectability is reasonably assured.&#160; These conditions are deemed to be met when the underlying equipment has been accepted at the customer site in accordance with the specific terms of the sales agreement.&#160; Consequently, amounts billable under the agreement with GE Healthcare in advance of the customer acceptance of the equipment are recorded as accounts receivable and deferred revenue in the condensed consolidated balance sheets.&#160; Similarly, commissions payable to our sales force related to such billings are recorded as deferred commission expense when the associated deferred revenue is recorded.&#160; Commission expense is recognized when the corresponding commission revenue is recognized.</div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">&#160;</div><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Reclassifications</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Certain reclassifications have been made to prior period amounts to conform with current period presentation.</div></div> 1015000 6250000 2151000 113000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div>The following unaudited supplemental pro forma information presents the financial results as if the acquisition of Genwell had occurred January 1, 2013:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="14" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="6" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">Three months ended September 30,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="6" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">Nine months ended September 30,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; margin-left: 7.2pt; font-size: 10pt;">Revenue</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">7,643</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">7,606</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">22,626</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">22,795</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; margin-left: 7.2pt; font-size: 10pt;">Net loss</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(136</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(551</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(1,420</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(1,930</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; margin-left: 7.2pt; font-size: 10pt;">Basic and diluted loss per share</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$&#160;</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(0.00</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$&#160;</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(0.00</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$&#160;</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(0.01</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$&#160;</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(0.01</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td></tr></table></div> 2033000 22626000 7643000 7606000 22795000 -1420000 -136000 -551000 -1930000 13250000 2151000 13250000 2151000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">NOTE P &#8211; BUSINESS COMBINATION</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">On August 6, 2014 the Company acquired all of the outstanding shares of Genwell Instruments Co. Ltd. (&#8220;Genwell&#8221;), located in Wuxi, China, through its wholly owned subsidiary Wuxi Gentone Instruments Co. Ltd. (&#8220;Gentone&#8221;) for cash and notes of Chinese Yuan RMB13,250,000 (approximately $2,151,000 at the acquisition date).&#160; The notes totaling RMB6,250,000 (approximately $1,015,000) are payable one year from the closing date with interest at the rate of 5% per annum.&#160; Genwell was formed in China in 2010 with the assistance of a government grant to develop the MobiCare<sup style="line-height: 1; font-size: smaller; vertical-align: text-top;">TM</sup>&#160; wireless multi-parameter patient monitoring system and holds the patents and intellectual property rights for this system.&#160; The primary purpose of the acquisition was to acquire ownership of these patents and intellectual property.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The operating results of Genwell from August 6, 2014 to September 30, 2014 are included in the accompanying condensed consolidated statements of operations and comprehensive loss for the three and nine month periods ended September 30, 2014.&#160; The accompanying condensed consolidated balance sheet at September 30, 2014 reflects the acquisition of Genwell effective August 6, 2014.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">In accordance with Accounting Standards Codification 805, Business Combinations, the total purchase consideration is allocated to the net tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at August 6, 2014 (the acquisition date).&#160; The purchase price was allocated based on the information currently available, and may be adjusted after obtaining more information regarding, among other things, asset valuations, liabilities assumed, and revisions of preliminary estimates.&#160; The following table summarizes the estimated fair values of the net assets acquired:</div><div><br /></div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="width: 88%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;"></td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"></td><td style="text-align: right; width: 9%; white-space: nowrap; vertical-align: bottom;"><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Cash and cash equivalents</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">113</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Accounts receivable and other current assets</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Property and equipment</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Intangible assets</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 9pt; font-size: 10pt;">2,033</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Net assets acquired</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,151</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">During the three and nine month periods ended September 30, 2014, the Company expensed $8,000 of acquisition-related legal costs.&#160; The costs are included in the line item Selling, General &amp; Administrative costs in the accompanying condensed consolidated statements of operations and comprehensive loss.&#160; The amounts of revenue and net loss of Genwell included in the Company's condensed consolidated statements of operations and comperhensive loss for the three months ended September 30, 2014 was $0 and $10,000, respectively.&#160; Genwell is not expected to report future revenue as the sales of its principal product, MobiCare&#8482;, will be through the Biox subsidiary.&#160; The following unaudited supplemental pro forma information presents the financial results as if the acquisition of Genwell had occurred January 1, 2013:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="14" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="6" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">Three months ended September 30,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="6" style="border-bottom: #000000 2px solid; white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">Nine months ended September 30,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; margin-left: 7.2pt; font-size: 10pt;">Revenue</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">7,643</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">7,606</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">22,626</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">22,795</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; margin-left: 7.2pt; font-size: 10pt;">Net loss</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(136</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(551</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(1,420</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(1,930</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; margin-left: 7.2pt; font-size: 10pt;">Basic and diluted loss per share</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$&#160;</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(0.00</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$&#160;</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(0.00</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$&#160;</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(0.01</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">$&#160;</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">(0.01</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #0d0d0d; font-size: 10pt;">)</div></td></tr></table><div><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">An adjustment was made to the unaudited pro forma financial information to reflect the acquisition-related costs in the nine months ended September 30, 2013.</div></div> 3000 8000 8000 -2322000 1093000 9054000 7961000 11469000 9147000 0 0 0 0 6883000 8384000 8384000 6883000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">NOTE N &#8211; COMMITMENTS AND CONTINGENCIES</div><div><br /></div><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Sales representation agreement</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">In June 2012, the Company concluded an amendment of the GEHC Agreement with GE Healthcare, originally signed on May 19, 2010.&#160; The amendment, effective July 1, 2012, extended the initial term of three years commencing July 1, 2010 to five years through June 30, 2015, subject to earlier termination under certain circumstances.&#160; These circumstances include not materially achieving certain sales goals, not maintaining a minimum number of sales representatives, and various legal and GEHC policy requirements.&#160; Under the terms of the agreement, the Company is required to lease dedicated computer equipment from GEHC for connectivity to their network.</div><div><br /></div><div style="text-align: left; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Value Added Reseller agreement</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">In June 2014, the Company entered into an agreement with GE Healthcare for the purchase of certain GEHC IT professional services in conjunction with the execution of its VAR Agreement, as described in Note A.&#160; </div></div> 0.001 0.001 166000 165000 165985370 164705382 250000000 250000000 155677283 155223981 -1585000 -435000 -121000 -1371000 0.8 0.77 0.84 0.86 0.87 0.89 745000 251000 381000 1015000 6576000 7182000 2268000 2419000 549000 665000 189000 207000 50000 26000 35000 91000 P1Y 0.05 0 0 4145000 4763000 0 0 4763000 4145000 0 0 2312000 2388000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The changes in the Company&#8217;s deferred revenues are as follows:</div><div style="text-align: left; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;</div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="14" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">For the three months ended September 30,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">For the nine months ended September 30,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Deferred revenue at the beginning of the period</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">17,712</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">13,270</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">18,019</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">15,602</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Additions:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred extended service contracts</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">244</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">410</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">791</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">848</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred in-service and training</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">13</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">28</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">23</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred service arrangements</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">28</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">30</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">58</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">60</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred commission revenues</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3,457</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,076</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,840</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">5,355</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Recognized as revenue:</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred extended service contracts</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(207</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(245</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(654</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(755</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred in-service and training</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(10</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(10</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(25</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(20</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred service arrangements</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(26</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(16</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(72</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(54</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred commission revenues</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(2,975</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(2,796</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(8,749</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(8,332</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Deferred revenue at end of period</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">18,236</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">12,727</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">18,236</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">12,727</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Less: current portion</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,158</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">7,684</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,158</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">7,684</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Long-term deferred revenue at end of period</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,078</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">5,043</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,078</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">5,043</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div> 30000 791000 58000 2076000 23000 410000 3457000 244000 13000 60000 848000 28000 5355000 8000 8840000 28000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">NOTE J - DEFERRED REVENUE</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The changes in the Company&#8217;s deferred revenues are as follows:</div><div style="text-align: left; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;</div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="14" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">For the three months ended September 30,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">For the nine months ended September 30,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: top;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Deferred revenue at the beginning of the period</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">17,712</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">13,270</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">18,019</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">15,602</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Additions:</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred extended service contracts</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">244</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">410</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">791</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">848</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred in-service and training</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">13</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">28</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">23</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred service arrangements</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">28</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">30</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">58</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">60</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred commission revenues</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3,457</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,076</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,840</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">5,355</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Recognized as revenue:</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred extended service contracts</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(207</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(245</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(654</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(755</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred in-service and training</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(10</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(10</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(25</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(20</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred service arrangements</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(26</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(16</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(72</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(54</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Deferred commission revenues</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(2,975</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(2,796</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(8,749</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(8,332</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Deferred revenue at end of period</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">18,236</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">12,727</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">18,236</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">12,727</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Less: current portion</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,158</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">7,684</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,158</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">7,684</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Long-term deferred revenue at end of period</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,078</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">5,043</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,078</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">5,043</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div> 15602000 18019000 13270000 17712000 12727000 18236000 9158000 10541000 7684000 9078000 7478000 5043000 20000 755000 2975000 10000 654000 2796000 54000 72000 207000 16000 10000 26000 8332000 245000 8749000 25000 112000 112000 266000 290000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">NOTE O - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</div><div><br /></div><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt; font-weight: bold;">Standards issued but not yet effective</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">In May 2014, the FASB issued a comprehensive new revenue recognition standard which will supersede previous existing revenue recognition guidance. The standard creates a five-step model for revenue recognition that requires companies to exercise judgment when considering contract terms and relevant facts and circumstances. The five-step model includes (1) identifying the contract, (2) identifying the separate performance obligations in the contract, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations and (5) recognizing revenue when each performance obligation has been satisfied. The standard also requires expanded disclosures surrounding revenue recognition. The standard is effective for fiscal periods beginning after December 15, 2016 and allows for either full retrospective or modified retrospective adoption. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements.</div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;</div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">NOTE D &#8211; SHARE-BASED COMPENSATION</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The Company complies with ASC Topic 718 &#8220;Compensation &#8211; Stock Compensation&#8221; (&#8220;ASC 718&#8221;), which requires all share-based awards to employees, including grants of employee stock options, to be recognized in the condensed consolidated financial statements based on their estimated fair values.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">During the nine months ended September 30, 2014, the Company granted 450,000 restricted shares of common stock valued at $157,500 to officers and 140,000 restricted shares of common stock valued at $31,100 to employees.&#160; Of the 450,000 shares granted to officers, 100,000 shares vested immediately and the remainder vest at various times through February 2016.&#160; Of the 140,000 shares granted to employees, 50,000 shares vested immediately and 90,000 shares vest over a three year period.&#160; In the first nine months of 2014, the Company also granted 500,000 restricted shares of common stock to directors.&#160; The shares were valued at $175,000 and vested immediately.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">During the nine month period ended September 30, 2013, the Company granted 400,000 restricted shares of common stock valued at $74,000.&#160; 100,000 of such shares were granted to an officer and 300,000 shares were granted to employees.&#160; Shares valued at $3,600 and $38,000 vested over six month and two year periods, respectively, with the remainder vesting immediately.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">During the nine month periods ended September 30, 2014 and 2013, the Company did not grant any stock options.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Share-based compensation expense recognized for the three and nine month periods ended September 30, 2014 was $32,000 and $189,000, respectively, and $29,000 and $300,000 for the three and nine month periods ended September 30, 2013, respectively.&#160; These expenses are included in selling, general, and administrative expenses in the condensed consolidated statements of operations in 2014, and in cost of revenues; selling, general, and administrative expenses; and research and development expenses in the condensed consolidated statements of operations in 2013.&#160; Expense for share-based arrangements with directors and non-employees was $43,000 and $131,000 for the three and nine months ended September 30, 2014, respectively, and $0 and $87,000 for the three and nine months ended September 30, 2013, respectively.&#160; Unrecognized expense related to share-based compensation and arrangements is approximately $130,000 at September 30, 2014 and will be recognized through September 2017.</div></div> 161000 140000 -0.01 -0.01 0 0 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">NOTE E &#8211; LOSS PER COMMON SHARE</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;Basic loss per common share is computed as earnings applicable to common stockholders divided by the weighted-average number of common shares outstanding for the period.&#160; Diluted loss per common share reflects the potential dilution that could occur if securities or other contracts to issue common shares were exercised or converted to common stock.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The following table represents common stock equivalents that were excluded from the computation of diluted earnings per share for the three and&#160;nine months ended September 30, 2014 and 2013, because the effect of their inclusion would be anti-dilutive.</div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="14" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">For the three months ended</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">For the nine months ended</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Stock options</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,402</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,780</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,402</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,780</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Common stock grants</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">490</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">585</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">490</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">585</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,892</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,365</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,892</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,365</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div> -18000 1000 130000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The following tables present information about the Company&#8217;s assets measured at fair value as of <font style="font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">September</font>&#160;<font style="font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">30, 2014 and December 31, 2013:</font></div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="14" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Quoted Prices</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Significant</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">in Active</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Other</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Significant</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Balance</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Markets for</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Observable</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Unobservable</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">as of</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Identical Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">Assets</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Cash equivalents invested in money market funds (included in cash and cash equivalents)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,384</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,384</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 52%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Investment in certificates of deposit (included in short-term investments)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">111</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">111</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,495</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,495</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div>&#160;</div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Quoted Prices</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Significant</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">in Active</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Other</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Significant</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Balance</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Markets for</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Observable</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Unobservable</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">as of</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Identical Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">Assets</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Cash equivalents invested in money market funds (included in cash and cash equivalents)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">6,883</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">6,883</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 52%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Investment in certificates of deposit (included in short-term investments)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">111</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">111</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">6,994</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">6,994</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">NOTE F &#8211; FAIR VALUE MEASUREMENTS</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The Company complies with the provisions of ASC 820 &#8220;Fair Value Measurements and Disclosures&#8221; (&#8220;ASC 820&#8221;).&#160; Under ASC 820, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the &#8220;exit price&#8221;) in an orderly transaction between market participants at the measurement date.</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The following tables present information about the Company&#8217;s assets measured at fair value as of <font style="font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">September</font>&#160;<font style="font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">30, 2014 and December 31, 2013:</font></div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="14" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Quoted Prices</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Significant</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">in Active</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Other</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Significant</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Balance</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Markets for</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Observable</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Unobservable</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">as of</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Identical Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">Assets</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Cash equivalents invested in money market funds (included in cash and cash equivalents)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,384</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,384</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 52%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Investment in certificates of deposit (included in short-term investments)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">111</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">111</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,495</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,495</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div>&#160;</div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Quoted Prices</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Significant</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">in Active</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Other</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Significant</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Balance</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Markets for</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Observable</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Unobservable</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">as of</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="white-space: nowrap; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Identical Assets</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt; font-weight: bold;">Assets</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Cash equivalents invested in money market funds (included in cash and cash equivalents)</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">6,883</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">6,883</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 52%; vertical-align: top;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Investment in certificates of deposit (included in short-term investments)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">111</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">111</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">6,994</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">6,994</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The fair values of the Company&#8217;s cash equivalents invested in money market funds are determined through market, observable and corroborated sources.</div></div> P10Y P7Y P5Y 800000 800000 2500000 696000 469000 871000 424000 476000 352000 462000 454000 267000 395000 272000 2038000 820000 533000 2881000 15000 448000 -39000 0 3303000 3280000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">NOTE I &#8211; GOODWILL AND OTHER INTANGIBLES</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Goodwill aggregating $3,280,000 and $3,303,000 was recorded on the Company&#8217;s condensed consolidated balance sheets at September 30, 2014 and December 31, 2013, respectively, pursuant to the acquisition of FGE in September 2011.&#160; All of the goodwill was allocated to the Company&#8217;s Equipment segment.&#160; The components of the change in goodwill are as follows:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="2" valign="bottom" style="vertical-align: middle;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Carrying Amount</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: middle;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Balance at December 31, 2013</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3,303</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Foreign currency translation</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(23</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Balance at September 30, 2014 (unaudited)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3,280</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The Company&#8217;s other intangible assets consist of capitalized patent and technology costs, customer lists and software costs, as follows:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"></td><td colspan="6" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: middle;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Patents and Technology</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr style="height: 13px;"><td valign="bottom" style="background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Costs</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,500</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">469</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Accumulated amortization</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(462</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(454</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,038</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Customer lists</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Costs</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">800</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">800</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Accumulated amortization</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(352</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(267</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">448</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">533</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Software</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Costs</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">871</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">696</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Accumulated amortization</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(476</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(424</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">395</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">272</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,881</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">820</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Patents and technology, customer lists, and software are included in other assets in the accompanying condensed consolidated balance sheets and are amortized on a straight line basis over their estimated useful lives of ten, seven, and five years, respectively.&#160; Amortization expense amounted to $50,000 and $146,000 for the three and nine months ended September 30, 2014, respectively, and $41,000 and $126,000 for the three and nine months ended September 30, 2013, respectively.</div></div> 23000 5187000 15613000 5375000 16023000 -1684000 -97000 -555000 -1293000 -35000 50000 26000 -91000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">NOTE M &#8211; INCOME TAXES</div><div><br /></div><div style="text-align: justify; text-indent: 18pt; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The Company&#8217;s provision for income taxes consists of state and local, and foreign taxes, as applicable, in amounts necessary to align the Company&#8217;s year-to-date tax provision with the effective rate that it expects to achieve for the full year.&#160; For the three and nine months ended September 30, 2014, the Company recorded an income tax provision of $26,000 and $50,000, respectively, consisting primarily of state and local minimum taxes and foreign taxes related to the Chinese subsidiary.&#160; For the three and nine months ended September 30, 2013, the Company recorded a tax benefit of $91,000 and $35,000, respectively, consisting of a tax refund on a previous period return, partially offset by state and local minimum taxes and foreign taxes related to the Chinese subsidiary.&#160; Our domestic deferred tax assets are not realizable on a more-likely-than-not basis and, therefore, we have recorded a full valuation allowance against our domestic deferred tax assets.</div></div> 48000 61000 99000 -72000 138000 123000 -6000 0 8000 6000 195000 214000 -678000 -1203000 75000 -521000 349000 1639000 -6396000 -4304000 -2875000 218000 -746000 -55000 -71000 332000 -48000 -13000 20000 150000 -63000 52000 0 0 1618000 1937000 537000 608000 651000 790000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">NOTE H &#8211; INVENTORIES, NET</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Inventories, net of reserves, consist of the following:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="6" valign="bottom" style="vertical-align: middle;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Raw materials</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">651</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">790</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Work in process</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">678</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">291</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Finished goods</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">608</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">537</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,937</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,618</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div>&#160;</div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">At September 30, 2014 and December 31, 2013, the Company maintained reserves for excess and obsolete inventory of $829,000 and $803,000, respectively.</div></div> 803000 829000 291000 678000 111000 111000 111000 111000 180000 66000 60000 187000 17462000 19215000 33517000 32319000 9651000 7837000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">NOTE G &#8211; ACCOUNTS AND OTHER RECEIVABLES, NET</div><div><br /></div><div style="text-align: left; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The following table presents information regarding the Company&#8217;s accounts and other receivables as of September 30, 2014 and December 31, 2013:</div><div style="text-align: left; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;</div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="6" valign="bottom" style="vertical-align: middle;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: middle;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Trade receivables</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">10,716</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">17,173</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Due from employees</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">140</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">161</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Allowance for doubtful accounts and commission adjustments</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(3,689</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(3,764</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Accounts and other receivables, net</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">7,167</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">13,570</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Trade receivables include amounts due for shipped products and services rendered.&#160; Amounts currently due under the GEHC Agreement are subject to adjustment in subsequent periods should the underlying sales order amount, upon which the receivable is based, change.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Allowance for doubtful accounts and commission adjustments include estimated losses resulting from the inability of our customers to make required payments, and adjustments arising from subsequent changes in sales order amounts that may reduce the amount the Company will ultimately receive under the GEHC Agreement.&#160; Due from employees is primarily commission advances made to sales personnel.</div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">NOTE A - ORGANIZATION AND PLAN OF OPERATIONS</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Vasomedical, Inc. was incorporated in Delaware in July 1987. Unless the context requires otherwise, all references to &#8220;we&#8221;, &#8220;our&#8221;, &#8220;us&#8221;, &#8220;Company&#8221;, &#8220;registrant&#8221;, &#8220;Vasomedical&#8221; or &#8220;management&#8221; refer to Vasomedical, Inc. and its subsidiaries. The Company until July 2014 had been operating in two distinct business segments, the Sales Representation segment and the Equipment segment. In May 2010, the Company, through its wholly-owned subsidiary Vaso Diagnostics, Inc. d/b/a VasoHealthcare, expanded into the sales representation business via its agreement with GE Healthcare (&#8220;GEHC&#8221;), the healthcare business unit of General Electric Company (NYSE: GE), to be GEHC&#8217;s exclusive sales representative for the sale of select GEHC diagnostic imaging products in specific market segments in the 48 contiguous states of the United States and the District of Columbia.&#160;&#160; In June 2012, the Company entered into an amendment, effective July 1, 2012, of the sales representative agreement (&#8220;GEHC Agreement&#8221;) extending the initial term of three years commencing July 1, 2010 to five years through June 30, 2015, subject to earlier termination under certain circumstances.&#160; In the Equipment segment we design, manufacture, market and support certain medical devices.&#160; Our principal products in this segment are Enhanced External Counterpulsation (EECP<sup style="line-height: 1; font-size: smaller; vertical-align: text-top;">&#174;</sup>) systems, which are non-invasive therapy devices based on our proprietary technology, and currently indicated in the United States for the treatment of refractory angina and used for ischemic diseases overseas.&#160; In addition we develop, manufacture and market certain ambulatory patient monitoring systems including recorders and analysis software.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">In September 2011, the Company acquired Fast Growth Enterprises Limited (FGE), a British Virgin Islands company which owns and controls two Chinese operating companies - Life Enhancement Technologies Ltd. (&#8220;LET&#8221;) and Biox Instruments Co. Ltd. (&#8220;Biox&#8221;), respectively &#8211; to expand its technical and manufacturing capabilities and to enhance its distribution network, technology, and product portfolio.&#160; Also in September 2011, the Company restructured to further align its business management structure and long-term growth strategy and started to&#160;operate&#160;through three wholly-owned subsidiaries.&#160; Vaso Diagnostics d/b/a VasoHealthcare continues as the operating subsidiary for the sales representation of GE Healthcare diagnostic imaging products; Vasomedical Global Corp. operates the Company&#8217;s Chinese companies; and Vasomedical Solutions, Inc. manages and coordinates our EECP<sup style="line-height: 1; font-size: smaller; vertical-align: text-top;">&#174; </sup>therapy business as well as other medical equipment operations.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">In April 2014, the Company announced that it entered into an agreement with Chongqing PSK-Health Sci-Tech Development Co., Ltd. ("PSK") of Chongqing, China, the leading manufacturer of ECP therapy systems in China, to form a joint venture company, VSK Medical Limited ("VSK"), for the global marketing, sale and advancement of ECP therapy technology.&#160; The joint venture is in the early implementation phase and had not begun operations as of September 30, 2014.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">In June 2014, the Company entered into a Value Added Reseller Agreement (&#8220;VAR Agreement&#8221;) with GEHC to become a national value added reseller of GE Healthcare IT's Radiology PACS (Picture Archiving and Communication System) software solutions and related services, including implementation, management and support.&#160; This multiyear VAR Agreement focuses primarily on existing customer segments currently served by Vaso Diagnostics on behalf of GEHC.&#160; A new wholly owned subsidiary, VasoHealthcare IT Corp., was formed to conduct the healthcare IT business.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">In August 2014, the Company acquired all of the outstanding shares of Genwell Instruments Co. Ltd. (&#8220;Genwell&#8221;), located in Wuxi, China, through its wholly owned subsidiary Wuxi Gentone Instruments Co. Ltd. (&#8220;Gentone&#8221;).&#160; Genwell was formed in China in 2010 with the assistance of a government grant to develop the MobiCare<sup style="line-height: 1; font-size: smaller; vertical-align: text-top;">TM</sup>&#160; wireless multi-parameter patient monitoring system and holds the patents and intellectual property rights for this system.&#160; See Note K.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">We report the operations of Vasomedical Global Corp. and Vasomedical Solutions, Inc. under our Equipment segment.&#160; Vaso Diagnostics activities are included under our Sales Representation segment.&#160; VasoHealthcare IT operations report under the IT segment (See Note C).</div></div> -1649000 -123000 -464000 -1343000 -10000 -576000 2586000 -244000 -1602000 -1250000 -126000 150000 52000 20000 -63000 1019000 3000 1017000 0 48 2 3 2 5524000 17317000 5679000 17466000 -492000 -149000 -1704000 -1443000 -364000 723000 -327000 870000 -82000 2267000 0 -1489000 199000 -1267000 0 -405000 -2361000 -385000 -1085000 -82000 2000 29000 64000 -28000 7585000 3918000 504000 338000 359000 573000 1602000 244000 -113000 0 1136000 126000 227000 40000 111000 0.01 0.01 0 0 0 0 1000000 1000000 0 0 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Reclassifications</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Certain reclassifications have been made to prior period amounts to conform with current period presentation.</div></div> 111000 40000 365000 272000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt; margin-right: 41.4pt;">NOTE K &#8211; RELATED-PARTY TRANSACTIONS</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">On February 28, 2011, David Lieberman and Edgar Rios were appointed by the Board of Directors as directors of the Company.&#160; Mr. Lieberman, a practicing attorney in the State of New York, was also appointed to serve as the Vice Chairman of the Board.&#160; He is currently a senior partner at the law firm of Beckman, Lieberman &amp; Barandes, LLP, which performs certain legal services for the Company.<font style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160; Fees of approximately $60,000 and $180,000 were billed by the firm through the three and nine months ended September 30, 2014, respectively, and fees of approximately $66,000 and $187,000 were billed through the three and nine months ended September 30, 2013, respectively, at which dates no amounts were outstanding.</font></div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Mr. Rios currently is President of Edgary Consultants, LLC, and was appointed a director in conjunction with the Company&#8217;s consulting agreement with Edgary Consultants, LLC.&#160; The consulting agreement (the &#8220;Agreement&#8221;) between the Company and Edgary Consultants, LLC (&#8220;Consultant&#8221;) commenced on March 1, 2011 and was for a two-year term and expired on February 28, 2013.&#160; The Agreement provided for the engagement of Consultant to assist the Company in seeking broader reimbursement coverage of EECP<sup style="line-height: 1; font-size: smaller; vertical-align: text-top;">&#174;</sup><font style="font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">&#160;</font>therapy.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">In consideration for the services to be provided by Consultant under the Agreement, the Company agreed to issue to Consultant or its designees, up to 18,500,000 shares of restricted common stock of the Company, 3,000,000 of which were issued in March 2011 and the balance was to be earned on performance. Mr. Lieberman received 600,000 of these restricted shares.&#160; The Company recorded the fair value of the shares issued to Consultant as a prepaid expense and amortized the cost ratably over the two year agreement.&#160; No performance-based shares were issued and no further compensation is expected to be paid in conjunction with the agreement.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Receivables due from FGE management aggregating $8,000 and $6,000 were collected during the three and nine months ended September 30, 2013, respectively.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;On August 6, 2014 the Company acquired all of the outstanding shares of Genwell Instruments Co. Ltd. (&#8220;Genwell&#8221;), located in Wuxi, China, through its wholly owned subsidiary Wuxi Gentone Instruments Co. Ltd. (&#8220;Gentone&#8221;) for cash and notes of Chinese Yuan RMB13,250,000 (approximately $2,151,000 at the acquisition date &#8211; see Note P).&#160; Genwell was formed in China in 2010 with the assistance of a government grant to develop the MobiCare<sup style="line-height: 1; font-size: smaller; vertical-align: text-top;">TM</sup>&#160; wireless multi-parameter patient monitoring system and holds the patents and intellectual property rights for this system.&#160; The president of our subsidiary Life Enhancement Technologies Ltd. and the president and vice-president of our subsidiary Biox Instruments Company Ltd. together owned 80.9% of Genwell at the time of acquisition.&#160; The President and CEO of the Company was appointed the nominee Chairman of Genwell at its formation for the sole purpose of applying for the government grant available only to overseas Chinese persons.&#160; He has never received any compensation from Genwell nor held any ownership interest in Genwell.&#160; The Company has received a fairness opinion for this transaction from an independent certified appraisal firm and a legal opinion from Chinese counsel.</div></div> 172000 474000 599000 180000 -54904000 -53561000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">Revenue and Expense Recognition for VasoHealthcare</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The Company recognizes commission revenue, net of the medical device tax reimbursement to GEHC,&#160;in its Sales Representation segment (see Note C) when persuasive evidence of an arrangement exists, service has been rendered, the price is fixed or determinable and collectability is reasonably assured.&#160; These conditions are deemed to be met when the underlying equipment has been accepted at the customer site in accordance with the specific terms of the sales agreement.&#160; Consequently, amounts billable under the agreement with GE Healthcare in advance of the customer acceptance of the equipment are recorded as accounts receivable and deferred revenue in the condensed consolidated balance sheets.&#160; Similarly, commissions payable to our sales force related to such billings are recorded as deferred commission expense when the associated deferred revenue is recorded.&#160; Commission expense is recognized when the corresponding commission revenue is recognized.</div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">&#160;</div></div> 0 0 5862000 0 7643000 19335000 0 22599000 0 4533000 0 0 1744000 6409000 18262000 7606000 1234000 22795000 3264000 0 50000 100000 2157000 1353000 3320000 903000 7606000 22599000 22795000 7643000 0 331000 391000 1107000 1213000 181000 230000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div>The following table summarizes the estimated fair values of the net assets acquired:</div><div><br /></div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="width: 88%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom;"></td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"></td><td style="text-align: right; width: 9%; white-space: nowrap; vertical-align: bottom;"><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Cash and cash equivalents</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">113</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Accounts receivable and other current assets</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Property and equipment</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Intangible assets</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 9pt; font-size: 10pt;">2,033</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Net assets acquired</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,151</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The following table represents common stock equivalents that were excluded from the computation of diluted earnings per share for the three and&#160;nine months ended September 30, 2014 and 2013, because the effect of their inclusion would be anti-dilutive.</div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="14" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">For the three months ended</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="6" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">For the nine months ended</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Stock options</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,402</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,780</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,402</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,780</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 52%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Common stock grants</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">490</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">585</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">490</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">585</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 52%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,892</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,365</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,892</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,365</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Inventories, net of reserves, consist of the following:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="6" valign="bottom" style="vertical-align: middle;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Raw materials</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">651</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">790</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Work in process</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">678</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">291</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Finished goods</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">608</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">537</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,937</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,618</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The Company&#8217;s other intangible assets consist of capitalized patent and technology costs, customer lists and software costs, as follows:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;"></td><td colspan="6" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: middle;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Patents and Technology</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr style="height: 13px;"><td valign="bottom" style="background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Costs</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,500</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">469</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Accumulated amortization</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(462</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(454</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,038</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">15</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Customer lists</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Costs</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">800</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">800</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Accumulated amortization</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(352</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(267</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">448</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">533</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Software</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Costs</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">871</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">696</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Accumulated amortization</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(476</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(424</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">395</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">272</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">&#160;</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 76%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,881</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">820</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div>The components of the change in goodwill are as follows:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="2" valign="bottom" style="vertical-align: middle;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Carrying Amount</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: middle;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Balance at December 31, 2013</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3,303</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 16.2pt; font-size: 10pt;">Foreign currency translation</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(23</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 88%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Balance at September 30, 2014 (unaudited)</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3,280</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div>Summary financial information for the segments is set forth below:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="18" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="18" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">As of or for the three months ended September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Sales Representation Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; text-align: center; vertical-align: bottom;">Equipment Segment</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">IT Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Corporate</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Consolidated</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Revenues from external customers</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">6,409</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,234</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">7,643</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Operating (loss) income</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">723</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(405</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;)</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(82</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(385</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(149</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr style="height: 16px;"><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Total assets</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">13,341</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,909</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,067</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">32,319</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Accounts and other receivables, net</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">6,376</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">791</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">7,167</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Deferred commission expense</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,763</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,763</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div>&#160;</div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="18" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">As of or for the three months ended September 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; width: 108px; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Sales Representation Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 7px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Equipment Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">IT Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Corporate</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Consolidated</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="width: 108px; vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 7px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr style="height: 16px;"><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Revenues from external customers</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9.25%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">5,862</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,744</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">7,606</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Operating (loss) income</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.25%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">199</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(364</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">)</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(327</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(492</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Total assets</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9.25%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,040</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,398</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,972</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">25,410</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Accounts and other receivables, net</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.25%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3,510</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,229</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,739</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Deferred commission expense</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9.25%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,145</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,145</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div>&#160;</div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="18" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">As of or for the nine months ended September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; width: 103px; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Sales Representation Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 12px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; width: 109px; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Equipment Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 8px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">IT Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Corporate</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Consolidated</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="width: 103px; vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 12px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="width: 109px; vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 8px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Revenues from external customers</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 8.77%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3,264</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1.14%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9.34%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3,264</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">22,599</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Operating (loss) income</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 8.77%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,267</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.14%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.34%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(2,361</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">)</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(82</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(1,267</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(1,443</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Total assets</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 8.77%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">13,341</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1.14%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9.34%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,909</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,067</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">32,319</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Accounts and other receivables, net</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 8.77%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">6,376</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.14%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.34%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">791</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">7,167</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Deferred commission expense</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 8.77%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,763</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1.14%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9.34%; vertical-align: bottom;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,763</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div>&#160;</div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="18" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">As of or for the nine months ended September 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Sales Repreesntation Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Equipment Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">IT Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Corporate</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Consolidated</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Revenues from external customers</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">18,262</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,533</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">22,795</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Operating (loss) income</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">870</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">(1,489</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">)&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(1,085</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(1,704</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Total assets</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,398</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,398</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,972</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">25,410</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Accounts and other receivables, net</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3,510</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,229</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,739</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Deferred commission expense</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,145</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,145</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The following table presents information regarding the Company&#8217;s accounts and other receivables as of September 30, 2014 and December 31, 2013:</div><div style="text-align: left; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;</div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="6" valign="bottom" style="vertical-align: middle;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: middle;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: middle;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Trade receivables</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">10,716</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">17,173</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Due from employees</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">140</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">161</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Allowance for doubtful accounts and commission adjustments</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(3,689</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(3,764</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 76%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Accounts and other receivables, net</div></td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">7,167</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">13,570</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">NOTE C &#8211; SEGMENT REPORTING AND CONCENTRATIONS</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;"><font style="font-family: ''Times New Roman'', Times, serif; font-size: 10pt;">The Company views its business in three segments &#8211; the Sales Representation segment, the Equipment segment, and the IT segment. The Sales Representation segment operates through the VasoHealthcare subsidiary and is currently engaged solely in the fulfillment of the Company&#8217;s responsibilities under our agreement with GEHC. The Equipment segment is engaged in designing, manufacturing, marketing and supporting EECP</font><sup>&#174;</sup><font style="font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"> enhanced external counterpulsation systems both domestically and internationally, as well as the development, production, marketing and supporting of other medical devices. The Company&#8217;s new subsidiary, VasoHealthcare IT Corp., formed to conduct its healthcare IT operations, reports through the IT segment. Operations in the IT segment began in the third quarter of 2014. The Company evaluates segment performance based on operating income. Administrative functions such as finance, human resources, and information technology are centralized and related expenses allocated to each segment. Other costs not directly attributable to operating segments, such as audit, legal, director fees, investor relations, and others, as well as certain assets &#8211; primarily cash balances &#8211; are reported in</font> the Corporate entity below.&#160; There are no intersegment revenues.&#160; Summary financial information for the segments is set forth below:</div><div><br /></div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="18" valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;"></td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="18" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">As of or for the three months ended September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Sales Representation Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; text-align: center; vertical-align: bottom;">Equipment Segment</td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">IT Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Corporate</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Consolidated</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Revenues from external customers</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">6,409</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,234</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">7,643</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Operating (loss) income</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">723</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(405</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;)</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(82</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(385</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(149</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr style="height: 16px;"><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Total assets</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">13,341</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,909</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,067</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">32,319</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Accounts and other receivables, net</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">6,376</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">791</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">7,167</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Deferred commission expense</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,763</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,763</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div>&#160;</div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="18" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">As of or for the three months ended September 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; width: 108px; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Sales Representation Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 7px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Equipment Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">IT Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Corporate</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Consolidated</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="width: 108px; vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 7px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr style="height: 16px;"><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Revenues from external customers</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9.25%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">5,862</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,744</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">7,606</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Operating (loss) income</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.25%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">199</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(364</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">)</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(327</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(492</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Total assets</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9.25%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,040</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,398</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,972</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">25,410</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Accounts and other receivables, net</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.25%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3,510</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,229</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,739</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Deferred commission expense</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9.25%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,145</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,145</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div>&#160;</div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="18" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">As of or for the nine months ended September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; width: 103px; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Sales Representation Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 12px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; width: 109px; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Equipment Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; width: 8px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">IT Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Corporate</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Consolidated</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="width: 103px; vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 12px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="width: 109px; vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; width: 8px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Revenues from external customers</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 8.77%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3,264</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1.14%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9.34%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3,264</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">22,599</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Operating (loss) income</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 8.77%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2,267</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.14%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.34%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(2,361</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">)</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(82</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(1,267</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(1,443</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Total assets</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 8.77%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">13,341</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1.14%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9.34%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,909</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">2</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">9,067</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">32,319</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Accounts and other receivables, net</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 8.77%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">6,376</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1.14%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9.34%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">791</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">7,167</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Deferred commission expense</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 8.77%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,763</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1.14%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9.34%; vertical-align: bottom;">-</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,763</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div>&#160;</div><table cellpadding="0" cellspacing="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="18" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">As of or for the nine months ended September 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Sales Repreesntation Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Equipment Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">IT Segment</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Corporate</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td valign="bottom" style="padding-bottom: 2px; vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="border-bottom: #000000 2px solid; vertical-align: bottom;"><div style="text-align: center; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Consolidated</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; padding-bottom: 2px; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"></td><td nowrap="nowrap" valign="bottom" style="text-align: left; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Revenues from external customers</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">18,262</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,533</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">22,795</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Operating (loss) income</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">870</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">&#160;</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;">(1,489</td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">)&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(1,085</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">(1,704</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">)</div></td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Total assets</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,398</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,398</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">8,972</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">25,410</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #ffffff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Accounts and other receivables, net</div></td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">3,510</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">1,229</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #ffffff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,739</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #ffffff; width: 1%; vertical-align: bottom;">&#160;</td></tr><tr><td valign="bottom" style="background-color: #cceeff; width: 40%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; font-family: ''Times New Roman'', Times, serif; color: #000000; margin-left: 7.2pt; font-size: 10pt;">Deferred commission expense</div></td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,145</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">-</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td><td valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">$</div></td><td valign="bottom" style="text-align: right; background-color: #cceeff; width: 9%; vertical-align: bottom;"><div style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">4,145</div></td><td nowrap="nowrap" valign="bottom" style="text-align: left; background-color: #cceeff; width: 1%; vertical-align: bottom;">&#160;</td></tr></table><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">For the three months ended September 30, 2014 and 2013, GE Healthcare accounted for 84% and 77% of revenue, respectively.&#160; For the nine months ended September 30, 2014 and 2013, GE Healthcare accounted for 86% and 80% of revenue, respectively.&#160; Also, GE Healthcare accounted for $6.2 million, or 87%, and $8.1 million, or 89%, of accounts and other receivables at September 30, 2014 and December 31, 2013, respectively.</div></div> 16867000 5344000 5507000 16843000 29000 189000 300000 32000 P2Y P3Y 300000 100000 500000 450000 0 0 400000 140000 7330012 1222 7500000 5000000 0 0 111000 111000 1500000 2000000 3000000 18500000 600000 69988 500000 710000 74000 175000 31100 157500 6465000 5206000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">NOTE L &#8211; STOCKHOLDERS&#8217; EQUITY</div><div><br /></div><div style="text-align: justify; font-style: italic; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Common Stock</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">On June 17, 2010 the Board of Directors approved the 2010 Stock Plan (the &#8220;2010 Plan&#8221;) for officers, directors, employees and consultants of the Company.&#160; The stock issuable under the 2010 Plan shall be shares of the Company&#8217;s authorized but unissued or reacquired common stock.&#160; The maximum number of shares of common stock which may be issued under the 2010 Plan is 5,000,000 shares.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The 2010 Plan is comprised of two separate equity programs, the Options Grant Program, under which eligible persons may be granted options to purchase shares of common stock, and the Stock Issuance Program, under which eligible persons may be issued shares of common stock directly, either through the immediate purchase of such shares or as compensation for services rendered to the Company.&#160; The 2010 Plan provides that the Board of Directors, or a committee of the Board of Directors, will administer it with full authority to determine the identity of the recipients of the options or shares and the number of options or shares.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">During the nine months ended </font>September<font style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;"> 30, 2014 the Company issued, under the 2010 Plan, 710,000 shares of common stock to employees and officers, and 500,000 shares of common stock to directors.&#160; As of </font>September<font style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;"> 30, 2014, 1,222 shares were available for grant under the 2010 Plan.</font></div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">On October 30, 2013 the Board of Directors approved the 2013 Stock Plan (the &#8220;2013 Plan&#8221;) for officers, directors, employees and consultants of the Company.&#160; The stock issuable under the 2013 Plan shall be shares of the Company&#8217;s authorized but unissued or reacquired common stock.&#160; The maximum number of shares of common stock which may be issued under the 2013 Plan is 7,500,000 shares.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The 2013 Plan is comprised of two separate equity programs, the Options Grant Program, under which eligible persons may be granted options to purchase shares of common stock, and the Stock Issuance Program, under which eligible persons may be issued shares of common stock directly, either through the immediate purchase of such shares or as compensation for services rendered to the Company.&#160; The 2013 Plan provides that the Board of Directors, or a committee of the Board of Directors, will administer the Plan with full authority to determine the identity of the recipients of the options or shares and the number of options or shares.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">During the nine months ended </font>September<font style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;"> 30, 2014 the Company issued, under the 2013 Plan, 69,988 shares of common stock to employees.&#160; As of </font>September<font style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;"> 30, 2014, 7,330,012 shares were available for grant under the 2013 Plan.</font></div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">No options were issued under the 2010 Plan or 2013 Plan during the nine-month period ended </font>September<font style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;"> 30, 2014.</font></div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; font-size: 10pt;"><font style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">In April 2013, the Company&#8217;s Board of Directors authorized a share repurchase program of up to $1.5 million, which was subsequently increased in July 2013 to $2.0 million, of the Company&#8217;s common stock.&#160; As of </font>September<font style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;"> 30, 2014, 10,308,087 shares had been repurchased at a cost of $2,000,000, which cost has been recorded as treasury stock in the accompanying condensed consolidated balance sheet as of </font>September<font style="font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;"> 30, 2014.</font></div></div> 2000000 10308087 9481101 10308087 2000000 1755000 155186000 160796000 157864000 155319000 6409000 5862000 18262000 19335000 1831000 1828000 5282000 5502000 P5Y P3Y P3Y 3 57000 5000 320000 300000 23000 -1000 0 -87000 2 2 90000 38000 3600 P2Y 0.809 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt; font-weight: bold;">Basis of Presentation and Use of Estimates</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and disclosures normally included in the condensed consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in connection with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013, as filed with the SEC. These condensed consolidated financial statements include the accounts of the companies over which we exercise control. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of interim results for the Company. The results of operations for any interim period are not necessarily indicative of results to be expected for any other interim period or the full year.</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company's management. The Company evaluates its estimates and assumptions on an ongoing basis.</div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt; font-weight: bold;">Significant Accounting Policies</div><div><br /></div><div style="text-align: justify; text-indent: 36pt; font-family: ''Times New Roman'', Times, serif; color: #000000; font-size: 10pt;">Note B of the Notes to Consolidated Financial Statements, included in the Annual Report on Form 10-K for the year ended December 31, 2013, includes a summary of the significant accounting policies used in the preparation of the condensed consolidated financial statements.</div></div> 2000 -0.01 0 0 -0.01 EX-101.SCH 6 vaso-20140930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - ORGANIZATION AND PLAN OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - SHARE-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - LOSS PER COMMON SHARE link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - ACCOUNTS AND OTHER RECEIVABLES, NET link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - INVENTORIES, NET link:presentationLink link:calculationLink link:definitionLink 060900 - Disclosure - GOODWILL AND OTHER INTANGIBLES link:presentationLink link:calculationLink link:definitionLink 061000 - Disclosure - DEFERRED REVENUE link:presentationLink link:calculationLink link:definitionLink 061100 - Disclosure - RELATED-PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 061200 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 061300 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 061400 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 061500 - Disclosure - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS link:presentationLink link:calculationLink link:definitionLink 061600 - Disclosure - BUSINESS COMBINATION link:presentationLink link:calculationLink link:definitionLink 070200 - Disclosure - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 080300 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 080500 - Disclosure - LOSS PER COMMON SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 080600 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 080700 - Disclosure - ACCOUNTS AND OTHER RECEIVABLES, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 080800 - Disclosure - INVENTORIES, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 080900 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Tables) link:presentationLink link:calculationLink link:definitionLink 081000 - Disclosure - DEFERRED REVENUE (Tables) link:presentationLink link:calculationLink link:definitionLink 081600 - Disclosure - BUSINESS COMBINATION (Tables) link:presentationLink link:calculationLink link:definitionLink 090100 - Disclosure - ORGANIZATION AND PLAN OF OPERATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 090302 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS, Concentration Risk (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - SHARE-BASED COMPENSATION (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - LOSS PER COMMON SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - ACCOUNTS AND OTHER RECEIVABLES, NET (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - INVENTORIES, NET (Details) link:presentationLink link:calculationLink link:definitionLink 090900 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details) link:presentationLink link:calculationLink link:definitionLink 091000 - Disclosure - DEFERRED REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 091100 - Disclosure - RELATED-PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 091200 - Disclosure - STOCKHOLDERS' EQUITY (Details) link:presentationLink link:calculationLink link:definitionLink 091300 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 091400 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 091600 - Disclosure - BUSINESS COMBINATION (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 vaso-20140930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 vaso-20140930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 vaso-20140930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Amendment Flag Current Fiscal Year End Date Document Period End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Document Type Award Type [Axis] BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES [Abstract] Receivables due from related parties Accounts Receivable, Related Parties Accounts and other receivables, net of an allowance for doubtful accounts and commission adjustments of $3,689 at September 30, 2014 and $3,764 at December 31, 2013 Accounts and other receivables, net Accounts and other receivables Accounts and other receivables, net Trade receivables Accounts Receivable, Net, Current Accounts payable Accounts Payable, Current Accounts and Other Receivables [Member] Accrued commissions Accrued Sales Commission, Current Accrued expenses and other liabilities Accrued Liabilities, Current PROPERTY AND EQUIPMENT, accumulated depreciation Accumulated other comprehensive income Additional paid-in capital Adjustments to reconcile net loss to net cash provided by (used in) operating activities Allocated share-based arrangements Allowance for doubtful accounts and commission adjustments Accounts and other receivables, allowance for doubtful accounts and commission adjustments Amortization expense Antidilutive Securities [Axis] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities, Name [Domain] Antidilutive securities excluded from computation of diluted earnings per share (in shares) Total Assets Total assets Assets Assets, Fair Value Disclosure CURRENT ASSETS ASSETS Assets [Abstract] Total current assets Assets, Current BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES Basis of Presentation and Significant Accounting Policies [Text Block] Business Acquisition [Axis] Notes paid as a part of consideration Business acquisition proforma information [Abstract] Net assets acquired Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Business Acquisition Proforma Information Intangible assets Business Combination [Line Items] Revenue Business Acquisition, Acquiree [Domain] Net loss Business Acquisition, Pro Forma Net Income (Loss) BUSINESS COMBINATION [Abstract] Consideration for acquisition Estimated fair values of the net assets acquired [Abstract] BUSINESS COMBINATION Business Combination Disclosure [Text Block] Property and equipment Acquisition-related legal costs NET INCREASE IN CASH AND CASH EQUIVALENTS Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents Cash and cash equivalents - end of period Cash and cash equivalents - beginning of period Cash equivalents invested in money market funds (included in cash and cash equivalents) Class of Stock [Domain] COMMITMENTS AND CONTINGENCIES [Abstract] COMMITMENTS AND CONTINGENCIES (NOTE N) COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Common stock, par value (in dollars per share) Common Stock Grants [Member] Common Stock [Member] Common stock, $.001 par value; 250,000,000 shares authorized; 165,985,370 and 164,705,382 shares issued at September 30, 2014 and December 31, 2013, respectively; 155,677,283 and 155,223,981 shares outstanding at September 30, 2014 and December 31, 2013, respectively Common Stock, Value, Issued Common stock, shares issued (in shares) Common stock, shares authorized (in shares) Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Software [Member] Concentration Risk Type [Domain] Concentration Risk [Line Items] Concentration Risk Benchmark [Domain] Concentration Risk Type [Axis] Concentration Risk [Table] Concentration Risk Benchmark [Axis] Percentage of accounts and other receivables (in hundredths) Percentage of revenue (in hundredths) Consolidation Items [Domain] Consolidation Items [Axis] Corporate [Member] Cost of sales, equipment Total cost of revenues Cost of Goods and Services Sold Cost of equipment rentals and services Cost of revenues Credit Concentration Risk [Member] Income tax expense Current Income Tax Expense (Benefit) Customer Lists [Member] Maturity term of notes Interest rate on notes (in hundredths) Deferred commission expense DEFERRED REVENUE [Abstract] Deferred commission expense Deferred Costs, Current Changes in Deferred Revenues Deferred Revenue Arrangement Type [Domain] Deferred Revenue Arrangement, by Type [Table] Additions: DEFERRED REVENUE Deferred Revenue Disclosure [Text Block] Deferred revenue at end of period Deferred revenue at the beginning of the period Deferred Revenue Less: current portion Deferred revenue - current portion Deferred Revenue Arrangement [Line Items] Long-term deferred revenue at end of period Deferred revenue Deferred Revenue, Noncurrent Deferred Revenue Arrangement Type [Axis] Recognized as revenue: Deferred Revenue, Revenue Recognized Deferred tax liability, net Deferred Tax Liabilities, Net, Current Depreciation and amortization Depreciation, Depletion and Amortization RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS Description of New Accounting Pronouncements Not yet Adopted [Text Block] Director [Member] Director - Edgar Rios [Member] SHARE-BASED COMPENSATION Disclosure of Compensation Related Costs, Share-based Payments [Text Block] SHARE-BASED COMPENSATION [Abstract] Due from employees Weighted average common shares outstanding - basic and diluted (in dollars per share) Earnings Per Share, Basic and Diluted LOSS PER COMMON SHARE LOSS PER COMMON SHARE [Abstract] Loss per common share Effect of exchange rate differences on cash and cash equivalents Stock Options [Member] Unrecognized expense related to existing share-based arrangements Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Revenue, Major Customer [Line Items] STOCKHOLDERS' EQUITY [Abstract] Assets Measured at Fair Value Fair Value, Hierarchy [Axis] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] FAIR VALUE MEASUREMENTS [Abstract] Fair Value, Measurements, Fair Value Hierarchy [Domain] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Significant Other Observable Inputs (Level 2) [Member] Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] Significant Unobservable Inputs (Level 3) [Member] Useful life of intangible assets Finite-Lived Intangible Asset, Useful Life Costs Finite-Lived Intangible Assets [Line Items] Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Intangible assets, net Finite-Lived Intangible Assets, Net Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Other intangible assets, net [Abstract] Losses (gains) on disposal of fixed assets Gain (Loss) on Disposition of Assets GOODWILL Goodwill, Ending Balance (unaudited) Goodwill, Beginning Balance GOODWILL AND OTHER INTANGIBLES Goodwill and Intangible Assets Disclosure [Text Block] Foreign currency translation Goodwill, Translation Adjustments Change in carrying amount of goodwill [Roll Forward] GOODWILL AND OTHER INTANGIBLES [Abstract] Gross profit Gross Profit CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) [Abstract] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest INCOME TAXES [Abstract] Income tax (expense) benefit Income Tax Expense (Benefit) INCOME TAXES Income Tax Disclosure [Text Block] Income taxes paid Accounts payable Other current assets Increase (Decrease) in Other Current Assets Receivables due from related parties Receivables due from related parties Other long-term liabilities Accrued expenses and other liabilities Deferred commission expense Increase (Decrease) in Deferred Charges Other assets Increase (Decrease) in Other Noncurrent Assets Accounts and other receivables Increase (Decrease) in Accounts and Other Receivables Deferred revenue Increase (Decrease) in Deferred Revenue Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accrued commissions Inventories, net Increase (Decrease) in Inventories Sales tax payable Interest and other income, net Interest paid Inventories, net Inventories, net Inventory, Net Finished goods Inventory, Finished Goods, Net of Reserves Raw materials INVENTORIES, NET Inventory Disclosure [Text Block] Reserves for excess and obsolete inventory INVENTORIES, NET [Abstract] Work in process Investment in certificates of deposit (included in short-term investments) Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Fees for legal services Total current liabilities Liabilities, Current Total liabilities and stockholders' equity Liabilities and Equity Total long-term liabilities Liabilities, Noncurrent CURRENT LIABILITIES LONG-TERM LIABILITIES LIABILITIES AND STOCKHOLDERS' EQUITY ACCOUNTS AND OTHER RECEIVABLES, NET Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Major Customers [Axis] Changes in deferred revenue [Roll Forward] Name of Major Customer [Domain] ORGANIZATION AND PLAN OF OPERATIONS Nature of Operations [Text Block] Net loss Net loss Net loss attributed to Genwell Instruments Co. Ltd. Cash flows from financing activities Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash flows from investing activities Cash flows from operating activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS [Abstract] SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES Total other income, net Nonoperating Income (Expense) Other income (expense) Notes Payable [Member] Notes payable due to related party Note issued for acquisition Number of contiguous states in which VasoHealthcare has been appointed exclusive representative for GE Healthcare Diagnostic Imaging products Number of business segments Number of segments Number of Chinese operating companies acquired Number of Businesses Acquired Officer [Member] Operating expenses Operating Expenses [Abstract] Total operating expenses Operating Expenses Operating loss Operating (loss) income Operating Segments [Member] ORGANIZATION AND PLAN OF OPERATIONS [Abstract] Foreign currency translation gain (loss) OTHER ASSETS, net Other current assets Other Assets, Current Other comprehensive loss Other long-term liabilities Other Liabilities, Noncurrent Patents and Technology [Member] Patents [Member] Repurchase of common stock Payments for Repurchase of Common Stock Cash acquired through purchase of Genwell Payments to Acquire Businesses, Net of Cash Acquired Acquisition of Genwell Payments to Acquire Businesses, Gross Purchases of property, equipment and software Payments to Acquire Property, Plant, and Equipment Purchases of short-term investments Payments to Acquire Short-term Investments Plan Name [Domain] Plan Name [Axis] Preferred stock, par value (in dollars per share) Preferred stock, $.01 par value; 1,000,000 shares authorized; no shares issued and outstanding at September 30, 2014, and December 31, 2013 Preferred Stock, Value, Issued Preferred stock, shares issued (in shares) Preferred stock, shares authorized (in shares) Preferred stock, shares outstanding (in shares) Reclassifications Redemption of short-term investments Proceeds from Sale of Short-term Investments PROPERTY AND EQUIPMENT, net of accumulated depreciation of $1,362 at September, 2014 and $1,281 at December 31, 2013 Property, Plant and Equipment, Net ACCOUNTS AND OTHER RECEIVABLES, NET [Abstract] RELATED-PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Related Party Transaction [Line Items] Related Party [Axis] Related Party [Domain] RELATED-PARTY TRANSACTIONS [Abstract] Research and development Restricted Stock [Member] Accumulated deficit Revenue and Expense Recognition for VasoHealthcare Revenue Recognition, Policy [Policy Text Block] Revenues from external customers Vested (in shares) Equipment sales Total revenues Revenue attributed to Genwell Instruments Co. Ltd. Revenues Revenue, Net [Abstract] Equipment rentals and services Sales tax payable Sales and Excise Tax Payable, Current Estimated Fair Values of the Net Assets Acquired Antidilutive Common Stock Equivalents Excluded from Computation of Diluted Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Finite-Lived Intangible Assets [Table] Inventories, Net of Reserves Other Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Changes in Carrying Amount of Goodwill Summary Financial Information for Segments Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Segment Reporting Information, by Segment [Table] Accounts and Other Receivables Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] SEGMENT REPORTING AND CONCENTRATIONS [Abstract] Segment Reporting Information [Line Items] Segment [Domain] SEGMENT REPORTING AND CONCENTRATIONS Segment Reporting Disclosure [Text Block] Selling, general and administrative Share-based compensation expense Share-based Compensation Remainder of vesting period Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Number of shares available for grant (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Number of shares authorized (in shares) Options issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Award Type [Domain] Short-term investments CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) [Abstract] CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) [Abstract] Segments [Axis] Class of Stock [Axis] Stock repurchase program, authorized amount Restricted shares issued for consulting agreement (in shares) Stock Compensation Plan [Member] Share issued (in shares) Stock Issued During Period, Shares, New Issues Value of stock granted STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY Total stockholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest STOCKHOLDERS' EQUITY Stockholders' Equity Note Disclosure [Text Block] Fast Growth Enterprises Limited (FGE) [Member] Subsidiary of Common Parent [Member] SUPPLEMENTAL DISCLOSURE OF CASH INFORMATION Title of Individual [Axis] Title of Individual with Relationship to Entity [Domain] Treasury stock value Treasury Stock, Value, Acquired, Cost Method Treasury stock, at cost (in shares) Treasury Stock, Shares, Acquired Treasury stock, at cost (in shares) Treasury stock, at cost, 10,308,087 and 9,481,101 shares at September 30, 2014 and December 31, 2013, respectively Treasury Stock, Value - basic and diluted (in shares) Weighted Average Number of Shares Outstanding, Basic and Diluted Aggregate revenue during the period from commissions earned from the sales representative agreement with GE Healthcare. Commissions Revenue Net Commissions Total costs related to commissions earned under the sales representative agreement with GE Healthcare. Cost Of Commissions Revenue Cost of commissions A type of deferred revenue by arrangement relating to extended service contracts. Extended Service Contracts [Member] A type of deferred revenue by arrangement relating to service arrangements. Service Arrangements [Member] A type of deferred revenue by arrangement relating to commission revenues. Commission Revenues [Member] A type of deferred revenue by arrangement relating to in-service and training. In Service and Training [Member] Sales Representation Agreement [Abstract] Sales Representation Agreement [Abstract] Refers to the extended term of sales representation agreement into an amendment entered by entity. Amended Term of Sales Representation Agreement Amended term of sales representation agreement Refers to the initial term of sales representation agreement into an amendment entered by entity. Initial Term of Sales Representation Agreement Initial term of sales representation agreement The number of wholly-owned subsidiaries owned by the entity. Number Of Wholly Owned Subsidiaries Number of wholly-owned subsidiaries Major external customer that accounts for 10 percent or more of the entity's revenues. GE Healthcare [Member] Component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Equipment Segment [Member] Component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Sales Representation Segment [Member] Refers to component of an entity for which there is an accounting requirement to report separate financial information for this particular segment on that component in the entity's financial statements. Information Technology Segment [Member] IT Segment [Member] The value of inventories transferred to property and equipment, attributable to operating leases in noncash financing and investing activities. Inventories transferred to property and equipment, attributable to operating leases, net Inventories transferred to property and equipment, attributable to operating leases, net The aggregate amount of noncash, equity-based Employee and Non Employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. Share based compensation and arrangements Share-based compensation and arrangements Amount of the current period expense charged against operations, the offset which is generally to the allowance for doubtful accounts and commission adjustments for the purpose of reducing receivables, including notes receivable, to an amount that approximates their net realizable value (the amount expected to be collected). Provision for doubtful accounts and commission adjustments Provision for doubtful accounts and commission adjustments The increase (decrease) during the reporting period in deferred costs capitalized as a result of related party transactions where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Increase Decrease Deferred Charges Related Party Amortization of deferred consulting expense Employees and Executive of the entity that is appointed to the position by the board of directors. Employees and Officers [Member] The 2013 Plan was approved by the Board of Directors for officers, directors, employees and consultants of the Company. Plan 2013 [Member] 2013 Plan [Member] The 2010 Plan was approved by the Board of Directors for officers, directors, employees and consultants of the Company. Plan 2010 [Member] 2010 Plan [Member] The number of equity programs in an equity-based payment arrangement. Number of equity programs Refers to number of shares expected to vest over three years period. Share based Compensation Arrangement By Share based Payment Award Options Expected To Vest Over Three Years Vested over three years (in shares) Value of shares vested over a period of two years in stock based compensation award. Value of shares vested in two years Persons who are on the payroll of the entity and work in the normal operations for the entity. Employees [Member] Value of shares vested over a period of six months in stock based compensation award. Value of shares vested in six months David Lieberman who serves on the board of directors (who collectively have responsibility for governing the entity). Director David Lieberman [Member] Director - David Lieberman [Member] The engagement of consultant to assist the Company. Consultant [Member] Consultant Managed by Director - Edgar Rios [Member] Represents the term of an agreement the Company entered into. Term of agreement Term of agreement Name of the acquired entity. Genwell Instruments Co. Ltd. [Member] Related party interest in acquired entity at the time of acquisition. Related party interest in acquired entity Related party interest in acquired entity (in hundredths) Document and Entity Information [Abstract] Disclosure of accounting policy for Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). and for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles. Basis of Presentation and Use of Estimates [Policy Text Block] Basis of Presentation and Use of Estimates Disclosure of accounting policy for all significant accounting policies of the reporting entity. Significant Accounting Policies [Policy Text Block] Significant Accounting Policies Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle and also includes other assets, if longer, acquired at the acquisition date. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables And Other Current Assets Accounts receivable and other current assets The pro forma of Basic and diluted loss per share for the period as if the business combination or combinations had been completed at the beginning of a period. Business Acquisitions ProForma Basic and diluted loss per share (in dollars per share) Basic and diluted loss per share (in dollars per share) EX-101.PRE 10 vaso-20140930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOODWILL AND OTHER INTANGIBLES (Details) (USD $)
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Change in carrying amount of goodwill [Roll Forward]          
Goodwill, Beginning Balance     $ 3,303,000    
Foreign currency translation     (23,000)    
Goodwill, Ending Balance (unaudited) 3,280,000   3,280,000    
Other intangible assets, net [Abstract]          
Intangible assets, net 2,881,000   2,881,000   820,000
Amortization expense 50,000 41,000 146,000 126,000  
Patents and Technology [Member]
          
Other intangible assets, net [Abstract]          
Costs 2,500,000   2,500,000   469,000
Accumulated amortization (462,000)   (462,000)   (454,000)
Intangible assets, net 2,038,000   2,038,000   15,000
Useful life of intangible assets     10 years    
Customer Lists [Member]
          
Other intangible assets, net [Abstract]          
Costs 800,000   800,000   800,000
Accumulated amortization (352,000)   (352,000)   (267,000)
Intangible assets, net 448,000   448,000   533,000
Useful life of intangible assets     7 years    
Software [Member]
          
Other intangible assets, net [Abstract]          
Costs 871,000   871,000   696,000
Accumulated amortization (476,000)   (476,000)   (424,000)
Intangible assets, net $ 395,000   $ 395,000   $ 272,000
Useful life of intangible assets     5 years    
EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0#.X$##`0(``!0<```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F=UJVS`8AL\'NP>CTQ$K MDKRN&W%ZL)_#K;#N`E3K2VQB2T)2N^3N)SMM&25+"0WL/8F)+7WO$Q&>`[^+ MJ^W0%_<48N=LS40Y9P79QIG.KFOVZ^;;[)(5,6EK=.\LU6Q'D5TMW[Y9W.P\ MQ2+OMK%F;4K^$^>Q:6G0L72>;'ZR.:V) M;>?CNXS!^,&$\,@;?]ORW"YM;YS;E\2$'*-UJ MU35D7',WY!,HHP^D36R)TM"7T[4<=&A.,"A.,#",>.D?TZZG>.87=?NA+R6W.I#YF4)NI\X.\/?L8QRYN[D.SL?<8@4Z M_10>:ZIQ]\SG01121T]%U:'"YRDQ-V"G!SYKG&CLV`R9`]E\ZO26?P```/__ M`P!02P,$%``&``@````A`+55,"/U````3`(```L`"`)?]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\(V(T'4\4 M"_'L)MI<3_3_MCAQ M(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?````__\#`%!+ M`P04``8`"````"$`,93SQAH"``!!&P``&@`(`7AL+U]R96QS+W=OO9CS$I!-I`])]YPC^>[^UV%?O(8Q[OJN-&ZQ-$7HZK[9==O2_'SZ=GEC MBIBJKJGV?1=*JI2;X]8.5?U<;8.5Y7)EQ_,^S/I#G\5C4YKQL7%JBJ?CD(?^?^?] M9K.KPT-?OQQ"E_XQAGWKQ^?8AI!RI]6X#:DTTZ-H3V^<+C*SL9_@Y/G@XMP@ M'%F1<62%":9'?W7F&L&PEP:NC&.+C(,B(VR1$2@R;(V!$L->*;A0CCXU<&Z$ M+;\"Y5?9-:ZPR)6M?PH%T.<@2LU9?HGTV%^Q<:X0#IL&PC@VC8,XPCXP"#PP M"/O`(/#`H&R'4&P1[#)WL,P=.UHX&"V4;:`*#=2S#=1#`Z73($5F;QRX;QQ[ M:AQ<*&$G'8%)1]A)1V#24;8$*I1`9;NY0C?W;#?WT,W]K&X>VVH,S8\TYMO6 M\[N*\\=(=&:%F>XG/K^RP,F"G)#A.CFVY#@H.8XM.0Y*CK!K7&"-*[O&%>X= M99>5PKKRLR;VE+_,A/<*/S7MZ1=&/V&;E$"3\NQ@[*?9L1\^?*U_`P``__\# M`%!+`P04``8`"````"$`Q''/F3`$``#X#0``#P```'AL+W=O^UO=>//]91A,DZC--$C-17D:O?;[]^N3FDV:^?:?I+`8$D'ZG;HMA?]WKY:BMV8?XM MW8L$[FS2;!<6,,R>>OD^$^$ZWPI1[.*>WN\/>KLP2M2CPG7V&8UTLXE68I*N MGGJEF[H^*']9EF(9 MB4/^/JD<*B\/4;).#^5/H;2O]<@``X?JUD.T+K9PO]_OU]?N1?2T+4X70;Z' M]*L*PG.J3R6IEG>J"(=.<9(44?'*:7*L?I1""\NJ4UB9IBK9=01?,KK62N-8 MQ?;<"7%],N'PS?<<.K$"&(PMQW)M@E3,`9+1_TX&'-1NS"'2J2K^"3M^`*YF M#3M(Q?RDFS<5[`;*7]?FHBWCL:GETO^M@'HNM]P)GT-1N'?'O3EA%EX3)*:6 MJ=C`:QI;/O7+:7-&?.+"4DYZ-J,!EKE",L.V&Y],9S";,S+W6$#=:64)NF;# M589D+H"ZVLVE)'-O,0*6JH[/YM#[R@^>CX&Y:L]W/-_GL'[@93:#NOBE'IZM MHZ=K_?;T.XLROK2$S8OD+!FUU`Q\+&%A``M:R;6\!,ZK5>\$].&'$)G1I MC1W2T#&QCD0L=9?P8(]1XG.7X#9<8"@T"=&IYTT>J.,@`Q2:ZDYIVP!.C"9! M.B%WA#%H`R/@9-&H($!]9_C8(/,'>:!%[)"PVJ;I_(+2DFK@TM M0`\?8/PTB;^RV6[@/'+J^PNHWAL/91[FS,,Z&$38B5L;WWCA4Y<`R^!K3-UV M"`:80EVBL#O3>(<98`QU"$,):ZA.797/(@_!G#\?V^_0XPE+H$Y0?Q M/*.#$=4E1+M3VE@6!O5XL.+-LQ73,T8PJ[K$:G=:L9$AQE>7\&W'578R!+5Z MW]4E<,\!=T8$4VM(U'8?28WE8(`-">!N[L!$U83R]6&(`3;^$F`P\2Z$`38D M@*N#1#Z8^$04802O5'&=RJZKW3G[;;/P```/__`P!02P,$%``& M``@````A`*^Y]^:[!@``!QX``!@```!X;"]W;W)K^?NU M*1-<18>0EYD.Y[CP<96KROCIT_?3T?I6U$U9G3K5JMH?B ME#?+ZE*<);*OZE/>RI_UZZJYU$6^ZP:=CBON./[JE)=G&RRLZSDVJOV^W!9I MM7T[%><6C-3%,6_E_)M#>6EZ:Z?M''.GO/[Z=EELJ]-%FG@ICV7[HS-J6Z?M M^K?7I^SOS\FUON_LQ,G\JMW755/MV*DGY8&7JOJJ MJ+_MU",Y>#4:_:7SP)^UM2OV^=NQ_:MZ_[4H7P^M=+>0BI2P]>Y'6C1;N:+2 MS)(+96E;'>4$Y+_6J52A(59L_/]75NR6C1KZSN>0J M!ME:6NZ5P3RN6F])E1J5D<_*2F=+JFBD?[X]A_QI]4TNZ5938J`$MC50/$Q) M>HI:0&4V[1\,8Q@>DO4,Y3VIZ"I++A:5Y4JW?^RP7H4:1%2X^'WQF$)T)F-& M*+"1=$PA1K(QPS""A+I8Z+1`19:Q9_K`QW.+@>(9%#+[Y"XCO8J\L>7:#2$6$'E`";L0C1SBW<1$F2L(G)HP9X+8SDS8=;ES?352)#?9 M?$6*3!2%5[/='HF!XG6*7)?LCP2A$4%30$4WEC&'"D(P9\-R($'^(X(4F0B* MB""@P*1\SR%P8L(B],G.24V81:Y+HC=#>,B-\4B4S%/SO:3(6%0T.!^\!!00 M%?C>L)0=G(9LR-6'.1436),-X$`VBD2C5CABY?GHS*3+.%31\8J#(L+_N MM^'%H.LN([W+R*882%[TB#Q%)CXCH10#!786%V3O)";JA@1-333PR+)D@.I] MY[`!1GJ8+%CS_=6QB2(29K'F@"06DC!*$,QI.D@1+#PR.D.P[]\2I2KV["!D M4-_-E!Z1KB'6'+V:(2<),B$X39$IP@6GC4N&<>$,88*]I6KV?&%0X9&P8<4@ M9S#@@##._9$PA'N,."1%XWT1D*R2(3Q@AG`L3!7K^<*@M"-AY,4Q`PX($VY` MA"<89R&I2RG"F>]P$N<9)@C_5NEBJF3/EP8%7D[^FN\B,K6XL[BQIW+B?4IZ MGY)-4K#_5!F?+Q**/O(?";Q8'7UD\NS]YY$=F6!*?!*$+ MGZ3Z%,%,D,C/$'SK2,8?ZDDZ-M4TQ`1X3I-N:8*V!M`/-)GP!YI,^*8FN6OF M1R-7;*J)A%JL27K6M/0E&!:"#$\UWN\C'A%79H0@T_[U9(A#4+4/LS<:AV8# M)Q&2OV)-TM(X@1,$TV-0BM#%.`1A`F#;.(]B30]U(APZ$:QI2+DZ!(&D-3': M)"7:B,8]?UCM;GRJ\=Y?[B@Q$H)OI%ZL[:$&1'W+)`=/YM`.1).FVJS[E/0^ M)9ND8)4/]2)\W(LP^JDCUB3PT"@OFIT*IQ4;#5W0,U&&8,/S6-%#C0C_H!%A M)!W'F@3?WQ:,DV*>8-PS=HN.27A)/]X-B($,&V#BUF=3_E`CTK'QQQ#&R*MC M39J,R;Y7N5G/T_M6LDD*]J"J_$:F5%_W9WP&AWX!91=&PB_F0`)/$#:!!F>"<%"6O@((PB-7`$[DC"$2S]#J(NYX;0H3^M!-+P%%,*]&UQ+ MG8KZM4B*X[&QMM6;NE/C,E"N3^&^+V;KI+L<(\]3>0_8/5]=`7D-=\E?BS_R M^K4\-]:QV$N3SC*05::&BSSXT5:7[NKGI6KE!5SWYT%>N!;R&LI92O*^JMK^ MA[ILNE[A/O\/``#__P,`4$L#!!0`!@`(````(0`IAPX9;P,``$L,```9```` M>&PO=V]R:W-H965T,4P2NN@(G=\UYTY!2*EK116 M[!8-FF4DP1%-S@4NA1)A.$<"]L]/I.*-6I'<(E<@]G2N[A):5"!Q(#D1K[6H M;17)ZMNQI`P=Z`C^9E>(,G7/QBUZ^8G(\"2AW"(ZDL57Z&F&>0$9!9N*'4BFA.6P` M/JV"R-:`C*"7^OM"4G':V-/9))R[4P]PZX"Y>"12TK:2,Q>T^*<@[RJE1/RK M"$1<13Q_XB]"+YR-JSAJ1[7!"`FT73-ZL:!KX)F\0K('O14H-\[4/EJO'UD% MCU+D0:K46N""0WV>MT$8K)UGR&ER97:*F=M6RRP,9-\@,H-2-VINO,5XNFK< M$+)\8*GU!=DR?4VA[N]7K+$A@W0;4U=_WJZ/^#JQ[Q.+4$>B/F*(Q'VB(Z(9 MG?:-!A^V9F-4!D$3=FH1A,8F=XH).HQ![$>):)2(APC-)VS$+.BX3QFTL2&9 M;<\%X4POQDXQ8=VUWF)I5&+?7?:G,R,'47>Y'QUWE[5HS1O4J^MMN$DE;'J: M&IX4`P]O?1O[WH\2T2@1#Q&:OYGN3QXRX[6306,]JI@AGZ-$-$K$0X3F$PZW M;AUO\RF#S'J:/:J8:X\&KMFCVO)\89Q9D;;YSGW$KH6$DQQ+TBQ.MQ)6M2.^A*S!_/E=?4E940+&G.95OFM3WBG3U_5@R MCON?5#A[Z@*6>"'>0$Z`(CM!OS,E@&P+1=9Q0B4&GW.#EL_&]H ME:"E'VS7.D$_*;F(UF]/G-CE#TZSOVA)(-NP3FH%]HP]*^CW3+T"YZ#C_:17 MX&_N9>2`S[G\AUW^)/1XDK#<$42D`EME;X]$I)!1H)G,(L64LAP$P*=74%4: MD!'\JK\O-).GC3^/)]'#=(X`[NV)D$]44?I>>A:2%;\,"-54AF16D\Q!?6V? M36:+"$7Q.$M@%.D`'['$VS5G%P^J!OY35%C5(%H!LXIL#OFY'1F$I'R^*2?M M"F@!R_&R#:/%.GB!%*8U9F@(;)OCQ6+>F"UUD"U7W7B=*2=77=SP MFS4TF%"K0^B]@+0UZ;-:VF);VW#M*["KZ3UFH\E@(I.Q<.DD-&F;X^7R/:&6 M*FB=CV=,.=GJPMBM>H.!96O6W!4XA+`TJ@'G[![C?:&&-H+U>?VQDUJ*\U>LU6]I`S((:; M0Z-=76YWU*#>]K#L_?V!U&;M%-\=F3-;?'O'"V-GU]AIZHT_5'Z#$#N#:@=W M=(XW"3+[/GPV7=J='C5H4.?=\P,!S2=T*B]WQ9W]9*>I53[54<'9CI(>HYU# M9WR,5.&MN=&IPO9HZ&BZ;;0U.6/CSJ-3=WZ$L7,RVB$#&ES7(8BM\\8@N:/^ MS`P8J;^A06$&,!J"V#H_-4R0F0/M?N[NU#6HI_ZND\0N3EN;,T1&ZN_6].C4 MGP&98U6G_FX;C29S33&G^(+P(TE(G@LO96=U!9E!DS5OS?5HAU9PU(5KB?,^ M@6N3?A\T!KBU5/A(?F!^I*7P9"LTF?K/9-P7]$_3W`_ M)7"(GDX`?&!,7A_4S:JY\6[_!P``__\#`%!+`P04``8`"````"$`*7F^!P<# M``";"```&0```'AL+W=OR`"58!(]MIVG^_:SLA@4QMMIF1L],*B[:!29>@!%KLH<_UJ23%J\O1QVPI)-S74_4*F-#]RVX<+^H;G4BA1:@_H?"?TLN9;_]8' MIN6\X%"!L1U)5B[P/4FS!/O+N?7G%V=[=?8;J4KL/TE>?.$M`[/AF,P!;(1X M,M#'PBQ!LG^1_6`/X)M$!2OIKM;?Q?XSX]M*PVE'4)"I*RU>,Z9R,!1HO$ED MF')1@P#X1`TWG0&&T!?[O>>%KA8XC+TH"4("<+1A2C]P0XE1OE-:-+\=B!RH M',GD0#(%]8?XQ)O,(A+%[[/X3I$M,*.:+N=2[!$T#>RI.FI:D*3`;"H+P9^_ M5P8EF9Q[DV13`:W@-)Z7TSB<^\]@87[`K!PFP:C'3(:(]24B)$-(=@F913W$ MAQ+Z.L"=?Z_#)`WK"(.>WI:ZV^,.`%!D-Z99-H.C+486:V:TB0D'@87P_B M"4E&?96Y.'SV>YRJ'RB'-^MZY08\5G[B=:W@,%.G?#HZE?4@&H\;^1A]5W4\ M5'W=^VB2QNI'OJX<)K+J;\)X=COR?1A/XM&Y92Y^A>_PRE_ONP$/E9/;D;,K MAW$=`_V2C(2?ATD(4W48AWO!;.'2ITEXJMMUBQOZ;B8V3&[9FM6U0KG8F8$> M@E_]JKMK5B2%J0!#?K2^)BD,A\OU#.XFN^[W"7`W='3+OE*YY:U"-2MAJ\!+ MH$NDNUW<@Q:='4\;H>%6L#\K^!/`8`8''H!+(?3QP=Q?_=^*Y1\```#__P,` M4$L#!!0`!@`(````(0#XL6?GKP(``&P'```9````>&PO=V]R:W-H965TEBU/$NAMHR./7SSDVIZOK9]&B)Z8TEUV!HR#$B'6EK'BW*_#/ M'_=7U5((:>%0[HGO%:#4L$BV)PS`C@O(.NX2ENB1#UC4OV9TL]X)UQH4HUE(# M_KKAO7Y-$^4E<8*JQWU_54K10\26M]R\#*$8B7+YL.NDHML6ZGZ.9K1\S1X> MSN(%+Y74LC8!Q!$G>E[S@BP()*U7%8<*;-N18G6!;Z+E;8[)>C7TYQ=G!SWZ MC'0C#Y\4K[[PCD&SX9CL`6RE?+3H0V7_!(O)V>K[X0"^*52QFNY;\UT>/C.^ M:PR<=@H%V;J6UW-@(;0Y^'W@5>F*7"2!6D> M)A'@:,NTN>$%P:V%/WU%[!:`G);U<$I5CVQL+#$I#5<`I/ZUDV6Y$G:%UY9#;G3.P3 MM^=$$IT0`EXG.2CY/L>X;G!1I>[6;C` MD#URF^R\<7S\<:N M:6,@7GCJGAE<]LO-+#PURR=FCCF:A6^8C8$TR*+^[,%%MR!$( MDS'@#-W`=/.DISOVE:H=[S1J60V689!#^Y4;E^[!R'Z8'UMI8,P-'QOX5F,P M7,(`X%I*\_I@!_+I>W+]!P``__\#`%!+`P04``8`"````"$`-(`B1V`&``#Q M(0``&0```'AL+W=O(]M+I[Q6..)8KJS&VE76JWV\LQ@;*,88P&32?[]5M%M0C5.%;,OR8SY./2A MNHN#>Q[??RU/WI>\;HKJO/&#V<+W\G-6[8KS8>/__=?'=RO?:]KTO$M/U3G? M^-_RQG__]/-/CZ]5_;DYYGGK@<*YV?C'MKVLY_,F.^9EVLRJ2WZ&(_NJ+M,6 M?JT/\^92Y^FN.ZD\SIL79-PKK>HI&M=\76:ZJ[*7,SZT1J?-3VL+X MFV-Q::YJ939%KDSKSR^7=UE57D#BN3@5[;=.U/?*;/WI<*[J]/D$OK\&<9I= MM;M?1O)ED=554^W;&GK<%>``;[M7Y_N-_R%8ZRCVYT^/ MW0WZI\A?F\'/7G.L7G^IB]UOQ3F'NPUUP@H\5]5G1#_M\",X>3XZ^V-7@3]J M;Y?OTY=3^V?U^FM>'(XME'L)CM#8>O=-Y4T&=Q1D9N$2E;+J!`.`?[VRP*D! M=R3]VOW_6NS:X\:/[F;+^T44`.X]YTW[L4!)W\M>FK8J_S508*6,2&A%X`PK M$H2S<+4,EG>RRMR,J#.HTC9]>JRK5P]F#5RSN:0X!X,U*%^=F7'T7G]D%3RB MR`=4V?CWO@HJ\$ ME@\L];[@;@U]W:[4=?@(X_"OU]V:#T"[]Q/2ZR9C8N485F/$$=%C8B!"[$34 M#I8I_N$$O-K"DV"J#5S$T1WUL35,/&`<&XE(*)'0'$%\PD"FEPWAC0\WL:]2 M'-T[_@RSZN9D!&US08\GP^/AP^BX&AX/5F-`#X$(SA]<@3B#:DUWAK#K;$5' MOC4,7+YW[U9.))1(Z#$11P_]2(C#.^H0YV@$K99?>GB2XS1V:K0US+*K8=#= MXWX`79M(#,#<"B5):$Z"N(0F-[V."+ONG`ZV-0PS^$0DE$AHCB#^,+,X#P2Y MT^!)4JQDT"V MG20\6YFN:A$SNNAN,#B;6H6`\7`K;!*3?R@-1VM4C'%)(&(*(N8"1QWR]2=P$;$3G&ZCHG'\$U9 MJ*/=+.2^?%F(ZT0RHBQRTX%9I*P(-?FF,!3>"D-N)[(0:U(,.\JJ6)-+;$5. M(=GK4),P\X:S=5HG"O$LMZ+?7V*[.[VU$&O6Z#"(DE4TBU"W&#X&:Q/=RITH M-)&%[T068JPD,J)D1+,(=0N#&;KE.U&(M%M3MQ-9B'5I=!A$614[@;N7+G<" M&Q%#<%\"X1>U;_!X*Q.-.I&)-U9TINGA9BEE\B(DA'-(M3MFZ)0=",* M+=TGB87,/D*,+9X^`A(".`<5.1A$L"X=0A-B=3\$J#6,().G:X2T\Y!'_(D/YT:+ZM><)<\`L'^TWX'_T.( M^Z_.Y]M@G73;X,[G"G;\N\_G_0'8<+^DA_SWM#X4Y\8[Y7NXU&)V#_FH-EOV MYI>VNG3;WL]5"UOMW8]'^-.*'/:;%S.`]U757G_!7>7^CS6>_@,``/__`P!0 M2P,$%``&``@````A`!P1]^3"`P``N@T``!D```!X;"]W;W)K&ULE)==CZHZ%(;O3W+^`^%^@WPH#E$GHXABSDE.=O;'-4+59H"2 MMHXS__ZL4G5HF2UZ,R-K/7UMW]66Y>3YO2R,-T09)M74=*R!::`J(SFN]E/S MYX_XV]@T&$^K/"U(A:;F!V+F\^SOOR8G0E_9`2%N@$+%IN:!\SJT;98=4)DR MB]2H@LR.T#+E\$CW-JLI2O-F4%G8[F`PLLL45Z94".D]&F2WPQF*2'8L4<6E M"$5%RF'^[(!K=E$KLWODRI2^'NMO&2EKD-CB`O./1M0TRBQ,]A6AZ;:`=;\[ M?II=M)N'CGR),TH8V7$+Y&PYT>Z:G^PG&Y1FDQS#"H3M!D6[J?GBA)O`M&>3 MQI]?&)U8Z[/!#N2THCC_!U<(S(8RB0)L"7D5:)*+$`RV.Z/CI@#_42-'N_18 M\._DM$9X?^!0[2$L2*PKS#\BQ#(P%&0L=RB4,E+`!."O46*Q,\"0]+WY?\(Y M/TQ-;V0-@X'G`&YL$>,Q%I*FD1T9)^5O"3EG*2GBGD5\F/TY[UKN>.@,1P^H MP/59Q/X.)_0;US,[,7#*!:5P95R467<)S M5"3J(N.ABBR[<]&^)^X2NLBJBV@BZRZABR1=1!/9=(G6BFTHR;4NL/,Z=?&@ M/E]O_TM=Q"BU+IVR2*0YN$TM%WH@T@/+KJKO>FH5XCN8U1W,^@XF^8)IV=BL M:G.;4:SV-*MO6RQH8;&X<<19F,M`RU`]$.F!I:X1ZX&5'ECK@>02^#Q>OJ=O MM]N,8@+<<,I^NVV"H!439*!E@AZ(],!2UXCUP$H/K/5`<@FT3-!WYN8VHY@` M]]X#)@@:WBJM"\[WM&,QEPQ,X7H):M?7HI>(>HEE+Q'W$JM>8MU+)+W$YA:A ME&+T4"D$/37AS%]M=EQ?O:'FDADW;ZO`&05J>M%..QXT"FH^:N?]P'M2TTN9 MOE'HN)=8]1+K7B*1A%SE"#I6=9J;=GKLM-**^?#25LZ!:`KZ7SYBE%H$W].+ M()D;-BUZB:B76$IBZ#6U'EAC;1:QE@^TO;#2\N.1ZN):SZOI1$]K\M`U"Z,^ MI_>YEV059$\LV[02T3U:H*)@1D:.HM\5J[I&92L^=\*Y+]Y(6GSAA(NOXI$3 MPGTLNN_K`&B=ZW2/_DWI'E?,*-`.OFI@!7!@J6R^Y0,G==-@;`F'IKGY>(#? M2`C>A`,+X!TA_/(@ON#ZJVOV/P```/__`P!02P,$%``&``@````A`%H>]],Q M"0``FS,``!D```!X;"]W;W)K&ULE%M=;^LV$GTO ML/_!\'MLDY(MVTA25"*I+;`+%$6[^^S82F);>?U]2I!3-4!G*+_G0 M.3,2#X><8TF^__7'^33Y7ERK8WEYF++98CHI+OOR<+R\/$S__DO=K:>3JMY= M#KM3>2D>IC^+:OKKX[]^N?\HK]^JUZ*H)SK#I7J8OM;UVW8^K_:OQ7E7SD.^^NW][?[O;E^4VG>#J>CO7/)NET+=_LV=_./E_Y\W%_+JGRN9SK=W%ZH/^;-?#/7F1[O#T<] M`B/[Y%H\/TQ_8]L\YM/YXWTCT/^.Q4?5^WM2O98?^?5X^,_Q4FBU]3R9&7@J MRV^&^OO!'-+!LF6JQNRK%P6_;O-LIK%?)FL;[F6 MQ&71O]LLXZ]E;M5IQ!:[>O=X?RT_)KJ"]?BKMYU9#VRK,[MM MDOQFLC2YM**5KI7OCS%?W,^_Z_G=.TYJ.?H<'6<=0TK64LQLFKRB/?`9PV"( M;!EMB+('],_N-/%B"8/REF/J3^O0B:&G&XL1Z<(=+KEV["8(CCW"0[>4_M`Y MO*+,9ZS110O_/"B)#"=1?I*8(4ES/TWT20%Z15`O6B=#-CJU,Y7:`TEW(,,' M1!O2G\LU5$[B(#4B*.\%@0'%<$!F-80+P`1I7J_BV&H#KS*U'/VSJTHTO5F0 M(8(,&62H(".G&$`KO2?V%PL]^8;\,-65U8T_YI]%U2SVU'+T^3L.UBC($"W# M;$$1G`/98E_F5RW#1*/%E;?84#301>_R?5W&U9`)@C4450^@09(LB0 M088*,G**`;326V)?*[J&#!G6$$OP.K.<==."DE6,2B"#\&(%*T3T8O'(X*8X=QC`%%H^Q?>/EL2:Q+T_,T?A39DG#)W?U M$Z2(!N0$I$>`EZ`5DG2A<>NCZ4W.G1.M(7%\6IH@P188I*DS)20K4RGC+GE;C M[#6SCA0N0>1Q4D9K299-:C]NO+]]F. M9.WD9\-UFWKK$Y2@#[\)K?=L&%C8Y[;=J3A M546!@@(E!:H._+IF2`K4Y":/S4=X;,?Y0I+6W0YM-%2DI$#5@80D[9F'*%`2 MO23ZRVA,U)&(ISD\DV3_>P/E[#=R1W3\U[S)1!/,+C%PYW M_9Q'*W1'7$("B]>HH:KN#$/;D&WX)`4JA*QUH(*L%:8;/K%$];07.$2!ZMQDJ+EOJ+W;:X[S1>OOFVW\&8.*E!2H.G!H MO&Y!M6<>HD!)D(,V;2S6&TM@8?E..N9H8:3=GCD1I%J:(,$6&*2I,R4D*U.PFUQWYKMMO_8YD=YY5[&W< M`%^N5_B3&L#91C^T@#?0)"2L.R^^ M]YT!F.$GB<+!5E_N?]0'X>O>(XUF#U(=/+0'V6V*I$!QC-_MN>V`.-8=TWT_ MLB37N*(HQIT-$-:+&._@`&=^`@D(?@+E<+)\*)\/%=)I;E#(L)&W]CI_9$EN M@44)NH&;`5P_\O,$HN-E(%XY7&?Y\@8V28'ZW.2M(]];>[W?<:P\`X_6(.X] M&A,0]Q^M0=R+5PXGY;'#&*9`>9"Q'MG3?(,=8P>81I1[;3:"+$P188H,4U28 MDI,4J!DRVR,ULW95+^RNJOWW:"+*TSK-@A01SB+#%!6FY"0%:G:3!8]\"S[@ M`UJS.W"'+7,9!@VZH$!)@:H#/R<1N8>P]T_M9[-_?YL3'( MHC[L;=M]\`['2BI6=2"A2YM^B`)TB9'/IG5IV*BEX9L1J2/9^TC>I=^ MQ?\&Z].P89UXK=UQ[#MZ:#XS"A04*"E0.7!XO*Y,K.D?IM@RL=]5L*_/GXOK M2Y$5IU,UV9?OYGL(*_TV0G?4?D>$9'1=LJU]^H9A)<=PB,.!IRP1 MZ;E@I38DDN54@WYUXI5JV(IT#%U!Y=.Y^I"*H@**/<^Y?JU)?:](5U^.I9!T MGX/O%Q+1M.&N+V[H"YY*H<1!3X`N,$)O/=\']P$P;=<9!P>8=D^RP\9_(*N$ MS/Q@NZX3]).SB^K]]M1)7#Y)GGWE)8-L0YVP`GLAGA#Z)<,0+`YN5C_6%?A? M>AD[T'.NOXG+9\:/)PWEGH,C-+;*7A.F4L@HT$RF+(38BN45$X;S%!""^=0#9 M'>\`P>@`*XV6XB;0E[MH'U1C=@;3MS2U$S>!4'.Y; M7`2X7D^2R"E#;#!0C+9ONWXS;?!'1#*$L&J+K]?1IPZ"-SZT6*LL(DX#Q@8S MI+Y!X*GEG%E)_U[';"F^MQ5CWA=_S#LN,`25O@#H>VPZTSS_8P56N'>>X MCXD!]>UT(JYF;B$1<8_=01[;#+X_>OTPLC;FK6,WAK,_8F)`@V8:"&ZP;ON; M(W%PO6T"7S,]$\-'$@Q]MY5PSN/X"AH4;WBB>AIQ>@LG2WS(V^N->#,YFI&H M8/+(=BS/E9>*,TZ%4Z!MH^W$^K#`^<&)Q]-57,>#]@8,DA4]LO^H//)2>3D[ M`&4X6<)K1II1U%QH4=6#V%YH&"'KGR?XR\!@/@DG`#X(H9L+?!^T?T*VOP$` M`/__`P!02P,$%``&``@````A`"V&!`*N"0``1BT``!D```!X;"]W;W)K&ULK)I=<^*X$H;O3]7Y#Q3W&S#?4$FV$HS!@,&X9O=< M$^(DU`!.83*9^??;LM26I=?#P)ZYF22/NUMJ=4ONUOCVS^_[7>5;?$RWR>&N MZMS4JY7XL$F>MX?7N^I?7[P_>M5*>EH?GM>[Y!#?57_$:?7/^__^Y_8S.7Y- MW^+X5"$+A_2N^G8ZO0]JM73S%N_7Z4WR'A_HR4MRW*]/].?QM9:^'^/UDB.ZZ<=^?W=::TW;#O[`\SO MMYMCDB8OIQLR5Y,319_[M7Z-+-W?/F_)`['LE6/\*\_QR_IC M=XJ2STF\?7T[4;C;Y)%P;/#\PXW3#:THF;EIM(6E3;*C"="_E?U6I`:MR/K[ M7;5!`V^?3V]WU6;GIMVM-QT2KSS%Z;71K]C!X]S:9-/WG$]D6*':5(/UGQ MIM=NMSJ]7XS858KTDQ4O])&V6C97^GF5CWVE1S^57N>FT6L[[8X(S9G%<2B+ MLA'%+SS9R[QT.!_$+ZQZH9\.Y9`<5B?39=%T.('$+VK4[F4)Y'`&B5]XPA?Z MRDDD]@NK7NHKYY&C$^E"7SF1')U)E_K*F>3H5'+.^EJ3NST[/-SU:7U_>TP^ M*W0B4W33][4XWYV!L,;'ALRJ_"#YV3E"!XBP\B#,W%7)$3HB4CK\OMTW^[W; MVC8QH%_V.&`DS(D:\NH\,=-`:5D!8@E5<&XQLX-E@;(.)#7P; M3&TPL\'U MK2#E(GF4@(R`>$#&0"9`?"!3(#,@"Z8N&%M+GPDA07'H@+9`3$`S(& M,@'B`YD"F0&9`PF`+(`L@81`5D"B(C$6GBKE*Q9>2)L++TEV'9!5ND,;N`KT M\CTQ4H2ZP/S-XW2MBLV30M2TT58R9DQJ5\Q82)LSEH3.Z7SP9M,Z+5F$=[&K M`,TI5W)ZUAD[DD+M>M8U.(YEU)./2QP2KV##(]&Z-`F>/WTR-=,U1A3M?)[- MCC61H9;*_6-4"!*C?N:.'1WUM"&OO,++V2O0/9X,H^9!7*L6"HV M.RTK1EJ*%5U&S=S6B%%'MG*F#8^?9M=(1I*)P2$F#EW(T*OC]+;=?'U,:(5I M[B7>-6DLU4S*NMMP3B$S1'8EG`U/]G6/XRK4T&BD4-N1(:K;>>RQ3DF41'4) M[3+=DRGWOB3OF7M7^"KK5<-7AXW)44[ M1;3I#:=M=>$>6RX)KRC3P/U">-G_DO#2554>7UGMB>^LC*T(C>24RHM:J6^?@4%RTR=AR1%Q$(T0>HC&B"2(?T131#-$<48!H M@6B)*$2T0A09R(R;*`2+8BDI*P]Q<6G'`M`(I3Q$8T031#ZB M*:(9HCFB`-$"T1)1B&B%*#*0&0M1&Q9C\6]O3F6-:01)HD)U**Z(*4::N(H8 M^PRJP9&6XGWF(1HCFB#R$4T1S1#-$06(%HB6B$)$*T210E2GD-MFU$1]C%&[ MMD!157:Q^I)(1V@H;M.MF$G2-E_LUHW?2.F1E(Y9KLAHC%(31#ZBJ4)R;;(3 M8*:0GOME02_%D7494=^=5*U;7+"4SHMMI68'S6$#^'[SX7ZXQ([WC)XS.#N:S%`]6 MMYJ$*0OHP6:,]&!S1F<'"UA*Y7JCT[!&6["$'FW)2(\6,CH[VHJE>+1NWZK] M(Y;`-J5Q72^=B5M)HMIKW34.64HCEU&A_6?4UX>W0C1=3J4Q2VE;$T;:EL]( MVYJBK1E+:5MS1MI6P$C;6J"M)4MI6R$C;6O%2-N*#%OF1A:->_&H/E^RBGJ& M7IK&AE6HN&&=>M=JAUE1)YK+J'"OP8CJVWP/-[M6Y^FQ%#4IN933L[)]S%)Z MQ`DC/:+/R!S1ZH>F+'5VQ!E+Z1'GC/2(`2-S1.L86K#4V1&7+*5'#!GI$5>, MS!&M5V'$4C\;T4P;.AVN21LA;J6-0CJ7APU`+B.=WB-&.KT]A8PM#+8FK*AM M^8RTK2G:FK&4GNJPOG4GQ0NE1897&EQQKM=6MDD'^)31MJ0][]*F)UDA`3H=>M(IT:'O.1^RI0$-4BB1?VS0]Y]E MO#F(LK/4LO-`;M!-;,EDR8M2)\B'4A?(@S(''KL#^O\MM$]7"P/15)<]Z0U$ M2XE/J&$DG;(GU"(-1!>$.M3CD+6R)]2D#$0?@CK49=`XV9-:OE[T%>O[^C4. MUL?7[2&M[.(72HUZUM(?Y7>P\H^3NIQ_2D[T_2J]+>AK-_I>.:82O"YN\%^2 MY,1_T-"U_`OH^W\```#__P,`4$L#!!0`!@`(````(0!#WM%ID@L``.4T```9 M````>&PO=V]R:W-H965TGVZK__DC^JU3K1R.R]>'Y?C\:U7JQU6S^OM\G"U>UN_ MTIG'W7Z[/-*?^Z?:X6V_7CX4C;8OM;!>OZYMEYO7JE7H[3^BL7M\W*S6@]WJ M^W;]>K0B^_7+\DC]/SQOW@Y0VZX^(K==[K]]?_MMM=N^D<37SO^,V@N5]`N_E#RV\UJOSOL'H]7)%>S'=77W*UU:Z1T=_.P MH2LPM[VR7S_>5K\$O3QL5FMW-\4-^N]F_?-P\O_*X7GW<[3?/"2;US7=;8J3 MB<#7W>Z;,8T?#*+&-=4Z*B*0[BL/Z\?E]Y=COOLY7F^>GH\4[A9=D;FPWL-? M@_5A17>49*["EE%:[5ZH`_1O9;LQJ4%W9/EG3@^WU;#SE4[J'<;;5+Y MNCX=TQ/+GBGL\4ET-$U[%Z%G5;0NC;>+S2\=@WI6'ILAJUVI^CVA89MUY". MKF'0N.B)JJWH(AU+3Q^ZMJYK2,?/75M`F60#:U+*!>W3@0T06?.?LN=E>ERX M1>:&6/_TG[+K0;/^3T$)D`?F/Z7+#\73Y+WUR:D0A'S1E[J+7`A.D^%#%XID M"#@;NES99Q,2H,EL?EW$ M,1[8:R]'B/<&"!H9C,H7(W-;I2NBVC_0J/;CKM&]OJG]H)%HY6SNM4W@6_1A M888=(SN08"A!),%(@K$$L003":82)!+,))A+L)`@E2"3(#\!-0I/&2.JI5\1 M(R-C8H2[>P_`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`LC=/VKG\."O2V` MV%L*=-%;!BOGK75=%W<@B/<)Z3>@3$PF,@%HZ!K'`S4+7INL?"4S1AX02(A6=`5KC=%9NL M%.4^1[CO-G*LX\WG^BXNQN@%=Q#IU67*,N[EG?O`*0 M%><09^,05ET["HLU1N1.>]6G=,<08=T8R.J*NS/1LE,TX.))@%AV!F1E0Z$[ MU[H+M&#=%(AU,R"G*VY#[NGZ!6KV`3X13;MMX$73H=,";=1%HO;-ZQE9H`YQ M5@YAY0I4W)X(ISG;1T"<[6,@UHV!K&Y#I-H$IUEW"L2Z"1#KSH"L;DOT=X[3 MK+L`8MT4B'4S(*M[+?J;X_29XC2["Y\(I]V,\,+ID%^<8D+NFS=ELC@=XJP< M.JLP*(JST6R)K=4(!J>3HU(>PQDKQVAHE<-Z6[R?FL"`E:>0X4I*@%AYAH96 MN=-IBIL_AP$K+R##RBD0*V=H:)5;C99X>L]A4"C[56IV)#X15F,NIE&'_"H5 MXT3?O,:45>H09^<05M?ES!H!<::/@#C3QT"L%0.QU@2(M:9`K)4`L=8,B+7F M0*RU`&*M%(BU,B#6RH'.5)W9>_A$>-Q6!6?0O7E;:^OIXBJGM.)G%8XR!+GJ).:PN>ES`BCVF0.PQ`_(\RN>#'%;O>?32QI3L)]*F,/?3!HB&]C*( M>LG&5F7:`'%=#($HXJP5B.5?Y*S,H;32:0,MKL0Q$'N,@7R/8H4R<5;F\+[' M*;388P+$'F=`ODUG!R$@/Q!2,2CSU:<35:KP7/LT%DUO,P,Q$P20>N]PX@(= M0YX]QD"^1S&33*!UT>,45NPQ@3Q[G`'Y'L5,,H?618\+6+''%/+L,0/R/8JA M/8?6>Q[];*)H>X.0?5O)V?2Q'7GS/DO,:4!^9\48W6GQ64T=%9T9>8= M1-`)&R*P$2QX+3;2TF,@EH[1T$F'[5!$<`(+EIY"AXL_`6+I&1J^V^LY+%AZ M`1V63H%8.D/#=WN=PZ*0]D-N-K%.5[DRY!]ZD48OF53$R\T['L8:H5S%H"&G M^L`A;P"Q6DWSTN?'73>0S^019/B)8`3$RF.M'#ODE-O7'3$:3R##RE,@5DZT M\LQ7UGV>0X:5%T"LG&KES%?6?K[XZ]0"T6Q M$"GWXDXC+Q8/?33DU!XXU*"GGY.93Z3,$%9V5ZQ;;XLA+W(&-(%B%!EI9V/( M7'06P\HZ:]6;8GTPT3E45KOOYGL$6N_>W938?BQQW^K1CY(H#I)? M]^@W,YK3:]G>T.Y=NHS]"JS9UY4ZC/T$<>7HLJ$ MEWOZN*/XA8CD(7WT<4;GOM'+BP<#8?^E2?K%^V=QXK[9R\_Q0;N7%:4@[`>= M'OUP0U]`TNEEY_B@VZ.?(&C[<;='OR+0/.GVZ(<`FJ?=7E;P6MDA^LCD;?FT MGBWW3YO70^5E_4A!KQ>+@[W]3,7^<72O[;_NCO1Y">4%_6:=/B=:TZO2NAEI M'G>[(_X@Q[7R`Z6[OP$``/__`P!02P,$%``&``@````A`.,&L'88!@``%A\` M`!D```!X;"]W;W)K&ULE)G;;J-($(;O5]IW0-S' MF(/!L>*,8IK>'6E66JWV<$TPME&,L8!,9MY^JZDVH1K236Z<&'_\W?7WH0KZ MXMFGY^J2;^V?>6-_ M>?SUEX>WJGYI3GG>6J!P:;;VJ6VO&\=ILE->ILVBNN87^.50U67:PM?ZZ#37 M.D_WW4WEV?&6R]`IT^)BH\*FGJ-1'0Y%EK,J>RWS2XLB=7Y.6^A_(^X<;I-E-N_LRDB^+ MK*Z:ZM`N0,[!CHYCOG?N'5!Z?-@7$(&PW:KSP]9^*ZJ%X%^W8M+<+,SNIMW(_!G;>WS0_IZ;O^J MWG[/B^.IA>%>040BL,W^)\N;#!P%F86W$DI9=88.P*=5%F)J@"/IC^[O6[%O M3UO;#Q>K:.F[@%O/>=/R0DC:5O;:M%7Y'T*NE$(13XJ$T'OYN[?PUBMW%9I5 M'.Q1%R!+V_3QH:[>+)@UT&9S3<4<=#>@?(L,^]''^E&H$*,0>1(J6SNR+8BB M@?'Y_AB$X8/S'3S-)+,;,^N`(O$-$0X*77:[\*[KTEN2&W&[A>.%SCH'8NP# M!?N&@4X/W2T>`8MX;JH[O`#:?8`>[4@\)M8KBK`QHH@D8T(5X6/$?_>$1.S3 MB,70^C#U]9&+FX`;!!J$$8UCATPP8)1(8R/!C$1B)+B.($Y`5^>/O8"W-MC< M#W40KA4'D-$Y8"08$NMNM?C^TE\NE[25Q*C!=01Q`+:9^0X(F#K@1?`G3=A@%&"ZPAB`.QM\PT0,#4@"._IX.R0P<[[WAI&3QF^ M&`F-1-MDM/.V1P#GCKM3N>`TAH/&)&C<2HP8<::Z@-!U.1&'#_&0,$ MK!J@Y*L=,FC`BK3;&10/?P_&]K#A[VX0#CO>"20$\,8`1V#:8!*["ZEO_NAW MM!J]KVP!$IIN'`TP(\R,)&:$:Q%JA*B09B\#%^LI2+7]1A^,=@():8U`'0W" MS"J)&>%:A!HA2JGY1F#A-:P+8-=79P1"40PF)G7A4R6EAZ7@<#J,,X:$-#'&9H1-($&D MO,Y*)B`U8V@1:@6$-7]E>()6)X3ZLDE"6BM01X,PLTIB1K@6H4:(XFWV%N%A MJ:?/&!+21!F;$69&$C/"M0@U`OK["2,$36?$.&-X".$6L8[&#]:Q)#16,:-( M8A;A1"2\)P_HU(5/%97B0&/D@IHQ)'1[R(A(XY@X):*U`9O2J"1F%:[TQ?OX M(<,3E=O\=8%U'MTK1T8@)%\EWY/*7OI@+!=9UZ^M_;%((@F-F9R(>!')X70Z MB+)MO@M8Y%$7U&<,.``T/6.8$3:!!.XH8QB;$L>1'_<&K<#C1CR-*_/ZF,?Y M^=Q86?4JCA)]>"W>7^V/.9\\<2:E7-^Y&S@Z&U]G[@;.Q^"ZT]\`IY+7])C_ MD=;'XM)8Y_P`32T7$2R"&L\U\4M;7;NSP>>JA?/([M\3G#_G<"BW7`!\J*KV M]D4TT)]H/_X/``#__P,`4$L#!!0`!@`(````(0!4*&PO=V]R:W-H965T=RH1"N]^[1"?/^V3V!LO6#HQ/!UV!7",^!ZVSB2L=#05/5 M8N'H>"=%.)2#+![^=NNMW;J__CBZITB8!.[!B:#]X=X[AU>WXSJ+W=$)?GR< M7];^\0P6[][!BW['IDKNN"YW=B<_<-X/T.]?S'#65^_X2\K^Z*T#/_2W41[L M"J*AZ3Z7"J4".+V];CSH`1_V7.!N*\IW5EZ5E,+;:SP^2\_]#!/_Y\*]_]D* MO$W?.[DPV#!-?`+>??\'1SL;7@25"ZG:S7@"QD%NXVZ=CT,T]3_;KK?;1S#; M)G2(]ZN\^5UWPS4,*-CD-9,[K?T#-`#^YHX>CPP8$.=7_/GI;:)]1=&+>=-2 M=09X[MT-HZ;'+97<^B.,_.-*0.QB)4RTBPE\7DR8EM=LDYG%)USTBPM\WEPR M-\&X5(9&WRH_WX3BQ04^;RZ9FV!=*L/GK?+S38"\%!,"0WZQT"TYN724%56! M6/&=@R=D#1?4<4$#%S1Q00L7M$4!=/<6[8:MRYG5RTQ1'I]%!F:9@5D]9J0L@+O)/V0!KP79 M(@6?)7>F*AC8K]P"%`U_C23J)-$@B29)M$BB31(=DNB21(\D^B0Q((DA28Q( M8DP2$Y*8DL2,).8DL2"))4FL'A%2,D&P_T,R\5H5!7+VEBA:"2>38.QX-\=L M342=+.HHNNWA0Y_;WU$ MBT&')+HDT2.)/DD,2&)($B.2&)/$A"2F)#$CB3E)+$AB21*K1X240/"H)270 MX[T8IW'BV.@N)!AHP-\"KT82=9)HD$23)%HDT;X2_)%.,]#FJI-4#882M)M4 MK1)ZO.HE5=M`8]A/J@SM,0=)$54<)C4-B2-)1*YC240U)TD1[[ZG2=%$-6=) ML8B&:"Y$,UYC=<-$2^`B*6NJA5;@95*V;0.9KY*RJ9M?JY\4__`SQ!/QSVDY M_G45#615,(_BGR3J)-$@B29)M$BB?25X_+_`%,BIWI%EXVN(XY]%NI)<-%'Z M]"392DQ07+LOR3B[!@_5H:1JJ%TC645Q,Y95%'03265(G4JJA6[),TG%PS$7 MJDB&%]B/H%8O9-TJH6LO)=VV#+3A6,FZKG^U3DH(^(7JB83@-$H(O-.I"D9T M[-Y.2M+O[*0D_2?1)8D`20Y(8 MD<28)"8D,26)&4G,26)!$DN26#TBI,3AQU[9?S+F-$H<#:U$5<&(Q"DQ?&NM M"?E!7-:3!DPU#;0):21UJVBC!;I)7J!%$FV2Z)!$ER1Z)-$GB0%)#$EB1!)C MDIB0Q)0D9B0Q)XD%22Q)8O6(D)('#H&DY,GVTS"OA9,(Q7A5,.(YOJ1::']: M$_*C)$H:6`8V:"1E4S70;K!)^K=(HDT2'9+HDD2/)/HD,2")(4F,2&),$A.2 MF)+$C"3F)+$@B25)P!$_#_+[$2IR2!SAB_/+HQOLW)I[.(2YM?_!C^>+\'AU M*Q5O#E19&E==8&8Y.TN5U5H83E'1Y@Y7A("5=WF1E.$])E[=8&8Y5 MH+QPNS"\,7!V=N[`"7;>*DM$.\-GG[`P``__\#`%!+`P04``8`"````"$`U(<\ M??(%``#:'P``&0```'AL+W=O>?O-HBRUJEP2MR]L3;_Z MZ_13B>3+]Y_I4?D1YT62G8:JT=)5)3Y%V38Y[8?J7W^ZWVQ5* MJK_B0OW^^OMO+U]9_E$*\YY'&ZK1NE1:^MZ5TO#Y*12A4'>1"/;[9(H=K+H,XU/)17)XV-8POB+ M0W(NF%H:-9%+P_SC\_PMRM(S2+PGQZ3\58FJ2AH-_/TIR\/W(\S[IV&&$=.N M/DCR:1+E69'MRA;(:72@\IS[6E\#I=>7;0(S(,NNY/%NJ+X9@XUAJ-KK2[5` M?R?Q5W'W7BD.V9>7)]L@.<6PVK!/9`?>L^R#H/Z6A*"Q)K5VJQU8Y\HVWH6? MQ_*/[&L:)_M#"=MMP8S(Q`;;7TY<1+"B(--J6T0IRHXP`'A5TH18`U8D_%G] M_TJVY6&H=KHMJZ=W#,"5][@HW81(JDKT6919^@^%JAE=1=H7$?A_$3&LEMFV M>O8S*IV+BGE3:;?:MF58W2?&`J.N)@0&__\3ZK-5@3$QE>;+8<`,Z*+>IM*V M6[9EF5V[]X0.FXO1NPVC\>YH=*"KB?[+0V`>HO)&9(8JM`=[%&#\'Z^F;;]H/\"LT849409>KXQM\LA8EC%X MPF$$,2_I><("-U73[O.-7,:P1AX+W!J)0YDRA+7QQ5OO6KP<9?=Q^N46[W'Q\4;),)33:9]3-B M@5L_9E_GUWY,F?NQM'G"D0G;XI&)C)A]0<9MP'@R(ZA,4<)'B9E,B!.:RXBT MO>4(S5E.#(QI@-[_D&SDB($)"]P? MD8(IW4>,D!F]1XR@,WW$"#K^(T;0F35@YHQAN2!@@9J)+AHP2\8PX9486+-` M34^;>H;S!-Q7/>$)0L-Q=9=:S;YPNS&B#`SAFGZ%RW6,$@Y*3%#"10D/):8H MX:/$#"7F*!&@Q`(EEBBQ0HDU2FSJ",YXW:>,1^BA"EGV9BI=N-<:4:;.>"CA MH,0$)5R4\%!BBA(^)>SJUT97AS\^=\RX[PG`?S]'>PCN%0Q;[F+!`SVICR7: MQPHEUBBQJ2,XR\$/M"?..D*+EA-RQ8@R=99#"06LF,D*?6*+&I(SCKD6>,XH,&_*Z?M!(M*/R`&5'&JLX! MP[;(92I>-UA-\O(XK4F&K,"/(\3)B90[^C M6_!-SDX3UO8NW_/YRT4)#R6F*.&CQ`PEYB@1H,0")98HL4*)-27HKI"$SR_Y MYOYK;L\XIQGP,.,)JU4X[S5+%QXXC"Y0G=MPQ,&1R06AMU5MPS*D57`OR.7$ M[;2K(Y=?*0^7F3:0\2],S;1G.#+'D0!'%CBRQ)$5CJQQ9%.+\&8D#X.?3[Q0 MIA(/0$L7'B:,+E#-[HQQQ,&1"8ZX..)=$*M3W2KH+5OOTZ1S>17N?J9/\CX^ MA!F.S'$DP)$%CBQQ9(4C:QPA)4_BI<[!AU^BUE/IFDDJ$$!\;`Z@1R?&),8`RD!SWC`'4;>1X8`R@%B/'5\8`ZBUR M?-0>C*KQ:-GN`&GH,SQ/U%L"[+"O9!^A8NU;E7_\%``#__P,`4$L#!!0`!@`(````(0`C M.;5@+P8``%P:```8````>&PO=V]R:W-H965T&ULE%G;CJ,X M$'U?:?\!\=X!VUR2J-.C@='LKK0KK59[>:8)2="$$`$]/?/W6Z;I,/+ M3('JBGZ17NN3A#9 MM5U3#/"SVP?]N:N*[7A3CS#O M;R(JRK?=MJ5[PG\8H-PQS$A/;+W]_JGJ2U`4TBQDK#.5[1$(P+]> M4^NE`8H4W\;_7^OM<-CX*EG$::@$P+WGJA\^USJE[Y4O_=`V_R%(F%281)HD M"MB;N%S(92SBY/TL`3(:)_BI&(JGQZY]]6#5P)C]N=!K4*PALYZ9`GU^/#.8 MDK[GH[YIO!70/93CZY-$D_3B-#2#JJK.>56Q<(`1#&)G!;'`T&$:V9*\D&1DAD06**R&\A"#5( M\7ZH1S6@YUJDS;GRL7ARR MS9";%!A6:F)-:3%COUU!@69L.T,T+554RV",7$(L)T%P'U)`O+IFYT+;K+6X M]%Y,WN\Y:,Z$(EO9V9CY33F9.@0QA5$NF;8R54Y[KT7O'>70J0DM-FXF$(/* M*;EDRN8TKL+)DRFQ65XO7+./IL2FI(A!8FF\G!0Q%;7C:G5M7^I'H1F*H5\3 MQ=@:S\:,&_]-,278'LDI0,5B+.,7KO-'W/D-QIB'=*C9YA^OKJDVR_Z%Z__1E-BL--OAI0@9[=SD>#.7 M:P\68E8+&-'4;*/)+@TQV^4C90ULMH`=C^-TLAQ22#FK"XQH1HRM\,Q@L)!B M.8V+O$A86H^VE-:L+B#=+A`SK\H,!@NU$C'3,R=Q`0^0$W'*3'OQW2XKT;EM MSXBGQ%A)@S&"6>W:"(8IW#"E-+ MA:Y-Q)H2&[%L9Q=IE##:N22`E123DU!JL[Q?OZC"HXUML/P5(S,8&/^JP=Z$ M4'JS_%^BMQ/EIGD;Y1!C-D"8.AO`CJ>1%:?$9CF_=)T_9A::&0PNI#AE%<]) M6,63W5!:LYQ?NLX?<^JPCW/?PK=S.P#ME M9C"X_M@<\BM!2DT[M.5RFIK0?>[V0YO2M]%FRMTL,QAC_@G;.CD+3UN>\IO5 M&Y3;&Q*V)S.#P;T!K[T)>P[.&2`.I\5+J<'BL*5[1S&-9HJQD3.%&*3V$$"!SBR=S8%`8@TOK;P9O4*Y?8*?BR5&0Q6-Y;.XSB))Y$E/*TLZQ9W M5M;M&LFTKDUE$8/GD$JZ+X!PW*_7L`'\X`40#_/QK+NINGV55\=C[Y7MBSZH MEW!@=[F*'Q$RL#RX!.-L_%_OJCZ+;UZ?>.U8[2!DN](%B MAU\'\,?0GL'R7>CI?P```/__ M`P!02P,$%``&``@````A`-.9;H?,`P``Q0P``!@```!X;"]W;W)K);7&1-456L88N[#?*[?OEES_F!]8]\QVEP@(/#5_8.R':F>OR M?$?KC#NLI0V<;%A79P(NNZW+VXYFA3*J*]?WO,BML[*QT<.L^XP/MMF4.7UD M^;ZFC4`G':TR`?Q\5[;\W5N=?\9=G77/^_8N9W4++M9E58HWY=2VZGSV;=NP M+EM7$/*^+O..<;81#KAS$?0TYJD[=<'36WS'#G]V9?&];"AD&^HD*[!F[%E*OQ7R%AB[)]9/ MJ@+_=%9!-]F^$C_8X2]:;G<"RAU"1#*P6?'V2'D.&04WCJ\PP$!N;6F7#R5TJ5MY7LN6/TOBHB$&ISXO9,`Z/MS MW_&3D(31QUY<)%(!/F8B6\X[=K"@:^`S>9O)'B0S\"PCFUR,#&BDS8,T4J:@ MYE".EV4TG;LOD,&\EZQ0$MO6(/%U17JJ",@@<0%O8(3(3<8`:G@^^^^,TDAG MC+W!O0ICA9)895G&E8YN:`"0F#'`]0^68BCP*/+`"'V%DLE($NIHZ36%A@9. MQFB?JY\T6M@0[5"<^)AZS`U*$E7<($J,\J;:<1Q-!GP-#AK)A/NX<-+(@#/S MAQ*$(T%D'*?:L9\<0]/@(AWN>E&E6"]J9'832B`Q0U+-HEY3:&CPV-R>-VED MY"T8RH)%1DVA(4[_#Z(T,A"-`JY0,L'\&7#GSS0L`D/K]M0I*P,LTC]\U6O.DUTXU-'. M?`]\7%6",UP;)+&)AAIL.O+USNC)M/=QYEP'E+/YYK8C.-$UP,0$1`TVGA]B MYQD/=]H[NB324>7POAT51[Z&:DS=%4%-_XQ$X30)`_-;+35$D]@+@^0X(G54 M.<=O1\7I/T9-C(2M"&IZU#",XMA/3FIOB'P_F%X:UW+?&J->G]=*K3\T(\JFG9;FM*JXE;.]G(C]&%8 M#'=Q6UV1&:P>L-H9]U/88M5]=SB`);+-MO3OK-N6#;A!;//0``)5OGKSO'JSN/4DFTW343X?Y*/O- MD[ML\N1?7OWG__3=9#)-^'8T^OC-YOKZBV^NT\'H2=++9Z/I;YYL[FXPSVPT^.,L M:[F?=K9>/GGUW63PZKOIJ_V\-[O.1M.$=23MT70PO4L.1VX"UOW=-]-7WWVC M5]WK+Y-W^6AZ->'5?M:/GW:RF[5D:[V1;*YO;,M^(7 M_#`M8#-.A\"DGWU*OL_NXO>>K?.?O:V7ZWN[\:/6;#SF\^1@,.DQQ(]9.A;< MDOUT6E_/ZNK&YNK61CR&7\8/V7"X^M,HOQTEG2R=0"_]Y'`RF67C^(-GQWG\ MDQ_C0SZ?_9C5OO-SV3C)RVV M>9F/ZQ#K7*=#%I"4,[3RZYMT5'O3#\?3ZYR-3_/>3XVD",%,54!?P"AU];[;!&AQI^?9N-!WD\6#_"[K:6S=^]NZFC>6%_]7?Q%$P;L M&Q,>#-/:;IY=I,-);:!BD7YUR^BJ=7*\WS[NM/<3_M4Y.3K<;W;YXW7SJ'G< M:B>=M^UVMY.LO!^EL_Y@FO6?\^_.?O+T>;S(PU'2OX&-1EPG[60R9L&-O78-5Z?W;6/NXFS4Z'9<13MM+)EA#E8"+9GJ3]/\S\ MG!K@Z5;CQ=[+))W"JC?3[/H<4@]"T>;FA=T7VWH!X/CG2P!T5BXPZ<]8SSB_ M9M5#6*N?W*3P9YT)#P'!:)J/>62;BL&ZGUUD"*8^&J+80O8)S5*GLA/A-^EY M.99.)ED=K-U\BG"[_YW3LY/3]EGWQZ1YO)^T?_?^\/0=:"]!WD,)S=RF^AD* MK3=(IX*LH+G1V'JQ.0=-IT(<*#<:FWL;CP+EFY.3_1\.CXYB<)QTW[;//`4N MA)?;8'/AY@,!'QTV7Q\>'78/VS4J+LCN)KT3I<7S\WP\F\/&(LJU5SR6JA0\ M'*3G@^%@$1UT8)9),DT_02@+9RX(89Q!,5#7:H%&$_UU]5]\H5'#U'<+H7:< M3YG=SVRT.\WG*+<)*8R^@,"/3H[?K';;9^^2>\!>+-5O+@:[(VTLKTLG M..Z9SRWL4:^V3MZ].^R*N#M&ZPC=[N'QF_9Q"\I(5HY/NNWDN"9;G_W\^>?/ M\0([W9/6]V]/CO;;9YUGQC3='^-W3L>!ER=34XY/U]8W)!<2).4L^S;9:&"= MZ+_)Q*G-=#9%6`[^E/6_349Y^!5!)A*4#9B7>G6.Z0H1UK#7'I1<7FF7ZYI? MV.:.+6O9TC9>[#1>[NTTMG;7;;J-%]N-W77^WMN,U[Q4S-:6V(#^I*>F@X_9 M\`[@[.PT7NSN(D&VW"3\O;FYQ<0;89('H;$8&/,SQ5AK]E&UB#?$YDTZZ*\. M1DDOO1D@1FMOS@G&BT%O,+WO%:?4$.N(T"OD.?M$(?)W3>AT<1HF,TQ!CQ]T M42^?3!O)QGIC:WVO@35K.WO9V-[;:&R`NT`_7PON>-V.J6SZJWS8QQY]9BI^ MND0N5/C35O:8+Q]I_,PJQL\IQB4.3C8=8+(_TAC*/O50],XP3?KI-/T2^ZA0 M#\9\IF_GK)*OMT5BB"]3PI@U"[5O[?M8V!1R)EF!A/OY<)B.$?E8#$8L-3%7 MDU:!I@J99`.Y7Q_]M9==6L(7?EEE[GL^GY=D7[KI^:^_:,<+/WUXNPL_>^1> ME\B%^_"RA,DZ71P-IPA/#A*9?\WN(2Z(5XOO3L_:;W%,#C^TDZ.3#KJQRH6/ M<4$\U^'_?"7G;3TZEK$5L\*9,YAJAEH;'^7&/+F)C*_XL_*QA`QNG9-DV?CC MH%=_6WAT'D9M("<\O653>]I"DLMT?NBYK;%A4M<6'2\WC"//R^WJ< M6KX4SGW+?#/.<3%OQOE%7>N=(&5P$0A.!)LX7GR'B`G/&\EE-N)=O#>,F[1_ M/1A96$@V0/S)638A1--S/F89S&^P#N0EU"CPTV\%S=Y$E$,UG19S4` MP24/C&R[E58213*8R>`8&ZO)>3H9]`S,_<%P)O_Z<5KM!Y9]I==38KWI938W M#2&2TIY^[)Q+U-BC!&VKV7F;'!R=_/"HH(Y%6"X(=DQ<9*&D:4*M@X\+W?*8>?:K@0!C MWFO%(_]D%!CC&W5P1H4P8'W-D,+G)D7"2,!>#3\+/0@_^5`NT,,Z7QGKB M-73D8:U"1LPE>L<`=]1KBQ]#SI?9XL!496-:;C\X=4!V,AM6Q5P\9^M*HTX` M:A6FME$CY8K5_.OXV_LMS_AM)ZX6PU"\_PNQ'5.BB^-)P"^GQ-,9PAIPPV07 MTA/P^)1@1*FN!/A)?C&]!3'Q?N8^GCPJ@'B6];/KFQ"8>MPWS1[*SXL(.]9R\<_[X=;#.N+P8A@Y_W? M$*NOK"9(4@4=XKW4EO28X=L7%_CEVBAFG=%T@G+-X&(>8'5@'HFIC[AAX4ASTH$VJEQ'W!&,00V->E4<"HQI>ET/#B?314AE0(I-<202,62 M2/8Q,<;$.T22WL9!CMGB;9Z'_ZK`=#V<4H"1-`M/9.O^.2>O*2%^II0 MS1?//%9>]@-)ONNLKR@$ZSX5VR M\7)O=RUY[[(SF($H(@S(3U-\`1,NE90-,!\.^;W@+Z#^YW__C]OLS__^/QOZ M5SX;AW_.)N%?+10;F;KPY[C(LH9?*@OGIP2L,-1U.L(RDO+3;S:GD%QYUV]2 MO#V83I+)['PRZ`]2)3'62#QEB9^8S--T,'2;5?(NN4JQ+;*LJO\`QO0VEP6` MZD2JG,\F@Y'259/LTA1P`Q&;)1V+CR/8L*_ECIE@]Z\8>>JE-F!SOH]_L@8V MDG?IG7+<9+KUCE^:_G""6SNX):HUO%LE8XM$+[9S9WM.]@?IY0CW9]";^(WW MOSG_)K6';[-T.+WJ@554V2>`+>MI0$+'YC*?#0C.+;K8X,=!:N!++\>9@3NY M'4RODC?MI!PU60$A;]IO6Z#BN=O`53%E"2LJ!DP>H[',?6H/$=!C+.2`B)7C M'SOM7S.V!LG!`?_4H/]C(AD^!.9$'^O+Y4>QJN"FAY*(DTQCV^<@+4`F&5RG MR-M+B8S^K`=(P:M/,_:2ZW3\$U9'P*B>:6,5*6J*Y2$8`H]>\^. M`*6RV?PH2M.O^W('!T[WM,B07Y\/TC7%XX7GW\Y&F1"].8=HRCCDE'FL*%\( M55D"%XR9(M/6'3]:KHK/_1H6PJ/$5D!-T@P(%)*`YY0)!`NM&`]V.L"PM7RG MC0NRDSM#1S0!,X-+J:@R3W*+&LPF^70.LC687&'0S M$;='H1`QF=THXU0,[B4?WUED1,.?S,90`OP\N&'O59J87@T*UDXD#-LC+(@> M^&D#M['"[%;XDHUO9D-ODJ^TVZU3)_`1M_J_4_X'!V[:',H+Q:SXS1-615BZ M-Q[<3)]\0P7,G]S/NVL[^K.7#QT=7U.[LZ%?Q@<(6_=.*QT.SL<#_7J17@^0 MS#;BIHVC8I[,_0!P\[%^_,86,'WU\_^NK2K,NV&3_'6F?9Y,[B;DJA%'MU<# MA4"`XR@?D9OXB%\,Y8#;<7IS%U`B=QD(8Y.A)DRK(ZJMN&2:]:Y&P.824URX M]9EA0#"`AGM!=8E6YCDRB(4IN0G+X(MIT!4J^Z&,A,$0!ZF-:=:NWJ>R!F`B ME1#V9B4H,I)U>GRL9K3EO('VX/2%N,%!* M';[R@&(W"#EC2N+U^1C><$(%53>\FX@DO>>Q5F"T**0R%0_#E`4""!E*``24 M(%\+=^`@G2`9<(/*]HA%(;EURC(8Y\0@I2M;5]*02&,HGBVSS9XI>M0O)LS1X*+@*BG0 MI!MPK.='T_Z:*96C=M?$E;#^>I!_0B0@6V>F`KBPU:8WA2Y;WLLN>58W[Z5_C>;4A$D`A*W^9CRH9@\O21) M)'\N\N$@%^$TAY-<*N4^_"@J-T8O('T)=E_J`):@`!+&JB8+8$YZPI,(@#'=L[$N$>+?UNU^I(WP_SQ`'B@=]I068X^25O^@ MLE\UG[^>W*0]](F9=^./V1,40E+(CZ"G_A8:0;0L>5\0,=2AT(6HQ,6A`^@+ M+RY0#EA8(/.FKQ!X3637T,I#(V$W&E&;*IT]O2(7C>E9L[&"1>1,VM85E1M_ ME!@X[7R_ZJS;I-,;K$HTX1<5P7L)GH:7/$]X]PG1P0ODG?^\8:*/C*TH'U?3 M!'K%3!GK;6P%/3=XE.*_^!+>IR`W29,_Y-CIE/R.)!2\!$4+?NA\G[QSOEPI MM)_PZQ-,Y\!8EXX3G"IB7YAC,H\E!]+^1]DS)GFCU9323`S?90_S:T`-(<:T M-UETJ.#KFZ$-Y$RZ&X7/;`ZY4:,<7RF[G!6^%(@T=%]4!&&H9/,8+DN#P6XP ME[?GD3N/2OB?TI2$(@BP?8;2L5K0PN`U3?*A24560+CI%._'O&U)U)ZC<+&@ MTL19I@@0K"O&1-DSIMPY&[,FE@Z[SR;)&3@V\R0Y;;:(DI]B_`M=38*)A+RA M*,$<\7.-"X2Y(NW1,>,((\FK=/[AQ8V]'`KR)CZ3UZ@8!_,0-]O#N\+VJ;=\ M'?;`%F5PTX&L]&0.!I`)Y:O(+_@'$I%!R;*R3Z@X4X74'P(1$N_>PZU875H4 M4"'^7M,'#'&>7:7#"R?!W[9,]Z$K;[UB26+W%6)&Z%:Q;WD]2!0(@(*)E%S=LEF%HF($!Y5V`+4BJ@KR950H"*DNR#K MV*0_S#X-*@(A=N9KT$CT@::;4I!][W1Z0=,)P&%Y%8#!H])Q M..\CBRLX&:<=$G`'QV)_[3E-+F7?CDP47%IQ.[#VJ4J#R+O\?-#">*_IC'\` MWZ;[KK:JOX4F`^2WQ-6M8-G8:Y4:#EQV+.GE]KT3BA0F.6L$/P`L.W,"&2_Y M@M1`\!3QS+&R@,8!X$'6OXD,X;N#G7:L2.7W"[7B#QD2R[Q?HVAG@$OR@N^J MA3-G*DE$51_&YH_SU@K&D"Y*XJN?&[`3S^#/5H_.%S,!`LP@0_WXCYBHPU M"H#8Z0T(0F@HHF7#C?LF<4SI:O@905<4(\I'\1>5%5^ZL"!ZB.N1T)9RGD\ MTZ3ZD8BSG'.9^D$+=#)B#):KMC?:(8,D'>X*:)(5#?^DTVX]>;Z6M'P(:U"> M<[(/R_DFV$(E"N#"'Q@1--\0G,,V:HY%DZID3A\Q[(+N:(S/? M%V:RF4:9Q<3WX\,3Q)L0P)0B],L%@W++'WPA-/P:JU19D)OC-D4^I(M]6(4@ M9_8I&_=T%@;`*;)BF0)M,+\A9,MNX(4R$N!,9%'\5_$N<3$+FLL8JIX_61&F MO57(?(Z,0:FB<&+ARKO/#8L49XCQP309$AT.DT.2)A?I0&&]BCAB-&D^[$^& M4UE"4'8%!@W0Q4/>KV@`&Y4@5!C"I4]]F'%:3"_#UH<)%71DC#`7A`-MJDRJ M9P)-JV2\4!+E%N9'Y9G@SIF=H46\:VJERU,V)SO`Z)MY%DI(QP6R:G4NTKB@ MY-LBI58B58+L.OV)=0:!;8(%(V[F"@=D3>#?IB[=K44ZU0@&TFN)6:,R5V5A MGU8*.+PKIH\DU(/T`^&/%4B.YDHQIR%$K!`&"D&V)N=[:M-Z-OV">6P(K7.. MO$T*P*,(\64;#Q6+EOF2E'6KL6R_*U/J(^DA8PW@D"V7R*@T(PK9=$99`*63 M08Y646*(-U=/X(J=.`@!LQ:8B&8Y:&8BK"X-A\"A`K5*D, M1SZ>-((3-I\K*0`@6B9H+M->"_W#K&_9R8#74BR6].76Z)\DF;Q>*`$?'[0M M7SFBAR05`0_"$Y=6YQ;B,Z6)U"%HR?F]GK2Q-(G7^*=8$#U$76RQ',N>?1V6 MJK^@;,+(59OC`(<&(6$BRA&U%2UD?52D9K6#@IC04$\%A-B65JJF(1)D;BRU(*LXA3? MT'9=.DG%5T[SS(?8M0H7%PSD7JS2+3_$#+2VY%#:*GLL`G2YB"(+[-9WT(+/G0(3O%>1!ML:19A+4[BBAA(>_4@0=N@`Y" M%(U'9N<*(B#(H;*ZYF)MY+_8BVW78.`04O"49+*& M,3KS3(B!?\F&\>\J-;EO=[S$CSLUO$L`MUMYP)G7P<9+=.%X88 MHZ-:)N'HG ME_F#_#SFD'+9Z)*(,>G`?,BQQ<"(&+>X.L.0%-"8'@Z6,G-D.AG`1,XS=F)% M/%<3*\1]+750V[#8(,R.O.E;%0DVOZ:Y0Y_ MGRJ+Q0D^(.S+553F8^4J9JI4RU5"TND<=X>#=M>R]7H6GA"\S:<*J1#3*66J M3G3AX\,BE0;6LE53X8^&"IP%:$.CS^?XG#TQF;,_C3BB4=HI*,KA6;4BML?+\^Z!JC$RS@<,P=*,+CI-[00E.F MP2P<(2.8:J>K&8.QJPDLB*OM9$DU`E6F\LRQZ($MCBWII+8Q5=".7D.A%6E2 MX3(7"/TL)3#DU[Z6G``.'7>9`+\12;T^X>\>UL8]5;9!/JH*C*%D&2C4TR`G M>JD25#<$"N3Y_VK*T8[#;Z"2"0U&.I"H3`;3:5/SN!QBE*>*:O=#P(']*U1*F=2VJ:"2B`^>%= MP0:%1&J?)#.XOR"K.J_AIJ\6*I:.2_+%[Y;B>\D+,,B2)P6`XS%EJX8@AK_<62_/9O%K*]OK._%O/W^N86!E;S-^ MJ_[.UEYMJ)6-[9?QAUUKE3[Y&N(8RL>967K MQ7;]M\U:'ZJ5[9S7T/J^WW^#%]46T01N*&M`/OH3%39JC@K8:4=&4 M=\60"Q(9>]N_LC=W=W\E!\^+L_G&$I*`8>['X.^Q4[]P4^^MWS^UJN3NW\33 M%VN;"7X@9768&]K5[J^;T&`+I*;M:T$Z0$8PBH]( M\O"N[NZ\;9ZU5TG@66^L=Z<<1E]XO*:SY+V'W)I]Y]8L^3KFVVYIO\M?OJ'Z M&A6JXOUFIY5T22'T$CKY,>9_R,S'2761:ZG3CHYAF?4??J;4P.IH]"U?N4(' M5]A;1*V5.9A4CBSJ($G?HG@<DTK4O+F=B$/.88:< MN^""G7>6 M$ML7/+?M&M+(0K/S`/QDT+$M@Q$[.6P;ME5@E$WI3;6SV]BAN0Y;SR^(GH8: MX(UMUW3GBP:C2=J&&RM`V(R7$Q?,#.OSBPK+KLRLYBUSO7[4"8UM#*X5%202 M(@,0%25;>4P[2?(L6(EZ27OY2%61SDR0:(;R@M5]D)V/,9SMM,L+B1N_FK#! M^FJ*M3<2#U'_SI+5O*PMV:754JT!Q]T2?BY\H?D/G:U_,1BS["JV$1VRZ^>1 M2XN%O,`PB+)V0P\C!:`&>]=0(.;TN[@E6^;HT%/`[HX-*L#6=U@3.@M)-41G MEAB%*`JAK$:PC]Y.A6!WM[5:`3+0"G`SB[^ZOPIQX;-XRC;:V9JG,(-&Y>T" M^9JAXSI.56:G,1X$+E`]W:+'$/_V(+-$ZF3PR1D@CDJI2J_@'OE2E>:4FTDV MUDE9SFR%X+\(` M>,Z[#8)92>V>8.Y9KVK+GFYM%J3Y=&/OI?Z(H6BXV+1''B\>P;]D>@BVBBO1 M`AQ$5+7T76&B:AF`"C;!7-&LP]D(\]TZRJ^]5[A$KU2T";1=AA2DCIR$T*;Y M(^X_\BU>WQ4Q,V@ET/(76NV6@-?V06GAQ-C4DU`EX^)MA4)J MV7)T?J?@2*O/?+J]52$)%(YX\#Y4+R>Q>1Q[H\XS]][NUP^\@'C>CRI\4;+* MT(+[R.HJ3-#4I7$DG,P!"<\^O2$"]LFJJ="'3S>H9Q80EMN5MYBOD6$3M./< M\9#=&KM;7R,:']%Z]=V[DV.:K6)QQH;?PI<>LBW;9ELN_#0>_^?/KZVQB77F M0(_*NC1;1M)9H0Y!S-J=(#(@9:2,4BXW6*"]Y`.\%,"0J5=P1HF"FIO!SZT1[8XOW$ M,KKE!ZK;J_;J<%34JH0&-06ZA%?C@CHS__RYU!O+N=GDA5-PYUDOG2&L-:\[ MS2JWC+\PP$UF6[.4VU`M1L'`8-5AX&-6`\8!H--`]>!73*?AS=IJXQ>=M^.] MCOAAJVJHFV%2"T,=-`_/**X_>M].WM$>@B8+UJ4L'FG):P]QYH%QYI*/XSFZ M0(85W\AR$(I+IT\P0TZYSC3F@LB5V]M$4N-LO M:B9U9+]P`ODRE)^_-[/?#\?YD\*QDC`@54H<"*GI>TEJTY8Y9=<'B!O*0FT,JDD&5KZAPE MC?.DS@T;\P2&5(I:R2IJ6!J@]'Z&#ZGNO]L^./UDYTB&O9*,>TW4/ M-I<]V*H]6+RF2D?">&[K$E,5WBX?`A+!"=HUNPO42D:(H`JI`B_297>JF[DH MP_Y1&:6V+O51<8W%-:X2*:YT``<=@J-3=DZSD_G!%W=WX?YE:H32'DD.G]-S'$W8KR`F!Q>J+/)SW^7$Y\MJ'.W+ M_ET_2=?#^ZS=:M/7Y_51N]-(Z``4;^P1GSPDWM^8>'_$0/'<"P00PL_;!%4! M1'T[<3@S'2*@/Q09G9="1;_F1PJAGS_?G\_JCE5WXH2_1$*-6?=GB%@9+(7+ M$<.@^=5M]>.15JS%_H)?Z:L?_UI;.,1JS%B47EEC?937Y&IPF:/+*FK]4MBS0T!JR.QA.OJ,2N/,!H^PY0@#Y M6+CUOA9?(]F8KE!M8J5DIB']TNDS3"T2Y4GJV*"W2_1(F5LPE?(KZZ=59Z"O MQD8!0(23.5)]Z_QH,`K]Z@K35;5\JD&QJDR5GX0R-3.^K5C:AZ0!?'IGEDQP M_\MK%0A.TL/GTA%8!6)N;W;(M0X>V3`X!-L)B1^H`>#B!X6@Z=JCRD9IH$%+'B9Y_W:T^:7Y'[$#@&_BG6K M:0T#APV9HZ06PK2%$INC@BBOFN(1>R@8O3[=J\;&]M8M>C(?^:@A+]PS85W& MG&(ZY.#:\9M#*:88Z/>__1!B#PVQ]X]1FQ'0&L&GEU2E7F+VPE=<2;*YYR,A M0(,_M]QF+6P$/[B"481-!:YF&D,7BXX?S!>$WA->J5HBBL]MS8.7@B5JE^$TEQT5:7XB@BJL;XVQ83(:U\0YKD9-MF6%1>?J9N+=M..:/XW4A91ZN&?8 M=?Z`ACYSHD=SBU@=1#%SF,$Y&I,:9W`N=VPEQTY]Q(CQ!KI@50-*_"[>\M)N MN?&[*YM;\4^5J4K`%5[+/8:O0%$U!%T\1=Q%OW`/<4QO:?=8MQHXWWM)4\8\4 MQ4;='7P&*"%5_%X=>[OY"Z"%]VZ$-GUF+V!^$:VD,7.2Q7 M6\UP4AV;)D9`\0GF"AK44D%,,Y?])1ZE"YB&^+K.'\E&.ER`OG+K+WN;S4L/ M;ZL5&`U1>6\_L0YB%4]]GE)4^71C^\77QZ[)/J)?BI(#M[:GVR[,[H;?_`7# M1Z*QIGGVVP?MLS/*&<[:V`_O:Z'F^/E#VN6W''".OXDI3P*A8H2)/JKR(2Z] MAS_OEY$A#%@/&%9$/)(J7D?XKA8^O/^S_=!J.13P(WRU!PI(RU:O^L&%J.-9 MPTTN=5E?#.QZ]T%IWI&0(079$WR.!RL^&8Q6P\LF*6$21>67OE^\7)[`63XX MO!L=(*J]>U9F(1&X'C(U;;:RN5XO\MK"MNCSZ"Q:VV7BYNV#2QN[+^HA[C=UZI>#*7F-KJS95@=L*G>%/ MRD!93%E'&*:_#H<`K#D9T=I&M)5:KT$E]'F1NSZ.B>((NCN6^DSIS%EF)7I46\8>E$E-?%N M3'^Z,`F2&Q=%\6=KI4ESXGRLH)[7@':>4:,?4_W^H[65EH0M`@3O?('?_R@ M+(ZIZF+9Y/XV@>@(T)(Y2]]GP8?648,T3C,<;;0L3LC5"-M^[I)AZ[NR_%2Y M51M""DK'2LU&)#L!K)$"\NIL)($`,H9!:>BX:A5"Q!KHO@;NJ0VP!OH8E[$@ ML4**+JLJUJL8A$MA:S@MV!UU4@1*B"B7)2,1$QBOQ%X+^P+F'(_]2>[S^3@G MM*/3$-6SMCW9LAS=,K3^L]_L7)O;SP!<_?0\E\R?K#@T:A9/N",^AG!AR%LZ M%CH\]QE2)J-(&TG`0Q@>&[UT-+CM0+ M.M=V@QHMK/E,B7#D=-'T(35NBT$ M%@\T741Z-'TEQ>E&<#4&1%O==9'S8&.-4IHTU4!=ARH=<67I]&E0J[H"K>00 M"+&I@8I^50]:XV5#C5A0*SOFOH#R'):O>O*PKT+/-$K9@15$E#5`R%^4""==C1>7U10^$TW^V[YN^HE-YV3#]_X?V?5W$$V*MM-"4Q"J/O&)[7SS4 M'%LR0%*N'$:_**VX6OX$Z48COZ[WT':U0M9Q>YI?9@Q*39M=,;&WOO;2CNL$ MCO7^@NKYQ>(5T@Y"_[38E9;3:I\$41"TP;RYJ1V,Z$HVHBJ_ZL94)I3>E(_A M:FF"7:7,BL+XE"NXI5!<:''P\$*MJ67Z,:5YA.+)^4C50!RO0%.HK7O!WBB& M"0:M]O(VLP8C(^*!,L&\\@M%5>%,C,L=AL72&(O#QQ0*6A,I(#A6]A<[&F,2 M)2F#VK\:H!6`HBXAY22F).URD=#ERVT*M4.4AU,ZKH;)TJ'((YVY0#>9L2\W MC'H.-('$4CH@*^@\.V&#NBD=O*5^V?4.LP&":-/Y<$JO%MI.BZZ-?LA1/S)' MO?HEJ9TE5TX#!EDY5H47JTB4CK4`WM@UG<.Y&$AFD2O.?D&H8PHLGG5_A.F4 M)B*N51^.A?VN7\PK$%3#$9OR-/*$1E'AL))Y`+W2;8J(.:#1F6>R8(R^2ENQ MF$_:#[6(M>5-#;A'&_$$X`K"RBMKN;2(1+$WB5@E_6E"I]I>Q2(,\U^G%!_/ MKI.R/K:(+-L7+B(*>-9Y>O'/GZFI:(S+N,5#^C]C)%\WK(;9X"N\XJU=" MQCD2-E&-$!3G1\J5`J7J*1G0C!00$$OIPF^%>Q)J1;1;;:3E$B:!!DI4B`]P M?]!*U64G+MG1HA+CS_=$]9<@5XG@<" MU>E)`<<&IQQCSTSP*MPQ-CPO*$I9HFW4_;KXZR)T*!PV#2KUS"DG\+A`?C,` MR.S]4I5)A!DW5.I*BAW4((4L/>E-<]70^\3LEF&J3A\N.E<1IUM+Q.E6\K<5 MIVZ^_UO$J5\MPM'.=#Y"G)9?0"W_%*?6SNSO)$X]*O[:XE1"QXR4_[>%JH-F M(WGQLO%R;R^(,W1@+!4+F7J_5-PE)89XWOA"R>B649.,1(6"HJD&@1;91DA< M)*PGCDJ\1>F'5;0#1T@Q5P8Y`2M,F44-66JS$YLL+C'9F@LKFF&X2#R7MB)) M'3MV190LV$"0K`PMV6$NS/AT8VVG[(S@0X58&V75(QX1):SJ@\B2<53LIC?; M)VKNZ>;:>OFYK#MHMN7L#U^P5>K%^]&&2MU:)XJUMQM(H+ALL=P`KLK4K!.< M)F9[:F=.)3Q#VLD"?D5K10P+5TK&CG31%Z=7PJE9=J*U?G%YB4PQ9JZKXSKN MCCF)UTZZS?]:+\3CMMCBV4/^TCM?3UE^$7M"W0CH)IB*6Z;!GNXOL3O7X2DK MK+0]V-E5GG2GCB\AL/6F5HRL)^ZPUJWG--F_`/3:[IP M\!.UV:N0XVA5+[ER,9!E0IB-\A(R1[$@2+,"2:-.=2'P)[R*NO?TDL(:B:T' MUE63(SK/>]BU8X-6Y4N/3/7+;',ODDC42;^>2,]G>Y M`)6M(!3F[D65\-)17J/J4!0/HSD!*KD4:C'POB"*Z"9^'O%XFP M.1M'-2K%<0TT@5W.#2_W.2RN\AM$M0Z3T[FG**2VR*4M``Z5MK-+)3XJV,`` MS$NEI[^=L<9H[I!K=%58L;)[:#G2)P0R".O*6)+V@IP#.[CHR!SA%EJM,-$@ M^8`FVP=]]%";%U1H49.5TD4I'!%"%[._>A4&)\E[=CNAN$J$VW'WZ,?DL--Y3Z%G]>Z;LY-C[L%I+3[-_.@/'Q)( M)]2$/GJP>/G438WZUF7*1^<4.Q6QWZ%U"K,C_@H1Y>_;]E@]:'9>AXBHQ<5N MQAD=FNV:6O4C#35VT@%T4[%SO2@TFSKDWM74P=WOF\&>#.!48W&CVJ(Q+F?< MIF/Y=EA=*M*-*$M2S=HK#YG4T7PBP8RDZIHQ"6>24?J]P5Q MAJ8#Y74`UGS:='L?5T4BPQ>0>GX5?V.@H"5\-.<''+=3N/E>>'$ M\=0-SE\K)S&XL+R,A$&8I9&L;-:?%N%B;`EV20J<^&Q^CLUI^L8.9$6C;#TO M8H[:A9Y6,R08:&J3NK+]/)S06/J6EQMES'K9(@2'E9WG@,>UU=&(`1\&5FN; MNOCKLF>].JU-E*=Q4"SP;LVE"BQB'C,=_%M>KR&?C9.L&B2M4&0V(;"V8 MP&CG@L/\R!=GKZF#?BA*3B\D8XM3(AL[IE!?&.)1N/FMJY'RP1@S@+#VQGDP M%Q51AD1=]FG^2=IWSK5;6\LYCA+[9#Y0.&$%!`->`CA M"@'=N6@U0\594]T6IM',NS63M,CG^FRX>;0HX9U?B:O@%PPJ&4$A+>RK"]6I M&F6N?.L_[V3\JUQS_W>^DU$DZ$("I#K+R@0II4JAA!U^E,7H$KI6:>'J!)P7 MA+E_@]2R1B2H&A%;[6)(+\WF"QPU?=E,'#?>KM-BT$"'1M*QO,D7Q+B,([PB M-YIU6W`VA2ESY"VJ7:'".$/NE367-F&3+:.Q%89U"0^'' M,<^"2%SP]+[TZ)B"B_7A4.)V^QD64X2P"@A+53H/QYIZP;Y4S+%ZGPLG`L-M M09W"9FV9PL3/49^8O75T[NL9XD8GB%&3YX@*/<%],S!9P^C"A1#HRW)6M**T MM'.9G!,D%XA02#A%Z:BI^-,=JBSJ"H2B^8O!N/D(P-N!?WG9K&#N_%Q9R\G/0E(7>S`+S5BB7'QU1NC?3$VDM%`E0%\WT!0VN M!P)K=J9,?J[SV9+=BO7,C50TQ.![0O:7OH<77?UI5";?22&K(KS#+PL@XZ:6 MD2^7S7QEX,>._A?-/J-60=AQNEC*+F`2-\2'[(^%@L[.C7(G MTS5"PK=N1()2-3[T!V&B^QG<2&AV)S?^XE(RK!A"G?G:B>!O"%LB#1.F%3$5 MRVYO<3\S0_FK!'#$++"L)R0I?&*,KUP#8N9,7>Y08@3727+)@BEJ+[0!I)N+OZS__M M?ZF_JZO!@O+RV:5K;V(%D?-1]R[CEMPZ&]FM%8@5W4'C;[JW&>1/7FU<_5A;6!/=W`]M8$SWA!XJ0DR) M;FC(8[A$9!77*%EO,\08+03/G&QXQ/FTK9HA02_YK[BL.ED)ERS6NG0]YDZL M9*4K]3&I?^PO/:&G"M$9]_!&-PI9/Y&Q0%\T[@=S'R5EY!"6>*6[N MLW38N2X_,@*`UAF"4%U^XD'O;RRS=(J6-9RR&\D23O?'=4N+)NC"T%/(O M[;+B0%6Q?YJ&L7BZN+'!8W93G.+VXK8&L$6QI*4#MXON624!%>D78<8MG!Z/ MEK#IQSL0P$K5YQK-_J4-U<+#L45X'8@%ZK1I1:#63LS?-X\-_ MM9BBY7)/CYK'RDW9= M"Z6=M7X!W@J,AUQRJ4VGN#VP]H&BJO&/Q(V9V5DJ-35\7/1M+BY1G+C[IFK4 M7KZ*>SL=7,YT?X3%%8SW7>G2!VYK+;/"952=&A9_9)\N7$,<:4O:>YL,.8>X7=+/7_AJ#N+1RT!&4YXE,$AB427'3)O"5LS7FOY]2W-N2F1<`>" M"CMYP?7-CS,L`MDG*^\[^\G3FH513KR,0CR]HF#D%@A=%9&1_/Y(1NXA[MOD MW^)-S>/]]^_^#VE7T]M$#$3_RM[20P7E0^*&%(4`%6E3)0$)]11"$06IK4@% M*N+'\][8'GO'.]X6KHEW[/7.C.?S^8)HXM6HJ(?A.FR_@5D4>*E%&98`[];; MAK[LY*(0_/(K,C787]S/5KWJ3&^@\Y9"T^1&FD#32Z>1W1_T3T@G,]X__KGO MTK_VQ==2OH$-"]Y)L&C^CV2^]TUG?>":[G$S["$L-20!B6TC1MCJX&4GBO>[HC!&MN>>2)HL\DT(_VP6JL<=Q8P-+LIKW-JBECY%+6,4H^1&KOI M*[TS"%8+?0(A8;E^R,>53H@N%&@"[)IOMKJE/#?R;UO5>/N"\& MR4V8-JYXM!Y>AGNJW&<_A/=I[%.+^ER[\;P/$>G'SO]TPY-`9'L?)GS9G@!( M$;XWQ51CZ_=EHS##,G:Y>70=+S8=DY93>F[L.E]#T71<:X>U*<.].8JK+L2F MHJ$BB21*=^$T*CCJ]YD4Q\0>&J;#`AH[OP>Y3@*<[,3L!Q('+ MK$,%Q;%4Q>P0/(G.F*+.NP)4`/;'$RWCZ,/\(HPPIC3T`[2"Q!K'>PH0^P:^5E+-HP-O-,P@[\D+L$M!KB\(PZ M*$;K^0HV,HNU>3Y6!F4*3B"WI\4V$2RU6FZ,8QQV\/[(@G%G;P8?CQAH;H+K:,Y8]Q2NM_/[7++/Y_9/TOWN7+< MY[C#/2;!!3>>-FJ`>W37?DSTXC"86FP3X1[=\6EP803ZFIA:&\66#(NFH)5+ M.`B0^.Y:G9_\H[;8^!A_V06PVWC4C(Y`"6N,HLH*T!T]J/U1I+4?=4"+*0P%L]C,;K M+=H:WORX_H4&MSEKGY%MV^/L7"#C36OU`+A%_LFQBNTN9V@,N2,_*HQ%ZS@5 MK$"&;/JP@G;_-C%RXH9>"O,R&.JIU)>T=V%SY,37&NZ&K M/Y6+2C.A,5%#BM6?VFKNRC]#&+=WB.ZR(=%NCJC$!.QA_\QF/S58=#%\I:3, M[+UE;MKT1A2QI^"'17"#WVT?+S_&R@EP-\*'?-O*_UJ3:N*\!H-E@I%9M=Q% M#"!Q(EM6=?(Y8D%\8Z;@HR#!;CI'4=M2-)A*X8']/)M^H^5/7AUFQ_3Z'TY*<^)%C1[EK(PV&4,AK^F*NKGTT\$#=_=5I;;<.HE60%VFE,I/T6L1$IO M/";3[`=$,]5W-5V*0%8`YMBF*:UUM#ZIME0-V;6<;%$L(>TP435><7%VU.2) MF$;V9YB&04N%RM:K6%@[HJ"*;([FOXO"&SM)M!Q0.H9@"WHV(&-(J+=.5$N! MZ2PI$_AW$G--EY75;-A<5@*PLB:8QD'!LR2CP2NI;J\X#*@)<#Z8&I$&C9$R M"!'ZS_`UV)6F#G816'Z\W]^^_`L``/__`P!02P,$%``&``@````A`)@I-J%! M"P``KV$```T```!X;"]S='EL97,N>&ULU%W[;^+8%?Z]4O\'R]-6NU(3P)@` MV9#50.+N2-/IJI.JE;I598Q)W/A!C9E-MNK_WG.N7^?BUR5\YW MOO.X3SLWW[\$OO;%C;=>%,[TP65?U]S0B59>^#C3__)@74QT;9O8X_NMDFK[[[^;^L\N8&]O8PV;@B?K*,X ML!-X&S_VMIO8M5=;;!3X/:/?O^H%MA?JJ83KP!$1$MCQ\VYSX43!QDZ\I>=[ MR2N3I6N!<_WA,8QB>^D#U)>!:3NY;/:F(C[PG#C:1NOD$L3UHO7:<]PJRFEO MV@-)MS?A+K""9*LYT2Y,9KI17-+23SZL9OJ5KJ4F+Z(5@/C=OW=1\MUOTE_O M?O_N7?^?WW[W]S^[JW_\]$WULY^^U7NY&B(3?-`N\[+?*A8^3B7W,@MN;]91 M2`P!KS."KI_#Z.?0PL\@&,`\_-KMS?87[8OMPY4!PG,B/XJU!+P,]K$KH1VX MZ3<6MN\M8P^_MK8#SW]-+QMX@05&]KW``S?AQ5ZJX;QZEH@FMVF",#B;AGB% MVA2`239>;+?)_E>-39RN4;>N8_CC=#$KVNV2IJL:%Q4.C]%5^(KHB1^7,]VR MH(8,^GVDE3KL1,JFBS[H.YNRJ]'9+!M:0VLLU3(N%JM^0X5#2R:5'0JM]^.[ ML]$I7UF3=5D9/E<&8,+)9=&#U&W)[[&%/^>(DS-W:%(]!@.XY+WO/89I=[O= M;6!$Y\3>)D'F."C9VR MOFMQ=6\M[IE>@DP418-0RUJ,3R#T?CY=R$>ZF$YE"S4L^)$L]/T(?R0+M>"_ MA31.L^IER@)9R-,2#^&0"D;TZ8JK,B&`*`\6@T&0VFA@G_L^IY>@2R.1WIJKU*$"CR M*D&@R*MLN-V34/FS3(&5!\6Y2A`H\BI!H,BK8\D5>*S:IRRA>P40]WT\8F#!'3*_=WOCN.H$9:>P]/N'O)-K` MO\LH26"CXO9FY=F/46C[\+*7M\A_M[2$K1S8M9GIR9/G/(,R;GDXY295<2H- M1=4S<39ACLW^V!P95^F$39+JP%UYNZ!J7:&[-BZ!1N2VVW#"85@HR<*A7*WJ MH14N&S M\H1K]^GJO7#T-EK;*KW&9F"_M+0`7\+2=?8R[>[3-V!34R.CL9%F;S;^ MZZ==L'1CBYW28"K855PB+]_-V3BE?,^V&@*7K0OJJ9@?XRAQG82=(F%;&TUX MA@UX!ID@$3S'Z#<;]`-/PGP9DLJ,$%-*C; M\,A$`*L+.0)P@@H$>+XGXP#"4P4"F+7E""!`2P0`IR4JCLF#`:EF$`.E2M!_ M*I508W(K.94GM+*I_(+^%BLMKOP>13.IMQ#H)5T^4-FFJ^,D)(T04,)2-0!MH8D1>5I.:"SA)`.R-SB>,0$A18 MBE1#`#A*(!!'#!3UOP.*05$/3*-!41=,(7!]\!ES@GJ"ZR$580`\2K*B'"<, MN![CC#00"*HJ)(D&0U6)I!A4UH*I$$ M`C"BI$)23Z@JD12#JAI9NF*HJD02"*HJ)/'$\,0ELD>73=-%5+)^.L(MU*:E M1W!0/OW?]]7+NG,A==`T:0)9>?-T]I3.',$7;"Y%IM)X1Y6-Q[1Q[51[BF+O M%YADXIU5#EQP8QWOQ$L\AU[Y.;8W#^X+3$73;:>7]5$&=F`J]<.*N:X=HEPZ M/T=@$?!T!Q&=EN.Z2N>Z_%Y@\&O;G0'2B8$M+*@&@5QG&*2'@*04P<7\[DI=7Z\Z MX-07K'1UNI,A"I+MWQ_6GY`([4#Y!CQJ8D8B(_LSL+/&L!3EE`SFCNX8;D@I MZ7".C%;I>)JCM2&KVQ%\)5D-WN2FKGP(-PZ;.T=%]5'":<,5?U[=/-M:Z*QJ M4M2#EO]/]31I\SF+%$9@UGA>1H9`= M[\#S$=A0!#OPB53!-[E=E%:1V5O5[_6PA8&^,5GEC,#D3!GXS*U4[=5@E&#><462IY_8EZW$<7,Y M!?3SL?H5%DF^%P0Z^2)>7VTDN/TT4=VQJ%?FO/#814F1?@-.@>S'\QV\=X43 MXBL&=/`Z-2EO\'+)QOVX^%^M;J>D!S*M9CFPJ]XJ3T>A=*C,;NIAGY)>D72` M[QR=#M*BKP*F<>!"QP9'=9Y<]+]-?UK%82S1$UQ[E::S>[&H(^:B@`QP6W_G^7"O/)9HW&)W=ENX37.>7LPV1=MD%9V>@6-%(@L" MX5!9Q?#(P&,71!9L[APJ"]2GU6<(UA)9<`?0P;+@*$PF"P_%E+A,V/@Z%!('*@G`[5%;A1Q-SO;1Q),C]5:T?^5C%LQXBN*BLTH]\K`X% M8Y7**OW(QRJ:?"BNTH\@E?!EP@>'RBK]R-<)4[!.4!M+/_+$HE5)ZC8_RH6"4IU)*?_'Q;0K&=RJE]!3((Q:9\(&X M186/ACR[IB"[7RK$\4X?"8K[0Q05'/$2#'@K M`N@'>/0X/-5<`UY2AO@8QK,KAX@I80-`BDCZY.Z2V"[BCT\I0Y"8 M3WA#,GN'\Y)Q%GN:08X!A:!/B?=@FA$5L1(?"L0"$A#UX" MCYW(DY@3@;!$<#Q$<*:P$+%7401E_-6.0\P6+G7W8K3!HO*$)HS^5R_ES>V, M]P0?SL]N>R_F`T#4REW;.S]Y*#Z7K/[('ND`P9=_ZT?L2)4S$3"]??\0G MY4`6PPP(RLW'+3Q]!7YKN]B;Z?^YGX^G=_>6<3'ISR<7YM`=74Q'\[N+D;F8 MW]U9T[[17_P7*,._9'`-C\(_XB\%L+]H`&_)Q!GQF;@/Y?79CIY MD\)GYY@`-LRH:9F66%.B0-))?1O:XX`!P[IAEP&[[3!L*]`"NW2? M)EN'K0/Z%?9(2K(8RTO2!AO6U8=$(G]\_]_C(W7UVH.(H4,B).5QVZM=KGJ( MQ#X?TSAH>W>&_4L;'I(*QV/,>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6F[CMA4HE MFY6*]&$8R\L\(3',3;B(L()7$53&`A\!W8A5UJK59B7"-/90C",@>WLRH3Y! M0TW2V\J(]QB\QDKJ`9^)@29-G!4&.Y[6-$+.99<)=(A9VP,^8WXT)`^4AQB6 M"B;:7M7\O,K6U0K>3!`6#?!TVM+$6:]?Y&K9/1+(#LXS+M;K51K;OX`OWU)9E;G4ZG MT4IEL40-R#[6E_`;U69]>\W!&Y#%-Y;P]?O/R\1?E M>%G$__K#)[_\_'DY$#)H(=&++Y_\]NS)BZ\^_?V[QR7P;8%'1?B01D2B6^0( M'?`(=#.&<24G(W&^%<,04V<%#H%V">F>"AW@K3EF9;@.<8UW5T#Q*`->G]UW M9!V$8J9H"><;8>0`]SAG'2Y*#7!#\RI8>#B+@W+F8E;$'6!\6,:[BV/'M;U9 M`E4S"TK']MV0.&+N,QPK')"8**3G^)20$NWN4>K8=8_Z@DL^4>@>11U,2TTR MI",GD!:+=FD$?IF7Z0RN=FRS=Q=U."O3>H<],9&R;,UM`?H6G'X#0[TJ=?L>FT1.[P:3?$45*&'=`X+&(_D%,(48SVN2J#[W$W0_0[^`''*]U] MEQ+'W:<7@CLT<$1:!(B>F8D27UXGW(G?P9Q-,#%5!DJZ4ZDC&O]=V684ZK;E M\*YLM[UMV,3*DF?W1+%>A?L/EN@=/(OW"63%\A;UKD*_J]#>6U^A5^7RQ=?E M12F&*JT;$MMKF\X[6MEX3RAC`S5GY*8TO;>$#6C\S210*:D`XD2+N&\:(9+:6L\]/[*GC8;^AQB M*X?$:H^/[?"Z'LZ.&SD9(U5@SK09HW5-X*S,UJ^D1$&WUV%6TT*=F5O-B&:* MHL,M5UF;V)S+P>2Y:C"86Q,Z&P3]$%BY"<=^S1K..YB1L;:[]5'F%N.%BW21 M#/&8I#[2>B_[J&:+T5';:S76&A[R<=+V)G!4ALZ%8JNU'N_*J8E+\@58IA_#]31>\G<`6Q/M8>\.%V6&"D,Z7M<:%" M#E4H":G?%]`XF-H!T0)7O#`-005WU.:_((?ZO\TY2\.D-9PDU0$-D*"P'ZE0 M$+(/994FRE)")J(*X,K%BC\@A84-=`YMZ;_=0"*%NJDE:!@SN M9/RY[VD&C0+=Y!3SS:ED^=YK<^"?[GQL,H-2;ATV#4UF_US$O#U8[*IVO5F> M[;U%1?3$HLVJ9UD!S`I;02M-^]<4X9Q;K:U82QJO-3+AP(O+&L-@WA`E<)&$ M]!_8_ZCPF?W@H3?4(3^`VHK@^X4F!F$#47W)-AY(%T@[.(+&R0[:8-*DK&G3 MUDE;+=NL+[C3S?F>,+:6["S^/J>Q\^;,9>?DXD4:.[6P8VL[MM+4X-F3*0I# MD^P@8QQCOI05/V;QT7UP]`Y\-I@Q)4TPP:/P@``'(V```9````>&PO=V]R:W-H965T M1\54!.M)%NCG(];6WNX)DH2 M:E0L(9.9?[_=-*C=S?2+<[,[Z3Q\0/<;&EIY_./[?C?XEIW*O#@\#;719#C( M#IMBFQ_>GH;__&W?/0P'994>MNFN.&1/PQ]9.?SC^???'C^+T]?R/8]VZ?EJ#AF!_*;U^*T3RORX^EM7!Y/6;JM-]KOQOID,A_O MT_PP9!66ISXUBM?7?).9Q>9CGQTJ5N24[=**''_YGA_+MMI^TZ? M;8K]D91XR7=Y]:,N.ASL-TOO[5"_OVC3=M+7K'Z3R^WQS*LKBM1J1 MGX1=MF>C&U"^ M%Y_.*=^&^2$CO4W&B8[`2U%\I=3;TB:R\5C:VJY'X,_38)N]IA^[ZJ_BT\WR MM_>*#/>,G!$]L>7VAYF5&]*CI,Q(G]%*FV)'#H#\=[#/:31(CZ3?Z_]_YMOJ M_6EHS$>S^XFA$3YXRU&;MMPV4@\-J\E[3:^V!"T#9P.>3MD5-,A:\NN6`,I?AY#G>^V MM2P>9CPQ92(4L60A%K%E,ET(99P>QI6-4,6#PI>%>+B!3(3=A+(0BT0RD'R8@AYH7_[!KG$JG-#M^)RPQJNJKGTL`8V8=)+_EIL,,4&2VRP MVX;+E4M*H--EA.G'[3)"DKTN(]3QNXQ0)^AAPAXFDLU,O^?3'OV."+#8'8$(H-4=N@"%K<982` M)*TA[X:>I9I%#X4`10A%!$4,10)"K!A8;<==\0&JJ?AN0NX1*(B3`[KIA1A08*$PH+"IN) MA_IY0M=FVF0RX>/M,#&KA6;H,R($XL(B'B[B,Z+HD0"*$(H(BAB*1"6XV-`E MCNLG/_6\3;40&UUXJEHQH^BD-10F%!84-A0.%"X4'A0^%`$4(101$\V?P$2C M?P+\'TE\+H<0^3=)AS^+C@:.2Y\H;+31RA\I'B*Y[]9^Q-+9,QMWI&.*= M3H.4$6)U%,3$52Q,;$P<3-R&L/G@09H,/%S"QR0`>PEQB0B3&)-$2?CXT)6Q MZ_CT6^[2V((:'R/A>6[5(-;I]_.I(?7[6B"3N41,CNCZ;+&0C"68^X4\W]N- M4236P<0]$[J:+\S:WOF75X\1YPM_O73O8Q)@$F(281)CDB@)'R2Z./8+06)K M:GR0+I>ZNM-6&D,L2'>:WA4DCDSG4RDDIE#%Z,BC)9CY5`Z;W1AED-C1*(@K M[(D_]8:)"8F%B8V)@XF;D-8E,A7>Z2)#9Z.C_<2@+V$ MN$2$28Q)HB1\C.@RY'6,P(6(K5KR\9%NLE5+FTU\(#$U2"Q,;$P<3-R&L/AT M78?@L?IX+P'82XA+1)C$F"1*PL>'+DC>$!^V?LG'1[JU5BUR-O&!Q-0@L3"Q M,7$P<1O27GV,K@3!P_7QC@*\HQ!7B3"),4F4A`\179R\(41L+9,/D71'K5KP M;$($B:E!8F%B8^)@XC:D"5'7AVP>KN)C$N`=A;A*A$F,2:(D7(AT<=VZW_U0 MO9GX>"9\+6/5(,5-\1H3$Q,+$QL3!Q,7$P\3'Y,`DQ"3"),8DT1)^##=MH*M MRRO8QKUPB[EJD#)$>`4;5[$PL3%Q,'$;PJY(G8NI'J[B"U4ZUEL#CNCZ7)?7 M9$/!=*VW1OAH8DP2)>%C1.:H&R8VG7+^LS1M(EV+&%+&"!*SV96BBH6)C8F# MB=L0]NV1.\V0!]?#57R^RJSC.R@!3[0I?0X4_DI#P2SHK9I@(GPT,2:)DO`Q MHJNNU_='/:'M?M7W0_')1?P)Z1SX"%3Z+#Q&(\!'$F-!7<7X^;"P\[%4;]@[)/CN]9>ML MMRL'F^*#OD9S3\[@W,I>\8FT)7F%@7S346@GK_Y\J5^Y$=I7VI*\!R)[4UN2 MESWD=EM;DOR6G M,AG=DW7-$WMGB/U0%_X?``#__P,`4$L#!!0`!@`(````(0`%T@G'E0(``)<&```9````>&PO=V]R M:W-H965TT8`U8P1K;3M/]^QSCQ2+)5[0V)X3TOSSG'/LSOGF6+GK@V0G4%3J(8 M(]XQ58JN+O#/'P]7-Q@92[N2MJKC!7[A!M\M/GZ8[Y7>FH9SB\"A,P5NK.UG MA!C6<$E-I'K>P9-*:4DM+'5-3*\Y+8<@V9(TCJ^)I*+#WF&FW^*AJDHP?J_8 M3O+.>A/-6VJ!WS2B-T[OHKIF0/%AO1"OLRF&(DV>RQ[I2FFQ;R M?DXRRH[>P^+"7@JFE5&5C<".>-#+G&_)+0&GQ;P4D($K.]*\*O`RF:US3!;S MH3Z_!-^;T7]D&K7_I$7Y170E+8I M\.0ZRJ?Q)`$YVG!C'X2SQ(CMC%7RMQ3"=`?GN=1EN;3FS>X$$\T M)'A/+5W,M=HCV#3P3M-3MP63&3@?,_,<(=?_I0IXSF3I7`H\Q0BR,-">IT6> M9G/R!#5E!\W*:^`:-%E\IEE?:I+@0H`X8$,QQMC_;L21SHD=G:NFPUWY&Z=9-U=>,^8\I[Q4 M9,DTU-M3^@'ASX_DNN9KWK8&,;5SAS^!C1_NAKFT3(?1$A[`7.AIS;]278O. MH)97$!I'4WB_]I/%+ZSJA].Y418FPO"W@0\`A_T;1R"NE++'A9M=X9.R^`,` M`/__`P!02P,$%``&``@````A`'E\A^^O`@``Z@8``!D```!X;"]W;W)K&ULE%5=;YLP%'V?M/]@^;U\);0)"JF:D&Z5-FF:]O'L M&`-6,4:VT[3_?MF-)=-BD,OP(@U5.:\ M*5/\_=O]U0(C;4B3DUHV+,4O3./;]?MWJZ-4C[IBS"!@:'2**V/:Q/<*JEE83R@\YW0J>>EO_2!:;W*.3BP94>*%2F^"Y/='/OK55>?'YP= M]=DSTI4\?E`\_\0;!L6&-MD&[*5\M-"'W(8@V9]DWW<-^*)0S@IRJ,U7>?S( M>%D9Z'8,AJRO)'_)F*904*#QHM@R45F#`/A%@MN3`04AS]W_D>>F2O$,-.R9 M-O?<4F%$#]I(\=,MAB<*EQR=DF&_4W(8>=$B#N-KV.P5%M\IZ8QEQ)#U2LDC M@L,">^J6V*,7)L#2.W(Z!H]_LPC>+,F=94GQ#4;@0D-;GM9Q%*W\)Z@E/6$V M4\QB/H9L>XBMG.7-^L!OWG"<.]?(MV,KO]]VX`'`/ M?B[<;*>(13R6EDTA%R2[*>*,9&1G]C]V+!B.UIGZV?QBZXW#S,\P%_*WKR*R M5Q&[?R%&_D#(V]MEP2F&X@W=B:/9N/@;AUET9S&Z#H)@O+X]7U^&D_7L?#V& MY8M\F#)6@^.?6<#`[WRY&>*NFF"J9%M6UQI1>;#S80:ZAN@PNNXB>P(OXILP M@7LQC6&PO=V]R:W-H965TR%K] M)+GZ<_/[;ZL;S5[S$R&%`@J7?*V>BN*ZU+0\/I$TRD?T2BYPYD"S-"K@,#MJ M^34CT;Z\*#UK8UV?:6F47%2NL,SNT:"'0Q(3B\9O*;D47"0CYZB`^/-3WZX^8IE>0>$G.2?%9BJI*&B_]XX5FT=.33 M),YH3@_%".0T'FCWF1?:0@.ES6J?P!.PM"L9.:S59V,9&A-5VZS*!/V7D%O> M^J[D)WISLV3_1W(AD&WPB3GP0NDK0_T]:X*+M<[53NG`7YFR)X?H[5S\36\> M28ZG`NPVX8G8@RWWGQ;)8\@HR(S&)E.*Z1D"@/]*FK"N`1F)/LK/6[(O3FMU M,AN93_K$`%QY(7GA)$Q25>*WO*#I_QPR*BDN,JY$IA`]/S^>CHRI/GM``^Y6 M!C)K-(S%HQI/E09\UG%,'M6`PBCC@,\Z(>-'-1:5AL'LK!+V\,,8C37PY='' MT;C-9:^QHB+:K#)Z4Z`402N_1JRPC26[0]U?N+M-#_JN`T'/82K/3&:M0IZA M;^30Z]\WIFZNM'?HJ7'%;#D#_QO&$(E=3;!NR60MN<&6&QRYP>4-[4BDNW@U M4=_%EQL"N2%L-6B0N"9[T-&%[/5769TD1K,DU3?>\@80;S(REC+2)4S]262L M/F8N,G:7D>[D=`G3D#+G=AE)Q4,)'R4"E`B'",&?R4/^,%KPAS>T_3'UF9C9 MW1V,=0=C]S$+\5[.'8Q[!^/=P?AW,$$/8TS%F,-A1G`+7A8/._L1Z&#$()"R5LE'!0PD4)CQ.\(I^,;D'Z;:"O4H(V,%LLYM*, M-!R*03`*%D^"4>R=A0]_["K9,"F$+6>&#$,)"R5L3O!4&N.Q7%2H@(L2'DKX M*!%PHG)\,M%U>;X2#FD(CK%EKF#9<&V5N.R5-/7=5M"063ABX8B-(PZ.N`W" MQBCI9>8U)_L&J7+AZ^-(@"-A@XA1B&:QM6U[(+ROOMA>@5Q@8^E!MQ4T:!K7 MF9?O?M@K[`XU5J7"$:-OL+'Q&SDXXN*(AR,^C@0X$@XBHH%L-=PV$*DVOGAN M3PSGTCI_:W"F&K/TB3[7Y]+;;E6 MQ@\8QU?2;>/,<<CO@X$N`(VY7_/B_< M.+[KSO=/4Y(=R8ZVHSZ&,:QI;7;[GZ=LOT]J=]FO`*Q=:T[`)OPU M.I(_H^R87'+E3`X@J8^>8)F8\6U\?E#0:[EK^T(+V'XOOY[@YQ8"&Q[Z".`# MI45]P&[0_("S^04``/__`P!02P,$%``&``@````A``;"Y9R_`P``FPT``!@` M``!X;"]W;W)K3^"PP(+ M(IPV66U[4BM5[5W[;!(#UB9Q:IME]]O?3!R2V%E0>`$"__SGY_&,,VR^OA>Y M]\:DXJ*,?#*9^AXK4Y'Q\A#Y/[Z_?'GT/:5IF=%J8M;D8ZQ*ZA\/55?4E%48+'C M.=GZVZ$4DNYR6/<[>:#IQ;N^&-@7/)5"B;V>@%U@0(=K7@6K`)RV MFXS#"C#MGF3[R'\BZX0L_&"[J1/T+V=GU?OLJ:,X_R9Y]@R<[^&.[(1XQ5N_P5=3"*)J`091_U_"/(48)6C#]#]?0K[4V_:7]#*V MIZ=<_RW.OS-^.&J(-(+R7PYG1&0>SNF]`M'2]]+3TJ+XC\C(HV5,0D;$W@_F]_#^TUFC0F\ M-R8D'$L2F%75"7NFFFXW4IP]*%?@5A7%XB=K,/X\*Y`.U#ZA./*7L&^1KV!K MWK;33?`&R4\;16P4\-HJB*U(+@K>HJYK4AN*2Q",.D3WB9#<>3# MZML=6=AQ8Z/HDRUM13)4=.P6&73$>#(4VV2/=MS8*/ID*UN1#!57R!;WD*'8 M)B-NH1M)'XVXE3Z47&&#AAJ?-10[;$ZIQT9BL76U7E=C,I1<8<-GY^CS`<4. MF]L&1G*3;2BYPK:ZAPW%#EMG:UK42"PVIU>2H:0SL3J!P)$Q/G&UVJ%SFC!N M-!:>TS#))YIK?'@.]S9VW#%'S.G=/TV(TY)QH^ES=@RF^AK)O'Z$D/E\L5R& MCUV)VHG$@[L'>ONT(^:8[P.&;NLVFCY@Z/;N)YIN$38?'MOC^^N)P>,OP,^ITGC1K.HJ_^!K(A3`#A#HTE_`2Z<&7W-)%

6`)RW/EI>*$HRP!Z_;;=C9OAN;V!YAR*WI@?U)YX*7R3):18FCG9 M7&A1U7/B3FB8;^N/1_@3Q&#NFDY`O!="7RYPJFO_5FU_`@``__\#`%!+`P04 M``8`"````"$`S$)[?=T)``#N*P``&0```'AL+W=O#^`;>Y*KNKJZ,+[Y\\?QT/M>G9M]?;KM!X-1OU>=MO5N M?WJZ[?_GK^R/>;_7M)O3;G.H3]5M_V?5]/^\^_O?;M[J\[?FN:K:'BB7X:-B_G:K.3@XZ'83@:38?'S?[4 M5PK+\V:[?UN?] M[A_[4P71AG42*_!0U]^$:;$3"`8/V>A,KL"_SKU=];AY/;3_KM_R:O_TW,)R M3\`CX=AR]S.IFBU$%&0&X40H;>L#W`#\VSON16I`1#8_;OLA3+S?M<^W_6@Z MF,Q&40#FO8>J:;.]D.SWMJ]-6Q__IXP"+:5$(BT"GUHDF`S&X60VERH71H[U M2/C4(^%_%^SAGN3MPB?.%`QFP6@1S0!=&#C5`^%3#PP'\\ED/)U_,'"F!\(G MSOA)WV"+R7N%3STR&H3S23"9BM!>N->%'@B?>B!(7+`/(&OD3.(_G_)NJ+)` M)E6R:3=W-^?ZK0<[%=:Y>=F(?1\LA1JFDYK=)-A[^06))53NA%#TH'#"$L)C:P M1;XB-D)&Q`:]6B&PP?)"%:,%#DE\D/H@\\':![D/"A^4#B"!@&W.`A%!LG37 M',P),0JJBY,3X6Q$5WRE;$*8V"3.A)K$QL0$@Y&4D8R1-2,Y(P4CI4M(3*!L ML9B(.GSEQA$RL/<@F"8`T2*B(5@IHXM1,B8F2HRDC&2,K!G)&2D8*5U"H@0! M^8HH"1D9)?1NI0@)2;08T[C%Q@B')8RDC&2,K!G)&2D8*5U"@@)'$@G*Y6TD MK*GOBH#OZ%;,2,)(RDC&R)J1G)&"D=(EQ%$X#XBCOWBX"!D:`45DER4/BM@' MB0;NO@IF7IE-C1$&,E,DD-T.<46TS_R<'(A>HGW>;[^M:M4T=:QE!.>A.B6% M"'5$$<<1'R0:P`XS!2*<>04B-4;&$44Z'($>XZ(C?]4O<(L?U7:A0CU1Q/'$ M!XD&-FU31C)%.FY;5$ARWQV!ABX+(RW-Z0TBR=9BE9CU?U$(V^-,C2033G)+7"7^J;VR97))54\EU5G$T!6FSL/9_X!BP-M MAY)H%%J4(H+$!:62LE6<36QL;!#,,43Q%AA,!*MY9S%*4<91VN.Q:&FATCLHX2CE*.-HS5'.4<%121#U6?0>KL^_5CI5 M!T-"H9!SG@4^29!`6IB=QYL,:X59DW&TYBCGJ."HU`@*+\C3V(AFAL4&'O;` M[8J6!55MT=N>57(C9-/$G'^0`Z-I[)&CH-%X#=BUL+&2,^E'CR)IP%K MM#+%/4>"RM-H0?=L82U0N=2H*V*B:V(1N[XBZ^;+#9-";IA\D@2:D)-J[#4H MJ;5"AS*-E$.RTURCE1,JHX[C"C2R'5E)I&@VB=;,CYYU/ M^"4-KU3QPMO5\,[]QXPXT':WB49NPXL(]HV)>#CW*E>&5F[W%3@-K]J.?,8< M!]J;*!#1&;WO$25:O3WD^5-:+GSCK08!]HE31!%QL$4D$077,)`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````__\#`%!+`P04``8`"````"$`AY'N,YD%``#7%```&0```'AL+W=O M,&8(]N=QNU3?+[F_'SS`/8VR\^/RM.%M?>5GE MXK*TV6!H6_R2B7U^.2[MO[Z$GV:V5=7I99^>Q84O[>^\LC^O?OUE\2;*E^K$ M>6V!PJ5:VJ>ZOOJ.4V4G7J350%SY!?YS$&61UO!G>72J:\G3?3.H.#ON<#AQ MBC2_V$K!+]^C(0Z'/..!R%X+?JF52,G/:0WW7YWR:X5J1?8>N2(M7UZOGS)1 M7$'B.3_G]?=&U+:*S(^/%U&FSV>H^QL;I1EJ-W\0^2+/2E&)0ST`.4?=**UY M[LP=4%HM]CE4(&VW2GY8VD_,3YAG.ZM%8]#?.7^K>K];U4F\[`V M/"?Y!)Z%>)&A\5XB&.R0T6'S!/XHK3T_I*_G^D_Q%O'\>*KA<8^A(EF8O_\> M\"H#1T%FX(ZE4B;.<`/PTRIRV1K@2/IM:;N0.-_7IZ7M30;CZ=!C$&X]\ZH. MKICHG:7!#&MN$:Z8Z5VES=MQ<,6, M[RN-0?,T&>4OF/)><8[J@::E@K1.5XM2O%DP3^$I5]=4SGKF2Q%L)O4@NO;Z M47=!6TF5)RFSM,$Q:)P*IL37E3>;+9ROT,99&[.F,4R/V&"$[%DI&YA@:X+0 M!#L31":(39#T@`.V=-[`!/D_O)$RTANL:HW@9I9K&($1."0PP=8$H0EV)HA, M$)L@Z0'-")CDQ`@/FN7^&P=[0HZ"=TNO)]SQ4"]TK6)<2-PUSE@/V70AG1F$ M;`D)"=D1$A$2$Y+TB>8)O+Z()_(M_,&)(V5@[H&9G0'>;*Y;L%9!#UWJ0CJ7 M"-D2$A*R(R0B)"8DZ1/-)3"$N"0[YX,N29G&):QNK8AFB3LVIU$7A,,"0K:$ MA(3L"(D(B0E)^D0S!18BS93'TTA&Z[4K`K5C61M"`D*VA(2$[`B)"(D)2?I$ M*Q36`ZW0_[BX2!G=`45&-P-,$+2@/Z_ M2;-$;L+I>CN06YCZE&(28(6L":Q7G$YLR8 M+-LNH#-#$55$DWAGJD;=(+GDC]C$,UY=<1>`JDE?5;,&=C\/K?DBKE#TSU8= MJ:)[HTC/&Q,$+>BO0NYH9#1+%X25A(KT_3&5(S(H)B3IRVB&R%5!<^1.4\!F M&[NB"==+1Z15-C8JV]RBL+0`$2Q_W;K$9L;JO<6H4=-4;#AE$]VT$"/4=XC< MT^T0W5Y?$:*'V6*,:K--V=28SPE&--ET*^4>KS_O?F*EVA*"'CJRAL?<-!;, M[,X1=VQN5FY1.#!`-.NTMHCFRK>1X6O8_M^]I=_AD-LV,D)T$XX1M<(38X.= M:,*Z07+OUS=(OJN]X0=?3$RJ&"W8(KT%C3[9X,!;4P0M\B8]WY26IS^#J=ES M;4;Y2L6O$38S,NYHQHAFC!'I&8TOFP2U?I11=UIN*4VGX>,95P!\S;U_.8## M!N)ZB_KWS>9&GVUPX*VI@A9Y\);NF6<,W&*4ZC.8]N09J/Q:!W>WA%,C0IF' MR6*,:IO:@Z,*_8G+TQ9I@,JFS%:G)^I3M^#ED6_X^5Q9F7B5)R,P8+7HL#JV M68]\V,?"O9E\[,-6[@Z?^+#SH3R8^K`AN,-G/JRQE$([*NZ3%OX6!^LYE+GZ:YS*D^6 M/1X[5ID69Y-%<.M[8E3[?9'E7I6]E/FY94'J_)2VT/_F6%P:$:W,[@E7IO7S MR^5+5I47"/%4G(KV>Q?4-,K,C0_GJDZ?3C#N=S)-,Q&[^X#"ET565TVU;T<0 MSF(=Q6->6`L+(JV7NP)&0&4WZGR_,A^)FY"Y::V7G4#_%OE;(_UO-,?J+:R+ MW1_%.0>U89[H##Q5U3,UC7<4@;.%O(-N!OZJC5V^3U].[=_56Y07AV,+TSV# M$=&!N;OO7MYDH"B$&=DS&BFK3M`!^&N4!4T-4"1][YYOQ:X]KDQ[;AI/>=,& M!0UE&ME+TU;E?^PEX2&8L\V=XG?+<\H] MX+K@; M/$6#]_640,ZP*:3)PZ?I=E\ME@1=3GEIFZZ7=?5FP$*%Z6XN*5WVQ*5Q13:Q M*>WSZV?I!7E%HSS2,"L3I(,,:F!-O*YMARRM5\CCC-MLL(UFL146-&EI6$\' MO@X"'80ZB'00ZR"1@`6R]-I`9G^&-C0,U4:,:B.`))8JU598"!=/![X.`AV$ M.HAT$.L@D8`B!"S>SQ""AEF9\%=*$EL=^8;9V-"3WFBFFFQ[DUX=1'Q$`D1" M1")$8D02F2@BP3[U&2+1,+`882GV`N"EQ(QNJM2;]"HAXB,2(!(B$B$2(Y+( M1%$)]N#/4(F&Z502H]LPHDAB.Q,M=7HCX>8AXB,2(!(B$B$2(Y+(1!$%CAY% ME.M'N=AKJ;4Z=D9@[&)86T0\1'Q$`D1"1")$8D02F2@#A0-"&>@OGC8TC*H` M(]KL3[79[XV$3!XB/B(!(B$B$2(Q(HE,%%%H82X?P;=GGUJK8V=$GGU$/$1\ M1`)$0D0B1&)$$IDH`X5"1QGH+\X^#:,JP,AT2'\=>!S(NRJ9:V>/WQN)_`@0 M"1&)$(D121@A72VM2$+W^2N:C&BMVAZ+['E3P3$`!:IN+ M/UB)X`%'\!`H%%8]B029]"C&*.$('A!*U886;;(V5S)%UH#5>(H&',DUE^WH M51?IK<1@/(%D8:,Q`8OMJX/[/:LCE0TY&B8_"V]$J(9.B"/HPD1CU&`48A1A%&,$;UU'3K!]&&WJ.S&J\SK0[[-3Z?&R*H7>D,*#NME MC]GU[8;,Q?VM_F;JPO=:V'YT/G/AJ]T5[KCP3>@*AP:Z5:G'>7"A=KYB3R`0 MS#U^XRU<*#:O<#)V?3:)6AM0F;FT]KKF0\"GJR^0#P&?:V_@JONQ.Z,UCPV] M`K_2QL9VX8X)M[V9N'"O@OGCU'V$.8(75M\"7&5?TD/^9UH?BG-CG/(]3.2X M6_4UNPQG'UI>$CY5+5QF=]7A$7ZTR*&^&-/-=U]5K?A`&^A_!EG_````__\# M`%!+`P04``8`"````"$`S4",2[X&``#?&P``&0```'AL+W=OGKF[;>,;;!=F71G-#=-YZ-<=OTNFS*L/G\KS\;7O&Z*ZK(VR6AB&ODE MJ_;%Y;@V__D2?%J81M.FEWUZKB[YVOR>-^;GS>^_K=ZJ^J4YY7EK@(=+LS9/ M;7MUQ^,F.^5EVHRJ:WZ!.X>J+M,6?M;'<7.M\W3?-2K/8VLRF8W+M+B8S(-; M?\1'=3@46>Y5V6N97UKFI,[/:0OC;T[%M1'>RNPC[LJT?GF]?LJJ\@HNGHMS MT7[OG)I&F;GQ\5+5Z?,9XOY&[#03OKL?R'U99'755(=V!.[&;*`XYN5X.09/ MF]6^@`BH[$:='];F$W$3LC3'FU4GT+]%_M9(_QO-J7H+ZV+_1W')06V8)SH# MSU7U0DWC/470>(Q:!]T,_%4;^_R0OI[;OZNW*"^.IQ:FVX&(:&#N_KN7-QDH M"FY&ED,]9=49!@!_C;*@J0&*I-_6I@4=%_OVM#:GLY$SGTP)F!O/>=,&!75I M&MEKTU;E?\R(<%?,R90[@:MP8H^LA4.<&?5RIZ7-6\*5MYR/;,N9+[KN[S0$ MM]VXX$*Z\X>QC0YWSAG!],$A8:]U8X?I8D$O>$*Z/ M!4D@C[HNZ3\?"G/,\J)+,R]MT\VJKMX,6+LP\\TUI3L!<:DWD6!L;OJ4^U'& M0:I1+T_4S=H$[2"9&E@F7S>6O5R-OT)J9]QFBVV(:K$3%C2/J5M/![X.`AV$ M.HAT$.L@D<`89.FU@47S*[2A;J@V(JJM`))8FA#"0C3Q=.#K(-!!J(-(![$. M$@DH0L#"1T),(5EN[T(B)V@KV&_DG'`F:J!;9F-!QWWB.*K)KC?IQ4#$1R1` M)$0D0B1&))&)H@EL:4@3NC,_N'"H&UA[(&8O`%XYS.BN2KU)KQ(B/B(!(B$B M$2(Q(HE,%)5`D%^A$G73J22BVS*B2&(Y^G[2&XEF'B(^(@$B(2(1(C$BB4P4 M4>#9I(AR?QE1:S5V1B!V$=8.$0\1'Y$`D1"1")$8D40F2J#P/%`"_?6JNQ,R+//B(> M(CXB`2(A(A$B,2*)3)1`H:Q1`OW)V:=N5`48L8?TUX''@;*K.E,U/_S>2.1' M@$B(2(1(C$C"".FJ:$42NL_?T&1$B]KV5&0OVXI5XS>28@IE%2^VJ!=5DL[Q MVI0T0<03A'3UF4V61%LQ_F#12\(1BZ7K/A16O?Z1(,+S;*K5?O%@(3PGBF=5 M)5J0R4N$9P4H$%(C^V.&) MUJ^AL)*DXOT-FW+; M#5:BH2<0E$1]K4(66D7G"RN[RS(RF9.9*ET@+-AYE>G4CTGT%@FKN[W%PHKW M-B=S;94GPJ+K3962UG8/2,E*045*CF"O[Q6Q'+V`);V5",X3:-%/BR_0DNEF M:[H&_+XUS&0HF@Q'BTB@P7$L$'<\TXJD1'&L"D3+.ED@N@ZGDV$=?FRW8L6A MHAM':@IJ>;(CO=6@&T/3F:0;1^H M%VJ/B?#UHQY5I6FMJ"M-X$T-?RR(#>^!9P3UJ#TC.)+'399:GNWH&88V')+* MXV@*3WI)/*VA+ZQ8GL&R1W/`/"L9C#J+A)N[G<7"BB?U%%YIZ?K+O:EBTWH5 MB>T,:2W4?F=K966ODM=R)=P]+'<$(0\C'Z,`HQ"C"*,8HT1!JA:0#$@+>K1_ M\!@+Z8+2C2&M2-<*@QUO*)6S'D8^1@%&(4811C%&B8)4?6AU*^?*.SG!BF$E M)QB2`MP1A#R,?(P"C$*,(HQBC!(%J3'3\E6.F6[[-BRG1W."E\'#$VL+K\II MFJ@Y,=.6[FZP&C;^OJ%`/K8*,`HQBC"*,:)O]?E0H4>F#WM+SUZ?EGE]S'?Y M^=P86?5*W\!#@\VJQ^SSP);,X?M`MY6B.PNXTSVFT9VE^*:@W[%=>-,"P]&Y MX\++AAM\YL+9_`:'0=T<$PSI]HC`$>PAV).W=.'XAK` M=Z#PAC9=\:S%%\$=6B7C-O#YY:DKF[466_I9YH;]UG+A)2?VLYVZ\*8/\R?; M?8)YA1OCO@?XO')-C_F?:7TL+HUQS@\P^:PHJMD'&EXA\4/*<]7"AY7NO'*" M#VDYG`LF],%^J*I6_*`=])_F-O\#``#__P,`4$L#!!0`!@`(````(0!^S_*Q MS@T``.)%```9````>&PO=V]R:W-H965T3S6[>ZW(LJV*;;DD93+S]ML@T&H"/ZTHN[X9 M33YT_TVB`9!H0?[T^U\OSR=_+C?;U?KU=N"=G@].EJ^+]?WJ]?%V\*\_PM^N M!R?;W?SU?OZ\?EW>#OY>;@>_?_[G/S[]6&^^;9^6R]T)*;QN;P=/N]W;^.QL MNWA:OLRWI^NWY2NU/*PW+_,=_7/S>+9]VRSG]ZW3R_.9?WY^>?8R7[T.M,)X M%N/X\76]F7]]IOO^RQO-%ZS=_@/D7U:+S7J[?MB=DMR9 MOE"\YYNSFS-2^OSI?D5WH+K]9+-\N!U\\<;-T!^5FIH4(_,_[H=^!1X M=;][NAT,+T\OKLZ''IF??%UN=^%*20Y.%M^WN_7+?[219Z2TR-"(T*<1\<]/ MK[SSF^$5B1QP'!E'^C2.H].1?W%UW48_X$BR[673IW'T?+GL`XZ7QO%J[WCD MI=*$:2/2IXEX<=0MWA@_^MS[>:/S2]6]!Z[3HY'0QO.HZXWCD5?J42ZUJR25 M;O=0,$Z@)QF\/#WF*CF!:LC]XE5R)CSZ'^-Z9/(]NAM]@Y+%(]/O<1K5_QQU MP6=ZPK3S+YCOYI\_;=8_3FA1H[QLW^9JB?3&2HUGGN[G_5Q\;RK2'%0J7Y3, M[8!NA&;9EM://S_[_O#3V9\TYQ?&Y@YM/-MBPA9J@BO9P`53%X0NF+D@V"I@/.*#W['-$$^(@<*1F5(^[=.P:=I#D)80MV M"5PP=4'H@ID+(A?$+DAVR61OLD\*D"F0$,@,2`0D!I(`28%D0'(@ M!9`22`6D!M)TB94C6M,A1VI]_\6%3Y-]UH!,@81` M9D`B(#&0!$@*)`.2`RF`E$`J(#60IDNLK%&"/B)K2J;-&O?VG296BGS?G5I[ M(W8+@$R!A$!F0"(@,9`$2`HD`Y(#*8"40"H@-9"F2ZPDT:N.E:3#RYZRMG.A M">6"NWD")``R!1("F0&)@,1`$B`ID`Q(#J0`4@*I@-1`FBZQ.I[>KZR.5R]K MZKGSBVN:DK$SHHDS.RZ=!\_>B-,6`)D""8',@$1`8B`)D!1(!B0'4@`I@51` M:B!-EUA)HI=H*TF'9X>RMG.A27=V``F`3(&$0&9`(B`QD`1("B0#D@,I@)1` M*B`UD*9+K(ZGO:G5\?_C5D;)V!G1Q)D=5\[LV!OM9P>0*9`0R`Q(!"0&D@!) M@61`UY-Q8K%0T0S1!&B&%&"*$64(&YW<]3L>)^#@WJ]/,,U"/QZ^R:ATZU+Q8K5D]0/07U3/PZZKXS1G*Q8O4" MU4M0K\2OHSYT5J5:K%B]L=3M7*OM[D?D6F^;K5QKU,VU2P)/$R?73G5V*E9\ M1Z%!5JY=]4C\NOWEU+5BL6+U!-53@^1N,O'KJCO[]ERL6+U`]1+4*_'KJCO[ MGEJL6+VQU.UH+JJ4%R-YGX=:_=4<_%BM4+5"]!O1*_KKJS:M1B MQ>J-I6[G6FW4,=>GZNO"W=-J\>UN34F@-Z&>=]PA?4EBOCK1VWTKTQI)WTS4 MUTM.IC7Q:6F73(]@!=];\?V$1LK*M*L>&2-''59P4$]0/85KS_K5G34V%RN^ M]@+52U"OQ*_]'NK<-<)6$C%E)!$S1@FH+A'1.B(:_>EKS0G[\H[M5M*M3C&2@3A`%!OF4XL[,/0JGF9\7$6'50@&B**$0T M0Q0ABA$EB%)$&:(<48&H1%0AJA$U%K(GN*HPN0NV>GW_Q>_'U/Y&/;UE;;HS M2%YX)D`"0]3'?E)C94RL.-VA0=UW-8,D7B1^775G_Q*+%:LGJ)Z">H9^.:(" MI4J0JM"O1M184G86Z;'X(5E4.DX6-9)>G:@-COUZ;8BZ/LDB5,;$BOLY-,C* MHJL>B5]7W7EHQV+%Z@FJIP;)W63BUU&'RIA8L7J!ZB6H5^+748?*F%BQ>F.I MV[E6Y:2/F+&Z+&7-6(VD=R:^2P)#G%P[6["I6/$=A099N7;5(_'K]I?S0A^+ M%:LGJ)X:)'>3B5]7W7E#R,6*U0M4+T&]$K^NNO.*6HL5JS>6NIUK6H@_)-=* MQYG7&DGO3&@3Y\YK37Y2&3-^WFJ0W$TF M?MUL..JY6+%Z@>HEJ%?BUU$?.37#6JQ8O;'4[5RKPA#.:WE;.JHR1O4,R+1& MTC<38R0D,$2M.K*"0V5,K/A^0HZG?Q:@#B#/0#T2OZXZK.#Z.ND:6#U!]134 MLWYUMS(F5JQ>H'H)ZI7XF[[L$8_*8.QHVQM`D;=R8EE,+;259O+ZVLG M^2$;R*YPQDB"18P.!HO9BJ;L?KWHV?F:3I"(*3M*Q(S1P8@Y6QV,6+"51"P9 M2<2*T<&(-5N]UZ$-&_3L?%4=RATTOUP&4Z4.]ZFMT4_*8.PH):#`(!KG,L^U M%MV%6MFP#,8N,H1G*!RQE0C'C*1TE3`2K12U,K82K9R1:!6,1*M$K8JM1*MF M],X--]S>"EN+@#HP"OGT_I\R6*MHOY$QDH$Z0108I*ZU,_/<,IBQH@^5V\N; M&^<5.F1EF2@S1A(_,NAPL-A8#>EMOG-)SN,]87F)F#*2B-E1$?.C(A8L+Q%+ M1A*Q.BIBS1'?Z]"&E7$Q&'Y,&:R5<48,EL&,%;U4\SP/$$T1A8AFB")$,:($ M48HH0Y0C*A"5B"I$-:+&0O8$_Z`RF'JX.TNV0?8V9^1L1"9B)7G36IU43M$J M1#1#%"&*$26(4D09HAQ1@:A$5"&J$:F?4:M>U3VA\Z9_%JU_EOFRW#PN)\OG MY^W)8OU=_>3Y4CVS]UC_'OON9MSH?MS= MW^+SS[X=-?H]^)=V5CK\CJ1ZE4BHUWY(`7JNZ13@MM"$M)*EM1G+X6 M*CE1G+X6*A=1G+Z6P+^@.'V9H9()Q>EKH7('Q>EKH5(%Q>EKH>([Q>D;,50X MISA]+53TICA]+53#ICA]+8$_I#A]0Y9*NQ2GKX7*LA2GKX5*JA2GKR7P:+S1 MH10<(70T9QSWMM"QFK$Z-(,^="1FK$Z]8$O@T7BC M%CIX1G'Z?.C0&,7I:Z'#Z]32M]31`6FZ@KZQ0X>;Z0KZ6NA@,EU!7PN=,Z8X M?2UTA)?B](T=.GY+EKH6.O%*=M.=LOUP'```I(@``&0`` M`'AL+W=OVL95M]V*#^MTDQQ>']I_?[7^NFNW\B(Z;*)=>H@?VC_CO/WE M\<\_[M_3[%N^C>.B10J'_*&]+8JCV>GDZVV\C_*K]!@?Z,I+FNVC@GYFKYW\ MF,71IBRTWW5ZW>Y-9Q\EAS97,+-+--*7EV0=3]+UVSX^%%PDBW=10?7/M\DQ M%VK[]25R^RC[]G;\:YWNCR3QG.R2XFDBSZ'E'S_W#&$1KH5W^ M`/E]LL[2/'TIKDBNPRN*SSSL##ND]'B_2>@)6+.WLOCEH?UDF*%QT^X\WI<- M]$\2O^>-[ZU\F[[;6;+QDD-,K4T^,0>>T_0;"W4W#%'A#I2V2@>"K+6)7Z*W M71&F[TZAO:Y^PKD$M$OTH M/]^33;%]:/<'5[=&=]B_)97G."^LA$FV6^NWO$CW__(@HY+B(KU*A#Z%R,W5 M]6VW;]`]SQ7L5P4'=4%C>%%!DBVK39_5'0VZ^9DJWE0%J-^+`I?=:5@5I$]1 M\/R=#/*0-ZELC@N?RA#MP;Y<>#=J.GXW>D)1Y+(G,VY%4?HBBO[BV:CY^-TN M;<<.[V]E]YU$1?1XGZ7O+1H3J$?EQXB-,(9ID)KHN-S#NBM_U).I"S.5)R;S MT*8'H$Z:4_I]?^P9@_O.=TJ9=14SPAA#C1B+")8?3':B@ZD.+!W8.G!TX.I@ MIH.Y#CP=^#I8Z&"I@T`'*QV$#=`A>VJ/J#-\AD=,AGDD6G.#EP=S'0PUX&G`U\'"QTL=1#H8*6#L`$40VA8^`Q#F`P-]$K2 M7*L.C'A,CVI29Y86,JY#:I>`3(%80&P@#A`7R`S('(@'Q`>R`+($$@!9`0F; M1#&-1NC/,(W)T&!);Y?:$!SJ>-!9U^J0VC4@4R`6$!N(`\0%,@,R!^(!\8$L M@"R!!$!60,(F45RCF<5GN,9D2M=$:X\X42SJ&3=J]HWK(%%L`F0*Q`)B`W&` MN$!F0.9`/"`^D`60)9``R`I(V"2*233G44PZ/>L5<-+,#B`3(%,@%A`;B`/$!3(#,@?B`?&!+(`L@01`5D#")E$:GM:*2L/_ M9G8P&=413K3LN-.RHPZJLP/(%(@%Q`;B`'&!S(#,@7A`?"`+($L@`9`5D+!) M%)/83$IQZ7QZE.&J&Q5J)@BB":(I(@N1CVI>3664$+<0V8@<1"ZB M&:(Y(@^1CVB!:(DH0+1"%%:(/NBQ5=?8,O4S7./+7<4UCIJNZ63"=OQH?%1< MZQE#W;4Z2KH&R)9:(LI!Y"*:58BW3KEW-*^0K+LGRS76;KVN6E-?1HDZ+!`M M$06(5HC""IWRD2U=T<23*I2-\H-^\&QM"`O.-E*$*TBU45:K2Z#H/(2E`-9CBM#G5\[9K^F1WFF_W&3E MJV3%V@I1*LGMB![LJ]91HK(3HT+]VLVI0(.R"QB#KM8#+!'`#S#8!JTMD%RZ M.0))95>@2OGV3LNYF0B0RG.!I+(GD%3V!?JHS@L1()67`DGE0""IO!+HHSJ' M(J!45NUF"^5S=E^6R'RYK;A=(5IJ--S6;!JSBI+`OT`J2\_,-O'V6L\CG>[O+5.W]A9KC&D MAJTQ/V@>#4U:Z]`PJW.C2R?090_2KM#1]%-9&9Z,[YNT^8UW M?AJ83_1H>&$T,&G?]02_-FFK[P2_,6DGZ@2_-6GSXP2_,VEMCISF^2:;X9ZZ MTC/9[`ZOT-R-RIRZ0C,7E%VV9#P MDJ:%^$&W[M3_Y/'X'P```/__`P!02P,$%``&``@````A``Z6<=$-`P``C`D` M`!@```!X;"]W;W)KF< MRYA7\DDE5,@./:N_I6G&6VD-EX86^O_!*)BKJ M&"(UAD-FF4CXG4P.):^,(U&\8`;RU[FH]3M;F8RA*YEZ.M17B2QKH-B)0IA7 M2TI)F40/^THJMBO`]TLP8\D[MWTXH2]%HJ26F9D`G><2/?6\\E8>,&W6J0`' M6':B>!;3;1#=!G/J;=:V0'\$/^K6=Z)S>?RJ1/I=5!RJ#7W"#NRD?$+H0XHA M..R=G+ZW'?BA2,HS=BC,3WG\QL4^-]#N.3A"8U'Z>L=U`A4%FDEHTTAD`0G` M)RD%7@VH"'N):0C"(C5Y3*>+R7SI3P.`DQW7YEX@)27)01M9_G6@P";EN&QJ M=\RPS5K)(X%^`UK7#&]/$`'Q<"Z0!&*W"([IDA*0T5#`YTWH+];>,YA.WC"W M#@.?#29H$!Z(-LJ@-EX9P:@,];6IW+I`6R8:-X"'`M$Z&_ M;/A=!@XS:V'F#:)C%"#CC2(8>@$9-O4[K;$#C9"&>]&6'F<>#]D4FF*[2%LO M]*^'S2ZZBN?+C."NDHO,[)5M7Q:X*K+[R(=)X$_[`1OTW@K%MW5>@N=F@GP;6\5R8ZT MQ44W]EA/PLV-KI\/)D?P7Z/#HGMB;GH,^!F8%HN+TR)PHP"JU+PQ;Z&NG0\F M5`"H=A'/WVF+[ME!@I@.V,$7M]>>F;^:7&X0'NR)N%#7T;1WX=SNO'9]'6[6*O^05V8&PO=V]R:W-H965T&ULK)U=4]O(UH7O3]7Y#Q3W)^`/,+B2G!K\)=F2)=N2WVN&.`DU M`:>`FWU,M;W4MT\,RY">31ZKU:ZM96:UO([__[Y\.WDS]V3\_W^\[_:?[QR\?3LMB^I^KTY/GE]O'3[??]H^[#Z=_[9Y/__OQW_]Z M_V/_]-OSU]WNY40B/#Y_./WZ\O)]>';V?/=U]W#[_&[_??OIUUS\\OSQYN[Q]/ZPC#I[?$V'_^?'^W&^_O?G_8/;[4 M09YVWVY?I/_/7^^_/R/:P]U;PCW&V?WEZ]O%]=8"V][L?SXW?3YZ_[G_,GNX_)?>/ M.SG:,DYF!'[=[W\STOB30=+XC%I/JQ'(GTX^[3[?_O[M9;W_$>WNOWQ]D>&^ MD#TR.S;\]-=X]WPG1U3"O.M>F$AW^V_2`?GWY.'>3`TY(K=_5C]_W']Z^?KA MM'?Y[F)PWNN(_.37W?/+]-Z$/#VY^_WY9?_P?[6H8T/50;HV2$]ZST$"#?NV MH?RT#:_?=:\N.A>7QCW04+96W9:?<#Q_-^B<7_<&X8:7MN%`&S;V-^`H)TSE M*#^/Z^JU;2@_;=L. M=C"*YI?C=K$C`U]W5&=`9_#&G<0CL^EBUIA?CMO'+F:/^05']FWG51>S MQ_QBF[;NXEF=@*I\-KY]N?WX_FG_XT0N$F+Y_/W67'(Z0Q,$F:S>U4-N>RVU M24XS47XQ83ZZ#E0_6/MCXH/!!Z8-M`YS)$!_&68;V M?S'.)HP99XS0#8`.?-<;5"C09.R#B0^F/ICY(/)![(.Y#Q8^2'R0^F#I@\P' MN0]6/EC[8..#P@>E#[8-X`RJY'T:U)[DG_9E",Y5TTH6',ZY>NT.VDVM,0GA M<$)?N)+107(86"(3(E,B,R(1D9C(G,B"2$(D);(DDA')B:R(K(ELB!1$2B+; M)G'&6J[3--;F4GQDHC9A)-?+)#D,+&?J6A0<_8/D,/I$)D2F1&9$(B(QD3F1 M!9&$2$ID220CDA-9$5D3V1`IB)1$MDWBC+X,]/]B]$V8:O0Q:C0.;DV\$[;CG;`'$6;`F,B$ MR)3(C$A$)"8R)[(@DA!)B2R)9$1R(BLB:R(;(@61DLBV29SQEELN9[S#)ZQ1 MNV-:D^8)2V1,9$)D2F1&)"(2$YD361!)B*1$ED0R(CF1%9$UD0V1@DA)9-LD MS@#*[;XS@'_S+MB$<4>V)GW-Q#X8U\`[G[U[J,E!A/-Y2F1&)"(2$YD361!) MB*1$ED0R(CF1%9$UD0V1@DA)9%N33E4Q=8;:+'U;QOJ=J6"^?+V_^^UF+]E: M;J-;3N*>5#9LO<-$<8>Z"BQY7L>:R-B2KJSR=?D]Z+G9>Z*JPW`SFC&*&,6, MYHP6C!)&*:,EHXQ1SFC%:,UHPZA@5#+:6M0V_J9"0A4O*=;:X2_VWZOA/V(N MU#47L<1PW8BOF1[-N>"3L=5T9$@J=9W'F4@UTNZ/S.<$SM0:6]*M/N^JYL.$T=2BNO=VUOBA(FX7,YISJ(5% MVL^$VZ6,EAPJHU`YMULQ6G.H#84JN%W):.N$:(_V3$:W+.O6WD?ELQUQ?]!YN#"1;M.&5=ZL^@:I?%>$O^^=>Y"D$]<>2ILH^`U*S M""AH%D-5FW6Z/2][S2%0LP60FB5`0;,4*KGK:NR_=^>SA$H=,R!US(&"CBNH M@HYKJ-1Q`Z2.!5#0L82J/J"#R[ZW--A"4)FY,]/4CHZ8F76IR9F9%LEM3N,` M>TO1D?G`T,Q,_0Q@#"3+ZT9#FIFVX74U,P==;]>F-HI\?H:,.T-@]8J`@EXQ M5+(*;/3($%8FDG$J!@)U*HW$YXE^!E>R>\2VF&6-J)'"C8B154 M;B>\:^GZ39W8()9VH@`*=J*$RNV$=\G=_JP3[G27AJR.I.]!+'$5G7*@-0I!PHZK:"RNW5^21/7CH6:;=!&S0J@H%D) M56W6Z_8ZWF380E&YN=/1U`*/R+YUZ=#)OA8YV??:2Z(C\P2%GWTM"IZ"$]NP MVZG7!;V!EV&F$#33+YE%\`^:Q5#95'_MS?PY>RW01'-+`A3T2J%R[AY5-MYZU;8+GG03-*Q/NO[@TKM(3R'0,WP&I&=X!!0TBZ&2 M>=U8%GAS90Z5.BZ`U#$!"CJF4`4=EU"I8P:DCCE0T'$%5=!Q#94Z;H#4L0`* M.I90O3:$6P@J,S=MRKP_)FT:N7<5KU&S=FX>]Q)5`XT931A-&T8K1FM&%4,"H9;1WDCJOD1F=5F0U4;SAKI'6 M&4;F43T1*1E;XA99_6O01%6XW9@RFC&*&,6,YHP6C!)&*:,EHXQ1SFC%:,UH MPZA@5#+:6M12$#,/0?+X_Y,B:Q71G0L6Z4)%558@^Y^@+BIYHNV9T;]V6J@K1EQP]H^BYMFM&]];7*U4A^IJC;RAZ MH>V:T;U50ZDJ1-\ZT9V<(DO7ECEU=)&U"N--)+\V/[(BG5IC2YI%5D93!-<" M](Q"1=PN9C3G4`L*E7"[E-&20V44*N=V*T9K#K6A4`6W*QEMG5#N2)NZ]-MO MILQGI]YE`JBY9NT,O-NYD:HP_<9`P17/!*IZQ7-Q=>G=`T\AT.75#$B75Q%0 MT"R&JC;K#/I>@6H.@9HM@-0L`0J:I5`%5X]+J-0Q`U+''"CHN((JZ+B&2ATW M0.I8``4=2ZCJ`SJX//=2ZA:"RLR=F1+YF)EIY%ZNL4ANCAJW(-[\&9FUBVFH M=XIC(%G<-AIZ]8$)5/6==^?:F_)3NUVR+*;\#$W4*P(*>L50R0),>W3M[>[>M:W4, M[/8&L;03!5"P$R54;B>\S+#]62?B MW_%&;@M%Y>;.2E/@/6)6VGIP`04-(NA MDIXU,KAW&9Y#I8X+('5,@(*.*51!QR54ZI@!J6,.%'1<015T7$.ECAL@=2R` M@HXE5*\-X1:"RLR=G:;Z?D3>M,5ZS1LWW1K)8A@3;\1HS&C":,IHQBAB%#.: M,UHP2ABEC):,,D8YHQ6C-:,-HX)1R6CK('=<)9\YX_JW*JM=$\5+1C72DL?( MBI2,+3'+2CW+K[V\,E$5)LZ4T8Q1Q"AF-&>T8)0P2ADM&66,C>/6FJ*D1?GF#\9YCEU=&6U"N-.)(MT'T=$QI;( MI0Q=G3":6M08UQF%BKA=S&C.H184*N%V*:,EA\HH5,[M5HS6'&I#H0IN5S+: M.J'@>53DV+@K>*$]O0WNAWN_Y#.%,(=`T]8[,(*&@60R47";VZ7GM7J+DZ-E14 M6T4LO3E.@(*=2*%R.G'E7827;^I$AEC:B1PHV(D55$XGKKVKZ?I-G=@@EG:B M``IVHH3*[81WT=W^K!/N?)=3Z9CY;N3>?+=(9J_.$2JW]@XJG>\6R8]&0Z\F M-T'#^F3NM#S`"H6FCAF0IHX(*.@60U6[M3S`"H&:+8#4+`$*FJ50M3_`BJWJ ME`&I4PX4=%I!97>+'V"%0,TV0&I6``7-2JAJL[8'6*&HW-SI>%SUO\?5?R`G M_5*=554Z'6VLX"DXL0UM^KWD!U@A:*9?&UG/]PC^0;,8JM<>8&6O!9JH5P(4 M]$JA-JBM_-K/.WRJR]NH3NW#_7J%D1\69'.CK$E3IE57O;L_BW\1%4Z%^K@3L',]XNT7>-.@!Y@ M516BSRUJ1%]8I'U/M%TSNG<3FZH*T9<J0O0U1]]0]$+; M-:-[=WREJA!]ZT1WKB6 M5GZ*@(*NL50V?75 M1<][6&X.@9HM@-0L`0J:I5#)&JI1W/">1%A"I8X9D#KF0$''%51!QS54ZK@! M4L<"*.A80E4?T&YWX'\&NX6BQ$APH`V@D_SGNW/.N'.;5/(;Z[:?Y)WC=S+NQ8Y>9=JJOV#"F,Q!@J> MN!.HZA/WBIXJG4*@66(&I%DB`@J:Q5"]9C:'0,T60&J6``7-4JB"27`)E3IF M0.J8`P4=5U#9W>-'6"%0LPV0FA5`0;,2*IMQ6QYAA:)REA#YF5AJY-RLM M5SEOV_+_)HW;BQJUE89C1E-&$T9S1A%C&)&2.J\P^YWKX-]^V*U_P11?*&ID_X#NDE>ZY M]\3"R#9L3(LQHPFC*:,9HXA1S&C.:,$H890R6C+*&.6,5HS6C#:,"D8E(_,5 M;&:$Z@-=SX'Z*]7JKR!ZV#U]V8UVW[X]G]SM?S=?EW9Y+G]%<\#U=[G)@^A# M\T"T+&K\+;W+H:GAMVSI7\@7P%4IQ6_3ES;2+VXCWQGW2Y7>_!;R77+5LZH^ M[TJW6N+<]*13+?R7_O"75N.;OO2HI<&-[$/K+L@>M.W`C1RGUL-T-90W7_,. M2VUY:"K'O$7JPL.X=8O4=(>F8LMMI!X[--56WB*UU*&IE/(6*4I*#ZY;MDB- M47K0MD5*AM*#MBU2`90>M&V1@I[TH&V+/'TJ/:@N&=[PRL.DTH.V+?)LJ/2@ M;8L\ZBD]:-LB3VY*#]JVR*<]LJ5MW.1Q^Z%Y.+SEN'7EN,GSO+Q%'IP>FL>B M>8L\]#PTCS3S%GE@>;AJW2(/&TL/VMK(BS6D!VW[(R_%D!ZT;9$76D@/VK;( MRRBD!VU;Y$42TH.V+?)&!NE!VXDI+UB0'K1MD?8_NT+PXE[?(:W&'YCVXO$7>(S_L^+?6WWK_L7^;Y,N4F1K[*3[T?=R?MMS\V[O3_O]R_XCW3W[/"- MJQ__7P````#__P,`4$L#!!0`!@`(````(0#/,^G%D`,``-,,```8````>&PO M=V]R:W-H965T&ULG%?;;MLP#'T?L'\P_-XX%5M.A-J6(2E-^_Q;.?6ER!FC@YY*))F9O=O6>J],JFXR.<^ MZ?5]C^61B'F^GOM_?C_=W/F>TC2/:2IR-O??F?+O%Y\_S79"OJ@-8]H#AES- M_8W6Q30(5+1A&54]4;`>,\@VW!/>P$J(%X0^QVB"PT'K M]).Y@9_2BUE"MZG^)7;?&%]O-%SW"!2AL&G\_LA4!!D%FEXX0J9(I!``?'H9 MQ]*`C-"WN1^"8Q[KS=P?C'NCV_Z``-Q;,:6?.%+Z7K156F3_+(B8H"R7">V1 M:KJ82;'SX+X!K0J*U4.F0+R/R3)441X+$J)#DB6RS/U;WP/_"C+[NB"C\2QX MA6Q$)>;!8N#S@*D0`413A01AU$/J3L_>,X+1,Z8+0WFPAKJ;L-O-P'6#R@=P MIZ?=X2'`U46,;BM^&X'%#&N8485PA`+D#QD0JB2;2UU?V1TURUV['H\G68$NYZL96AJN5XL4'/7"\%#+KVUN$(FW4)P M'-K*4M9.+2XHT,^Y,>9/BT!SSG>K`61\NXWZT%R^ER,0;M^BI- M;3D$V[V6)E-AP[-JS+&&"SLX7#WDB)ZK9@P"4)E?.\(B&PO=V]R:W-H965T&ULE%;; M;J,P$'U?:?\!^;T!$](T44B5;M7=2KO2:K679P=,L`(8V4[3_OW.X(1RRZ4O M41B.SYDS8\9>W+_FF?/"E1:R"`D=><3A121C46Q"\N?WT\T=<;1A1?/RWV4FUURKEQ@*'0(4F-*>>NJZ.4YTR/9,D+>)-(E3,#CVKCZE)Q M%E>+\LSU/>_6S9DHB&68JVLX9)*(B#_*:)?SPE@2Q3-F('^=BE(?V?+H&KJ< MJ>VNO(ED7@+%6F3"O%6DQ,FC^?.FD(JM,_#]2@,6';FKAQY]+B(EM4S,".A< MFVC?\\R=N<"T7,0"' '<63D*SH_(%.B;M<5`7Z*_A>-_X[.I7[KTK$WT7! MH=K0)^S`6LHM0I]C#,%BM[?ZJ>K`3^7$/&&[S/R2^V]<;%(#[9Z`(S0VC]\> MN8Z@HD`S\B?(%,D,$H!?)Q>X-:`B[#4D/@B+V*0A&=^.)E-O3`'NK+DV3P(I MB1/MM)'Y/PNB55*6JTKMD1FV7"BY=Z#?@-8EP]U#YT!\S,DRU%F>2A*R0Y(5 MLH1D2AS0UU#9ER4-I@OW!:H1'3`/%@._[Y@:X4(V=4J01C.EX?(9QT55"G6Q;:2I1X/9L-G;MN+Y,B.XK60C0;67FYL% M]ES72.#-1I#8>05```8````>&PO=V]R M:W-H965T&ULG%G;CMLV$'TOT'\0]&Y;)"5?%NL-(@5I"[1` M4?3RK)5E6XAE&9(VF_Q]AQK*Y(Q\D?.2K'<.AX=S.4,OGS]\*P_>U[QNBNJX M]L4T\+W\F%6;XKA;^__\_7FR]+VF38^;]%`=\[7_/6_\#R\___3\7M5?FGV> MMQYX.#9K?]^VIZ?9K,GV>9DVT^J4'\&RK>HR;>%CO9LUISI/-]VB\C"303"? ME6EQ]-'#4SW&1[7=%EG^JROS8HI,Z/Z0M\&_VQ:GIO979&'=E6G]Y.TVR MJCR!B]?B4+3?.Z>^5V9/O^V.59V^'N#M)\+[=+WLK>FKW$(0;.!G/38/7/ASKLYVP@MJW^6E:R^\VE5]7O4B'CO.#S'`XGP&'KM; M",)Q3CG>SJL&L]B)Y?GL7=9BQ(1=[.2*E61"K'-;$X03]!"/V_U^T(LX-YL7 MY(88Y*:8,7&-EC8AIN<=$Y/[Q/0B1DQ:_T@,,4AL(FA$$]*LV/Z%1L0TK/;HWX0X]+V$"5W84#< MSZE`*2<*YZ0&DVI`M]KT)H3RU%+MU-[M1A4H[$3E9$CK*C:@J&O5N5K9;C3Q M0R=H#U5@UU-F6J?',T-5=YDIMG$L>N77@W:05==H5U)*6J#'4T(Y)Y1LM9A< M(L9TJ%*L$!/AVA>VB2@MKB\6*#X$[-7Y@`DD4D%@C"FIX(J'K:%(D!](F^-MH% M&P5WJ`UG0&A+UU28*_.3Q:#`7//*LJ8!8V/@#JNA_H>#NG<5?A*Q<":"F!?. MH0@OR2;`;5X=FBI_:"L$HV4P?1YE8.+EV@LJ.%8$,HJ.\;.@/K8R`( M$:7VT&A0.!J(D"BFL;$!7AG0>V(B@UH/\`-8WFM6;5W6050=>IH?T^-38>1K8#RCN-'A\3JI\! MW9\MV767&"?.M8`&[H>&@[HP')RKO@D@@C!`(EBQMDF,$Q-`J>2UW++I,#*` M%Z8$_TH0*P0AA<5JSE0Q(78APKD=,S2*;$Z,I(AB3W+,)T*L$(045T$TZ!!B M%\XUGS)D(V,D0YP*1&-"%J18(0C:X=SHK,V3FQ#",V3#X_:MO4.S1@YM&6$= M&A`V,I?F*T;*Z:&1$5X8&?S/S+$!(:?!-PEB=8J2LM*Z[:BQSNC]OT&'>A6[ M?G+5C0WH5D9O0BA/-C5&\KPP/4)65G&(((PB,R;4:*63DM,B[@3Q3KFAY-.& MY7,#7O-TA/&)003"[HSSEMAM.2(M?,?#9ZXRKW=YDA\.C9=5;_J-3L#?\\Z_ MQ??#&-X/N\>VV=D`SW>G=)?_D=:[XMAXAWP+2X/I`H9%C0^`^*&M3MTKTVO5 MPL-=]^,>'FIS>!4+I@#>5E7;?]#O6N>GWY?_`0``__\#`%!+`P04``8`"``` M`"$`0W6+%5X%``#]$P``&0```'AL+W=O7X]+\ZT?T;68: M=9-=]MF97LC2_""U^7WUZR^+&ZU>ZA,AC0$*EWIIGIKF&EA6G9](F=4C>B47 M>'.@59DU\+,Z6O6U(MF^+52>+6<\]JTR*RXF5PBJ1S3HX5#D)*3Y:TDN#1>I MR#EKH/WUJ;C60JW,'Y$KL^KE]?HMI^45))Z+<]%\M**F4>9!I[9K6 M:M$:]'=!;O7@?Z,^T=NN*O:_%1<";L,XL1%XIO2%A29[AJ"PA4I'[0C\41E[ MS\V?]!:3XGAJ8+@GT"/6L6#_$9(Z!T=!9N1,F%).S]``^&N4!4L-<"1[ M;Y^W8M^L\:&" M\ZX@/+N"8!6NR.(6MR,69DVV6E3T9L`T`#/K:\8FE1W8,-)BK+B$'+V?#1Z, M&E-Y8C)+$ZJ&\:DAX]Y6[GR\L-X@2_(N9HUC;#5B(R)82C#94`=;'40ZV.D@ MUD&B@W0`++!%>@,I]!7>,!GFC>C56H#>+$"?:BG>Z:BP+L3.`9_ON M7)V"B0P0JNE05;$&SC2?6O.#7G]F#1RWA#=,1?6&DX$W.@@[`&N]7(0=3UM, MMC)(]"3B9.B/KARC0@DBZ5!&,83M"HHC=Y)BT/,V7.VZ0,/]U?'U';:/$ET+ M!1I:8L^T(]Y61/EM4OD3;=^*Q'M^ZF='O)U`_>(5"_1I78F(XG5-]>-F*MZW M=:DVL@/?<,[]AXW\?`AZPHTU#'&;5#"K^P3Q?375-WV4*!@*-)-:6X'FW+/I M3%6)NO=.7_U.%.G/E+%`O7`B$!=V]$-$J@BK!K&#X-`@_E7P/Q$+R.P;^Q5J2ZD@VY'RNC9R^ MLOL#*+!:2,PO-]9>`*=/&%^=3P(X@-WA?@#G%]N=^'D`.P7F\3R`I1]SN)QY:A-?TU^S2YL[\6LG@.\VK+-V`_A6P?S)"Y[` M-WAAR1K@\N6:'K?P$``/__`P!02P,$%``&``@````A``=L0L6("@`` M/3```!D```!X;"]W;W)K&ULK)I;;^LX#L??%]CO M$.1]FMC.'6T'36S'-G:!Q6!F]SE-W38X25S$[KE\^R4M41)%-VTZ?3DY_9FB M3(JB_[Y<__[SL.]]+T_UKCK>](.K8;]7'K?5P^[X=-/_Z\_TMUF_5S>;X\-F M7QW+F_ZOLN[_?OO/?US_J$[?ZN>R;'K@X5C?])^;YF4Q&-3;Y_*PJ:^JE_(( M1QZKTV'3P)^GIT']3P6&S._:5A\7I(SZJQ\?=MHRK[>NA M/#;*R:G<;QHX__IY]U*3M\/V(^X.F].WUY??MM7A!5S<[_:[YE?KM-\[;!?Y MT[$Z;>[W$/?/8+39DN_V#^'^L-N>JKIZ;*[`W4"=J(QY/I@/P-/M]<,.(L"T M]T[EXTW_+E@4T:P_N+UN$_3?7?FC=O[?JY^K'^O3[N%?NV,)V89UPA6XKZIO M:)H_((+!`S$Z;5?@/Z?>0_FX>=TW?U0_LG+W]-S`+?QJ M^V!^-1N/1Y/9.S--]$CXU2/A?V?.#,ZCG0E^+PL)-E8[$'X_%-);V^E3]Z,&VA$6M7S:XR8,%.J':46DQU?16 M,4$5H9<[='/3AT1!G=2P`[[?AI/Y]>`[5.U6VRRE3<`M5F2!)8IN8Q\D/DA] ML/9!YH/UHD(H)BZ6XP5!,X"EJ)6Q/3(0]TJ6Q"F-@4SIB;K(R)288@B2"I M(&M!,D%R00J7L)Q`NQ(YP:9[X<9!-[#W()DF`7+G**.S63(F)DN")(*D@JP% MR03)!2E*"?>/" M/8)N>`84\58_]!J',:(TQ8(D@J2"K`7)!,D%*5S"DH*JV[WBGE]]M.:Q*^*N MOB"Q((D@J2!K03)!>"BMXYN^$XL@ M,1%HLO8:,8UXM2?6RH2C45<\*'G<(E1K8^/YLWIY*QZX)S`!*>4$\]"<2Y@, M8W0#\DE,-K:!)1*E&L$/..>K@3K%/?N.K+MGJ60-.TN-7-T13D<\I:O`6%%X M,2&0!68M@IFG:A*R&K5*.(J&WF*E9-#>C?'84'"XL?DK\[%*4[*%A:P1]"5S MYN'4%UN!L;(A*Q1:`9MHJQ"VON-KPM.7DA7;A3-KQ>-&">'''057M,&H("_8 M;4J4L!QHQ)=]RL][%1@KFP.%0F@0)N".95=6<(7#&Z`H].LB)<\=RXYBP0\_ M&%^\(97F8#$KY%XO4*;"'G50+%$B42K16J),HERB@B%>"J@G9"XNE@V!TB4L M&4:JV'4,IS._`(R5+0"!$NW>R6(JT5JB3*)(('IXO:Y!.M4PLA][JND)LGG\2! M)I.V_XV">>!++FMA2XTZLA8^)Z< MHY2=WUFM&Z[G-'+2)$A,A%V%1I[X2*P5!91JI`)JM^V:K&RJB%AQE4M4,%=L MIX6^-'PG!U("MAY0`MK=$DZ]]5H9(XHNUL3IIXE$J48L![[`S.2X7**"N>(Y M0.'G[JAWJ)D3IZ.;Q4UV[]>)M,Z5)\7IALA3. M_,<_--`JUU@C5\P2@B;O^/(Z5TI6;XE9O1W->=&"9C30GD1.B,_HW2,49/76 MC+QB47J*3/^=:T"HQ*Q[K21D*V@E4:Q1-#$]*=%HA'>.\&9@&'F**R4W;KGJ M^>UDF?2<$YJVG@/O=J9@?GG"4`.+A%TLN/$%F7=+3\@N^$JBF%#[6K`MGH30 MW"0NU0BZ-=73FJRL^XR0]943LKX*YHOG`L6MFXMWVIW2PJPR-.+MSKNDK4)C M1='$A"(38$+(UD]*R"T/X2LC*^LK)V1]%80ZNA5*X`O2H!0S2X-&O"UYO7D% MS:>M&;N",2&[@@FA>5O9,]GAE1=6&L)Q1EZLXYS0&XX+?5PYYG6".MA-T.?: MN5+3+&\:\?(1[=Q8V?)1B/4:C?@:>(TAQ4<7N&]1(],;R\!Y-J';N9@QTP.= M&7-"?$;[G*/U5;PW(\\TBF*1Z;_5SK7,MIUDB4\S,`>V#E<2Q1I!55#6$T(S MI?-'HILKQZPTQ5P9>;&.^C\52W2PMO9((1X6_+; MN;6B#1(3LBN8$%(B>N:_JDSIN%L:^HS:^3V&D+0B4VC#F=^QR&KM[2R:N=RQHP&VI/("?$9 MO?O7@JS>FI&7XI>K\TBJX_&4 M)G.+2$R6?6BRG"933S]FH=>1"S87SR4JY'.Y_-B#OPC=>)=,A>!9"%T%5MK* M0;%$B42I1&N),HERB0J&>"Y0W/JY@%OT2[_.@"];13(4P@=#IF;"N;=,*SV0 MY<<,I"PFTBJ5:"U1)E$N$7Z7BV>O3D+E1WUGJ[Z2/)2GIW)5[O=U;UN]XC>T MVVP^L!W&4WA"]]VSXLC,_KVUS\R7L`70A"FSR<+^*"F@\,4G3/`!&UK M\?T$,`'+TDC\"CZ04^>)9',CB"SY'E$7AN"V/:I_?>&!;-6`:R[ND4; MF%.`C[=?-D_EOS>GI]VQ[NW+1RC,8?NR^*0^_U9_-/HKCONJ@<^VH6'!][WP MF7X)+UF&^'KHL:H:^@-.:F`^_+_]/P```/__`P!02P,$%``&``@````A`'D2 MH4$.`P``C`D``!D```!X;"]W;W)K&ULE%9=;YLP M%'V?M/]@^;T0/I(T44B5KNI6:9.F:1_/#IA@%3"RG:;]][O73AF$M&$O"&Z. MS[GG7MLWJYOGJB1/7&DAZX0&WH027JK/^^&%UD.I1%YP;`@RU3FAA3+/T?9T6O&+:DPVOX9=*L\PN MJDH_G$QF?L5$31W#4HWAD'DN4GXGTWW%:^-(%"^9@?QU(1K]RE:E8^@JIA[W MS54JJP8HMJ(4YL624E*ERX==+17;EN#[.8A9^LIM/P;TE4B5U#(W'M#Y+M&A MYX6_\(%IO!9XL)6H0/HJTRJ(U71C`J0WUM*KLL0.-D(9]T94> M9QX7V13:8KM(5R\*X_-F9WW%]\N,X+Z2B\1VRW8W"^RYH9&+;<15?7X7Z3MY MHVUX[8X^&0CN*[G(T,FB3XLM">.+3G!5G]]%^DYFYWN"NVF\%8ON:QU#0S,! MGO9.D:R;:]@N[_?=+CN1(%VJ'Z)/:N=`9.WAP3]H33Q;>94>X\$3$A?H- M6IPX+S=N%OOM+S`+&[;C MWYC:B5J3DN?`.?&P/\I-4_=A9`.IPT24!J:@?2W@7P^'"39!Z[F4YO4#E/WV M?]3Z+P```/__`P!02P,$%``&``@````A``]0GTL)#```(CH``!D```!X;"]W M;W)K&ULK)M;<^(Z$L??MVJ_`\7[";$A":$FSF9<+\U/UO2RW+4AL^_?EK^S3X M4>\/F]WSS=`Y.Q\.ZN?U[F[S_'`S_-=?_A_3X>!P7#W?K9YVS_7-\._Z,/SS M\S__\>GG;O_M\%C7QP$H/!]NAH_'X\ML-#JL'^OMZG"V>ZF?H>5^M]^NCO#? M_-T_9IY)Z?7XZVJ\WSL%68[=^CL;N_WZQK;[?^OJV?CZW(OGY: M'>'Z#X^;EP.J;=?OD=NN]M^^O_RQWFU?0.+KYFES_+L1'0ZVZUGX\+S;K[X^ M0;]_.9/5&K6;_PCY[6:]WQUV]\-S]7.XW=\GFN8;1ACRI#'S=[;XIT_!. M(7`>"6^_R4"Q']S5]ZOO3\=J]S.H-P^/1TCW!?1(=6QV][=7']8PHB!SYEXH MI?7N"2X`_AUL-VIJP(BL?MT,70B\N3L^W@S'EV<75^=C!\P'7^O#T=\HR>%@ M_?UPW&W_TQHY6JH5F6@1^(LB9U?.^?7X"C1.^$%K$QS^:C_G=""8M8T#_-4. M%V?3BXO)Y?2-2-?:$?ZBX\DKG M/:"Y#04?M,>84G`JUA5ZP@?MZ9R?N,I1F_QF+GFKX^KSI_WNYP!N4!CUP\M* MW>[.S('!Q5G4!N_FU6O3"N:34OFB9&Z&<#$P8PYP+_SX/)Y>?AK]@/F[UC:W MTL:Q+>9HH2:KDO4X6'#@<[#D(.`@Y"#B(.8@X2#E(.,@YZ#@H.2@,L`(TM/E M"";B1^1(R:@C>(J"DN2PA:($N'@<+#GP.EAP$'(0<1!S$'"0\K:SD5+(!D$*04I&H)G%F@IU:*U.GZ M`_;32L9.44N,%''@MM.[4?5HC/J4M22MBO-KGO)E8/.B1Z"KGMM*X>= M$2I'0CGFRHEP2@7)A$S.90KA5`I2F3)6RN!D^!$I4S)VREIBI(P#KP5VRL;G M]L`N.B,<6+\E9LJX$RIE0SKER MT3D9RF.VQI2=$2I7IK*56+5K^XC,-CIV:C4RD!^YFBQ\T1(5J@>2?58J"?D9ZJSHTA*5JB>2?5D%)5JA>6>IV MKM7A^0,67AAT?AMK9.:Z-2+B:9LQ[)FZ(% MFK"9Q);VD*Q0/9+JL5!/R,^\=J:>DA6J9U(]%^H%^9GJ[.%1DA6J5Y:ZG6MU M+I>Y/E.5P./C9OWM=@=)@!SU;$S'4)S2):OV=`]3"D/>JI(?K.&4U[D@GB8N M'#PITQ.^9I,5BOL:0;<0+85Z0'ZF.E^WR0JE(JD>"_6$_$QUML*F9(7JF53/ MA7I!?JK^YYX[;#$JR0"%*TO83K(ZV9]*\E^[E]>2#)7:+LMM@<#*NVCS+MFY1VG1;!`K0Z&2Q$*SCG&9?$;O(( MK2ABC(BZER`Z&3%%JY,1,[2BB#DBBE@@.AFQ1*O7!K1"@R:8/6E4X8%/FO'Y M[R[O2H5MVEHT-J_C^WT=%E*X0"M M2#A$-.T>$Q$BTHJE5H)6I)4B(JT,$6GE4JM`*](J$;W2X0K;&V$[GZJ>P?/I MP+M&F/[J:8T+^6\\NML*B;4^:$03=>X(Y&GDPI'!N//$8M`Z0D5?/8H8(Z*(R;LBIN^*F*$\1__:Y%O7_F2W:+ M:,,SUT9$/$WLTY$H?)$5IMO'>.:.G,<+R(_N3UG\(BM4CZ1ZK!%=>R+]4HDR M*94+J4+ZE1)5EI2=155'^8@LZGJ,>:NUB/H]=SCQ-+&S*&IA9(7C[&MD[;BY M>D!^1A9%/8RL4#V2ZK%&U)N$_`QU41,C*U3/I'HNU`OR,]1%78RL4+VRU*U< MNQ]4&6MT[$V61C0ZB,J9M MWJB,D17VR,=XQNHLX@6:L)G$:EH35C,LR0K5*TO=SO6'5,;4:++GL$9FIGFMS-,V;U3&R`K[XV,\,]-"_6"_'1EC"UU)1F@<&4)VTF& M\VO/@_IWM\0J3SS++3*/(NZ$7>M<^]'@>9H8):&%1#[&,[.,\;#7@?0+)8JD M5*P1754B_5*),BF5"ZE"^I4259:4G3%5*>);J[?+8*XN,!D[*8W>*(.A(QUM M/$0PXL8QDY]\T:JMVEQ.IRSY/AK0J7")B((%B$X&"]$*3MO&);$[.D(KBA@C MHH@)HI,14[0Z&3%#*XJ8(Z*(!:*3$4NT>FU`*S20)U^HA\I)\]MEL$:%[=#> M509#1RH!>1J993!$KU2%?&RG*;R4P@%:4:P0$96N(D2D%4NM!*U(*T5$6ADB MTLJE5H%6I%4B>J7#%;8WPO8BH*I*?!'XO\I@L."*%5PCFJASM"+D:?1&&4Q; MZ3+8Y?4UVT+[J$PWRA(1!0O>%2S$8.:SQYF*Q4!WCR+&,F+RKHCINR)F*$\1 MUT]/A\%Z]UW]M.-" M3<,.=[\[^=)<&N.W\'N4YMG+N0N_4U$U,,['LVK?YR MH8M9U?2(\\M9U:OC7,&5-O<<\X`MYFP!&R,9&[:',[7YDRVPM9NEO2VP+9NI MG9?T@1T-Q.GK/&Q0($Y?"^PW($Y?"VP?($Y?"QR$(4ZS5+">PB$6XO2UP`$4 MXO2UP.$1XO2U>*X#%BCT0)R^%BC20)R^%BBP0)R^%GC9 M#W'Z9@B\J(O!=[\0IR^%GB1 M"W'Z6N`K21"G;X;`UXD@3E\+?!4(XO2UP-=X($Y?"WP=!N+TS1#X*@O$Z6N! MKZ%`G+X6^`H)Q.EK\:YF9>\Z`=.P;]X$,`G[>`)3L(\7,`'[N`?3KV^^!##Y M^G@"4Z^/%S#Q&C[J;G_XA=[+ZJ%.5_N'S?-A\%3?PS+?OOO&PO=V]R:W-H965TY>TXA*M8H%]/3, MO]\3PDD@Q^ZUM_K&CX>3-R%O3DA"__NO\ZGV,TS2*+X,-+W>U&KA)8AWT>4P MT/[Z87_K:K4T\R\[_Q1?PH'V.TRU[\,__^B_Q@S#K`8*EW2@';/L:C8: M:7`,SWY:CZ_A!:[LX^3L9_`W.332:Q+ZN[S0^=0PFLV'QMF/+AI7,)-[-.+] M/@I"*PY>S^$EXR))>/(S:']ZC*XIJIV#>^3.?O+R>OT6Q.>X_B% MA;H[AJ!P@Y2V;#TSC@W*MHEQ;E-/;]Y0#U;S1\%W4UY5M_J"^ MAZ(<#/ZBW'WU]8IR\/VI^G2PD_>N[)G[:M2Q:]B/S]4)G=/=O@HS`?U):?^<-^$K_58*:`<99>?3;OZ*8.8CB!IX*%"I8J6*E@K8*-"K8ET`![A$'2&0 MIAF*(1B!12P53%1@JV"J`D<%K@IF*IBKP%/!0@5+%:Q4L%;!1@7;$J@8`E/$ M5QC"9&#Z+R6-H7>J#HQXC`$M$9FEA(Q%B'")D`DA-B%30AQ"7$)FA,P)\0A9 M$+(D9$7(FI`-(=LRJ9@&T_17F,9D8+*$!XTPI-55+!GQH`]=$R'"-4(FA-B$ M3`EQ"'$)F1$R)\0C9$'(DI`5(6M"-H1LRZ3B&JPXOL(U)I.[AKT]XJ1BD:%W MJ]DW%D%8S")D0HA-R)00AQ"7D!DA]4I M;B*"A$6$3`EQ"'$)F7'"NR1?SL\YD4WV1"'Y,#6,9K6%"Q&$+5P2LB)D3<-T^J/,`-FQRAX&<5\BWYCHFO![H?OB9A(U3).Y/V/56!QT-+S M+51;[^EJ1HD`[`R;DU(W3U551Q1B&[.VWFD_5KO8%0&H.B.J(WFOS%@-RY:K=;`--#S,^ MF;:02<3M`L$D+Q;]AJ'8-,:"PBXL(==4\RP^M2>$Z%/8R2P@M$[[1XB=>E\(H*KS%*"F\0O=/B+5[G![+E M$Q&6=]1I.$ M5)5IF]EI?9YPI83FI^_\H/(<)H=P')Y.:2V(7]G).ARW#_L"BV/_I[P="A^Q MUP',&I4;YO9F?,N$(P0:_]0VGZ"A],*H;<+N]0;OF+!ANL$?3%C/4VX]FK"L MO,&[)JRM*/>Z)JQH*+=ZYB0?B\H-.ST3'O,TWNN9\*"F?-TSX5$+O"&$X#7& MU3^$"S\Y1)>T=@KW8$8SGUX3_B*$_\F*I^ISG,$+#/`+CI7AA54(#ZXF2]%] M'&?XAU4@7H$-_P4``/__`P!02P,$%``&``@````A``4K-!E>%```]FP``!D` M``!X;"]W;W)K&ULK)U=4]O(UH7O3]7Y#Q3W!_`' M&%Q)3@WX0[(E2[8EO]<,<1)J`*>`FWU,M;W4MT\,RY"[W>?[IZ\?C\MB\I_+XZ.7U]NG MS[B01GEX^'G][??T^/#U]N?NV M?;Q].=E]WS[)EB^[Y\?;5_GO\]?3E^_/V]O/5:/'A]/NV=G%Z>/M_=-Q'6'X M_)X8NR]?[N^VH]W=[X_;I][QNX3X]?[A_O6O*NCQT>/=,/[ZM'N^_?5!]OO/3O_V#K&K_U#XQ_N[Y]W+ M[LOKB80[K3O*^WQU>G4JD3Y]^'PO>V`.^]'S]LO'XU\ZPTV_>WSZZ4-U@#;W MVQ\OC=='+]]V/Z;/]Y^3^Z>M'&T9)S,"O^YVOQEI_-D@:7Q*K2?5".3/1Y^W M7VY_?WA=[7Y$V_NOWUYEN,]EC\R.#3__-=J^W,D1E3`GW7,3Z6[W(!V0?X\> M[\W4D"-R^V?U]\?]Y]=O'X][%R?G@[->1^1'OVY?7B?W)N3QT=WO+Z^[Q_^K M11T;J@[2M4'D+X+T3KJ7YYWSBP.B]&T4^6NC-'H2<)=^5KL@?VV[;N=DT#F[ MZ@T$!1K*.5`UE+^V85]W/=#NRK:3O[9=IW_2[YX/+JN#%FC9D?&M#[<9Z/I0 M=D\Z_;-#CE,'A]N\L$%Z[]KA3@_V\L*VO#BY/#_O7US^Y%AU,#KF!?9:3=\Y M43H7Z("\V.^_SI30H1N@J;RP30>-219JBH'NZ$@W9L@[^][%V)D7^[Z_Z^!U M<9:9%[;IU;NF6A=C;5[8EN_N^FE]KE>I8W3[>OOIP_/NQY'D8^G%R_=;D]T[ M0Q,82:,^AOLT\E86D?1AHOQBPGP\EN&0!/$BJ>^/3[W+SH?3/R1=W5G--6L\ MQ0T4)C>9L",?C'TP\<'4!Y$/8A_,?##W0>*#U`<+'V0^R'VP],'*!VL?%#XH M?;!I@%,9XOTXR]#^+\;9A#'CC!&Z!M"![[K#?@,%FHQ\,/;!Q`=3'T0^B'TP M\\'Y:EK) MM;UQKG8NKMQ!NZXU)B'L3^AS5W*SE^P'ELB8R(3(E$A$)"8R(S(GDA!)B2R( M9$1R(DLB*R)K(@61DLBF29RQEFLMC;59W1V8J$T8R?4R2?8#V[OT3MGK6A0< M_;UD/_I$QD0F1*9$(B(QD1F1.9&$2$ID020CDA-9$ED161,IB)1$-DWBC+X, M]/]B]$V8:O0Q:M..;$WZ M.K`^&-7`.9\[`R^_C_"_:#S21*9&(2$QD1F1.)"&2$ED0R8CD1)9$5D36 M1`HB)9%-35H&6BH\/-!2E;+C7.R^RP@>,N@FH#OH-6D,N@]&->C*,J$QZ'WW M:CW>B_:#7I-ZIZH9-_4C1[:1V1W4:1YW[DQ#9R^WSA]CG= MBQ!Y09$S/W*^;]3L\\"-O-R+$'E%D==^Y&+?J!GYTHU<[D6(O&E&=K*$66_S M[#G7-('ITY(FI&R*/%&%<>>,18U)0V1D2?=B?]T8,YI8U)PE%"KB=C&C&8>: M4ZB$VZ6,%APJHU`YMULR6G&H-84JN%W):..$>W<&W@WZC:K0<`3D7!(NS]Q9.X:J7U7I+OIG7N0)!/5;!*8,-P72 M%64$%#2+H:K-.MV>EZMF$*C9'$C-$J"@60J5+,LTA_E5R`54ZI@!J6,.%'1< M0A5T7$&ECFL@=2R`@HXE5/4!'5STO2O^!H+*S)V9IHITP,RLBT[.S+1(%D.- M`^PM+F_,6Q'FPJ9%PA&07%P;#6EFVH97U>8XS=6RJO#D\1RSM1`(4[$0*E=L)[Z*[:.^$=P'-$$L[D0,%.[&$ MRNV$=Q5=O:L3:\323A1`P4Z44+F=\"ZXFY]UPIWNWWL[9((XFCBF0.H6`07=8JAJMZLK M/^W/(%"S.9":)4!!LQ2JB^I,]A+$`EO5*0-2IQPHZ+2$RN[6V05-7'N4U6R- M-FI6``7-2JAJLUZWU_$FPP:*RLV=CJ:T=T#VK2N!3O:UR,F^5]ZLNC'OR?K9 MUZ+@*3BV#;N=>EW0&W@99@)!,_V2603_H%D,E4WU5][,G['7'$TTMR1`0:\4 M*C>W>(X+=LS04!USH*#C$JJ@XXH=UVBHC@50T+%$K'KP!AW_--A`4#]!TGQC MT+R'<,C$-'(O3UK4S),]+W??5#9>FK3M@B?=&`WKDZX_N/`NTA,(]`R?`ND9 M'@$%S6*H@@NZ&53J.`=2QP0HZ)A"%71<0*6.&9`ZYD!!QR540<<55.JX!E+' M`BCH6$+UUA!N(*C,W+0IO3QD=AJY-SMKU*R&FT=/1-5`(T9C1A-&4T81HYC1 MC-&<4<(H9;1@E#'*&2T9K1BM&16,2D8;![GC:@JJS:;O&G0"5556%Z#.+ZB-7E6SG%NG>)-JN&=U;MZ6J0O0%1\\H>J[M MFM&]]?5258B^XNAKBEYHNV9T;]50J@K1-TYT=T[)>HOGU.%%5A/&NX;42`_] M3<;LR4\>&ZM([Y'/$TDXD0,%.I%`YG:!W!;03V.T,#=4Q!PHZ M+J%R'*^\V]:5.@9V>XU8VHD"*-B)$BJW$UYFV/RL$^[<-O7YYIK])UG7R+VL M:Y&3=2^]*7AC'EXQ#?6\'0$%S]LQ5/5Y>WG6]R;_!`)-$E,@-8N`@F8Q5-:L M=^6M7680J-D<2,T2H*!9"E4P!RZ@4L<,2!USH*#C$BJ[>U?^,T0K"-1L#:1F M!5#0K(2J-NN>]SO>R&V@J-S<62FA#YF51N[-2HNN$9`<>;WPTI,`4-5G7;_3]]YYG$"@ MI_@42$_Q""AH%D,5S&`SJ-1Q#J2."5#0,84JZ+B`2ATS('7,@8*.2ZB"CBNH MU'$-I(X%4-"QA.JM(=Q`4)FY>?.PNK_Y\*:?-VLDJ1D3[\:J&FC$:,QHPFC* M*&(4,YHQFC-*&*6,%HPR1CFC):,5HS6C@E'):.,@=UQE]CE9YV]55J5F0<-= MHT81Q(J4C"PQ.5$3SY675\:JPL29,)HRBAC%C&:,YHP21BFC!:.,4C?\_J:Q6$;TEDU]3O[&BYERH-28#Z5P8>'<@ M8]M.5#H7ZH;-&AE%C[1=,[HWTV)5(?K,HD;T.45/M%TSNG=/FJH*T1<$X=7%GMFC#>1*J1 MCOZ-%2D962)3'ET=,YH@>*,>3Z$B;AD967MC/1/[O&-W!M1BYQ[?'I\M;M784Q'0,ZU@Q>MMF&] MXNEU+[R$,D$875Y-@72A$@$%S6*HWC*;0:!F7F3$WSP>8#IF8E=Z]V_8=P)A#H'=X4D?6^-`(*FL50R>F@ M^W+E7:%FZMA046T5L;03"5"P$RE43B^'O970X[<2@)Q43.565>E\M[&" M)_,8#>N3N=/R`"L4FCJF0)HZ(J"@6PQ5[=;R`"L$:C8'4K,$*&B60M7^`"NV MJE,&I$XY4-!I"97=+7Z`%0(U6P.I60$4-"NAJLW:'F"%HG)SIZ.IRC?O*\(K M@YXMXFNNNP9RTB_5656ET]'&"IZ"8]O0IM\+?H`5`NW2E,TBH*!9#-5;#["R MUQQ--+O-!U@A MJ`;/G9@RYP^9F$;NK0LL:N9)*K/V]B*=EQ;)'[T&TXH5#>N3KN4!5@CT#)\" MZ1D>`07-8JB"2[H95.HX!U+'!"CHF$(5=%Q`I8X9D#KF0$'')51!QQ54ZK@& M4L<"*.A80O76$&X@J,SZX^N7SOU5F[7%5W2*M?]P0&5GBE5F] M=Z;&JD+&FC":,HH8Q8QFC.:,$D8IHP6CC%'.:,EHQ6C-J&!4,MI8U%)F[4GV M<:XZ_[C,6D7T+DS&Y.-Q)5[U._JM*Y4(=J%$*G5J5^D;9K M7.+H`595(?K,HD;T.45/M%TSNG<3FZH*T1<J0O051U]3 M]$+;-:-[=WREJA!]XT1W7V'Y.>=^W!/1L_5S7N=<6Z<#>$!E9TBRS M,II8U!C7*86*N%W,:,:AYA0JX78IHP6'RBA4SNV6C%8<:DVA"FY7,MHXH=R1 MEM6P,](_N9DR^:=E2NK MD@.MN]WQJ\MKQ-).%$#!3I10N9WPWN_9_*P3SMSN'_8>0B5WYS:0DW>IIJJJ M_=P&"IZX8ZCJ$_>2GBJ=0*!98@JD62(""IK%4+UE-H-`S>9`:I8`!'\JWKDB9]WAO*5W0S_Z4__$4ZRANN^_*C+VW\?"A?`-RB MOQC*]\JV\(YLD,_3MVSI2BAY'I2W2&UH.)9R`V^1NLXP;MTB-9FAJ;AP&ZFG M#$VUA+=(+61H*AV\18H*TH,J8WD'4FH$TH.V+7+++SUHVR)W\-*#MBUR0RX] M:-LB3X\-S>-BW#=Y&&QHGO[B+?)LU]`\S,5;Y%&MH7DVB[?(DU=#\Z@5;Y%J MK?2M;7RN>S(YI,3212]J=MBSS.*/O3MD4> M193]:=LBCQ%*#]JVR$?FAV/Y%'9+#V1+W+I%/JH^-!]$YS;R,?.A^1`Y;Y&/ MB`_-!\!YBWS66GIPU;)%/CHM/6C;(I^$EAZT;9$/-DL/VK;(YY2E!VU;Y"LU MI0?5]=(;'_F&3.E!VQ;YPDOI0=L6^?Y*Z4';%ODZ2NE!VQ;Y$@O9TCH^LJ&5 MR^%L/9IR,-OV,9)#V<83.9!M/)?#V,8+.8@5/]T?*OG5J>^W7[?I[?/7^Z>7 MHX?M%TG;9]67?SS7OUM5_^?5?JGNK[M7^;TI647([]/([XMMY3LIS\PW[W[9 M[5[Q'YDFI_M?+/OT_P(```#__P,`4$L#!!0`!@`(````(0"Z9ZR_%@P``&8X M```9````>&PO=V]R:W-H965TMV6FG"24W,SGCQNO2VK MNV59QI_^_+E[;GS?'([;_-/\SU_!'X-FXWA:O=RO MGO?MO__UZWV=6NWVKXTM<+H\!Z-_H3:;OT>N=WJ\/7;ZQ_K_>Z5)+YLG[>G7Z5H ML[%;CZ+'E_UA]>69KONGUUVMH5W^(>1WV_5A?]P_G*Y(KJ4[*J]YV!JV2.GV MT_V6KD`->^.P>;AI?O9&A7_=;-U^*@?HO]O-CV/M_XWCT_['[+"]3[8O&QIM MBI.*P)?]_JLRC>X5HL8MT3HH(Y`=&O>;A]6WYU.Q_Q%NMH]/)PIWCZY(7=CH M_M=DFFZ0^N_$'/ZUV3 M?>/+YG@*MDJSV5A_.Y[VN_]I*\]H:17?J-#1J'2NKWK]=L?[@$C7B-`17;D: M]'K=ZT&?>G+!.YTMKX&.IN&P=@D7&EZ;AG2L/';]7G]0=OM"P[YI2$?3T.M< M["*56]E%.E:>WG5M0].0CA^[-H]224=6Y90)VE7?:P\[:CC?&5@/D57_J7I> MJ5P8(C4@VC_]I^JZUVV7>76I(?+`JR<"I^2EIL@$50&X9I\O^E)3Y()73X9W M72B2P>-L&%Z]YT*1%!YGA<>=O1RAEJ[C4[,0%4Q<$+IBY('1!Y(*Y"V(7)"Y(7;!PP=(%F0MR%Q0UT*+P5#&B M6OH=,5(R*D88W3N`6M#LD(UA@283%TQ=$+A@YH+0!9$+YBZ(79"X('7!P@5+ M%V0NR%U0U(`5$)JB?D=`E,Q-D_ZM%8UO1^!.V_C4D\JH9YN,*Y,J2H),!0D$ MF0D2"A(),AWA=P1-R=!D27?)*B!RJM-& M%Z-6F511$V0J2"#(3)!0D$B0N2"Q((D@J2`+09:"9(+D@A1U8D6-[LR_(VI* MIHP:1OM.$RM$_K#CE%9EA&830::"!(+,!`D%B029"Q(+D@B2"K(09"E()D@N M2%$G5I!H#60%Z?S3!-8*RMJ.A284"PSS6)")(%-!`D%F@H2"1(+,!8D%201) M!5D(LA0D$R07I*@3:^!IP64-_#]'(!-!IH($ M@LP$"06)!)D+$@N2")(*LA!D*4@F2"Y(42?6P--#L#7P_[`ZE(P=$4VZ/%VY M8**!53]>WUG;32LCU$\@R$R04)!(D+D@L2")(*D@"T&6@F2"Y((4FGCE+I`5 M(K6.^ATQ*G7L(!E4BY(@$T.L./E#9X$]9:LJ4!+-)`HEBB2:&Z1'IWSNC0WB MOB?MJNO][M:;E, M1F[''*!E!9&$0'H*5!W..,VYFA<'J< MLP%4"H/H0,BN3O4`?"FJ?^U?WXHJ[>168=7/T598->*>C]6.H17HB2&T'5Y+ M^:Z(K6ZG-\W+-`I,0WU!)9H)]?!=ZA%;8;CF4CT6Z@FWN]#WE*V@OI#J2Z&> M<;L+ZCE;0;VPU.U0J^=F-]0=FIW/%&P]M/IQVPJM0127VA-RWYZIQFJ_5]U5 M>,J"+WG)8&6^]Z[8SD@4L M2F]VNJ@']GJZ_$V:Z.=[*TT,HF5S%6U_.+"O=ZPV]56:\*[E!&A0S8-3H&&% M`H-\OI7,8,5:(1!K14"L-9=:,:Q8*P%BK12(M192:PDKULJ`6"L'8JW"TK+# MHQ[5/Q`>_61OA<<@NXJ==!RK%R=N%1O4J6(QA=6UOHVZ4WB`\YS4,R!.ZA"( MA2,@+=SU1&V:OK!PC"8LG`"Q<`JDA?ONJXP%SK/P$HB%,R`6SH&T\*#KY'N! M\VL_`"JE!]8KKM)TQ&ZL76F[%&<39.(754,_"SBHC,*>MZA.Z M(418-P+2NL[HS*5LC`9L:!I4+]!.6[Q1JZRP!IBH]XXJP)R54R!3H,[P!#C-V3X#XFP/ M@5@W`M*Z'2?5YCC-NC$0ZR9`K)L":=V>T]\%3K/N$HAU,R#6S8&T[K73WP*G MSQ2GVH/X0#CUEH453H,H.-7ML./>D,?J#:U;G`9Q5DZ-E>^5Q=GI]IS%5P"# M^LU1*(=PQLH1&FIEO]UW'D#G,&#E&#)<20D0*Z=HJ)4'@ZXS^`L8L/(2,JR< M`;%RCH9:N=?I.8_W!0Q*9;M*U;[%!\)JMCFXBW>>07:5.O/$F*VX2DU#SLXI MK,J?!YDG'6/%F3Z#%6=Z",1:$1!KS8%8*P9BK02(M5(@UEH`L=82B+4R(-;* M@5BK`))51[>7CX2G-*>)KQ8>H'K5^4-WE<-657B`.,^F0!226@4[CZN!L5*' MRLH;.&4T@Q9G=@C$'B,@VZ.3WG-CI0YO>XRAQ1X3(/:8`MD>G=XOC)4ZO.UQ M"2WVF`&QQQS(]NA,:(6Q4H>S'JVJIGGQ0VDC-Z5*A?+AE=W)E11;<=H8+<[X M*:QH>51UO=-V;FD!K&A!6UF=21LCSS46HB%[C(`N>IS#ZJ+'&%;L,0%BCRF0 M[=$ILP6L+GIR/+K/!P6LWO)HIPW-X1^X&:@]976KKL\V!M5G M&[ED0T.NBPD0U\44R*H+SUG^!<;JS;K0FV/08H\A$'N,@&R/SI;!_%T>8VBQ MQP2(/:9`MD?GYKEXE\6CCQ&*,AE\O$H`[?8Z=`5F9ZSITD@-9;Y6*RJ>H7IKT0\NPQ`K(] M.G>2^;L\QK#B:TP@SQY3(-NC\FAG MD[OOYF;3^W;D?;D?!V1WUIFCQVR%X$Z`N(RF!M'TJMY">`._XP0V@`7/CC/H M<(6&0"P=H:&1]ON^$\$Y+%@ZA@Y+)T`LG:+AF[U>P(*EE]!AZ0R(I7,T?+/7 M!2Q*:3ODE!B_80)1*L[MR"!K`O&=YZXQ;?:7#3G5)P99$XBVZJJ7/M]OAY[[ M3!Y`AI\(9D"L'$KER""CW+\>.+/Q'#*L'`.Q`K%R)I5S M6UGVN8#,F6<:6K&(:'>\*QK?\CTJZOO]+U75^S,W\@99M>X[BX8`QH68)99":=A9"YZ"R"E7;6:W>=]<%<.HNE MLP0R%YVEL'KKRA;2V5(ZRR!ST5D.J[>N3'THI"*KAU'/&?K#'_T+_]WF\+@9 M;YZ?CXWU_IOZJ*>HT[FNK7?$X+>@4[4B]891MZ?3I2+T?E&7KU.5(O-N49^G+J\SE^1U]4E6^V M'>]W/GUI=4;GKC,JR@<)Q_YSE_3/#DAW5)3OL9T&D^$H+U_6N-QKTV67J>^< MH1]YT,6=.T,_<:!!/'<9]!L%4CMWAGYD0(-X[@S]2H#\E&=:51?H*Z_7U>,F M71T>MR_'QO/F@1*F72Y3#_H[,?W'R;SR_[(_T>===$>A;T;H>[X-O69MJUGJ M8;\_X0^*4JOZ0O#V_P```/__`P!02P,$%``&``@````A`"BNM7.Q`P``%PT` M`!D```!X;"]W;W)K&ULG%?;CN(X$'T?:?\A\ON0 MF$NZB0@C>EN].]*,M%K-Y=F=&(@ZB2/;--U_OU5V"'8"-.P+(I7R.76JRD6Q M^/)6E<$KEZH0=4KH*"(!KS.1%_4F)3]_/'V^)X'2K,Y9*6J>DG>NR)?E'Y\6 M>R%?U)9S'0!"K5*RU;I)PE!E6UXQ-1(-K^'-6LB*:7B4FU`UDK/<'*K*T*KL&KF+R9==\SD35 M`,1S41;ZW8"2H,J2KYM:2/9<@NXW.F79`=L\#."K(I-"B;4>`5QH`QUJGH?S M$)"6B[P`!9CV0/)U2E8T>1B/2;A.=\#M17[OV21?RMJ#MF&.F$% MGH5X0=>O.9K@<#@X_60J\(\,4C(&XB+7VY1,XM'L+II0<`^>N=)/!4*2(-LI M+:K?UHF:H"R6">V1:;9<2+$/H-[@K1J&W4,3`#[$9!&Z*,\%"=$AR`I14G)' M`N!7D-G7Y>0^6H2OD(VL]7FP/O#9^=#.(X1HNI`@##>DT^DY,*,S,F.Z,)0' M:W!IQJ=I)CX-*I]`32_3X2'P`5MJZW0%-32,2WV=>#QD0NB2;2TN'W5B\L3&/N/E-*.SSV0M4]/+;K-` MS_6%3*/Y"`*[S(#G?`9K\;3$QQ[VM.!$=B[-929T]IFL9:AE[L.:HDP_5(*G M?'QK\96+Q MBD9OFBO&NT=F1\NP;O3$**'C#V>).=:C&,X.&D^Z2^[K`=4W)`^]!Z6;=M!M MZ:R7F\]SI<.K[Y3NN@F"/W>]9FU-+B6-CW'YDF\:(G0X15K3B1+^WSE"AX.D M-?F*SJ7QIE%"A[.D-9U0U)LFEX<4[::(>[/C?GL,)\L97=C];GM<9C?>_DUH M37X2C_%X;3&^:8P8[QX9`J1DF$18!ST9V.7QAQ?;G.HQ'&:'F][CXF#EV,W1 MKF<5EQO^)R]+%61BAUOA#/:JSMIMK"NSL/;MTV0UQY_*OIU&R0K&SJDW<`1Z MZ=2;>;("1?`F[.!@+6W8AG]G$PZ(6X6_T6@A]>$""[B_-\C\```#__P,`4$L#!!0`!@`(````(0"4 M+/$0N@(``(<'```9````>&PO=V]R:W-H965TU26ZTU:4+@"[T1H\S+\-E M"$SK52$A`;:=&%'F=!-GMW%$P_6J;]!O*?9V])W86N^_&%E\DZV`;L.<<`); MK9\0^E!@"0Z'1Z?O^PE\-Z00)=LU[H?>?Q6RJAV,.X5$&"PK7N^$Y=!1H`EF M*3)QW8`!^"1*XM6`CK"7G,Y`6!:NSFFR"-+K*(D!3K;"NGN)E)3PG75:_?&@ MN#?EN7IK=\RQ]$"&X&2R!C;&ET^TY*",8E;%=:.76%\8R_XQ, M9)*I#"9/8*;GY?`0X$8ADC098G@''C,?8=(!,7$`D,N#(AB&!`Z'_AWWV(,N MD(8+,Y:^+#P>ZBT,S?:5L5Z2SD^'74P5S[<9P5,E7YGW=WE\6>#.C8.F1:NX=$OY;P2@J=*OG(<8#FEQ4G,HV4`G3VO@.>F"KXRS;(X/0R\ M1I>'Z=%3K;?2*(Y?>WZW*&$J\5DTC25<[W"ES6`I#-5AW6YF.,__Z_-L`_3P M(AS>P!KL6"4>F:ED:TDC2N",@FOHDO&+U#\XW8%/6(;:P0+LO];PAR=@,438 MTE)K=WA`@>$O=/T7``#__P,`4$L#!!0`!@`(````(0#[@/6V>0,``/,,```9 M````>&PO=V]R:W-H965TL(B:L4%ZPB:_>-"/=^\_'#ZLCXL\@) MD0XP5&+MYE+62]\724Y*+#Q6DPJ^R1@OL81'OO=%S0E.]:&R\,,@B/T2T\HU M#$L^A8-E&4W((TL.):FD(>&DP!+N+W):BQ-;F4RA*S%_/M0W"2MKH-C1@LHW M3>HZ9;+\NJ\8Q[L"=+^B&4Y.W/IA1%_2A#/!,ND!G6\N.M:\\!<^,&U6*04% M*NP.)]G:W:+E0QBY_F:E`_2'DJ/H?'9$SHZ?.4V_T8I`M"%/*@,[QIX5]&NJ M3'#8'YU^TAGXP9V49/A0R)_L^(70?2XAW;>@2`E;IF^/1"004:#QPEO%E+`" M+@"O3DE5:4!$\*M^/])4YFLW"CTT"V)`.SLBY!-5C*Z3'(1DY5^#00V3X0@; M#G@_<<3>[3R(T&42W]Q'RWO$$F]6G!T=J!EP*6JL*A`M@=BN!X0H[%:!U^[< M=>"N`I+PLHF#E?\"<4L:R(.!P&L+02W"!Y^M8W`VW;$"*\-A M$$5GQ@$"U=TH7@B>0@^"9TP6/8-^GUAMZN=KZ,+6^O&9_%S5^VC<_(W)HF?0 M_E/K;3P(D&T2S,_HN6H4H/$L:$P6/;9I$%RO_T& M5LX:[\EWS/>T$DY!,N`,O#FHX69I-0^2U9`*V#R9A&U3?\SASP6!U2KP`)PQ M)D\/X-EO_ZYL_@$``/__`P!02P,$%``&``@````A`.'.>=^.`@``A08``!D` M``!X;"]W;W)K&ULE%7+;MLP$+P7Z#\0O$?4RW8B M6`Z3$:)V+9*Z&,SO+77I^?Y`-VG%M MA&IS'`4A1KQEJA!ME>-?/U^;N%V_HI6!:&57:`.B(3_2MYSMR1X!I,2\$.'!E1YJ7.5Y& MV<,,D\6\K\]OP?=F]!N96NT_:U%\%2V'8L,QN0-8*[5QT*?"A6`S>;-[U1_` M=XT*7M)M8W^H_1`\\!\X(@(#HH@]KUR@[LE%UM72H//C"6B8=$SF22]\@X M<([A.22?I"^\7MECTA%FDN>`L``.PZ```9````>&PO=V]R:W-H M965TTC^>??O?]V\ M[_9?#L_K];%#'EX/M]WGX_%MVNL=5L_K[?)PL7M;O]*5Q]U^NSS2O_NGWN%M MOUX^5(6V+[U!OS_N;9>;UZ[T,-W_C(_=X^-FM9[O5E^WZ]>C=+)?ORR/U/[# M\^;MP-ZVJY]QMUWNOWQ]^V.UV[Z1B\^;E\WQ[\IIM[-=38.GU]U^^?F%^OW= MN5RNV'?U#[C?;E;[W6'W>+P@=SW94.SS=>^Z1Y[N;AXVU`,Q[)W]^O&V^\F9 MEL-!MW=W4PW0?S?K]T/C>^?PO'M?[#9U3:--.@D%/N]V7X1I\"`0%>Y! M::]2(-]W'M:/RZ\OQW+W[J\W3\]'DGM$/1(=FS[\/5\?5C2BY.9B,!*>5KL7 M:@#][6PW8FK0B"R_5Y_OFX?C\VUW.+QP+OMCLNY\7A^.WD9X['967P_'W?9_ MTL91GJ2/@?)!G^QC?#&:](?.&4Z&R@E]MC@Y4?NE*DB?JN#UQ=5H=#F^FE`7 M3A2DJU77Z?.\&L>J('VJ@I.3%='5JB+Z/*\B6J150?H\KVO7JB!]JH*#P<7$ MZ5\//Q@3AR:@G`]B)DJQ3W?.J6<0?3FO>PY/'/'EO`XZ/%W$%^[B^.>ZR!/& MT3/F@R[R3!$+Z\PN\EQQ]&3YR>GI\+017\[L(D\<1\^:V2U73'G*@S?'; MW7`TN>E]HPUMI6SNT<8Q+69L(78OX79N`]<&G@T6-O!M$-@@M$%D@]@&B0U2 M&V0VR&U0V*!L@![)4VM$B^9W:"3<"(UX=.\9:-$&EB!LP47F-G!MX-E@80/? M!H$-0AM$-HAMD-@@M4%F@]P&A0W*!C`$H:WH=P@BW-!MV%@T5Z8"]])F0"VI M5];(-)G5)K5*0%P@'I`%$!](`"0$$@&)@21`4B`9D!Q(`:1L$D,TN@G\#M&$ M&]HLZ:Y9"X);G30ZJ5IM4JL&Q`7B`5D`\8$$0$(@$9`82`(D!9(!R8$40,HF M,52C&_'O4$VXJ53CT;Z7Q)!H.+JVEE9MQ,7F0%P@'I`%$!](`"0$$@&)@21` M4B`9D!Q(`:1L$D,D"GD,D=K/)!PK"&M3"TE("Q[F&9`Y$!>(!V0!Q`<2``F! M1$!B(`F0%$@&)`=2`"F;Q!AX"KB,@1?1VY"VIC.C-^'&5$02GE4YJ8:"C47"*(Y(A>1AVB!R$<4(`H118AB1`FB%%&&*$=4("H-9&HA3J!V M-N`7[B*&6L(T!RM7$0>H@4B'U&`*$04(8H1 M)8A21!FB'%&!J#20J84X@)ZAA3RO&EHTC[!5'FPFDI^F/'-$+B(/T0*1CRA` M%"**$,6($D0IH@Q1CJA`5!K(U$(<*\_00IY"#2TDNJQ7RDPDDTD*3>9,KFHC MEQ'=]>HL@3.Q=CM/6=&ZIG5H-EP6VNJ(( MA51U,>?*BOM=56[4KQ*]CF/Y]=3UMGZ)DTRS7WQ@^6##D@<@HW\*4=1=MW0X MMEHR$\EXZB$EUGFGFS-JJJ6LKJO^@$KRZD`^GFOF946^WNC-![V0)P2C%PK1 M5MOHQ:6M4VVE>Z'0L.Z86[6&^CJ6Z7?3A\=7JT>#YEP3\;.MB3.Z$`^0CL^; MU9?[';6-[N@MO1M27>H!@(S"C+0R<$;68<-CSR@OC4A+]QOR1AVB!R$<4(`H118AB1`FB%%&&*$=4 M("H-9&IAQ]V_F.T98$"ND`[Y9D#FBHCVZ7WE9DRTF2N"+6TBI/ZCA5*N]J` MA\CCJN1/W<3/3A;@V-?EE&/KI!%H`W8Z7'N+$VW`CE-TG('C7)=K M;W&A#=AQ:3@V=U=Q"`*%SX\BU4FK*:M"QB*<6$?.V:"VXL;.&=%^K7=<.*NR ME9P1D_&E)9S'!O(WDU)^J,QGJY.5!6S%E?6M`T#(!KJRB)'>2V)&)RM+V$K- M]<%X8-66LH6N+6.D:\L9G:RM8"NN;7)M'>1*MF@Y@HC#:G/R?!`FJ;-MJ?V%*)HG*?2@JVT>Y^1]A4PTKY"]!6QE?85,]*^ M$D;:5XJ^,K;2OG)&VE?!2/LJ#5_F0A9GZS.T4*=S/5CW`X6:"];IPXFBMN)1 MGG/!1LZ"$2VX>@T/)_;AEJWH!E!;.5?6;%^PE9[:/B-=8\#(K-'*^81L=;+& MB*UTC3$C76/"R*S1VH92MCI98\96NL:"!WAA:5N1E*,6HN8?K!N)6MTE;U M$F;4O%<,)]9*=-G*G'_6#N&QU8_F7Q4++]A*SWB?T7+-$,T1N8@\1`M$/J(`48@H0A0C2A"EB#)$.:("46D@4PM: MQ<9V\(N)#WIYR3YR*60D-883Z]@YTU8LY1R1B\A#M$#D(PH0A8@B1#&B!%&* M*$.4(RH0B5?"Q*C*>2YUDZ]XR;KJ=E=0NR?3G]:2E7+URA M6F1&`*Y0+?28O*469TA7JGC%+C.@>N1=W;I";]=]:O=%KMKJ$,/2QJGJMIH_ M74X_M0_)Y;2L$@Q6@^Y'T[(ZZ=A\/"W';15/IF45`]CV5].R"@0L3@G%J4BE MX?!1VFHJ$DEXA=)$5*;M"B5&IB+W@64HLT'>VJY0:F(JL@]8AG(+5$]UI5NB\K!]I,O>K1-Y>OJTH_SFJQVV?=T=ZS9#B$GKGB-XJ M75/>I2^>R3WN=D?^AZKNU>^IWOT#``#__P,`4$L#!!0`!@`(````(0!NS"X( MY`(``*@(```9````>&PO=V]R:W-H965T^SOKFJ:[(H]!&JB:A@>=3(II49;(I$OKSQ_W5-27&\B;CE6I$0I^%H3>; M]^_6!Z4?3"F$)<#0F(26UK8Q8R8M1-8MJBL6 M^OZ"U5PVU#'$>@J'RG.9BCN5[FO16$>B1<4MY&]*V9H7MCJ=0E=S_;!OKU)5 MMT"QDY6TSQTI)74:?RX:I?FN`M]/P8RG+]S=QQE]+5.MC,JM!W3,)7KN><56 M#)@VZTR"`RP[T2)/Z#:(;X.(LLVZ*]`O*0YF\$Y,J0X?M^:9*)G.\K^UT=/@E9E!;:/0=':"S.GN^$2:&B0..% M7VAVW?+/6ZD"@WX`V+`PLP'F;RE&1@$RW2B"H1>085^_\QH[T`1IV!=#Z6GF<5&7 M0E]L%QGJ1;-E7XZ1V<58\?4R(WBLY"*S;LL.-POLN:&1UVD1/*9UD;&!Z\L& M<-I./A`('BNYR+F!U9@6.Q$NW]R'N&K,[R)C)ZO+3G`33;?2H<=:Q]"YF0`/ M^>0B=>@39C@"(Z#H1O%[J`>0Q=L7)@-JS=[`E?$:5..H;&= MT['G[@4W?&NA"_%!5)4AJ=KCS`]AG/;1_C[:AG@23N.S>.ON*=;_`O=$RPOQ ME>M"-H94(@=.WUO"R=7NIG$?5K70";@ME(4;HGLMX1^!@)'J>P#.E;(O'Z#, M^O\8FS\```#__P,`4$L#!!0`!@`(````(0`/>\JC,0$``$`"```1``@!9&]C M4')O<',O8V]R92YX;6P@H@0!**```0`````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````"&>TMI%S6D98F:G5QBXHR+-X1O*[%0`FBW M?R_KNCJC)X_D?7EXOH]JOM-M\@G.J\[4B&0Y2L"(3BJSK='S:I'>H,0';B1O M.P,UVH-'?@T7467%#@DT@RG@I;HR8$2S'VH@'-?18;)H:;SFD> MXM%ML>7BG6\!%WE^A34$+GG@^`!,[41$(U**"6D_7#L`I,#0@@83/"89P=_= M`$[[/R\,R5E3J["W<:91]YPMQ3&9Q-0CP+_)IX`;/#^^>?L"P``__\#`%!+ M`P04``8`"````"$`%()SKET#``!5"P``$``(`61O8U!R;W!S+V%P<"YX;6P@ MH@0!**```0`````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````````"<5M]OFSH4 M?I^T_R'B?27MNJNI(DP.N(EU"7!MD]WNQ?*(TZ!1B,"+VOWU.T#3TLZQU+T9 M^_SXSG<^[.-]N;\K)P?5M$5=S9SSLZDS455>;XKJ=N9D_/K#9V?2:EEM9%E7 M:N8\J-;YXK]_YZ5-O5>-+E0[@1!5.W-V6N^O7+?-=^I.MF=P7,')MF[NI(;/ MYM:MM]LB5V&=_[Q3E78OIM-_7'6O5;51FP_[IX#.$/'JH/\VZ*;..WSMFC_L M`;#OH?V^+'*IH4I_5>1-W=9;/<'WN2H]=WSH`3JF\I]-H1_\J>>./SV6RU(% M$-C?RK)5GON\X2V5[$A+9=&TOG?05P>5Z[J9M,4OH.W"F7R7K>K@S)R#;`I9 M:8#5F0T?_;K?QIA[%`/B`="QBP*T(7"E@2]!JJ';13U&_E1#D,0A MCAD.!:Q8$I$0'%"BP%Q6E".8D7?2K@+X!= M:G99(HHA5<_S*@7&^SQ&VRAA3`!>Z,AJ!76PSM=H>8T(%6L495BL,&(9!2YC MSHRV*`B2#`Y[K`E?0GR*`TS6:!YALPN)UQ`NH00S$6,S%XLD";^2*!J%)4!B MO"`GPX;X&E,*3%`,\3-S:11'G1!31/F-X!0!84'7&3-2QI/@WV42A9@R@?_+ M"+\QDD!BX!0+COX_47)'.>$]B\>F=@W&<0`D&$-V),8\NA&$L0R*>N2Y4T5* M$Z/+/&,DQM!DR#8G\6DEV+5I_@7LXC3[&!4GN/P.=Y&Q@A/"L[G8]6?&]4J` MMO!V'9K#OQ:B+;ZI9S9[^TUDQF-OW86Q$W:?CV8?\V4D0J5E`6_OT^/0O87# MRV)6R.#P-HE8DM@E8J[_M41LD.P:,8 MU=!ZDPDC%J/&#?6^F%]>32Q14?UHLSVO0ZG5<21[N>FQG6S4!H:5X_GSAK>$ M::PINR#!3E:W:G.T^?.@&R#7PY3LGU^>33].838<[7GN\SSL_P8``/__`P!0 M2P$"+0`4``8`"````"$`SN!`PP$"```4'```$P`````````````````````` M6T-O;G1E;G1?5'EP97-=+GAM;%!+`0(M`!0`!@`(````(0"U53`C]0```$P" M```+`````````````````#H$``!?&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"F'#AEO`P``2PP``!D````````` M````````"!8``'AL+W=O&PO=V]R:W-H M965T;X'!P,``)L(```9 M`````````````````,X=``!X;"]W;W)K&UL4$L! M`BT`%``&``@````A`/BQ9^>O`@``;`<``!D`````````````````#"$``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`%H>]],Q"0``FS,``!D`````````````````@BX``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$/>T6F2"P``Y30` M`!D`````````````````KD4``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-2'/'WR!0``VA\``!D````````````` M````5%X``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT`%``&``@````A`-.9;H?,`P``Q0P``!@````` M````````````XFH``'AL+W=O&UL4$L!`BT`%``&``@````A`/MB MI6V4!@``IQL``!,`````````````````4;@``'AL+W1H96UE+W1H96UE,2YX M;6Q02P$"+0`4``8`"````"$`,!X07C\(``!R-@``&0`````````````````6 MOP``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`'E\A^^O`@``Z@8``!D````````` M````````6,H``'AL+W=O&PO=V]R:W-H M965T&PO M=V]R:W-H965TXSF04` M`-<4```9`````````````````+#@``!X;"]W;W)K&UL4$L!`BT`%``&``@````A`,03=&$^!@``2QD``!D````````````````` M@.8``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`#8)/'M&PO=V]R:W-H965T&UL4$L! M`BT`%``&``@````A`(F^;H^B%0``MG4``!@`````````````````Q0P!`'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`&3[ M`@&^!@``/QX``!@`````````````````SRD!`'AL+W=O&UL4$L!`BT`%``&``@` M```A``=L0L6("@``/3```!D`````````````````6#8!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"BNM7.Q`P``%PT``!D````````` M````````$W@!`'AL+W=OP$`>&PO=V]R:W-H M965T0,``/,,```9 M`````````````````.Q^`0!X;"]W;W)K&UL4$L! M`BT`%``&``@````A`.'.>=^.`@``A08``!D`````````````````G((!`'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M``][RJ,Q`0``0`(``!$`````````````````*Y0!`&1O8U!R;W!S+V-O&UL4$L!`BT`%``&``@````A`!2" XML 13 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT REPORTING AND CONCENTRATIONS, Concentration Risk (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2014
Dec. 31, 2013
Sep. 30, 2013
Sep. 30, 2014
GE Healthcare [Member]
Sep. 30, 2013
GE Healthcare [Member]
Sep. 30, 2014
GE Healthcare [Member]
Sep. 30, 2013
GE Healthcare [Member]
Sep. 30, 2014
Accounts and Other Receivables [Member]
Credit Concentration Risk [Member]
GE Healthcare [Member]
Dec. 31, 2013
Accounts and Other Receivables [Member]
Credit Concentration Risk [Member]
GE Healthcare [Member]
Concentration Risk [Line Items]                  
Accounts and other receivables $ 7,167 $ 13,570 $ 4,739         $ 6,200 $ 8,100
Percentage of accounts and other receivables (in hundredths)       84.00% 77.00% 86.00% 80.00% 87.00% 89.00%

XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE MEASUREMENTS (Tables)
 9 Months Ended
Sep. 30, 2014
FAIR VALUE MEASUREMENTS [Abstract]  
Assets Measured at Fair Value
The following tables present information about the Company’s assets measured at fair value as of September 30, 2014 and December 31, 2013:

 
(in thousands)
  
Quoted Prices
  
Significant
     
  
in Active
  
Other
  
Significant
  
Balance
 
  
Markets for
  
Observable
  
Unobservable
  
as of
 
  
Identical Assets
  
Inputs
  
Inputs
  
September 30,
 
  
(Level 1)
  
(Level 2)
  
(Level 3)
  
2014
 
Assets
       
(unaudited)
 
Cash equivalents invested in money market funds (included in cash and cash equivalents)
 
$
8,384
  
$
-
  
$
-
  
$
8,384
 
Investment in certificates of deposit (included in short-term investments)
  
111
           
111
 
  
$
8,495
  
$
-
  
$
-
  
$
8,495
 
 
  
Quoted Prices
  
Significant
     
  
in Active
  
Other
  
Significant
  
Balance
 
  
Markets for
  
Observable
  
Unobservable
  
as of
 
  
Identical Assets
  
Inputs
  
Inputs
  
December 31,
 
  
(Level 1)
  
(Level 2)
  
(Level 3)
  
2013
 
Assets
        
Cash equivalents invested in money market funds (included in cash and cash equivalents)
 
$
6,883
  
$
-
  
$
-
  
$
6,883
 
Investment in certificates of deposit (included in short-term investments)
  
111
           
111
 
  
$
6,994
  
$
-
  
$
-
  
$
6,994
 
XML 16 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY (Details) (USD $)
 9 Months Ended 9 Months Ended
Sep. 30, 2014
Common Stock [Member]
Jul. 31, 2013
Common Stock [Member]
Apr. 30, 2013
Common Stock [Member]
Sep. 30, 2014
2010 Plan [Member]
EquityProgram
Jun. 17, 2010
2010 Plan [Member]
Sep. 30, 2014
2010 Plan [Member]
Stock Options [Member]
Sep. 30, 2014
2010 Plan [Member]
Employees and Officers [Member]
Sep. 30, 2014
2010 Plan [Member]
Director [Member]
Sep. 30, 2014
2013 Plan [Member]
EquityProgram
Sep. 30, 2014
2013 Plan [Member]
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares authorized (in shares)         5,000,000       7,500,000  
Number of equity programs       2         2  
Share issued (in shares)             710,000 500,000 69,988  
Number of shares available for grant (in shares)       1,222         7,330,012  
Options issued (in shares)           0       0
Stock repurchase program, authorized amount   $ 2,000,000 $ 1,500,000              
Treasury stock, at cost (in shares) 10,308,087                  
Treasury stock value $ 2,000,000                  
XML 17 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
ACCOUNTS AND OTHER RECEIVABLES, NET (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Sep. 30, 2013
ACCOUNTS AND OTHER RECEIVABLES, NET [Abstract]      
Trade receivables $ 10,716 $ 17,173  
Due from employees 140 161  
Allowance for doubtful accounts and commission adjustments (3,689) (3,764)  
Accounts and other receivables, net $ 7,167 $ 13,570 $ 4,739
ZIP 18 0001201800-14-000018-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001201800-14-000018-xbrl.zip M4$L#!!0````(`&"%;45,H=6DGZ@``(_8#``1`!P`=F%S;RTR,#$T,#DS,"YX M;6Q55`D``^,E953C)654=7@+``$$)0X```0Y`0``[%WK<^*XEO^^5?L_Z&:K M[LQ4A<3&20CIQRU"2`\UZ9`)Z=F=VMKJPDW+]^)?F!L0V8AT$F MZ@]=Q)*.CHY^YZ%C2?[XKS?;`B\0$^0ZGX[4$^4(0,=P3>0,/QWYI*83`Z&C M?WW^S__X^(]:[0MT(-8]:(+G";A!Q+!Y0"`0^/O=ON70=H)\I) M_40!;7<\P6@X\H#:;)Z#&J@KZAEX&KDV<1WP"'V/]@U:A@$MGYR`EF4!7IT` M#`G$+]`\J=58[V_/V`*468=OKZ\G[,F)BX>G=4713I%# M/-TQX%%8WT+.CP756?&S3N+J;YGZKQJO34?0/.6E<56"\BI2LNKI_WR]ZQLC M:.NU-#^L>W/:,,G-Q6E0&%5%Q#VKJXU%@PUJQ`V<%TB\6=H$&B=#]^4T**/- M5*VFJ#5-C1K1>1[J^CAN-=#),^\A+&!-SF:;F!#E=T(+II=H9KN]X>)(_B+`P1U2&CS%5D'GM MPM(<"3@Z,DA^*U[$FJBS30@R\AO0@KSJWAC/J4]+2/F$3@-"'&[0"?6\>";!Y#YZE0'5C#QF\+%->6AJG1J,BLE#JZEU M:N=*D8?2",V/5AFDS)@?Z@`;*YH?K3SSH\76O+KB7-6:ERC.LQB=U;%C:>>X M*CI+=([U*AJ_>IG&KRJ@FG$&I3E');9>2F60,J-NRNK62YF%5XG6ZWO;=8AK M(5-GN8BN!VW2>D.$/L9CEZ4M[EVG#X=I^9P!?SS-[6/*VVD>@LA)G>F"5'D3,,Y4<"27WO>Y01]N#:)\B!A$3EO%5?MR!YA&.6[W0\3O)= M`&Z.M);!;146%@K^Z#/+)%TM$[^$?WK-M5WX=YV!BVU.Z@D:(\>UW.'D(!2@ M"/J6CWZ;^E"22I:E`D*MD]4BD:;T`-(#;"UH%BGI7VRA)3U`)15@Y@&JL0@42Z'1350U5H92`/UG@U4M9RI M7,7*5>R.[>WL*_6O^E\N;OO$OF MS+XZ"0VY#VW.3@0)#?GF?L[K3`D-^=8R'2\;=#B8AUV/B/RXGEQ#QQC9.O[! MX=$R^$VXY!$:$+WHSU8HP;R63Y,Q#/(!&)K(R]0(6TH0EA(^+YS':2`];T)+ MYB;"1B*'L@@D!Q;7LZO>I*Y)79.Z5OIMNSD[N*36;3DW_J[@+T/0'9P@D0YR M1ZIZ&,HAEKT2)_U8VCV[Z-/N>:T2J]80\"_8&7<=$ M+\CT=2MX`6B/+7<"(:FV:LT(8`JA7$EL$\VY0HW>-,Z*MCJPW=D9Q?5AVQL, MD`&Q!.T601N_VTO*5J(VLX19'[4W"$/#(>)DRTF,`X*MF(9-`E6$1,F^\SR[>J846.!N>32;KOVF,J+I_,?+/TP M@ZT%(]V7=1)H6^/B<$NB1(9>RT,OB1(9Z>0=K)`H$0,E8IVQD,OZ/:R/=G7U M1BJ8H/R9R/(]]`+[T/`Q\A`DG3?#\DUHWF+79EKB![>B]`8='3O(&9('B/LC M'O:+:78?961_@/W?*I0..?O]*IUK$QFMS!%QCL0XG+N@Z=$\(+ZM4& M8+&13[&T0`2'MG=D0V!H$AC:(0(C.%TN@5%-8)1X5\C&P)"N9(^NI-1+9#9T M):H$ABI=B02&6,`HWY4@!WGPCJ[LS*Y#:0_1LP5;A$"/7$^"^T\LG819R/`F ME#M$O(IODU]AV(F\8G;\AP6)T(E(2%0,$N4O45>`Q(/N0>==@F%FY(<%@S6< M!<\I0MQW!]ZKCF&JP3N$1R&)')9#61TVTGH<(`S6B"ND]:B(]2@U]IC=O2;M MB+!V1.A=9>NC2"YO]K:\.51$2<T#&AD&E9R5 M)X_T'JD;.(`80_,1OD#'ARV,J5KQ3RA.SPI#_(*,9%'%G=SR,4>?BY\W/>"@"I\T9C3A.:H5C;+KN]W'@W:%H\?.F[UH&4M$UBV":Q@+2&DV.G`1!A MB\XFC=PZ>(RIWH+P*CK1'KIF$]81VR/]#L!TORA[PM*`AVQ7<,BR6A) MM&A)+.N4/JLEG5Q%G)Q8AZ;6@)&T3*)9ILI#2L9-HL1-8D%IC1!"UP;JZ[S\39"(= M3WJ#X*Y^6@;?DPN(/V&Y4!)R>;W)^D>B3&R4";4,FDWB7/L$.9"0EO&WCPAB M`N:0^@*=5VA978=XV.=9_+9[YYG51M2<.&098)&`D9(P.SR;D3VU>E[ MW0Y><;(_F*VJ]@PGAQ1.Z^S`#FL>%>5";>3.HW*H\ZCL;1X5=@.&VMBM/LIY MK)(^IK/2TL*^R[1R$1B$^/_^A#P+]@9=QT0OR/1UZX#>46RL_:MTEBM(^>ZC M1)!&7TXC+S)WM-M$L3`.LT+(;;WJV)P>D9KW/;]# M],8S0]_"-PUE)"`N5-_[4F"?>O$.H*HI9Q2@?8_28T/D]YWV!EQ2A_4E[[E# M%.`[W+,7D)Z5=^&FILJI%FFJ&Z5]P`XGGA%G MG>5G5Q-G??92X^U&?I?*1:AX])=\T2;8B[:T)EY2**RHB.]ZD#SH$_W9@CUO!''XN^)YFQ+QM@H;>2*?.ITELI?`EW"7<"\S MS$XAM\PP6WI[L;V]0'%W>CNRA([`T!%[C[&$CMC0V>/&8=]!`6Z^*4KZ@)(- M=>)C^#ED;*1C2")245F2/*,UCW9]#FU$W+.ZVKCZUK]9E[26(LW?T6;$QUK< MTQG'NN=FPIK"_"0%G$\QT=T-=%P;.8L[7";<=(]9HE%I8MQ%Q'8V9T;"ZUTX MPM>=DO.%M%D>;EW*%XLHLP^OZZE)M+E*M] M_^>:I-5TOF]&)AUJ8;W)`W:'6+>+]?"/6JU%D64R=(%;2Q_6:D&!"=%57,(* M0&BM'N$@-Y8^^CS0+4)EEFD9]]3V,>;](&+H%O@3ZAAT'!,P:YGL-ZP75&.U M.H%%7H M)YS0N;,@)EE^XAI!A57Y2#5/]Q\AYQ&.7>PA9PB8U?)S^`AKQA6#>LO9^9.9 M^V5DTFQQ9D&;3N70Q9,L,[P\*E[.0]_6+49P.LK8@LZAF6;H$0X1C:3HM<,AE&^$LDP-\B'8,^]^R@YWLLJV!2(>?P-7WM%%1/U,XR MJ:K4X`-F4ODS'K@!$QJ(SB;Y=$395L_/+QJ-^J4VP_6"3K(6*FDR;^E#DF>C MII:.5REFI6;M4XK$7$9"B[F$E:!6069^U_)829#(,L.R67F]L^?+.U25VN^S M7;)V4[]H&"ZU280JE0'1"\N)'8/P#"1@AR`1C(<>[V<)VTR;)`Y-TOHY3#%6 M9M!33Z*G1J/INDIA__&T:!^['8"FUC6U[`%0K0`NRTT"'+9/ MUF#:![F'7N1&UAF$JITWE-QQ+.QK]X,I`JF&>M$H>2PL&!US+0T7+^!_@^7[ M_]5Z8[9(XUX\*"+3LNW,)T^SL!M07`N9.LLY=#UH!Q_(CGN/.@_?3,3[$:*, M150>[`&,AA,^#9,R2S!3KS=+%O,B67:=@8MM/GSP!(V1XUKN<)*=C^W!;KLR M3_`_97\5^>]-\GV=5F-Q'/7KM"28@G+D7@+6.?>SS*\B=>U<+=M0%D5V%2V- MV*AONY@N3M@:>(>"C#N]7PV)XCMKK8"S/FMH97N18O:J=&TJP8=L:,LNM,;% M`0=*)0A\K4"ITD,=.4=Y58-R9PU\;0 M1!Z@(S9XWH6;BD=$?I0EV&DWK)?KR35TC)&MXV`[='8Q&:(TI^7T?]EPI:\J=*V_)/VR<\8+Y5L::D/;@/%P&]M2AL-ZF[!ZWLQ/ILR2 M+HW%(C`XKY^OR"+VH0F"N'#ZD9I%K+(&O/ZT^B9"K:L7F9A@?A>[XKQ@OC:C M<2MP?H?T9V0AE@E=QG2BZD;X/6_DBCI+OF1FBTCW3,O'Q0)F'QY[#YW'IS]! MZ_X&='[_UGWXVKE_.@:Z8?BV'^3#3;9$,!#W(3D#B.K=)*K1WQ;D^YD2\R,=RO0FZB?IF!PW;%DR`8 MAF*&:U/"([;3[04"Y-"_X0*A\#BAG6S3Y4WN7,)BAM[@27];;^S*Y;RA%^ES MSR,L`O[+3/"UW@!-DV\\U"TPUI%90PXP]#'R="LSJ+CF`ZW8==I!M;68OU`O M+\YF^<^G7B*?16!TH9ZG@;2,3\MR#0X7OE&N]JP3^EM/?'RLQE]L\_T+=':" MQ053L?F+BX@D?QE^S0@F&W?>V,^\E[J-!1-PQ#/XFL_UA8/U;K#D$_ZS,.6Y+.!:);D171*[E5W#`@&+@:F MZS][`]]BD5 M$TD13Z0UT@YS/9$DXCL``PAE!I.HPVX2\ZAR(4JK10CT M.@##\DWJ)0;8M7GT[H=.M/)PP\Y]:,3AIB_V&\3OSI$(&L0_N>QE MKLZ3?QFAS\L^%GCE4-?4U#N'V?SB&OT6RNMKYVJC<+_;/XRP0&)"G390-2V= MA%\@IS(.0,;Q+Y4S9MJX7V?UX?I8^_K>@WP+',M:0][KG M+BZ;C7IAUK=T;F=GMFFM@SG-IE+<8:P]F:4:@>#/8W"K(PS^T"T?@AM$#,ME%VWE#YI5Y36G%=?;J]=LGN6PED.^ M(+>_^RZ_#@0C@_I)N@)H&7P]\57'/]ADL4TC77XQ)+OV)9S!G^_@"[2`^LN2 MJ2X\ZN]QS>M)_/-71*<>&Z,)[XW/:US6=6@L37B!6NP@Y[8%UT=#!PVH5*@R M?'/<9P(QWXP"`M8B&6E"R$A;+Z2J,*P"HU(ZK"[/FN>EP2HXO=>;!ZVZ$'*J M[QI:FPUUG_-9MIG8>"YW;B9VC?:-#6F):)]W>HH7;W8>3;W,BV!,+?CH:T/JU@6XC:W(% M?GI"-F7N'KZ"1]?6G9^.`7]R#"C6T>`#X+4)^C>\`JHR]CX<_7/H?4A19-W7 M=(NR>P4L./#"5G$?F4XRO1@T"L97X+_XB69E3J_WO:<.N`8U<-WJ=_N@=PL> M'CO]SOU3ZZG;N^='Q-J/W2=V(21HM=N];_=/W?LOX*%WUVUW.WW&]"GE.C&` MZ./`*T7#D78%GUS*#8<^'W#<"V?,.\2B2/4BV-T*VT1H- M)A\`?X@<%@Y=`>UB7-;(73`&,.QCFD]&M8Q*MI4SXF.,*)$Q2[\-H4.M MJV5-6#D<>T%;:N^I2T3L+[Z:X_)OV71`A@Y^/OIVTC\!7UJMAZ-?^$2,?4Q\ MIOB>RYLFNF+%YM3J8Y]URAYB.&3'Q?A+#$J<-9LFYWF-SILQ8N%P<^L MWE&_TS[ZY02T(?9TRBU*K(=G^R/`825L>'3$P:N7<'BK"'B16&-9)*9A2IO& MTJZ-/$8Y*23B&Z-\69QPXXG95:/6Y)AQ2E;CE8Q7T`OZ"$X@.^R`-:X\A'41:HNT`O3\1T'(2WIJJEQ?::(H;8P#$\UIS#``_5( M>`!*@ND5Q3!C?DZW:]AH1B*CB=Q@'<=E>0/'=.W@^*Q6>-0D/'>EDQ$86.XK M`:;/-8X1"'!)(H6")C/7'K-U$<7`7`90-[@E-A&5/`[>^'LCER1F*E"T11,7 MZR2?8\+U+#AT2"$THO;!Q3Q-,]`-^I,.PH@6`0@;OLUNK3;@5#ALB!A!YKS8 MH[]\,T@9A_,ZM>!3?`4\1ES`%[I4XKPB.L#YG'-/3/\?NDQTSRR$VZ+R[C8` M7;*RJ;!-8A^8HRN*LGE#KM^S?V^"%!BB0:'-DVJ72^W_F./)#_^/WFG\@*L',&0+CR+$M:O86<"ER MK-C_&@/7Q%"0@@C)<<2$R=/-UI3:=%UH2N]A$*=M`\4,^:(5D5!:<.]0:1F. M)/4A`L%F\\GGC9C M>4Q1*X>1?Y2-%3]%F/EHG&#,.$?K MDHWVW@;],'T<:H9I<"MDRB^4D1?Y,;M`D0<\78(EBT?DC#@D.$M[2F-.66+/ M)I,X8,;#[#M\T9B"M+UI`:K\&^.R`Z,1L*Q5;3I!<:2Q*\\6?'E(NCC$U+*`.82#"+R5(SM@WP M>[Q0DI8@\7SCU_*F?`YCR=]9N'N7$'0:'9<>%.8'$E8$_O+#>,$CUN>BV?.X ML"++558$[7K'/H>PG$@W4F1;<1+`I?LKR1$+T,Y'+'4'[5_F.WN`Z2B0"I[+ MPG;M"F99"V+G!ZN;OCJ30$.?WOO;;=PDL'T+K#\CL$YS)HO"O@3&LYC!0,1" MK(+B62^'NW1.NH[+K9IIFH>+N#.P"3GR+G#%"S^N.CRU7479==N&;7T==W<< M3;;C%S?-RHL=UQO&>-SW\%GN/`WIP[Y'7ZC M-EE2#CU,6H1>:>0F.R!!-)DX8D&!J?U\C\EQY_>48E="QN.RP$$2YH.9PQ[& ML<>,@S"+)'`>F;"L&\06_'],-\+H1ASY>+^%"Q<*51M`TQ/30B<;3:[X=S`Q M!\F_8RZ^V%8X0IXT_C+KR6W-TM!/_[+8L_`@?WSSZ(6PTDK[?0;_#E?CB8,I M'R]TM4-KQ^;F&@$/%%@!K>BM-]NVN,11QGSFW*_0Z3\3BTPO"L!:!F_G/-FI M<;O>BV].?GPC_[MTZ/.QU`W8^WU.^@5P$$/T7/[\GC4GW]9W5T[)40HV!4%-^`ZU!D$I5M!5=#77,K> M]6A4$7CH;BJ/+A+RSD(V2,C'+V32Y!,0LOJ:O*$S\&@._GSRO#`:< M#X$G\6J]W?S+CHNDJ6V<\^Z[YDX;.;&$QJ;_9+OGV,-[EF]SR>&$K992Z[FC MKV/.YLHXS\`]D+$JG+4G]?AN*Q;G1^OC<:U&\F5X/I7C5 MDK%<(V;H6*L1*^C8)TK+9\_!94+04)4]!Y<)04-5]AQ<)@2-P[*'XKNSN_<\ M9(X7S-T_.+&%45GJI."*Y4PW%%Z=5\"`-2?O".M'A/5V6R>L$]9/`NNZUFHV M".V$]A-!>]\@M"\;/85WE5ANTFJWL5D*(,XE:ZL M28C!WJP>X8DOF"KPTK_;\3YJ?5=HC7<-6J"1=I%VD7:1=M62Q2>M7;1Q1-I% MVD7:=<#0_?D^V2(9KBQ$>O!\;1E)\F61I_!A M9+H_>Y[U8@-I%2;E:QCEY6];.]!42O'5V]UDD^-+D&`C23B^)HU;.;QM=IJ= MADA6=(MG27=3FLQW)3DB)%RQ"B1(XT:8<1(U:8\CC2;W?[BO+E%6+(H M,:2&F2%%<0>3X2'0:W?@C3D[^^P%P=O],P^ZD#U@^P>Q/.=ZJ[DXD^U:>NO$ MR/+MU;EN%-?.FO*Q"BMWWEZ2^_>H^%B^;3S7^\:NBCV5P5J6,LN^W9MWO"Q/ MMEZ%'L\F]M:-'3)[ZZ?$N=D<]D62=M>1<7M(0'^BD-L[Y\J!W*(,\+E*X:LK M.\]WF'VI0FKP13&AZ<(N>R^ZAF6)0QL-GZ(7TQ_T7]XJS$`EAF7,_Y;],W6V.4($(@UMWPO>AJ)NE\O M(P]K`WLOKL@$_PB:8&-R=OP`NP\]EQ?J'E_,=R_LRR"I<2#KYL*(D`0LS?7W MR'39W9:PO]7:FXE=2 MG=?#9.3`1VB^L[1U:%EOXY.WHH!44G@*AROJ],75*F'9"JJ*K8GRGZ+.CJC1 MRD&X,5U^7!BT_1=Q0,1TW6B<)RV1XHLI:EF-I4B$,/`/P$1&'[X(K0+VIS>7P!2?>Z@-1Q'3FB?8[G!,=9K`QZ&-M(Y M]L`B>Z)D:/`:A'PL(`!`LV0!`7@O+5B*O!2EW2)9?``8&+[*L'Q2E=<.XF9F MQ3WQ;5$F<1+Y$R](JYKE88(L!X;%&B=@[@Q*_&Q0@INXE=^/2Q2",7#WC M!)("Y;.FRIO.1"U_E<7EIFM>%JGYG"M0.UU'69;U&T]\/H+/L)*@.&*5%,L, M19)T83O21-EI]=D%^;(%E;,(*4+@5(TZ5.D%@X]K5`>K:EQP45X8QS'-SSKC MYWJ^MF&N_NL]3EBF;^&D8*7ERUBOT=;8(I)R;5C`\MFT195'6:AY;+YBA4I9X!S'-$3K MZCUBM3CD^]CSIUOR^1.(`1Z)NI%8+UW4$@?3Z3YA\6?D$9-UBZ48%G!(BPLW M/]NR$B,@&U33L;$*)]C8K&+SS-BSBC*R*(NL72N*E8:YTL[3C(XMM3M?RVJ; M:C#'4C`F[K?7V_]>_P9[N%N>'=BZA^6[\KFM]WU6=:B^:F4E!6RV$\"&)[\+ M0[3:X]TQ\PL?[TYKKXD%"L]J@FUUH*3*(SH5'\98A>J]92RL^(C-JC'II>5: M/_P5C9G+(G77X8LE):JE[Y/4PI7NQ;X.Y=&MJ)UN156@P,WJSL_FJ[IK] M-0D#H3JG->I/_&#MD>6H6*7#-:QOL(]B:,<_9<^=G]U*I[=D7AGWIM<6%%)D M.M^,4%4G_"F<]9>BK*DUC$HK)JGC&\R2UUI"WI$Y##?S<<2]6):"[*M.88$@ M9GD1&-""IN5`=SCV'S;8D"&U\G?$1G=%!JML2"^]A5.C7:^/D=B[WGH74ILZ M[<&_3>2NXW<]<1`!=_5SQZY\[HCM$8<_F7A9)PCGMEC$CPLW8'&7G]FXPW[/ M'4=L`/W,7>Y#2Z(-_!^[L,:V:P;R\N++5UT MQL,.\!2*$/H@WL+T^<3S0S:,0CPKEO)`[H\%IB/WP_`PS@1P-[`G\O"!%0U" M+3O>(8_6M'K-'S0F[G4]\O0@#S;TP?:^Y0[P+-^FBUPSLFS!O6@R<03[9(_B M<(HYM;,(L@T$>[&+H>V:0!^\G)PD@$'8\X)?90Y/9I]L_(VRS8OK[K.S2[E4NV. MUZG+J>+;V6#MNL_-X5)+^3ZLF7:J7+36HI;S4:+@)O4DZPF"TJV@*N@[PDKB M5"[^!(2L?KEX$C)I,@GY,L?.2"W.(;%=D/O0QP14VT>@@LGI<+M:IU7# M@Q$$=@+[5F!O*%QLC\!.8-^CG]?4.DU".Z']5-#>[;?KAW:J#*;$87DJY$+0 M(&@0-`@:!`V"1@TOI]4]OGL3GUL\\0#OD5U'6UTRV5!X=5X!`TZ]ILDI8;U= MVDT$PCIA72VLZUJK2;7@".VG@O:^06@O4#V*PKNT&E=T-4[0(&@0-`@:!`V" M!H5WRPCO?C`#>R"N?%NV$XF+^7AQ'//ZB[(,)[Y@JL!+/^GROK1`(^TB[2+M M(NVJ)8M/6KMHXXBTB[2+M.N`H?M]I9S;+MO.XC3U;ES(1Y1PPY1B8]/B26FC M+!E7EG\K2[.5S\0E$HF)*E2S^;;2%')3F=WW*!P]8UQ@?LH8WROA"I/R_BS)\7KO4Y*V]T(:L;)71] M=4PWA#>N$M(6%-XLJ]ZRL:X0Z?Y'E\KE8G7&P;T)*-?/G>SF4H"RZL+UC3<_ M]=:Q>PFM"O.L]`K-._,L+:PC_KC*"NMH[*O(FHEEU7V.M=+./G+YU]M9'N&W M@&+\3ZX%^7WR>?+QNLKIZVJ@-XUFZ!M['/5L%:5B M([L(+TW?Q\RCOV%5N,66>,U`^HUVJ\!`9KJJ:@2&WC3T-2/H]CNZNB-H%AB! MKKC MR-4Q7^P+I6]^>$W__,7FOND/1J^B=S'MI,\D8>)!LY!CM);O"VBME/>_NMXR MOAM*\MT@OF_#=V&OB>\'L34[\[[&MF:_3%S#@4ZO5\3W.P0?_F_D82-?L8JR M"&1")0]HU?$BZTU-(MX\PKS03EH M[FPOBT%S'];B]LN7ZXKF\OKJGIW=W#YA'_$W[/L*"5H,]N4$94W+ M*,)4XSD0_(X15R9"KO-06D[?@HCMV@#"3RO#^EO73RA4DWO?=02D1%E<0Z.I MZS^PE1A8L$NPY49"];7&[T5!$9_'E3ODYH'YY'.^J(AFC:KR7+OL?R*7X\9% M<[K"#D`YMN$F#!6&:8G(OBESC7F^ M_62[IN.\L@`&!PT!S[Z8KTSOBXV2QGQ-F[@3C?'A4-:#`>J0Q><\#RBS[B:"T8(`MK(7,_-'%ZL_U!-`Y"TX4Y;&9(&%+,/TYJ M\8AJ-F,3&K4%?\S!R.;/HEI0W*JL8//DP92AQ6_;+C[!ETR&M8?&T9BYD=AZ M@L$'X5&_K>6!*"LSR@S142M\/7 M>!O/]K&"-`5A/"CQB:FCX<)`!M8C>J&;Y+GW^/%7T[_U[[%$ MER70]97[]_A-$?_-R#NBUS>?8.7^KM'0IP>WII\#CFB!`UC&B.[EB,0[&KL. M@HA;*\C??I]%[W2F5P$SC99"6)%HAMYI;T18C`$A:=!.09C`@?QEE?"%!`(Y MEB),U&Z%:WT39ZS1V)-J-P!&[6OS$!J?EA9<[(U:.1V"$WL>N!!;_?F+.:ROM087G>3 MX;6,6HUNYDS/6N$U]7J-;I-#*>>ZT=U\>.`:8146\XG+RKH#66T6UXZ>V,;R M^8#;8AM+1'O9"!;%X/B'([#>TU[^TB"MYV(7LK;LG1W\F?6IKU/'/[Z8__3\ MRP@FDS'W@_B`5M;IHB!L+\\9'?W$7IXGRXE1F"G=O3*EB4SI=FO.E=D#?7OA M2J]5>Z[H)7"E4R57+O*OR\WTN]SK*9LNX0,[9%,$,:0H>Z4"!L]]_.'U`W<' M(]PG$^Q.AI.-09*QZ,N'UPD7'\FQS;T1?[D?H59J`+875E$X[&G:$1N#]15J M?T.AX@'D-*RLY2X=S+$S`-?A9\^S@GO/6;2>W,19Z;9F_ M=:3*I6XS)]WH54W=)BLD>'"R@O72E[=`Q0[[>YL<&Y9 M3Q70OAFSNWJOJ0[M&RI9L]-3A_;-5+#9TOO;TIYMC.'Z$)H4XTAV/!8/(1WE M;E!OMQ91G31>+J6;`;LS%Y>NCM+-8*SW#LG3C4#;Z!:B-/*1M"34@8&)JV\3 M[N+E&_"!^-`.Y^.V\AOY"7P1?Q"_O@-J&P#:F0#NRJZJ'451G&`HNJ/H*(KK M)8QB-CJHT"B*:D(#KZML,XHO9ACYXM!"?`K%]4)>]!HC[C\'[*OY*J*#RY8L M'_ECF+7S@/W,@Z[7Z,2@@[^VN\7XQV?/?<)A8(?IZD30&),HEEGQWT&\\OCI MJ_[WC&OSM*:P&JUU1`EPL,:]#/I;KUK2;&\^]YT](^J;7"Y;046B4V?7TN/-LM+<3CNMA M]REYM#R`L!=.I/TEW<7($=+#'Q+@)<_%5^D`#L"\7;BPAL*6/K/LWX5.>5+S M;OJD9A7R;NU?WJ++Z:%L(OE6MV/LC:_[,Q$K&75@$W&=RPWRP`Z MXB\7XP6Q'"7/%KK9CGS9Y%<=63,KJ*-(A)]X#FJ028'D0 MDR2RJ6@L7M$MXX9X*UF4;G-J$MYH+M29?,NE4%L6INQR9[I,\:9T2 M>L>?N1O-AZ.2%^+G'UXO?!^_1IFJ?TFJVJ/S>,]ED/$V=W8^O4?5_0%/J<<\ M]V.>,]S[-/%&I.-X+\%[)>\%+,\D*(\_#6#)/#$M/..'$1?Q[V!B#I)_QP-( M,N0U&G^9)71KX1?)P[[GA)#KLOM--P(,!E9`*WIK:9[!+3/`8R2`^Q7>>CD3 MR/:BP'2M8$T*SZU3+&[`W@WS\5>)@Q7-I8CHE`J(?0O_4WRK1][&6YXK\1"P M(.$5%-Z:/)*I.923CYZOL7]M+M8Q-@M M$Y[[UK5#2L4:^GLE`8F$C)V'WN3@$C9(PJ3&).0C$++ZFEQS-W\Y9E1$Q%F: M9/T@"SR2#\F'Y$/R.37Y''UIR5@FA4M+?IR)E#-3EO)XY/"]R)84)RZ:B+3K MJV6Y-1=/K)[0*L7Y;BL6*UU%:-5P]:[6U9LEF8B#`(_03FA?BG9#:W85+OA( M:">T[Q'M/:VA]PGMA/:30'M;ZS1JZ,GLOB0:BO\[FB71A66)FRKSIX2VM1$S M##J4C:B6C.7*.T/'6N5=0<<^%:I\]AQ<)@0-5=ES<)D0-%1ES\%E0M`X+'M. M,FBM=XI$K=."!G&N!W$XWC<'87#BD>JR5$W!A5>S5=8!&HHQ$`:+8;"E4U27 M,'A8#';[.F&0,'A0#/9:O?IA\"0CH,7\:W@]\:PQHQJXUJ*$%@5&E5C'5K)C M79T^4RB%(+AH3B$$$@(/&V$@"!($#PS!&L[#%+=>ZE>G3G66ZH4BUB>S2JYR M/J%`#4%P`00-BE<3!`\+P39908+@82'8J:$5I&CU4J\ZE_XS2?Q'D>I362$; M6JO=K=\BF5!X5"AL:HUNAU!(*#SLEHG6:U7HVA`*"86+%GB:T6[7#X4G&;9> M=2'NC@^\)Q=^M#"%=NQ9[^UR'*V2=UHE5W27@0(H!`V"!D%#-?8<7"8$#0J' M*AH.+?]R'*W!5%^#G34;"@=%*V#`FO23A/5CPGI+X7`#89VPOD>L=]H5WGHF MK!/6#XCUKLIAY`-C_22CU4I<7J0X@^K'N\Y4SLI0ISF2H$Y0)Z@3U-6`>K-" M;Y"@3E`_:/26H%[:PN=H-W[*O%U*X1+EPR5-A0\@UVE^)*@K#W6=H$Y0/PVH M=RNL+4)0)Z@?$.JTM;FO5<_"ZN"GM`>TKRO!6S*RC!.OGF]Q/R4D9@X2Q`+/ ML:V8]X>/NFQ&:,WB,EJ_6U84LBRH*3M)DVZ1;DWI5K=?UK*.=(MTZY1UJZ=U M6V559"7=(MTZ;=TRC+)B-$>J6R>YA[?JJGVZ;HT7J\P,&7-0 M!VGJ4$*8/SSFR&Q__3X*SI],<_(^.8EV M)U=V'UXOLF02'^U@X'A!Y/,'&-('QQO\^=-__@=C?_VO\_,+&!'NF@7OS^_C M-!2Y+P/V^Q<^?N3^/\[/Y2=+^DN;$4G+H9<[/OSQS:#9T(U&MZ&'GOBK;S3^ MF/TPZ^SA=<(OOMG!'S$A>3HD%6]8Y-JRZ5\;C>8;6-`.[+'I!#^^.3?>_&0@ M+):R)"5QT=BODMSK"1,ND]SKNW.@U=!C#K2*^[6;(A]S;S[$N3?W,7Y] MT_%?NXGP72LAI!@'#"7U?PL([*3_+7U[.UB*#K12!A16_RUUP&BUNTIB8`L6 M[(2!9JNEGBW8@@E;VP)]>UM0EA^TL2'<=@[LJ.D';<&!G72@U]K>%RA1!S9V MA;:?#Y7SA38&P);S0-MHM]63_1:.P-:R5TST6\!^2]'W>JWMS5]9RY^-Y[UM M3?^F*I]>8(O?8%FL@/V.T0(FP@7KQKX@PK`.`F]^6AD-F@T&S<:"%L9^UF[$ MEQ)QNKE]N&+_P\[9QZM/5W=W5Q_9W=5O5S>_7LU&H7)_/OKL^]E@SF;'"(S. M/@X1+!S0PXBSP0B!%S#;9>$(W8#QQ'1?9:2JU]2[/P1SIPD"9@)JS``:=1SO M)9@K.:S$X&:";3GR1(2-#;CCQ'&^']\TWHA_!Q-SD/P['D`2VFLT_C)+Z-;0 M+7*&9<^A\771VNE&@,'`"FA%;RV-FFYY4&8`+\Q:./(Y9V-X912P M9.$S"<5,RXR&=@A8D/`*"@]\X;K(;A_WN:HX%;PSDII+.;G^2*V*6$-OM,BH@XBUPSLNR06P=9X)%\2#XD M'Y+/J^=7[VI= MO<)Z-!5\VTV-#+RA%/:">TJX7VMM9IU-"3 MHJR5$W!A5>S56&19XHQ$`878+"E4U27,'C@]+E]G3!( M&#PH!GNMLK+'403T$/XUO![D+IR'\3UO"HPJL8ZM9,>Z.GVF4`I!<-&<0@@D M!!XVPD`0)`@>&((UG(JE7O4@RP^:)/ZC2/6IK)`-K=7NUF^13"@\*A0V MM4:W0R@D%!YVRT3KM2IT;0B%A,*%]?@,B%H4#A4T7!H^9?C:`VF^AKL MK-E0."A:`0/6I)\DK!\3UEL*AQL(ZX3U/6*]TZ[PUC-AG;!^0*QW50XC'QCK M)QFM5N+R(L495#_>=:9R5H8ZS9$$=8(Z09V@K@;4FQ5Z@P1U@OI!H[<$]=(6 M/D>[\5/F[5(*ER@?+FDJ?`"Y3O,C05UYJ.L$=8+Z:4"]6V%M$8(Z0?V`4*>M MS7VM>A96!S^E/:!]70G>DI%EG'CU?(O[*2$QD]K&@IO;U`2 ME].`(2S'F@I?(208G@8,R1H2#!6`84VM(6T;%=HV^LR#X#T;1.""NR&;>#`2 MSZ78@(J$UBHVT-?TTK*=JX,T=2@AS!\>\UVMTROK'(].CP@@9&P4.F MWVVWD[090VH5V^EKC6Y5D_?A(*T.):1<)Z1<;:W1*JN$K3J05H<24JX34BZ: MN4BY2+EHYMID??M]:()'UN)WS\_EHR5-B33DT,@='_[X9M!LZ$V]:>AO M6.3:\K=?&XWF&UA;#NRQZ00_OCDWWORDMSN-)@AI*8%[H\8H0DVOH?>KH:;1 M,1KKJ#&:W48EU+2*4-/MZA5)JM%?3TVS*YA3!6\*4--K&IW-J$DB*^>SV])K MZ+N,W]Z&S+[>[JVB,FZ[?&(+Z6*CW=+5H+8`:[N=7FLK8N/G&KOQW)C<-61F M+VX'`O`I5U&:-5\RL45`T&VI0FP!SK;!H=B9V,0,9<79SJ]==I_+=_L0Y[ME MOW_AXT?N_V/-J-+_I-7>Y@>G-_302X;YQTP#%UFZJ8?7";_X9@=_7+LQ21>N ME1`DR5G#I.;*&6V.ULTX=9541DGX=9E41CDHLQ*R8JI2H@HQK-MNE\BQR^P> M??QTCZQJ-;HQJUI%6971DY!3#%7];IE<*ET#M^#4UAJHUUT#6ZD&%F;63AK8 M::^`=N93`*4?Q86UZHGPY>@KQJ50LEP<93WI:>0<\PZF[-MU"\W:QYJ\9KOHV=A&UQU6VMC-6K;LVW MX-3V49==\?1@?F.?;?/1=NS0QJVV&QYJ[')U6`T^RGVS4S!XR=;#PAXJI;[0 M]L"6U$]\:,;$R+7&X%\.QS\%&B_&&-'^M[DXJIU]EWX%@,E_LVXZ6#OMS"#&\H]J&6^MKSS:5LY-_/O^=7=_?_WKUD5U<7M[^>O-P M??,S^WIW>P-_7UY]@3?N9W?])P"3P`XEASI?0@Z M8OI6P&"ZC$#&CU'(W!A)?#CD@]!^YOL;W3^C(+2'KS/GTHW./DZE+Q0ES+E? MS%>&&-58..+LT\7]AV2P)B9]!7T<<3>`83(7.O/C>=N74Y?0O2#F$GL9V8,1 M>[$=AP71A/L!MSB#!IYM+PH8APE5:.:B-IXBVS)!K]ZQ!Z`B;7'@&XR]L*!R9(?SPK\CVX3L<@.F"K6>A!P1P?V`''-AL/:$" M`\%<6+#`MH!I0%I2V)WAJ?Q`6$B?._S9A)>'PL7%GP:V/XC&2.2`!Y+B6?)L M=^!$%O1[IK]E-LH1Y(H]().37C1VUIQ_&O")Z<.H\>0_C'*,O3#O$1`BS!]@ MT9UMQ7@+=A5)EAX3/H5';@!/D2<3'SP8>*WUEID.6#PS7/H6\JD0$\%D[AU>`@8L'%4,T],G"E2VBX%-E^1M'B7TGEE M`#4GRN1CPRN`1IC=\%_)]_+?\%TZ//C-#@,!9;P%9>)\-+1=X+L-@X370CEC MO5/5$,V)"SON",X=^D%(=!_/S)]?OYH M@AEC7\W7.&BRRF](F[X=YAN.VQ7-BD8_8)M)D^DYL!/S(#XR*?1>4]=_8/>_ M7-Q=G7^XN`<_XO+VR]>KF_N+A^O;FQI/KGDEQXG(P7GH!>P&N[B_9`_>Q!ZP MKMY+V=!L_#`%QRGVA`B0_./T*WAZEFL"VX96:(W@7OGQ,S>^_1KNKM>$CD)(W',(L[\OY&\S*YHT9NJ;+ME*LO,NL-[N54U5"9]Q>0GZ.`@U8 M,_7.,U"!R!F/N04K0`ZSH:@V/4)@C4V4D"]>0C*>35\XE:$033@"5^!IQ#[Q M1S\R?>'0=A90E0QXGJH<[MM%J.K/O<2\9Z#/1%I`/UZYZCY4Z(1#I'\Y(7#])='2+AS8_X MZ+0NELPRW3.6Z%YA">0XVVWA-WDQ)+"'CX((K')>)#E$FFZB*D(JQK2RS+Z] M4!?O8W3FE%?KQ%+^SNB)]F)I"_`&]K>8/T+Q7KP\C('OT%CLRCJOFIS)YK43 MN7T"V%ENN`7SYE%DV98('0BA,?QE:@ZM,Y_RCO(@[\'`P@UG_[QC@&LGL?(4 M9A)9M0EK7V#A^)W13&W5=WJOC_^8Q:9XUNQG[R7JLTOWQG0O,Z85AAD/%R97 M4,XX`B!VC\)D9:1@PAX+.M$O\H-6X"LN.5>=_N&5X#I5S>G M+YD*R;4IV/I@F;H):>:990.#)A/?^R8\:7!=@!E2#V`R6&*Y1/ANVIE/W*OL M"WB[.V>Q%JS4=UL09VOV"%#A>^-LFIM;>D?\$[QPE3S?:>^K,W,-8G';)5!7 M:&^KU=B(NBO3Q[A6P+Z"W`2S-0;LAK4G2ONC[40@B5F"DX_@FT0^]N#"M>+7 M-]O-,O)#:+[YZ;SQKJ%G`UC35[4#6;E]5:^!=`L.I/'FIX:B@Y@Y!K+W07R^ MO;]G7Z_N,.+TY?8F#D*M(?I4XW574P&IA:RKL0^;S;\2Q3!M!>@0I@N[D7#J MY):2`"OX&3Q1`IAE'7N`%X%Q@LZO!4>>8V&\!<9IHR/P^"I\!;G7"!IBPL++ M?((%1B0FUMQ*,EY:1J&(\N-")'$TYN,*B0(MIMKG0X?CYI7XV`MQO\ET@"3X M*-TS&WB1`^O`P2#RF0U+4PY_B&,2N*'AB:;%\N M7\21M1^3;RDYP:P"HDOJ^/=EO\.YB8@^3?L823*_J-QE]F MQ;BUY2R2BV[/*2[695V8;@3@!ZR`5O36TNP'6R:\&P`$N9\P!Y^_9W8(#P3Z]+":DH#1")7!F15Y7YB42N MC,A)RT].Y.IK^>Z54FM8JVE5$O+[_"[T:O%MS:-#%6"KEHQ:51O0M5:CK"++ MAZD,<6CQ$PJW06&WUR`4$@K)%A(*3QZ%M;2%)55$/;)2/Y?Y/4%YGV(K7WM+ M]AV\$M;]GV1-W&/>7I0?(-Y9V)7MZ\$+3R3_'OF3ZOY7YP%=SL($501O3 M+"R+N)3?%T'`0>Y?N(EI$T36GD^8_^PW3.(SRRM\(A[(KT",N?3621.W[AW> MY<14-O`"$.U[S0?\%YGP.)KG`F5*$XYP(LQ1V>&T83`F.&6G8=DI;?1Q7F'I\97Z6V'NG4_=*T[2IAB[/ M`[^?)F5F>J4[HYLW-]<(W1FE.Z,;WS=0\3;!_XT\=!Z^8A[J-:=CCN:::+TD M=`]=V$.@"LPYR6<3(TT,J=/5X>-A^B&L!,SA%PL+8Y!**""=6TSE0Y)14#(T MNZHMGP^F@X5,5)(-S6L5RO^+Z?^)@9VA1_931?G6QGF;TRO(F*8,D@5TIL)\3T`GH!'0".@'] M2(!>4_?E@*F':[."NA8+IK&\P0I+:A@&'C$.N;B&:O&)%]CA]+HI&'E^>`Y+ M[W&\W!IOOVBBS'Z4V2^764;7JPRY4RY+0OR6E!(0"8@$1`)B+0@E'X"R^U+N MN^.((1QSBKV>UNH?2XH]4BY2+J64JZQ@M3IP5H<24BQ2+%(L4BQ2+'('Y]:" MTQF7DZ%-?T@)+D_IK"DE-E1=0I1ZB8ZOUY(A]4^142,K08D-598.)39453(T MNZHM'TIL>-KRI\2&:LN'$ALJ+1Y*;*BX@"BQX=ZEG\0C*;$AZ2EESR/1D&@. M)II\S365!$1Y#0L5%S+E-:2\AG7W M]8DAQ!!U&4*)!"F1X&I8'?.QZ=J>B>YHO5Y9[ANEG2*P*P5VRJ]&0">@$]`) MZ,<"])JZ+Y1(D!()%K=_E$3HX';F>)(($>*/`/&4OTU%^1(0"8A*R/<$@4@^ M0'7+#THDN!SHE#FF($-J%F;H]ZLJWDEIF4BY3DJY*-\9*18I%BD6*18I5CT4 MZYC_7O'AS^^&30;>JNA-_30 M$W_UC<:;GU;B9.OTU=_X%]NKB^8[]=?/[UBGVY MNKC_]>[JR]7-P_TL8'-_/OKL^UFYKQC./Z,@M(>O,UN$1F7K-=LI!QI-G[(H2N&J=@8 M%$GN4^CUO,/7[[+M,G]BN,WT^ZU=@0.WL6G=D!L_C0=KG%S"`F MU1YP^,L,V8L7.19[Y`P4A-O/\$[H`5,#.;#%@]`WW6`(_9C, MB97NE9W9[_@[332<(Y=_LT/949YBW!^%AH55=EYE>^8@!*X!#>$+YVYR('5B MHAFQ@=G(HE`T/\[8QBPSY._V!Z8%F\TE(VGH.8[W`A:)"8,7`+-X(/>9AYX_ M-@53S$'0,HG2-AB(9MR*O6JN'C^GMDA M/!R4I(%G8(C"D1<%`*9U9S/*N<*P4S#\>&Z+4&9BDA#E3JSK?2MB"-GQPUD) MRDRLLG0H,[&JDJ'956WY4&;BTY8_92966SZ4F5AI\5!F8L4%1)F)]R[])"Y- MF8E)3RG]+8F&1'.XU76R.34)[$J!G1+($M`)Z`1T`OJQ`+VF[@ME2J9,R<7M'V5)/+B=.9XL MB83X(T`\):A54;X$1`*B$O(]02"2#U#=\H,R)2\'.J7&*\B0FH496OUV12=)N4Y*N2BA*RD6*18I%BD6*58]%.N8W,&EF9*3H4U_2`DN3^FL*24V5%U" ME'J)CJ_7DB'U3Y%1(RM!B0U5E@XE-E15,C2[JBT?2FQXVO*GQ(9JRX<2&RHM M'DILJ+B`*+'AWJ6?Q",IL2'I*67/(]&0:`XFFGS--94$1'D-"QSC51%0E-?P MQ"1->0U/1=*4U_#H)8U55Y47,N4UI+R&=??UB2'$$'490HD$*9'@:E@=\['I MVIZ)[FB]7EGN&Z6=(K`K!7;*KT9`)Z`3T`GHQP+TFKHOE$B0$@D6MW^41.C@ M=N9XD@@1XH\`\92_347Y$A`)B$K(]P2!2#Y`=26F92+E.2KDHWQDI%BD6*18I%BE6/13KF-S!M8D$X<]'GWV?OI3[?F^RJ'WFOJW1^" MN1-UZ\[EF3YG%LPBOCROY_F^!\@WL<'`B_P!#][- M`27^^Z_?1\'YDVE.WG\"VG]#TC_:P<#Q@LCGP0/P[H/C#?[\Z3__@[&__M?Y M^2?;Q>N*OOM'X8WDCP8?7 M+^8_/?_2,8/@XIL=_!$3),EY\]-7O?'WW/`+4+,-%RX!A]Z8^_"O0"5F)'0) MLE*6="O@R+TW#%\0TNKP`G0T`O5**)OY(.5.>UON7'K`Y-VA$/SL>T$P-W1# M;QKZSL)G$7POVORUT6B^`8,SL,>F$_SXYMQX\U-/F+XBPY=$5C3T_>"^U*%O M;P;W-N9IP[=ZM,WV;L/=0;OW!^]"^KR:#YU^1RFI;\Z%3:3>ZO35$GI91GR- MJG?U[=BPW MG-7I=A6KEV:G6Q5';WBXT[0#WRLRQ1C]=E&F`=$'9=!A/)QFM["QVY1!.]BP M_0!HHR5CP^B5Q8@]X&*=S]\LO-[=E/C=C>B>P+ZQP6P;AIH2%4A>A\=>K_`R M[L"*6:XCH9=FP,M!=A5N?JNUE:WZV;1==O89UOQO&3@Q'^U`7/U!A\8;QJR9 M'3U^@U_1CL,H,(XMAG![^_%OUY\_ MSY'I>=:+[3A;S0)@[Z8M7M+:]MT6D:+1[#76=)LTCUM[<]K(LLTZ]CONUC&Q M73>GB$DK%^X4&]]9%V5;>!"QET_;F]N&*7;-T=U;_@25R M9A,^L>\,#2"H MX:D(!!C\$Q1!_//%#)C/!WB"PD)3L70SVT/2`XX;SZXX7B]6DX^RO`8+1AQQ M:H;LGD_".&=K0V.()=%E/I,K_FIHT&TPX:+FD/.JL4GD!Y'IABST!!'FX%^1 MG=FL3S]?X;9YUCJTH;_+CAJP"QARO!G_E+``!V#$>@71YK2[G"I8V*I">CR)7B_!8BH8.*Z3%-; MI*X:VY;E\+7V9RISH7C^GMDA/!R4I*EG-JJ;%P6@'^MN#I>38&O_-\5/+BWF M-N#:-Y`N3=]_13-_,?:BTNI0J9DA4^FD>;/@.*JD>;W>9L*LB+*X.A MSS+GG&QW#)62QU#RF"7#%0YW28:Y]LECZF!)5N:/^>3Y'*AA@\CWN3MX9:%O MNH$CMI2VPCG=!J?;X+F%0K/2K.=[$%\%3%FU8*KFTGD=S%9!!VA!T.8LI%=V74L:+.N;[4B+02?>E-K`[)5^66A1N];"<.;.S;0Y3;G-@:-D. M0@RQ#LR)"+[]FUO`=]P,%6'DD`]&+G3]]`HO![A/.4CV*!VQ1XDO!==-F401B(OOQIF@3"E`A(_V4C_ M0>K@%5VQG6#YHAKOQ-0XPI`Q74(=0-F MJC?K>;=^S=[MJ!_;6UT4#)>^VT6':!N3MC&7#+>IM1ME1=>HX`N!72FPMSK] M^D&]FAW[VD^/^1NQ9NX"Z%ZVNFBW?L^$UFNWOM5I5AF8J?]V/6D6:58QS6I7 M&N2NOV:5Y`ULO%@NKQ[*P8Z/;*KYJA%:*U>\J36,WH%5O_H4TX3Y4\:\WCX2 MP.]^\V3CU>=>`D'E^VJ*N(SUJ==V&(_ZT#(A:!R6/7N_.E>'\-FJ?=W+J3.7 M)[[+5)92;>J25*14M"=#T%!K#^,$MBOVNIM/SHOJ@E9OLY$`3!H\%@ZK$ MNQ6?3@ZR^ZU:,)"BEJ7LT1GM0^]^*WARJMS=;]4`2YI53A:(3I*30WA%%W"GB3M`@:-!F3"F; MWTDM*=J.42(47K.S)`0-@H8ZKN+A+2U=8J^)VU+%EF-7KV[+D5QGPN`"#';Z MG?IA4)5`M^+3"5WZIH!E:5=3NV79C2.]FDJ:19I53+.:=.E;A6UONO1-!UXJ MQ;C1/Y8;L(1X0GRA-`?=NIV=5&C7B"+N%'$G:!`T#K(9LV5IH"J<:"J\I4PJ MU&,NO-74>KVRMF_4@;0ZE)!RG9!R]9I4TV[IWM(_HR"TAZ_5E;7+E[7("M+- MEJ+3IFO1X?]L=^!$%K?@C[@&7ESX3E0*@W<&`UDM#R2"Q?!@)`&W1%D\7-F* MC:O'N&IG,.(\ID$T+_>SX`7/92:PR3<1X$"*R^&;P`Z8!P+#;FR?<>#86#07 M!7P8.?#:,S#&&\)X7&3&,_X'VQ["`_;*31_&X_-@P@VF, M?YL@U4A0Y&(/H<>^:SZ3NL9 M7@BI?K2#@>,%D<\?`)@?'&_PYT__^1^,_?6_SL^3SP!_6:EH=F$AEL<(KO-S M^>YL/[G7/26#7UOS"ZA6]N-T-C=3K@O@!:P1PZJRUG\_H/Y#IOM* MNMH14.=ZI]>:XER)M)Z8)#93I_-^E^10DD9L8NW/V^TV":(DA=C$J)_KS;YQ M*$G`Q\!6Z4>>?>`NAXGD[6+>P:OQF_%[NYID8Q'^YGHIE>+-)(7T'IS@36QM MLW-P@C MV,O-[<,5^\+^3U(:7O^!7=]XM,/EJ"UQ$:)I3&K=BT5W$,):7*Q10>"F$Z^\P98"]?)U4<3>G$P<>X!! M$PTC!G*%'3"7#W@0X.0#2VTQ8K'P740/+N3/0^\<0PG8<([`%SL_X<"C7 MO\P7;XW,D($*X;I^`+UA'X.1S>%YLL0>1HXCFLX'!3YMN;S/D0YK\0$&]2SX M/,>\'-'`N^_B];Y8_,LXPVR,(&8U3L03'_3:!UDO8#L;VZX]CL:Q@.9D`*W* ML\/``D'E"`8$UBB('@/;LD$`.X_?6#9^,>['V)KAJ/NYD(?17C-J^$"VX/-A MY,8AHHG/GVTO`I`"L#T+GH61[VIL8OJA;3J"1<.`A^SQM5Q.W48^LT"V0.L` M+.^0^SY^"N3&T3&,;[E>"*T"NO^-^)S&3C^Z-J,[^KLV2*G:'J8C"01F]BOB(0%A`% M*`GX1R[_>^TF7WR5'SSXIL5WI+7?GZ6U0)]E#V%#][[;W&4,R>OL+/G@+<%QO0QXK@`O)/??96?)8S9O8C?!',A(P6O^R<4W M._@CH_9V*&F5I$I"5W`4%D#KU+WF/-4/P=.]J**TFH[G/IV'W!\SQS8?;<T` M`\-%[.)XKYS'7NP>/95N:YW:K2&@VM%M:%7F-^FW'-P2+%Z[(.'0\POY M8[F7=Y;:NAD^UU=E8]A,-H:Q+K*W:`SW)II:L?6,@[7B MZUWQ-1^CWJ#SR@:UZ6&O=3Y^H4&EYSNRU8O<&M.8RQ<<,)%O)TW&4?W=1M*< M/7&PJ(]R"=[0[YL[(U$]Q1L>.>C,@N40/-[H0.JLV2E&\.*=)?EP#YM="RB: MV>7:EH[-5&8]'=(FOVKL9I'`XJ?P;)X0O6GH:Q<^<\Y5UN(^B"BDA7UC]I#E M:B(^V:X=C,#UP0/I@2`*HZYW/.#^\Z)9-?XR^4Y\!A_=#I-/MF)>>QG9R_LY MT&B*2*'36(*$`J.Y,U\87AOQ;6AN*<'PUI?DI3W0VY[UR=9U4QJY1<#2[<]. M-87)35\M?FHL_N!83XT5NHTE3I'],G.*[+>KFX?;N^NK>]"SJX>R3Y*5>-G(.$-/G_/[!`>#DJ"U9FX<>A%`3B,P9HT?5O?+=V`N_O(659%:J9M^TBA MTUS*O_5YC?8!KGT#:?X(9Y49C$CD!Q#Y1SZ():[+0ZO*2WQ#ZU+E)+,;@&:; M#KW)8;%Q%KEF9-DAMPXRJ=1'.(?DQDD6FEA5TF=JH;A=\I%#)]D__OPNM4W> MTFE360N"^DE`O=LO*T_1<>4J57LZ_)OG_XD[V!/?PYN%^YH0*8&FZKGV.]VR M"DU3$E?"8,$\DOT*O25%LL7NK>2"VO-*N@/ZA%N,6TTKE"^?\N7GYJM&6?.5 M.CA3AQ)"_.$1WS:Z1X+XDA*L5U`V8DM2%,X!K6"!JP/G@%;0,=:U?F7*?SA( MJT,)*==)*5='K\J7+!O2:U.L3W^HX*&WBY#-GRL19]OGSAY,)\P:F[8;PO^X ME1Z2$UG*^#<,9,K3\8_@`_(0D[$GQRTQGU:OV<\2:O4:QGQ&K4+IGI8?R,SE MF2A*V-+SGK\E6:NV/JHJDF;,7C%8UGJUI*\[%(RD-V>O\:XE?2:FO90^?$_< MQ,&W=C\.W)Q+';FVGS))+G3@>B['0G&2\5V9)AX)'Z#U&H+]"F5M`8M/O,`. MV5F^#D(P\OQ0IM"PTZ^#M^?_-_(P\#R%.?P)!(TV#!%Q_M'V8;*'WS^:S[;%/MLS%+)?\;O16MK;EML MDK0IH4(0D=)0)&63N..58T=*7I4CWR$%V/8C[W0./_"9ZY(5#5P)B6^=H&P7 MK'?7C#R7;D!+$C?.#2I[9WEJOP)VJ-OJ3%]_G6]XWW05FG+[3;V]!5W"J;_Z M5V2';AGEW M^[7+!:<72@P_/>2O4C)Y+W*"\217E.J#V70L==%8UZ);G8?GUO)P(MTH/:$;I1FOZ&YIM7T<[45#NEMZ?Z;W<"@Z[>T=6[92=8&EI7[Y1D%>FB*:%= M+;1W-;U;EG.HSJGGX[]K^C&IM,/C9-%TW?1DKOKIK0IOB]-U4\+@(@QVZ+KI MD:ZY+M**KGC^`8^HA\/(F=Z2R8HJ,-/"<\[B\-!64Q!=U*.+>KE(E:%U>OTJ MHY?U6*>LB=N1;I%N%=&M;J?2O:#ZZY8JUVT5=QE6'M<0";CW8K_H5J,R(;!C MOM78U?0.71DFY2+E*B-R8&CM;ED!+.7N##OJE\J8VV-E\2TE9H[EK"[*NGL^ M"T;V9()5W7W/B@;Q=)]4:B7+[ MT$TJ$`BQ!I$3(E_%?@-RSW;E(7-Q!=R+?!!O`+K"_0"E-C;_ M1`;_*[*Q*NK$?!4=:*+S?(^F;P=ILSGA2C&(BX;SDH0>1F8(?;Q"%P!"+@B2 MSZ:NM+_8CL.04VS\!GY'0!%P#P8O209 M`!IXKLN=`K??MSI#GQ[IOS%#/*0/@KB%3L7YZF#ED7WYP>TP]_IIG<>_8.?L M]N[GBYOK_^_BX?KV1IS$__KYXH;=?F*W7Z_NQ*_W-38#OYD!:*.%LYG&KMW! M._9B"@WW_(GG"^46A8L=\P4M+OS]/Q'`6N_WNN_8KZZ#^0E00V)<),H/-,18-F@T5"VV5;MHG%IMZQ MAYP1`J-D.Y*YXGK"R+38(^8\B?D40@B_A;:F)^"5^\@X(95],T7MC*N4'_@-1&,'+ MR'."S;8K.S73Z?['#$9AEEK7*SG("0H.=$\U;.:!1]G+: M--Z90I/X,W>!SPZ[OQHA_XAKURTP_$]`M6!U_-T=-`00ZQ:_E6@F\QW/@@ M?%O+NY?PFF.C^',X@&8 M?0VDZT9#7J4/F:TE8"H5.1:L M1'.FM2-1T=#GIEQ%B"*`0]\)CT$TPR%A=&A0/ MAH]_SH@?%YJ"JT+BS]SQ)E,B%\W&4D\D;8X?(\<4?4]`)$C1V`.2/5\L6R3# M8D\G)>`Q2[-PQQXJ[S2@4XF%U3`F7)\57L0/>6^4_>QXC\+>^Y-W<<<\6'JU-D%[BO$?!/_R#=Z#"R%6 MAK&_)T62:(Z'5W>E3P*6NN0YA>4GE63*2+$"S'[AL!`QXZ5).I?R=&+VTF5N MSA(9_IL M@DN_]%`GQF"^_^D!M0PSILFD1O$BY;?[_V5?8IFF)O_-;TB+EJK3D\2_G&P% M8<(IE_&FY]1NSU"3V;B\NN/J;9H6._7+T5\$IV,\<42#4FTG(_`21%^XN',] M6,'QI\C-X6[I;?6:`S)91[16K2.82";%+BQ<&&+>.U3_7,0W/P'^=G&W9&T0 M+PQA[2`6:P`/8#F3+CM(_EGT88H^_*2/.7MZ_?#?L((&F`JALZ\7E_?L[*LM M)Y@+?S"RGQ'!*$H8RSC"*56(^%[@]FWJ=^%!D"@6K8L]BNP\:2!_B=C!4QJ%S1:4F:LL$@Y: M['%^38]-//*1Z0PERWZYG)KL'.0MI(N"$JBVG>Y@> MA?\PLUZ'UQ-37G-=N(B>H-=%UCEQ9#%>%J^7O2C$):4`2#`R?;FZ_YF[8BY; MZR?&+TZ[BHZ7+H3^%GVS<[9Y-LHS)T7Q`78?>J#01;K'%_/=YP&3#",'@,3> MXQ]BH2[46<3M`RS#+IQ1X(#)GG"QY0JH/V$\#[$3+Z[$^U^\1_L2&+9WA^/A M2][/R`WG!80GXJ%")<\GIF^..1BXY0LX.1=XCB5=,'B/)ULO8!+1-H'%D:MY MF"+"5[E[FZQ6<7DGFLGS]!Z<5=P@8/];9S7Y&^X*BOEVP+;1//[-MD>$`_%;MW<5@\/@4G`N\_P<%W^N369IL[U3FLZ:]=4ZSO2 M,I,$<"TM3:,T4F82,:XCI=5IE<@5?2.N&*V-V+)RQEF6SW`C.?[Q(9[>+W`: M#$3`3"0PC+O.]7SI0;=%,AB>8T*V0H.\-(,1^^I[S[8E79^S7P,Q';U-]DK! M:%^DA@#F3+F*QY\S+5O``&PX:??#*S9Z[:8M9@UFS:W8:]U0"]O=SNSH=Z"F M?NS:3"6:[=XAV/4)G!VY/[$O=J4MELJN\V9KSICM0$W]V+7QE-AH'H!?,EWS M/OF5ME@NO/1F>\YV[T!._?BU*;Z:A:S7QNSRW"P\+>=.=G;U;<+=@,^E'\^_ M+-^-W]P1#/HL%);U4S[9F[B>[:8:5&^&I*8BO-[0M^X8&Y.-VQ(3\U6<[,2C MIJ&7QNC$T.;63BFN&S.YCC?H\$##*I1Y>B]C M8G801/'&NYFM$!8.YEJ\JN]J=1HS";/S;>^=MLV4="U5D=@]\(8+3@?9R>'F MF6C$R`SD@3-S,L%=#1A0=JYIP8FFZ8AY%C!AUS,[D'-\$,3=#N71BVOW;TC- M%9`9OMXF.Y(%]*>=9\KUS:-UAS)S7F*Y_HHAWEY&\D M)3I;M\8SQ1QSTS>2%W;U#]K-Z2747`=[)6XS"Z-WC1GS5S9UFTSW[4ZW7R%Q M&TXJ=PT>MM:(N=RJ=QT M\=5M+-'DLIFYV9JZ-1/TW8;,[/=T;DGCO]F^2OQL:6AX"T#_`0M5D59!+%&O M\7B(B`_/S4.RRS_$S(\_)$8_>2Z^2DF-?RU4\.OS@;; M]\I+0?4TT9MPM=O<'967R765*A"7=G:SV4#/C>:2*55U^,S6GU()/J)*58E, MO[GWV@F:E$)W%'7=?[NS-U/XY-08NXM6.C[\.J'6@2+A5! MIV/52O5EMK-JK4:[1LO=4KV6[1C8-#JZ,A:L$+RV7YKU=L?*OA:AA=R#[6UU M8P]#/=B"J40=J73!],GS.=YGE-2;KTQN"3 MC+B+>W-9XW&;EW&3N<+0%Z[UD+5_D6;6N>'A[?#!_+9CF'9FV*606!?.;1:& M;_:)=5M&W6=#L2?-NDT/;_:JY)TL77QQ?W_U<"\2O"YDTD40\'#7(MS=]NSD MMJCI?5-6Z!A,7U_`].64B3O*\O'2&O:Y)G8Y>-2>W;V::W;O9!4K6;^488O) M*EA27;R\O[KJ1GN!#5]=6[TL<@L)NVML2N[7."^?./9SQR>1/Q`WF44&H?$8 M(SFA-_ASEO#D,[`@V4>W0_F)^&+7,PJS9ZK7]WB`,6UX#6'F6/TV0PJ]Y+1- M[@`.0(S+I$]X^GG9:9RDC0@4%:3H;^5HOL9W737VU3$QHQA>ZTS#%VN'EGPN M/@8/)8O1[&AKFFO&N+1C-4:[H16:V:C>TVCO1YX?RKP\\B+"PD.,OIG_KB["+);)[?.7^_2C)@K3&=3'F3G0VWC7TW,`* M]73PD2WP(4L;V;T38> M7GZE.KU0%7&6!8-:O$;$F,Q6D=9.>W8$2SNHBNY"J^ENG'W\'?V<'=Q1D.R#9_H6&K6/-DQ&H>>+?*56 M^H\X9^&ES&>83WSVQ7^7=88IN">86-T6B5S,$#YV^6N2.E6L=+$M'.G?18YI M3!!H8NKHC"0LGX-Y*I,DRK_9`^AY9-IB.#$E@N`\';^('*U9JDL3&G'%E`E* MXF*2:9EQSC%?V-"6Y00^\,&?@NJ,6Z)%_!_[8/I8R`)D\/GSUR1_/2@WSK9! MFLS=X4^FDU6_2I+1IHP">*#L2JVEEN/")R[32`(W?>];4O7HNTY#@\\%%+[3 M>_(?`@B/MN-D*!!\R;)C\SA#-G[FVB['+(?A*&!8SV0[G:IT`JJ#0[5Q-A(#! M$B6PL2^1\A@-P"MFN\$R7J8H*//Y\Z64D=#!5/W,5.U1;6'V^&?D#F2-@R1A MY^6"A.(#V;10^^E,TTOZGLVWO+"!,^PNEW9T<6+@1QZ^H*\\G1#;6M;S5"+3 M[.%4DP-97436HOAB^@`@66!$3UDFY3DB18[%PF9(J2>")CZM1X<27,^9_(OD??,RU1?-<>/T9^ MP.-M@V?N0XL"#M65`-G5`JZQ>%,Z&R?U5C0]ZK*LP0A\D+S,SY15!TBF%%F8 M:)++:97#0I92-$723.9A_%G,J2*$B'_D/D<=Q_(/HE8-1UH!$/"*WM/`'Q=6 M.4M-+*HWV(.0R^J!F`=5[(I/^P8:,_`[\2T\D;97F-HXAFDG^I0J$W[]:#HB M`3`JEAPQZ)0KM2B>=/'YNVE_(ZGG9[%.UB4T%_`\M7((LZIWF1:E$.55)!E# M\#+BG8.DK-%4`'::?6@W<9$],6VA]B+;D4@X/X;EEHCZR0)JH*L@7O,1\RX_ MQP+#FB/"<)B+B@_>>/EAG\NR.#$M>6Z*:3&KI`&"02HDE.Q`$#6(G2I$$1*Z MS*KGZ%!2?XJ&A]("IE92P/'3SU=3.=>?8*1/\HSS=[W,$>ED;@CTY4C&6;*" MRJZ.2)UYFL'R-LUQWI$NW^EE.1<&>H!G3J3JQ579DGHJ?X_`*MU]^0#R;[:E M23J;\7V;FM[6)>KD%)Y++"6\U*F5:I"DA_Y*"=9+3K".L\(D[S5C`O`<=@K4 M@$JFLZP9_`4G\O-5+2\H#2552C0:>D]<6'>)YE[C7?\O>2V*812"9@OY9G": M'=W7*;(NKVYG)N^9I0`^<;TQB'UZ`9[KV)8L'<\X+YX#/(C\B2?/W4&3LBAS M6JQE%H'FLVD[(K&=YX*2`""3BFNI:DU$-=U@9M&/NL*%T19!!)$63RR/33L`O(HUN/`AXMA"VBHVD)5MBL#7*%)7>(-0 M82Y`"8Q'%PWIL+)20/-A2/G>A6OE"@;M)^VC/A-97=E7Z91OLMG0ZK:4H7RS M;83VS*WFPU*^R34E<0!_8\HO!H-H',E@O,6']L!>0#2&^;AU!:L1,&!![I./ M\HNM]@W.VZU^8Q8FZWHJF>XB^S3G;:,]7K'8D0T6P*U:D''O$3#2="U3-9#+3=719:'Z;B8.!:X'EK;1L$>>*Z(*X.'#3&[->"S2 MK,H*M;+"C84K_"0:`!ZV'`I2("))TDG+RB9FB6,'`US@6HFOF149LT-1.AY> M\'Q+AG"294=:X1I'DNXAR;*7"X,>&%J!SD4(6TOC]+@E(+B0!;M6%@M':F3! MOZ3+E%HYC/RC;*SX:1H+0C=X,)#]^VE((9[AXF-),?J2S2WD-"J@..D57UW& M>%TM(#FFHO?%,II98W#MQC^\)+#5K,Z M._W=HNC(06S.3&!YC6>]9CJ:G??B\R,\*6X-66S*W7S@1.5!5R;M&C[96/QG%Z'F42V M2N35:AN[6NF=O+12$UK51J/43EZEMD:IE@E>[[9F`[,J^SWJ)G_O`$FU8:3* M:=#U7G/GI=:6^KAVC=#HE"CB/=@7]7*7ZDUC5_NR):C79X;HE[E.V8LT54ND M:C0[NTISI^!?JAK\83QWO%`__I0.ZR4Y@RA=*R(8HKM.*4 MXV7NY,9%MI/RX35[)GL[RLZB/O=*WX>$>HVU4 M3=\F4Z%AS-3*+9V^S6*S_<8&[$L/"82@28]1O(&XZ@CNJA'L+OPYIW&F^0H) MWS7.=SC*=W7M#LGSG78A]DCXRE/H2^?$S8;W1^)J7F2G>Z_O2@X[7 M^F73>4B6<2,S27@A$#X41Q>2.T6KQG0?O[.[Z`Q#7RJY7"\ET[R9;3+Z*M"\ M:9+&QO+)ODI&;Y9T45^NUXN(EN$>>=!M8`><8:[LN-KXTG3%XB-,PR`^@2_B M#W:JY=Y;`)'E?50[@")G.$5-QBT&D2H7#GLGIQ*'G.-Z+ MN!XFCFP!E6/3%Z<4Q=FRE&'9M<*487ADT90,2^Y-O=_N<.:Z5R1M`YAL)J:% MQ[%P$A'_#B;F(/EWS*07VPI'..3&7V:/5&W-L=!/_[*0"_:3^^.;1R\,O?%L MO[W>7^;O$,E7%Q[0"JW"3>OK6B[:7OY`FL.'(=Y>VK*'!2V*:TIIDWUH\F5D MA_P<906<=;T7WYRL[T>9?%UGXGBD%P5@^8*W7LE]1.'5X\[[YK[N/F9IS^!GMXS_)MSB4=2^XNBDN,>/X5QHO^YVK9 M[*A:O;WA.KOMF+6:CT_])ATW3BP>BX#R8:*^F@._GSRO25HV"->#O-30F*&($%,'$&( M^7WXZ7PS0E6=\*=PUE^*LJ;6,,HR(55C;T>[TEI"WI$Y##?S<<2]6):"[*M. M88$@9GD1&-""IF532I4-&VS(D%KY.R(95D4&JVQ(YPS6]R+HOOSN\)[W0K)- MIKA=W&6X@-8LVXDP`1V[YX/(%PW@]I,3B4RC(J.0-YY$\>EIS`P:9_%@7[G/ M9-6CWT5?JQ)S9*/)]YEUF?2(^>AS_=T.D]Z2NDZ2GQP@#Z;S M;^9"N"P<8;YCS&#(IZ0LK^1/25J("9[S1.)I>:PT2U>:\#"#?)$\T&+M*E,@ M/O*!&05<;H<-AWR0Y.FP,;LP4"AR`KQXD6-A1@H3X'.>X&>;E(FUV.O:\WRY MV983P`]8`:WHK:6F=$MW:,`QA]JQ[2V5MZ%4)0Y6-)/(HK*4MK.:`6=V][,O\GJ`HJD-'S)0D5-4C M9@M1U>J793#4P9DZE!#B#X_X=J]-B%<42(1XLO&$>"4)K17BC\?&5W-(?OW: M:'>-/+T#YZ536K/@1*]?5HA,':RI0PFA7@74-S6C4]5<1*@GU*N!>K+U2F.) M4$^VOOBZH_A=MWW=#DNONUV[S]P-/=]&4=S((L!8^MM_7I#',B4C^>HUSG"H M3%Y!):Z>3?$T+JSLQSS51&U;.TBK+:=WU+;)74B7M0I?UBI^UV-L6Q982;JK MM=^[6G0B>%MPT2%P$OF.(O_(!['$]>,\`Z[:U<+E`)IM.O0FA\7&6>2:D66' MW#K(I%(?X=3H7N7Z=4NW4^_#6G?F"\/4X+YM.J=^):*"E??>TO76(]#0*2VE M#ITU)J@K!?5N:6=7U#G0O/[X0-VGP[]Y_I_,=MG$]P8\H)35)Y.RNM/M5:>^ M%1R9.K3P"8-;;,OT*_26%#GWM>Q8VI$MLS[9KAV,N,6>L"CF5M/*EIP[^'E, M]?9P-SXXJJ"[V6F4-5^I@S-U*"'$'Q[Q;:-[)(@OZ:CTQDNQ\@X2'>Q.P,8' MB3:E5-G`R=[.*RGH&.M:OS+E/QRDU:&$E.NDE*NC5^5+E@WIK0X#KCZ%MS"C M/2[G0G[^V7Z&)5VNH$Y<>'B31/6R*=%2UI!L1^GC@`M6U26GH<NY;K>4K MQ,IJ%_8$E40VXT:'I@DL!/8M\AKU^G7#^K5)#NN_?1X,1A$X\@QL8*I.?9@(/\660.V M0C@E!Z3D@+EE>*M356Z:?0&M`JZL"4F09I%F%="L=J5![OIKEBK'O.D4J7*$ MULH5;VH-@TY.JPHEPGPI)[P.G6.ZQM=5Z>K=X:_>K:!#Q1MQ!`V"!J6?*5@K M;.K,Y8GO,JE2`+`BI:(]&8*&6GL8)[!=L=?=?')>5`]T]JK<9"<'FC!X+!A4 M)=ZM^'1RD-UOU8*!%+4L98_.:!]Z]UO!DU/E[GZK!EC2K%(TJ]FI6RJ5X]S] MKF`W@LZ]T+F7W$'4UJ'WOLL7GSJ4$.(/C_BV4>G=5G56I(Z("D*%R13\-CQ@0N2J>B[:+U>6=LWZD!:'4I(N4Y(N7K-LBYC5@WHK6K] M%:ZVEY;]NQS!6\!XVV67IN^_PA#9Q1A&)(K+_>QYUHOM.,OK^R5OJ%#'#__$ M2GH#;SSQ7%%0`\80XB]BE#C(IYA>AF7O3J#>W9Z-Z3K]GFYD4$U](/'\&&K4 M;TI6AM MW;RH8X[6&EJS=]+QVKGH:1J73=[!".8]?QJ#U6%W?()G\=TG=NT./7\L7!:- M/;ZF;_PNHKP,FV.BO7\LC]S&WZ2-YMK\\!H_5"6J>Q^-P5*^LJ'M@A6T38?9 M&;7PM2^BO($D.F!V`'^'^'LX8H_<\5XHOEMJ?%?O;5TCF0*\)Q[@78&=S2.\ MVZ!KWTBZ$-M.8),2NQ2.?,[9&-X=!8R#!VDM\.&.+1!<7T#N<\=!!3S>FPZT M`O.\SP/H1\Z9\02O/.KJ)/Q%$EU%T-6_(GLB_+:\-$@"QZ5^UP^D;"422/@))NX(ZO"*OO+!/9@M_]6JUVBU\8@@QA!A"#%'J&%"K4>]= ML#O^S-T(&A_ZWI@!*=QW38<-XC*+IYX"3=E-K-KN4'6T5J-?DH-'N=8([$J! M7=>:1EEQ:`([@5TIL)\3T`GH!'0".@']2(#>U3JMXS^VO_[`;]T7^;<3[IOB MF-N9XP7!6V:[`UC=[VMM7]/T-#6W%PJ>U.^6=E*_'N*>03:I%JG6_G+1-LI* M2;E/V+TEL!/8=P=[KZQDE/40]W97CDBC2*.6:I314WCZ()4Z!A:?FDKIK0KW M,164=^$KR`D5(X[RQ60"DV\9F:=\^N+!"TV'F2*=W+X,%$5O*7HK-Y\-S6A1 M63M"^TF@O:_UZ5P1@?TTP%YA>(2`3D`_I%5O=+H$=@+[*8#=:&J&7D,?ALY; MS%?[Q4S$`3-=BWGAB/O,YP-N/V/^&VC?Y6MN+E,X4FWCH6`XLJ,9I=4!ICI8 M!':EP-[M5QC7(J@3U$_BL#D!G8!.0">@$]!+OE6A5QG3VA?N*'7"C!P_\B'W M?8XY,<9C.P@P"2#_-N%NL+>;%10:I-"@Z*.E=3LUO(E%8">P*^T)$M`)Z`1T M`CH!G8!.0">@GZB?OK343C**I1>;:U'2I;Y9GJF41X&"M/5+"%U?0.Z2=CQ5 M_]Y:4@Z$3E4*>\2Q+:5KW1;5(2&PGP38Z;`!`9V`3D`GH!\+T+M:IU'AW7;*BT%U2':` MSXG?L%-C>:_W3SLY[_(3>Z1===8N!89[9G0JC"5L*&\J0$(0K]7*BG(1$-`/ M:$5&K?E=KZ5+VJ4%V0?00%ZQX2H0H@QV**U#SFT-,:K4;] M0J>$]]KA78'A]C2CWR.P$]A/`>RT^TM`/PF@][1^ETYJ$MA/`NS-MM;2:^BP MTUD'J@&B7BCJ],X]&%J[2O-!NU@$=`(Z M`9V`7NIP6UK7J*'[0GOX5`CD-&R&FEOZ+4UOM>L7(22\UP[O"@R7=CD)Z`1T M`CH!G8!.0">@UPCH-?73J1:(HLF9C[\6B&N[ZTJ!E'7SF$J!;(S'O90",:@4 MR&H,)IPZ,5ST5<7%02N#Q.Q9GT?]&+"@HO2I2LC)B)JJA)R.I*E*2$%`E8B= MS5S"/HHVK4X%\_YVQ5MK'#WG"^\G@78'ATHD$`CH!G8!.0#\6 MH#>;6KO*`@"418,JANP`G].^BJ?(*K\)2YX#YL(NL,JO@`G+#_>1BM58Q12) M*IPU-:.C'T['J';(L>-<@>&>]2C].\TUQI51BL([`3V`QX4;6J&7D,?ADY:4+T2]2)2IW?JHJ,9W<[AHI!5 MK?H)\@I`7I%5?[>O[A$(0OOQH%V!X5(I!P(Z`9V`3D`_%J!W-5WEHSB41X%J MEE",4+UE?DOK=BH\;$2;^R<,^0++_/-Z!*D)>[7#G@+#I5O>!'0".@&=@'XL M0#^P]TR51!;RLKX)G*F22+.AEZ505$ED8SP>6T+Q7.T0'ARP=@@)_]0*A)#$ MJ2@(B9J*@I"DJ2C(_I/I[[FY`MA9AXP]28(80@PAAA!#*F<(G4NA^AX46S]H MWHF>UNS0W61"^TF@O:6UC1KN)!'8">QT/H"`3D`GH!/03Q?HS:;6[;?KAW;* M-D%U/8[?8"AX7:W7;51G+104]_(C=J1:1ZQ:F-RYUU<*[6_I(O+)P._(UCQT MXYZ`?KCA@BUO]"I<\R@H<:I^04JU=Z7J-BHL<*Z@Q*GZ!56_H*BF"L:HIQG] M7OV"F@1V`CN!GRIV<1HV0\'@8$O36S6\H41@)[`K[0D2T`GH!'0".@&=@$Y`)Z"? MJ)^^M*9&,HR_?A\%YT^F.7E_/QAQ*W+X[3#.3GW')YZ/E^ZOW:'GCT5:^@^O M\<,'&,4'QQO\^=-__@=C?_VO\_.IW?%;L3M^E^V.GY_+%^=[2[Z[\4(>?/9, M-[APK4^V:[I8N2-K(NT1!.8B$^_X\,,!N"+'PR\7G`D?-V)BCF\R?3M\1+\,FE-YZ8 M[JO$2:^I=W\`.:T\SL!,421CK@Y&2[S^$5Z4O^JR.L;[6=U0@EO+[[/7HF1, ME4E3YQH9)*E2.X53I8YMRW+X6HV92L0MGK]G=@@/!Z7#X,QV01^\*``0!VON M"9:3VG6GV"OE>]\69ON&U+Q=+`E,)')51#XWYRDO\9/)\Z\"/,XBUXPL.^36 M0>:56LGGJ'*H=SOUWNY\\$V+YUU_VN2DX,E^SW4VM*[>J5_TA-!.:-\"[5U- M[]8P:_K>[_O4?6+\&/&XKLAXXGBO?'\S8TV/#.Y&1JW.\NDMNG5#&#PP!CMZ M_3"XCXCF\:^Y+G`'QW0'7)0@M[SH,1Q&SO263.[TJ6G],PI"W'?;;@K:DLME M&**UH3]5//R-"*V5@WIF:)U>60?5RX):!7S9+F\DZ1;IUI1N=3N5[@757[=V M=!E:2[AP9*O1LK)/;,G.ZLP"$"0\)(<7-&!'3A( MJT,)*=<)*9=N:.W22ME4C>FMSK!N?*HT/<<:'W!EZ?%7]M$.!HX71#YGO^/[ M3'SPC[DCK3/'9K//U#ZZ6@H";VX?KM@E2P^REQWWCL[OLV>8O`;/!`WR,`MOE`1[X9>'(YQS:$-@+IAB.!W_O33S+"YB4 M9X3EV>#X;4V\)CZX?DM_>L8=<#0P07V"Z#&P+=OT7T4?=L`&D>_#U\XKX^Z3^<0M7`%R^*<8&F?# MR!G:CB-[&"X]RPP$33PWL!]MQPYM(`(,$3C(7N0S\PD8)+Y_L<,1^_GJETLY MFKF!(ST)%="]Q0-`$BBR!DZZ&PW-01CY\3_]/[DP#3B*()HDEN+JZO*KP"<* M,P$%/,_9MVY+(CCYM0S4P"A&&%RT&&"?^Z[I,&$-N3^)G"`6VVL0\G&`)G@$ M$QZT*2RS$TO&%=_AF_B;AJ?!7[B#.>V%#"S^S!UO(N$R\3TK&N"[*U@#PI.+ MEC&WL"-LPA[P0,IBD4Q=&'4&&&T62P#.2\^?O-,PA`J-LM!#\XJ4""493;TJ MT0DD`NM\8:&G@9J'^FWZ;H+"["E[Y$^FF_P>CFS?8O^*3#]$M`W%0="I$3$. M\VHD]")I`5H7Q_0Q^OMH!D`YB,-+*QS*TH;OV(4UMET["/'G9U0$=R!I"J+! M".4P%+,9U]@H@L90!0#N`\2&E&!V%R#D@Y$+-NP)A.MS<0S.!S/Y;^@:7_6Y M`P1:28X#6&$Z,%F)GX"GW(3N,MX(&0Z\`/CG>B&S;%B$HOJ:8>C;CY$\5P^? M90-*;).64B[.R6DP_3R9CA8WX?ELR)%XVWT&+'J^)$M*+%WR!E-('(`[88(H M9*&%*=LW\6V`(F@1&YC!"/CL(*^FWT%>2"P(A9]2W-C2^/`4&`$*%=KA*PC? M\5[>99X*2AH:P89<3RI-(F4?-,2-`-^YM^^C\1AMGY2<#4J0EQ+N!&"OJ2VW M$3,A_@XJ*KI>=,MBW?Q(-QT*WW30>X5/-!8,'%5^U8$N.%3;1Q'L;'[\YE8>=742 M_B*)KB(H6T?EI4$2."[U@R40*=MIB#I=]I"DCU[2KJ`.U_K*"_MD;C.N7JV> MX/5!8@@QA!A26X90@N&9:?TC]%_FW MZ0&X,\<+@K?QP;Y]K>UKFKZAYO9"P;L>W6:%UD)!<2_/\4RJ1:JUVV'*5J/" MG/];P^XM@9W`OCO8>TUUL5[!^+?+_D$:11JU/!=(3^'I@U3J&%A\:BJEMQ2N ML'Q@E9H*P214C#C*%YKH3+YE9)[RZ8L'+S2=^,[@O@P416\I>BLWGPW-:%68 MMI/V*@CMAQMN7^O3N2("^VF`O<+P"`&=@'Y(J]XH+34?@9W`KA38C:9FZ#7T M8>B\147Y<2D>4FU*FF=_R;]Q_YD/L^GZJ.%^&-[$([`1VI3U!`CH!G8!.0">@$]`)Z`3T$_73E]:U2T:Q]&)S+4JZU#?+ M,Y7RP%(>96D4E?+8&)"[I!U/U;^WEI0#H5.5PAY)G?"3@(6*0%A<2$1E"T02 MIZ(B).I"HJ:B(J3&H#LD.\#GQ&W9J+._U_FDGYUU^8H^TJ\[:I5-!4@(XK5:65$N`@+Z(6UY4^%4!!4P@.J"D$KMNU);GZI7%:H+LH^@ M8-U#(E0!Y%A,D9K'''I:H]6H7^B4\%X[O"LPW)YF]'L$=@+[*8"==G\)Z"@T==CKK0#5`U`M%G=ZY!T-K5VD^:/?J9/&NP'!U MK=E4^)@/@9W`7LOU/@&=@$Y`)Z`3T$L=;DOK&C5T7V@/GPJ!G(;-4'-+OZ7I MK7;](H2$]]KA78'ATBXG`9V`3D`GH!/0">@$]!H!O:9^.M4"430Y\_'7`G%M M=UTID+)N'E,ID(WQN)=2(`:5`EF-P813)X:+OJJX.&AED)@]Z_.H'P,65)0^ M50DY&5%3E9#3D315"2D(J!*QLYE+N">YE.E=5<&K0F[2?GE5AO-1(JLJ8@XQ MA!A2`D/HK`V5"CG=*'[O7;>KP(@-K5EEQL-9F;_36[1Q=2J0[[\SUDK[^"%/ M>#\9O"LP7#J10$`GH!/0">C'`O1F4VM760"`LFA0Q9`=X'/:5_$46>4W8$^4K$:JY@B486SIF9T],/I&-4..7:<*S#9@S1J MCQJE']8U4X`%I%2D5'M7JE;+(*6B0B54J.2DX[6*A%]T0S-:%:X-Z93%"6-> MD7A(7^LW:KA+07BO'=X5&"Z5<""@GP30^UJCRF@%@9W`?L"#HDW-T&OHP]!) M"ZI7HEY$ZO1.770TH]LY7!2RJE4_05X!R"NRZN_VU3T"06@_'K0K,%PJY4!` M)Z`3T`GHQP+TKJ:K?!2'\BA0S1**$:JWS&]IW4Z%AXUH<_^$(5]@F7]>CR`U M8:]VV%-@N'3+FX!.0">@$]"/!>@']IZIDLA"7M8W@3-5$FDV]+(4BBJ);(S' M8TLHGJL=PH,#U@XAX9]:@1"2.!4%(5%341"2-!4%V7\R_3TW5P`[ZY"Q)TD0 M0X@AQ!!B2.4,H7,I5-^#8NL'S3O1TYH=NIM,:#\)M+>TME'#G20".X&=S@<0 MT`GH!'0"^ND"O=G4NOUV_=!.V2:HKL?Q&PP%KZOUNHWJK(6"XEY^Q(Y4ZXA5 M"Y,[]_I*H?TM740^&?@=V9J';MP3T`\W7+#EC5Z%:QX%)4[5+TBI]JY4W4:% M!PJ!"D(Z`3T0UKU?I<. M41+83P+LS;;6TBO<5Z13"%3S@B*/1Q)Y-+1VE;:#]JX([`>\7*,UFQ46AR*P M$]A/8K%/0">@$]`)Z`3TDF]+=HT:NB^T>T_%+D[#9B@8'&QI>JN&-Y0([`1V MI3U!`CH!G8!.0">@$]`)Z`3T$_73U];4@#\???9]^E+N]R4K]']&06@/7V<6 MZ49G'TOTA:S_%!=I"$<^7U>EH27VYK%<@\9^OF*_<-,)1P/3Y\R4F_?P$19] MZ+7^(M[L=O^"I2!\F490@S^""1^$]C-W7M]E7&6?BA>**$Q"1Y+0:Q0CX<() MO-4M?M=YUV3`>\?V7`W+6_2Z?]%$']_UWNG33_KP!'HU5QYI8&:X;'P?X2WY MJZ[%@YTF?%95XK__^GT4G#^9YN1]G`/]CD\\'U,[?+2#@>,%D<\?`%@?'&_P MYT__^1^,_?6_SL_O.9#N/FGLB;O[41-Y M&2D0BXP+@-@R=AK8".S)^:,9@"VY],;X4-0AF1L-OOOP3-\2_]]OLNVOHFE]K31^^MK\ M^[I!;-=UH:%?C2>.]\IATO[]BYB9_P&O@[;;`W0/[D.83K,G5?)I1L'^$-\\ MO$[XQ3<[^".C49`H"?SCP0X=?CN\=L%KL*T([!>^FPY1O@4<-\KF^,_P-?+O MS'99@%\';U>P=8$,]L7IVPF^&`AZ@FM7TOFS[P7!.F#ND>%36JQO97!V&NJ6 M8KD=#NT!*,UQ""4>31&1Z`<6R4<;%A.AYU=IDC:0R?XL4S+0(D)I'U@H<]IP MI#+90$]:[<.*1+(]_EAA,Y7,!X)>V6H1]A)GUP*[?IQ5RFIL,;NNL0@'-M(' M\>8/8J8W\C'U5G5B6;8B9KGFV>,KR[\7=\%$'QJ[B42(%!9KXJ6`73R;MB.* M56.\5O1^_M4Q71%!W;]`9?^W0]E[VODGSQ==+Y`JRA()NC''4I3X#R2NB'2Z M!JP!].8>Q+.&\(/)J*&RC!J%-*C9K%)`&7>E96-F%(X\W_[WC+VK3@FR_O>- M_KTY]LLHWIJKY<-V.5<;C8[>W1ZODJF5<'4/QB0V(==!$,%#D(2<6):YH26B M7E(B"4GFMWWYI-OKR#[DN&AD5!YR?PS>H"7KK-WYM<%>M/0UVV=Z?J,@9EON`S:"NTO;T2;0*//)Y$_&`'' MV<3WGGQSK.6G!W.,^_WG(*\Q:,6:A00^O4O;^RJ;RRSGA6AKT.=.^C[`O5!Y(A-)O/)Y])XYOV+2_D"NJDK.245_6/DISLL>0,`3N,]]Y_M M`9]7$CVU;GK#`-;=<00BVKF@/IEL%'\]FVV&>;@^C&,/.J!["$5$%I2F@1L'7VPVEI MHV)'17X8.RN)%Z.)PW?BC:"(M[F*#FA)-K36!=G:/>ST^[U>0;:DY.S*CIP_ M-[]?51V#&N5M,)7*QBQ2B4>AXDV7!6N<%6O00S$U)?W"M1+""ZWT]9T8_)OI M1%PLW@6GGV3X=X/X+CZ-@\;Y_D2[HM/'69>\I*CY[$&>;FN>+UL0NHY3NVPK M[XMWU>P=SR\(1)2I?!;OM/^@'H]7;C+,'4?#15?Y+-YA'UX]!J_8;)\[0]E& M#.^1OZ*!D>=88+[_FUW]*[+#5XU=NP,GLL3DA>?+,004PG`>(W$-@H4>N_%< M9(COB8.R\`$LZV'("[D=-R\;3YN.6\XW_.!--YNTNE5HHM/J+%#WG6FI.><* MG5]O-CI57UI]DK.+,W M4JSXWMP]7[#.3MUYZ35W_@=T_W%[^[R^WGS]>W=VGOW=_8%?_ M]]?KA[\ON+.TZ[4F21B^\)[9(3P=E#38?*2IA'%4=3WKUF7_$[F,3PK1%XFQU2I^@ M+!B9CL,>>1+,F&XPA\BI73BP(VB@Y"+*PTM5Y@"T/$DJ`V(77<_2,S:_V>-H MS-S9#3[X*_\=>QG9@Q&\_HJ4Q=TLHMX.6%L#V>'_XK;FKF;5"&L/LX,#IDQ\ M&W=Q4"XO'K0V,7T3[#"7-CF.]$(_R)ADJT9NK7]-HL"2,<100NC7:%&F4A0 MQ6T+O@Q'9KC$$H@+B*9,KA2&G"C-%QN4+[E?!<.S0_@I'+%AA+]+?0,I M`WD6QUT9O)XIAHY0Q"=QV]"@/;%YSB(D;R0!>.%XOGCH*)2S@(MZ]FZ)?314IZLK< M@HAREYV-HMZ,L<:;,0[LS1BU]F:,=,+O:NUC\V8,\F94\V:,:KP9?$]T1#X- M^33[]&F,V*?I]+5^KU?$I5'5*>EJ!ORCH6_HF!BU<4P.A_,;+S4&@JDKP@C` MY,PJ6M/Z<2[T([Z&KI"6D/!7L>G:91?@:SAQ[IYE3N`BSS=W9$XJY8*3=?A) M-$$+\YW^KIVE'I+>P0M,TT'T&(!7`\QSP(BY`_`I`WG>]G\B^$7ZWO!Y\UTC ME[EHN;NZS!%5R9C!"M-H]+1&KYM8LY$)WC7G;HZ%%F9=0H:F*/ MIB.8A-*<*SU4J\(*E4T6V5="?G(>'9O?1RQ;:CQB[B!8X&8`-V?^$` M>JO8X="D1?&6:"YI#)N2+:W=BMW/&='&@B.B1]?9`O( MDA@QGPP!=`]4;PDGILF:9T"R"`JE_JTXM;F@V2*[O[/T]EL]/)VXDMRRR5RP MU;H56U=KVWH%VFH/N`#R]TY7H0L'W7:[*%U_XY@D$]3DXIG[YA.?OZYX&X5! M",L\D97L@QG8`YF?SW8B/&4R,X2DO;BYJ3M1N99$.Q>N%;>R67HG?6[`[;;> MF]Z.WXX.U=FR,D'7/%LZC6[_--BR(AG<`K1T>YW6";!E9>:Y14IDZ/U]LN4R MK6X2L#N9?10.]S[\2OP!L[YI8$X-& M.1][S4,0N6&&U+YAM(L3"2[+[9`M(':&T""\'4AJ-U,M<-`VH?9B+,->>#-3S"HF)D^^XQ.86V#E$M]` M3NX[30T@_A2_!,N-WTU_EGZU_AS@U_;?8X(+-YJ.X!JX89O.-B.(/]W+"(QD M!(4;/>P(\)2I'`'\M>L(8J\$4/^WD>_E MV^+E_+M%UDS=//"O;SZ]^([MH`JA)SH,\;Y<7#H--Q1];\+]\%6X M4KB!.<'AXMIT^C0QOF6**X$.Q@!E(?49`:6=/&1]/'A?XQ[`N;E*VI\^QGN; MM/U9-+W[I-ON9G9AGV0=$4,WG!A*YJ?PAIG,]#"U-2PR=V>I"J9U:TEF`]?* M)3=8>Y]BSXD8NX#>@ZF\8OL@9V''33R,:\3?=*LF`S,)_K>V+! M=;P5A!4FDC]B$W@)<'H2D[JXBP9NR:_2;Y-/HV_S%_AWG&\FF-T9F7%UIGO; M8!3S%^KW,XI%=^:W'45^QKA-L/*$>*2XH/',&LZNWT& M]CR(XCQ_YZ8?;)4@?=5\43B=8T+:@X>$(5V"+$'5$KY7E+BROWY6W,LH%UPZ ME1%.3!_?9$'P*F;9E)9GL!"-"O7HH77X]OD0DDK M,S23=?!,I[DT,7*&FXB9RDXN>X*\TK/%\KCC^<_&.PZY=X&DDG95+[QW[ M'%KO%@\T3UYR=?/:3?9VK^0IRL7VX$,4V"X/Y$9P8`O-Q`'&1.1HN/2`@$6" M[>4%BZ["NUZC'W.C"&4IBS!P+TYB?,W',-`'_%4>?KT*0N@F1'/ZU7/LP2M; M<.-4]"N:NAWF&P)/#)J!"2-I1#:AZL5362IOWZ=-Y`\O8B,%2^HYEB2D..O5 M/%A6^/QYD<-!0]LUW0$&UX+D,`:>7'KF\@32Q,=3ZM+68G.^)8X2B3/-\ZPL=6=@_;CYSX*+3/GR+'C`]`R[-D]WP0^:#G M\1M7WP8CG(=SD6=YG>/-_=7EF[?OV"7W0Q.HM5U8HHTS7&3]!R7B,/HTD\11^86\>,#5$4`S?N%Q,%Y)B(:'(LL-"[4GZY`3A>J$X@0^V$@8QR]'X*.!_!^S" M=<$U8[*>((-^8?4Y!K2?_Z]83./+Z/;$)U07U"\T`R#&@60?377RFWW:1B_`]:+HI/42M M\,&^A03Z?.B`<)@IKB-D(8`S_-269:6@/PEC/&$8^>+(;^[=MZ(;6]ZG`$G# ME&GZKX+3)AN:ML^F`N_0FICB[3&6B8PJ*EIU M7],FXK/&N%(!=*3=VT+C+#`76.%.%M64S0%P'I''\3:%B.%]'FN[8YN/MA/;X51;$,.9YA0&N%2/W`P@ M;CZ(N0&)7]+M%C8ZN5XSI8G"8&77I18-/"[VBG?]9!W&.+1G!B,V=+R7('_( M7N(R2!2*6VBN0[1U28O27$JH#X0EMFS@O,^&OC>&-KP@)RFI:*L$EUTN01D' M+(L(`(1&8!\\G)(=4//X7A/:![&@L/U!-,9S)X/L>T07;D4=VFW]XBRD`CIM M#X$3&"+)G`_QNEW`)\]]GWV>?$W.>.:,KV%TC>VSR!CT(=&$&^GI>.PR;W@^ MI8;G/F?@9OV@G;V?N,$`+W5$XS%.YC%908[]>7\^P7D49&3,3#8;VM-UVKJ) MQF2KZ'A%C^;D$3H5M-WQ@0=MX266:W&M_?Y>KF8V?W`K'8OJE+>(8">DYRC/"\W3+'A*J@8(3&_Q12@\ M;F]YCH.1T?37M]M(?OK,YF?HYBOW14#PVOTH>TA^6!O'VX/8C+S8FF]^.F^\ MPZL)&]-Z=)SNELKI1K;1>,)S6K\]?MOC[X#?_S_4$L# M!!0````(`&"%;468@%[NW0\``!K8```5`!P`=F%S;RTR,#$T,#DS,%]C86PN M>&UL550)``/C)654XR5E5'5X"P`!!"4.```$.0$``.5=67/CN!%^3U7^@^)] MEF5[]LA,C;/E<\M5GK'+]FSRM@53D(4,12@`*5O[ZP-0A'CA:%*B"&M?YA"[ M&WU\`!H'FY]_?9N%@P5FG-#H].#X\.A@@*.`CDGT7A`# M"SI?,O(RC0?''S_^-!@.3HZ.?QP\3>F,TVCP@)-8M#TX"P(<)OQP"*TC_NF-D].#:1S//XU&KZ^OAZ\?#BE[ M&9T<'1V/_O/E]C&8XAD:DHC'*`KPP4#0?^+IC[5/P^.3X8?CPS<^/LA4E(\!C2CRMQI]9I/PWL=1^G1-*@01B^BU MV<)[@\'*?XR&^`%/!O+O;P\W:^X%XG2&QR1`X6%`9R/Y?/0;I>-7$H9GT?@N MGF)V$PEY+^0YQ/P2QXB$7*B2BHV7F!%#R4(3_Z^.%( M^N4'B-116Y5OH@6.8LH(YE]QO(&6!D&M%1,`ITD4G(1G+0>HQ%G^F#=Q- M+A"?7H?TE7^+4#(FXFD;[5LUTYU1=W,Y&LMQ5X3_@L[F#$\%`UG@6\H[MA3< M]G;-/T>A'-0>IQC''5AH$E\T0B@9)&%J^ZWX?ZEI_!9C(7:MD#1D>U:F2B@U M0AJ4F@[EE$99V>RLY71FF"#^G$X/8EI_06@^DNX8X3#FZI?40<.CXVP.^R'[ M^8\SSH4>2G*(GG%X>E#^,2:QM%3]..I+536]5)2M_IRIF_]<5K@0XC-6UAVQ M0`D1_RS%MSX'9Q0CGLQFJ;2AB.-,\4\8G=7\2(W*%I3Z-%AQ#6(ZR*DI&V-V M>O!!)G&O6&9164;76S32*6FEZE<:!0EC8O"HA,9*DYENH/$I:!`S#!$TL&;A M_-&?<-XS*D;]>'DO1J=8#/M7_TO(7,X'(M6H1!5"FGG%3NI3C!L890BU74(6 M\1-_(K[2_$+;<;7/2O/`A;ZC[E)_:WILL*L)C[(7QM,WF*O*TW;6:L"=$4J, M`R5Z/5OID6$FJ,]3/L?<:8<]P#KV+)H?_8FF@F$.OP<WE1Q[&SZ*[/6YEQBQ>/_D3K\8.^\0M0<\D)#(E M$F%ZC&GP?4I#H267X8J7E>X`)<^\XB;O;Y"O*7,3!6$BCY;OQ7`F$1;'C#PG ML4P>GZC<^Z)1+&`C5'FYB6+,Q%A7G1:V*E1-)%L2VINK'^0!6H3'5XA%0B,N MA2@?/PGXZ M2X^?Q;+G;O*$WNI[/&VX\RV?9MQ[!="-7-<5<)LJE0'Z9W\`+52>T2AUB79Q M9'BLUD&UQ_N$.8?Q'8&JWJI_Z^Q[EFW,&8%CH5@?NVHH]@D^;A=TA"!MP_XM M3)]8>@5O:<20F2#SGXY@GQ#D=$!'`-*UJSM,&?:\@0/>JZ`=+=Q+_G=IDVZD M;DD+_S+C@O7&JU96FOJ&DOFJU:X/Y2'&N0F+A_0@,WOJ2QK-:0/[3)TB9U@? MXAO$^9?PJ(/(![S`48*-('#258YP-70>0P!J'0P!%FD>'A8TF6LVZ27&J>/= M])6"HOHK#F:"^AS@Q14^EHA<&H5"&[$V(UR^JV:\NN>FS;=S;+1>(%U_AP=L MH@GCY5L\-G'^H?LKC3&_1\OZA:.+$`GE)P2/]>!HP9GYL1&GK\!I;SX`1HV$ M^WM7,+/`?B]83U2Y%U@E\A45(*-@XXA6CG_;'I6TQWX+4$^D3R*]CS7(*$"L M37+\VUU7FCZA-V=6!**M1-Y`ZSL`("8VP(%!7`:'?_H#ARS9<4+!25=.(=\3 M!*"FP5-'2^@]VAY+$USYPM5;0#@6B+5.]4!J=7W(1>TK&)J9"8"$4R#PE8!W ML+'0S$>0706/;SO4H"[#TS57IN(C9@L2I!4`+/C34&EP6*+R,LPPFUR!-DKQ[U2FJ*HL2.2( M";=*\P_8CSC=EEQ]/4!6?C\;STA$>"QM6V`]*IHQJ14DD,E3G+2R MV0T8J%@/UYZ.^<`U)$)F!8T,G2/ZGAEW<2)!(=OR)9]VJ%4I-D5M_$O+A0&T MK*E^3'/2K2\<&^EZ/'M;A27_<(?4JW9L9B-:GWCIB?KK6^ZX4*!MI6)N1@>9< M9&#U\V,'5>F>@(;*6[BY+()`12/#QVT+R,4@:K]C4]G3,LI+1Z6R'/^`;RO' M&VUC=-E)\6[R#1KS'ZDZ\ MVP3T72GDF,=]NTVI^<287^5^[S$C="QB(ZN8X$N\^KMZ5M&"U5K\U\3:YUU+ MJ>(]HPLB$'"^_":">A.M*CB+O.5,P'.QNOBM28.J"\>M",MOA:(R#-L_)Q.Q7W-&561K`:,O>9AVT`'WDUJ4@D&S"8QHR M]QB0+=S3]4!IA:/S0*-//)XGG$28<[PJV)JF>:LGU0M,;5A-Z+2R[B5(X<[J M&JM63:`%#_V`;'JU!`[3$KD;FAGYGL-1YY3=03!K75=,O_?=Q3:+9;KE56-Y MJZ:!1MF&Y4::^'>GQ6#1^L!Z&\O[AL+LRWNPL#Y/2TK`$3K++;^\VI[V.^0- MN?+3%!B7=V-N4U#0MBZ"#+U`9;+S')@2*E?]V:.9OZ[\^M.(4\1>:E>83>3NJ?O$]H@:^B M;(X<[V^KU*%=KVWG',K,+,8!3,>R#]AJX9S.!RN=!@J)'E4BKBNNON4-P:"& MU@B^$NU^HL[LCL[A5FI:X"!C\7KVT4-//N M)S#A[MK%N&A615>IW3O8A76)5?+[)Q`WDMR^3;?S[B>%F;MO-`MJF MCAJ$/:I';=Z/TE=M`=,[=Q4]J..RBUU%0-&7+G<5JQ5B3CPZO[K$K-#I]=3&K?N\$+839"%L[\WX"MX'# M.H>N71<%WJ-M@-=0\R\U1Y:DNZ;LDB;/\20)"\NZO&1=_O:3YNYY:Q'Y3?06 M(O8!GUMPWI91VDXCX,59P*QK,/$&OCGBTC#*C" M-C]:9\!7%>N52T>%\_.E8R@#(1/*@ M_BZZ)'Q..9&6W4U6EY*.*P"%$:NO83B(]P&&C1RR9>2YVE9SJ5=E[;;\;D.[ M*_-=O-L`UL2_^S!7DPD.XKO)U5LPE5/E@QBQ[B*]7RH#0AO6+`C-6-\?8C=P MS4;X;-:N?XM`0_^Z)A&*@BV]:=-0F/U-&["PWE]DO*;L`<\3)H#!\>KC!C1* M/TA8W1\",U1>9K0Q>#??-T4!;>$8R)P/U*/X0J.M_:Q+.R_BOH=!=*O]MXMI M'ZR)+O7OK^S4-2+L=Q0F^(NP+V&KU?$ECA$)>6_UI5:9ZUHUD=4&(97:548G M)YWZ7K>9KK\O>FAAY[:Y,9^U>A;`)[L<'=P!I>T]4.KUQI;2CV?`6_#Q6'U= M_\.-)ACQ>F_)3NPY;AK9"@>+2ZQCF;?C\=YR[5-,;+T/_%;M]"^7->)1$P*, MI[<^K/3+]7*:;R.M6*TG[;'W-HH@;61SN1]#&I)]VMZ`?QLW9V%(7T7ZB37G MOKD-!@"UX56(:L;[GB"V@5=:8JY9B[I"H= M80AF:3NT&&7[5=6X\#J4!^F%TF99_TJQ[E$A[WMRJ&@37L> M%FRVF*&K?@LE=X.M]^JW6X&6L[KM1D`J5Z\UO6UBG%"R!_*/9\2Q^.7_4$L# M!!0````(`&"%;45FFS&UL550)``/C)654XR5E5'5X"P`!!"4.```$.0$``.U=6W/;.)9^WZK]#UK/ ML^,XGM[MI#H[)=M)1E6*[;+=TSM/4[0(69BF"#=`VE;_^@4H4J)(W`F(H.*7 M7,2#<_T`'-Q_^=OK,AD]`TP@2C\?G;Y[?S0"Z0S%,'W\?)23XXC,(#SZV__^ MYW_\\E_'Q]]`"G"4@7CTL!I=0C)+$,DQ&-VA),\H!S*ZN;W^.IE^&9V]>__N MP[OWHPOTM,+P<9&-3C]^_&ET//KP_O2OH_L%6A*4CFY!GE'9H_%L!I*3DY>7E MWS!5A&QS`E693.P-&(TG\BQ8]3-(NRPN1:\=<' MG%0,SDXVLH04['_'%=DQ^^GX],/QV>F[5Q(?E2JRSQI"*O+7%GUI$_7>QY/B MZX:4,H(2UC6S"_KL=$-<)_RI^%^<'5$GCT9K-V.4@%LP'[&_?[V=;,H]1P0M M00QG4?)NAI8G[/O)>4Y@"@BY0,L'F!9>O019!!-")1?LLM43^'Q$X/(I`=5O M"PSFGX\8PV.&B/4(KX1+<1Z^=5.1QL5;I+D.SWQ M(IRM[G&4DFA6-$H=U%2RM%;V$LP!QB"^!<\@S4$''468OD$:`O2L8=4,+17%#RRF-R")X193[;NTV;T)UQ((#O_ MNX7D]RY&V`OS9Z!/>[JK?XT?HQ3^6;"C[&^2*+V>7S^![LKKS7U^+KMA.VUE;)SV`7; M:RCFY:_9M]=6F[5]RQD12*[G-VPRA-;2LH6^P#!C="7ZJ.0;E$`V\*S^MFI8 MK66Y[!@<=0F=AI$L@LEJ0D@.XIK=&*7TG[-UM;$;3>IQ]C'1X7B&P\W41L3&6YF,3Q,7[BY4/)@GZ)2WI#'%'`-?2JCM,>N\[JB# MUI7V>GX1D<77!+V07],HCR']:I?/6(CQ9]36=06.ET\8+&@!^`Q8(^'74FW9 M;LT_CQ*V)GFW`"#;2KFA;4]*.Y&B%C@S5TO6/LSS;%&7G`[-<@8(BH$OM.') M5I-TCO#2NA>1\ZNK&>%9I6GYS[JRFP5JF&8G,5R>E#0G4:*!#\&2>+72S5;J M?RK4+;@YT(K^F]4=E!['8![EB49"I:TCA[=;C=$R@AK!ME&X9.U"WX+5\1(L M'P!VJ>PN7P>:+JA2>)8_@..-(QSJR^5>UYJ"!*:0U;^.8/":`=JH;)HC MIFZ7YL&;6.NVKR\M)'V*?Y4Z]^K[55&58CG5QBAC=2JY6Z;O5!7#09-;V1K# M2J<"5<-KI\(T9ABO*S;*JB8HW8, M%,'DO.-.1G-=PG'LS%=OW/8IJF6N7GNP$'HRWGJKY^[%NTCM1?L]=C7>Q:NW M?^RKV_$N6V/+D.]6Q+M,FQUF^VTY*A4*!2H5$C3;D9NP4R-H,_^P,W8OQNWS MB#P4@_><'#]&T=,)FQT[`4E&JE^*^;+C]Z?E,9&_E#__:SV^_@W&H,3!]^C? M"%_D)*/&8.H!,*%#J,VT?1(]@.3SD6$I2LP=\+1)RYK MT^G6:'3O-DO0.E&DQ/8'ANWL]!,[X`CBST<99L-"]@,=;-#NYTM2Y&&?C\BZ M>(\58=>R\2ML=A)B@M+?/`*?J)-,D:]1Z!)22,,!=<`YD,W`R),91+MY%2VI M;3OJ7>XL`96H4=*5OI/0>>U1!0M8:P!)(H[T3:O#HLV115G"Z3""_:\/P85[ M=X6U4[Q;UG6(..-5[SPL8MY>3V>__.L;^#N(DFPQBS#XOI-!EM$3$Y1F\0AZ M2G?5=0]I&%2/DY`C"Q>/4Q`ULSD@K:VLB@9[)D6J!%2K2&].*/O5IJ'-GTMC MMC_WA%VC`""A'3O9A@9+AN,MJR#06T[=,'W9?#^;%6W$4$)1NH%+,9#(JJVS M"3*7:\<^Q4V\QX2`K!GBW1]+NZL?!Q)(K@TVL:L8E>$ZZS=+$742U*Y9=27VX7F)'057Z2D@U M$'SH66F#""'G$@,_!3+3*K'G?%5^E,^L&G-HS:0:<-CKS*DIFKK[Q`9I5E)+ M%/[W<.9$-QL.J\7.:GZ.,SVJ15O!4$X;R*2I.:"0F1OX\Z7:8@L@RL4%,+.F'&_[8ZZ^Y\&U8LIDENS$VP9PR*LNXR&%<;6=&`_@>1-<-I%4CJ_:19+ M?].;;$_B$Q-4RN-.<?3NM*>+0L;X)(E2DI;19 MK^T$E,5*E[RJ9$KRT.)G:*`TDFI>?FI=K7.^![-%BA+TN))%5;]`:;9.@=`B M:VRD-+8ZW(*8+]J>U:&J%F,%3IXL)]INL>(2#3DSUC+<04HLDA/$#'!;.6X^ MI2(3PJ3_9%D19BX0E`DSGRD_VD$ES1WCWX\X+ZNV#[DTLS8/NH/LVO'" M7C48X.8""JKF`E^3JJ=>7UE]D:YE\F!O$P`AMT"J.*;=$AT$7LGS>27=IHH+ MZ0*.N*YUNC&7\&O7\%].&@Z9TO_V=@9">.=R,,<`IH*M,6I"T1&`:0#;8-Z6 M:\O*JHJA@T5:L13SI=F^F^\?YHR,'C0LC\7($:%U$J;WH=FNBKPE6#F1*/A] M+*1:!ENU0FH8YMVES[/A+'VV+#E?G8-TMEA&^'?^K(X6N0@A+?)>9WH4J.#A M1FZO%$'UF1L%TS![C(V2HK&]%KD0&DWR7N=V]*+.18C4;"E"&F+X6&FR/T2L M\.:#PD"+8%[(&5Q4,T6=`1/,W%&5/&^39NYT@HJL,5AIDX62A(K:!:1MHQP* MN^SKPY,VVT#;C-4]E:F7=30IQ0G'EG)XN8;`2NLT8\LOB":@K3N5J-=AM"F% M@Y(:95`I12NXW'&*R$Y%OU`QYX]6:DS#;`IL@*!.&GJ`@F:^8(@%TRQ!$PW! MY`87&,0P:VG*7V_0H:T0(:<-)57@5'ID9JB\A]BP+_`@9QM$^W"`EU:H\P&C M>RC$:8#D:HE^MQ&]72WQ=K7$V]42;U=+O%TMT=<*O_1IZ-[.7S"MSIM:C3&. MTL?U`835EN0F6K&?QB\1CJ>BBS"<,:RVH#M@V-_Q%EOEKY^*71_?*&%&)ND- MP!#%WW#[+@>/$KH&0":AK\WE[M")]N'[G9W+G74OSC3XT#F(I(??P+8M>Q!8 M]@]`,A!?Y0PUU_."E%O9/(FHUS;G(@ZGNOGUOJ?ZYEQI/QEGU[;AR^L3F%%M M[Q'3^OH9X'LJ#_P31-AUMZ4CRE'_)1=U.#5K/]$(KT>3*Q_$Y$WQ3$C1\X+X M,L?L88>B^RV>'N"W,-QK1OTJ M)'=)<=%Z5IGW.AN?I'?P]3M*LT6SA]4C+CVE(CX(#!EYQ#UV5.)+S/S/'C!S M_X)X(R$M6AEBMK2'"QB!/_:$EZWT$BX_!Y@H:5A:_,&,VJ2&S<-(/EAW'89S M61\$U#UZ.Z!A-E?9LB)][+4B?5D^)6@%P!W`SW`&^!9>H?2Y:`<*.\@]RJ*D M_OT"D>P*9?\$V2V8H<<4_KE=%:PNR/(MI[ICRY^<@ZAO^XJ#^\KG4?-J[>9] M*/?8JAQ&1!Y3W&[KAF_[SMNN?/=[$Z[;#LR3=SWT7NXTK2K,Z7#.G:[5YQ_W MX'ZK9CMVOX5R49@CK"&Y\8);P[H)+^8S=H6&LWAN9=;6FO7;L6Q?%O\Z5X\B M=,<85B+ZV\_*AZ?.R*&[+^OPW]%#:S!@)?^M)MB+:-^//.2ZP-OLN]?*(-TB MO)?J$,SQH%LZIL"0K9`7"XS675I0I.<1HS370I_UXV1< M/<)H:IE&=7.9^OQKJ]64]K4UWH(C3]9TE.;7L*XTNR_'S];- M6>]PI'.Q^.U&UR`RF^W$0T>KY#N77#)O;5]RPWRO>YA\5"&OWO95EUPK74\C M![*QJ9O=YRL^`]XV*?^2W/1OT"#Z/`GGEW8XZ!WE-L11)_) M5U"X54:77%IW`MG,M0>,"JN"WC8O?QJ*P1WXFJS!`*M]^ MU2],@YE%/_QM#-IMF>66!!5_O>T%?=_F7DS9";?F";]O[FUO?1]`M%56F4:9 MPZ_G%T&_1A`7IY&_@XCD>+U]H>])V8U28T)`\13C%$8/,"D\6BH:7Z>WS,MX M_8SI%4IQ]=_SB$`BFIGUPKN$@V/>_57VB"S8T[#TKR]_Y/`Y2A@J-M9=0L(& M[=289B-@6JYJ'/3+]=1H^$$-LG=9O>5QJES13.DK%43G-"E.I"[U0*I'7+I9 M17QH<#1RCE<,JC0)(C=>&ZO&G)*N&K2)Z0X-:;HN\0HRB1)!;.IU83!OU<-*7XAWN2]PVA^`4F267O),VB]!$R>WM?%F16@BE\ M9KJWAH4J2JP5I'^VBRQ>A0?XP>2X6C6/"!A5DCMB)U"?35J M)J%%EC[8:=8T!!:MF::@,)(EH;*_$C#/DRFUW"Z.Z MF##R*+%)O`>B=,G5[5"_#SXY;(%43S5U+K";-M_)EGK"'6,9+ MA#/X)^^!)GL&:E`)&0P?9GJ^<0P\H=`@W@.3]]9&>911_G0(<&K;[#Y?"N7M MKQIRV1G\73V;VSVTB*L]'PKB@<#$R&8;F*@$='R7R_5978E9\G.XN@5;9VS5 M!?>[I\(00-8>L`&3B;#ZXUT#V<,@MNE\]3WZ-\(7241XYT\M2JI[NW;)0,Z' M:@--W@TJ/,,_RZF2K>@9VS(#GTX@6WV%A]PL2ZL1R"_=XR8%"S#),:CA'\UV MLJF``HA\P3\>&-O;%@*%(W?CPE[P*-^_X!61P6QCN*'#X#3CWW7&_5:ZJO$M MO$&!M`%"(@P:%HE.TNJ7V9ZNU2DS0.Q8.*,KFO1$]KPMX1+,`<8@ MO@7/(,U[OT:QH4[M+O366+^Z?U>_1'4IKTZ)WJKZ=_1HB3YBC"[ M_KWA`I,BI0_TBO14STU"BJS,KU=M#6FL.NM)"2)G:"AXD=/_M.ZZE!/QJ\J& M:!C`T#+1`@HBOD&D"@WEKE`ZTXE_FXX/@3K=(%$@-+0[$.JL@U@>;^@G1X`\ M[@.-MO,8![+:W%0^C@NK5,E1DTR0$6W)!AETD9G=HU_C',1J5$N(P MMJ$H=ZW-I(@6C/I?XC4`A1)"RN51=!76 M'9`P6[U.NFH5=KDJ&$ MJ"YY&4(U>6^I]A0\1LE7`)H6MGXO3:G]WE,UT_8]$EM1KU,J?JP^U?CXR6[N M`5Y>S\>/&(!E>]5/\+5ZTKKY=0"!D5MD&IX6MR#6=(N+_B>$Y""^S-G%@S<` M0Q07[X.0]>]?$2Y[X6;]LRM#.0,BL\`+AU\H-L!F4[1TK5G1`0"M@R],868FJN-*N2#/J>LY23-` MV]-LDHYG?^20BET_8"[)M55%./FVN,@`T&%ANRDJ]$0$L1"^/3XI,(RTVA`A M)0T@86ZOHAA8)XKL=MU$SBR(JERI*`VU-+B#"&?'`/I=IV;#9MH@1:GH#"__ M\V;ALODYR$@HK%#'HLT@B'G2N_R!P!A&>'4]7[_(2_4&@E#J$5?C0@5QD&$V MLE`==!6[H.8NBUD.LHY!>P"FH&K,2+:HACVTTC/>R3A**"J(53R>=NO),?Y& M5&UZ"7X:]/V-L%0H$`!%9F\=,@+V(E`TV`:1CCF'1VL\$@Y`>,,P%PB1#L&Z M8,3?\.L;2%]`DDQ2DN&\V#IW@:99S,TAM&A+RQ6T/640^G4U%5L6SB,"8G:Q#:W(T1HNM6-&6Y*; M:,5^&K-+,::"G6_N&%9)LP.&_8TE;)6_RAE@K^?K+27C/%L@S#GZZXU_5^>+ M^??41#G$)?+O]YV\N;/FQ;C+O<9^=CI6\M;MXPU&CSAJM3)RHM*)(J*#0*"6 M!]S#2"0VB*&8=%O>%7@I/AEMI&P5TME`62MT$%"S\I"'%DQ3C3`F$1TUM\\T M.V3S(%\1_D;+-K=E^A;C.`UHBSF,"K*?*(2;%+05#V(:U]J\^D;N2;IN9US5 M/!GOKM6-S_O'KF,:_@ZH8O&U#>)6JJ+_O05/.9XMJ-IE[K<=$(R7["7%UF5'5.Y*;F!0@[(Z*B>C/`BL MZ?O"/;ZDLNL[=\/`5/'F>*7@!2+9=T!K@A1;`VY#J#>IR"VE)C$*G6SI&>8L7;&:,7+.G>%WFX_.UN87+HK^_Y M[Y1Q/];\7__84Y(KJ!!(H3W/][6'QAI%_:R/EE+.9+X_D_G^+'3?\[77\OU9 MP_?]KD?>,\W98]0Q?(9Q'B6A3E>XO_Y'CAP`=;* M:4*%&"]MKUM>/B5H!0`9I_'U?`YG``NN6E825M[+.OQW M]-#:4&,E/XB.<:`UH96W#KHN\#+]O58&Z3!@+]7!P1C!386H4MEBN?[ZB5DF M'5$(Z1H#"@Y=J'LLNK2F2-\S1NO+%CK5!R8<7<)H?K,H*^R[2")":+[%].2D MK4JZS=9%(=WAI;.Z3O&6VDH4"&(+>ETM;M6E.Y:AE28NAL$-)@59WTQ4:"9\@HC[?7.%5^M[ M3ZF&I"XBM1WU6+8Y52\)-3CT?,G")*7_!/?1*]B\&E2IX5Y8\9!25O15-/MA M3]U!VG>E,[@/X9P+V_N^3X)S2<=4<%.$#JGXBIMI`+<[O#UQ8'(C3#NX[IXW MD(FS?MH@C(NC-%2>PN@!)I"]`4(;/_8*2/.0@AMFY@#D,CL<2*I]Y0FD7,%! M9$Z7X"';WK[$'MYJ+O4)":KE/@Y!X)!1VF0"`QZS()9L=A6KW@*YI1E^D>;' M-P#/Z(?HL7GXQ+P@%PKR@H."B($/[*$C%Q+$]`BGR:O95MX&R@YIB9)'_8+B MSDM8,'!(6?N@8Z4W203>:/"0'9YCCX.*VGN/0;[=#B\GW#DO*!=G/1K%F_]R9/W)VXEAO?M M\8Z=EVO=@C@USO'##49?$5Y&DW3._BH`(Z\R9H7%,W/2P@,!LY4O;)"I*ZA^ MV#HDF)%*ZS)W4&-+5$(,J':)X:%(875'Z+2Y5U.8[X,%C"RW,RZG`9YAY82V M'G`%)'XN>>KX+.MY1.",]K:7,,GI,)+)N@&XV/(Q22]1DD1X\T,3(A9%*Y08 M%0T=*/9^,,**D9@*+F&\S.(D^XO(@GY@UQX_TZ%RJC,AY4&8CU$'1UCHF-^G MKWL;;W`4J^J5[3J`J!GV-4RB7`#5GI8LCJ5E"X!WON]K\*ZKA^]!O5J/'ZGF M=8A0$),`:IVK^AK<(HNU`VA^^`1PMF+[O+.R>7I:7^OEK2HK97JHMA*9/U`5 MU?5\7]51HE]5]?I=C')I["3-HO01;HB+!N=^$:7?$(I?X/:&0P]54%NVAZJH M(?L'JI*FD>BK:FKH6571?M<871KM/:OUGJ[^@'EH4`EF,W/L=_5V>U2+-U=X MOJK]3W[IL%GQUMW"NL7W>H6P]B:-;EXPVL5A+*K"V<_#N<7W1WJY.ZA29BB]#$#>,DV MT`NN+9.1E*[ADPPVE="PN&L>P1<1Q$&FIFK`L``00E#@``!#D!``#MO7MOXSB:-_K_`_M__UW_^/V_??H(1C+T4^N#N&5P%R39$R3&&8(W"8XHM).#F=O5Q<3T' M[]^=O[MX=PXNT>$Y#NX?4C#Y\<<_@K?@XGSR[V#S@/8)BL`M/*;8-YAMMS`\ M)N_`+`P!%4]`#!,8/T+_W=NWQ'L81+_^E?S/G9=`@$L=)7]]2H+_^NXA30]_ M_>&';]^^O?OV_AV*[W^X.#^?_/!_/E^OMP]P[[T-HB3UHBW\#F#YOR;TX37: M>BG]R37UI[LX+`R\_Z'TQ94@_WI;B+TEC]Y.+MZ^G[Q[2OSO\B*2UPI."O&G MCGS^F_#7^_$'^K84Q88"@>GR9^.O!T#V_6(4PENX`^2_7VX77.T??R`2/T0P MO?;N8(A=4O7T^0#_Z[LDV!]"6#Q[B.&.;2>,X](,^3H_DJ\S^1/Y.O^KLOS# MD.+=$RQN4.J%9LI)[77+VG$SO-!+4Y]65.2ER:^,>0I/\)5K;H87^@;&`?+G MD6^_X&U7I@J_3KWX!%#I.AO^`^R7FE'4D#RZQG\U_,*G%$8^]`O/Q+8@=E+7 M--A2RZ5MM&U8#4DK@F+FSZ$&$[A]=X\>?_!A\`-I^,@?;\D?;\\G>4/QO_"C M_YGM<>GP_ZT7V(W9+D`D9OOZR_`X'/DYV6CP!Y]I\_5&7N_LY9W*P: M+]X6!<)_2GY$+O'#%N'V\I"^;?R>78SVO%I`DH^7?PMJ[Z^@(092!#BZ/YP& M=)?'."9^<1KGA7^'7HR#UQ5F50L=,K'\-_+%!J"29]040"7V>5@5JDWSMR![ M#`\CW!QGW^!8?C? M$?H6K:&'N]307R3)$<8MD"G)YK]>(CL`YD++IN"NXH0'>[GN-!,!1.;MKT0( M%%(@$QN7!VH5C33KH\D+H5K!#P7;)^7)SR@\1KA[\_PQ"'$?D\D/CDR#%QV9 MP7QH633+`[9Q,?Y9.@7NRW<@>^D"VGG5AA2_,@O=+?$FJIFV3HKF/)^ZA0<4 MIT%TCSONZ9$-:K%H`]L\T<$09QLVBW2A#S'@!:H%[HNDOI0!F9`+^)?4,-*K M"18;V%I-4H@LGY0;E)27.!N[1_$SDQ),B0836A*#"="P9Q;W+--BN'FF2JW98;GR$V+AI-CIG%)5LS0*=/A[!V@+P%^ MZP*4>?6&%#\S,_-MBK=27I:MT\(9[?8I%(M2:,.E(&IHQ:-DU/&K'-RZ:-6%K5Q%%]8I2^=V/J MB%>'2/F#LZ>/6@KM"22FO5%`GDUER6'.D&,"O2%G#.HUJW;`WG6@!O>V7@?P M^82IN8'.QO='XN_&QB"1:L.NTAR(M)V7W-'?=4S>WGO>(8,;#-.D>-+& M7?[X?V;?O-@GY9@]!>U0RWR7_[K6NY[P8Y;"!`9%AEE`Y,M/Z2,*1?"5//W_ M1E[]QZP4I/`MF[ALB!%@"O3'0^=VBXX1F<*Y06&P#6`RNR-C-MOVL+1;V6:Q6H+9\@I+Y2=PL[I>7"[F:\R+W,K8W)"C`.G65XLU7)T&A226Q^93<@NW M,'CT[LA2^I"NN??B%!>3S2JI>)-;`G$S#.,ZT.79(XSO4'LK"9-N,I<*I!.; MF%9O$^`?(2"(!G$F"`Z9I!/LDJ.ARS&E&F,RC:O)X)O$RPG`-S$&Z!O970MV*`8^ M.MZENV,(O+J!+=KO@X1LK`:>_X]CDI+>9T(,_-O[LS_]Y4?@I6"-V0?W=]C1 M^_.S;&\T4<4"?_[3OQ.!*^P_>S^A[]^[$1748,H(#G`^=[TVF^DD^2L5^"IP/G>@3Y`53AIZB\2Y0[V6$CT M6<9U\WOEQD'@3*^;W<[E-['G0_=BO["2A5UIG329I27N05M*BGD.+([9],M^ M^?KLL1HL=59L"GI=R%(>H.D'+1<&9FZ\9U(P<3AF"[4"<5O($&V:9BT.KC`= MJ?"%H5@1Y9"]=(,7G'ID,(+_U=E4:,JS2,"R:`TBQF,JVT4_=-3C:/[6L?@Y M!">2F-D'*"[$R2J&?Z:#D-+$M2G&35H+,>-)1F;8PLP_SX=>:E%3;78(:3^F MEE\DX&LFZ\;OEJ+03+[MF%E,C.1 M>QJ$J$D%*2H$*BEW\A7#`.-G+X80-G(N0PIW'7AW01B0Y0'"*,V7:T9HEIP9 M&G4MVXO,7%\*'.+HEO2!3P<8);`^XAU6*DYP2%#97?Z(ZX5)G:X*@S8\NS;1 M9#H@\[WT!E(M$-<$W(K!!O`CCKT#`#1RS#WNCW1)UA4\Q'`;T,/V\=\A)'_, M(G^V)Z<$_8L^OXG1`<;I\PU&2HK?S?]Y#`Y[9H@V:K:*Z(;,#J>LD8(8[O^: M+),D')AS-;VY7=W,;S=_IPOIYW_[LKCY/%]NSL@2K<(+\&MN1@\H9J&-[,*J M$ZV,>&@%-X.E=B$4TD$>G!_C'_.`,Z/@$2XBW&V%UR@A$]>KW<9[XD<\'>UN M8%/3-A>_5/Q9"E,:KA6CD;+%:4TI3WFW=3404#UG0HT6IM@11;>BN8%#Q1`G M/JB78;PPX/L!"5->>.,%_B*Z]`Y!ZH5MNHNE"EKSI(;2EVW7*$V%+H1T%&A. MJY?@@-^^#2*PS=Z/3#5)?2*MC]^B#ENA01&1S1&I4*Z%WZ!;2#Y?0!<)5*3= MH$LO>FR/V@/.![P$J MG."N2>%E[+!ED3[H='!M!TSSWIK1UM:O&2]4A]0X].E17!\\7%R29N$!0&,75#TU(6)$3X+;EAT@=>'&/CD")T MY`"C!Q$TI`);04!)OT%K#8^C$I5N1_R(XJM\,V)WY01GXJN/;HVV&KH&V*OL M39G$HCL+NUS6]2^CM)Z]Z:SWOM/Q&:\/,F2@[KO\5S;3#@.:_D^-=G.3>GT\ M&P6ZPE;3_CNP?VM,X$TQGHP*HTY%UN8(5KM%E&*,!KAXLR2!:>?H'27AHNV3 M"`^EO]"\T115Q9.0WG(#T[I,L31D[!M=E2H;]:F2%M.$>@UJ*7@8CTI1&OA! M>,2=5+B&VV-,NZKSIVUXQ+W9C_BCDL3XF.:EGWMQA#NUR0V,L]3YF6V`=0:B M?4\%B6UZ&AH![)7-:/BP7DQA[+'L?5I_#RH!-XZE/`%/T,D!V0J>]IPV(J_M MW_92P_9U$,%%"O>&8W3'K)F`7#,[;O0M"^)0J&V7R6)<;;KB!M'"7G;P8LTB M.26KL$G.3<]NT0!?B5U`#;_LT-N%O[DXRX2>T:!:>C`805NE=BQ M"R*E,-@5%X:WNKB5L%4YL!^..K[TPTS+!"]\G-%+U,#73-3)@,``@I3H[,I2 M(7"E*2=FVXMCA%..&[C+?.S.:9BT:28S*6R.FY9DI7`H)VD4R&)"4O/3#"=) ME8W`1C:R;68C5(%L:RJRD@/.2NCT*GB#^4;_2KYW,0;UA;VYC*2+.J/I2&;> M8"Y2+^]X<9$Y0LT!;I3=P*.J"H[P)9\=1;4&2I=]'/MVL2* MX7@F\-(;*),"*6>`2``J`BJ9UP(@8;`<@J#Q0VJ^/(&W@4`DTPBE'1DCU&A9 M-=I?$SB0$X*E-[W\;]8N@)]7F?9&AKH0 MXT)P&T9U7SBKG&?"CGH7-L5I%.]/PBAI<44-KMH&UU#?16`+>D<_[T]M\W:4[_6K1DE3>-Q6T MH=RVTV`\LK(XFF59JXIKO06/ON"PW@E5D'C/-$#+$:CWB#"_=R)0RUEZ9*(A--N'6D)H@0P2>D(*8P^"1*IH MMGE20\,'VZ[)@4"Q"R'E!9K3XB6HO75BL;RL0I'6UV_1BJW08(S(YNA M#BJ)"IT'.)@N40H3>O@6\!+@X;]B>E7RMF[(#?X/1"]P27.,-0K')IXB&P(\E'I"48/134XA@Y80OW-OX% M_86/NR"XV^&5&Z7I;\(!#'=):F$-OSON\4/6NDI[#OCIS&`'YE.<@46RG/:8 M*9UF*F3"Z70)BYF<+,AA'3]H2V[)[NDQ3W5"&94X`I>9X=&$7^@-7K MUQ.D!;2Q%+#%X+07O+M^;05RWB]T/D*8FUPZ25''#0^36@^UYN4,5'Y`W5&Q MEZ1P10-+S1G(O9V!,NS,?X\X)P#[ZPTYCLVF,<81N"MH^FEKC=,97">CY^_T M(W5:RV!Z6&3/[MT48W4U/3?BF"ZLM$?H5):TZ!G2'Z,3+UQYF5W*]M&'](J? MS8,7?4+(_Q:$H<4>IK)O"QU.!=\.99?2TKHZ(*A:\%-EGFKEF59B3JP+'X=T MEI)'+2S;2R6EQ;"562K^_M%;EUI;>,TYFE!%E)]!UD3-IXNE<I'E)04B24M_`11LW+);[E;3#[,$EE><'J MXY:\A77(#0^V5R2SG.FN3>[:8(YCG!5#MJX<*:D.!\G:96Z-R5W,=FW=N+"VQ>.;"@?_B+0DHX>N7#S,*!IOW\I$SBBIJOZ6LVYXL;C! M;#+2=K))/T:*S4T;K^GEC;5]'\[Q4XZ=?AO")EK\Y5KIN=EKXAZ_^R^)R8_< M$YUU=S)_-M8@L_TY-`W,+*&K4[^BPIYLH2&W#--YD@9[>G7[CIPL^TC.3J5G M8Z0/$$3=;20NYS:6*&9K]:`,Q1;7#[)<6UM"R/^=+K4'U8'!LK6#:DK\R,Q4 M,A]>&6Y.L5N#[U8SVO$,,;M&%8=&W[KW5C>Q.@`X_3Y)B1G6F4+[P_[[OFU M)_5IH9,A\.E01X-;2E<[&[("GZK#(2['M'A--R/!XIUS@=$BHRSU*90`:Z]? MP75OJV\A^;TN-0FU6:1;&)(>]R5*5':N2Q3YP9FK:#["@A#>DW/3B9!SD4N&&7'X4:A-:0SAV)`$`J'GT=B<;X(D_ZEMA+R! M<8#\1;2-H9?`*YC]M\69/JKYM]53'Q4J>[OO<38]K8 M($0?QR8!/:F=,$+_J&F=@4P/%(K@3:$Z\B*A4Z.;,TIQ*GB/.6+!+NLLO?3B M^#F([ND->DHM&4='V(1U=*SPO.7%9"JJXU"?URP[KIX8I`<**5D%=:9"TI:Z MG)U,?Z="HU9S%K MPI1=7>AC=9UZ<6H$K1>FT'HA1NL=O`^BB-SW\9O![,6I,7OA7-8CO^M<6T^8 M_=BX"UW9D_TLJ-\UZ7JV,A;7R1M$CS`A@W)!!/8H@L]@[\6_PA3LCI&?@#=! MM`V/?O9^RPL!3O9_%*_5[H4`%=)+;MW6]#L>]T,O25:[=8JVOS*WPO(%"C8S M!(;2MF/2*#]YUH5$9"M-Z7/2+M(WCNQ7%=094OW*+0YT9!M@YU@:#]5HOP_2 M/6UK,0D1O?\*1N3VJXIYG"7*O70++NCI#J6)CC>C#.KA6$@N;7O3R]7GSXO- M9S+VG`U(K^@=C_,EN>#1F;6X_;"$#%1QB[XZ9AK,UO?O(NG5*:Y.:)OT/1%9 MAU%3A8AOEJO-'"S'SB`5ZEN-=+THID@H=^DC7P+>3UFGU32W)%S/G86S&WH5 M8'#[V5HL+N2MLW157)+;OXI[M)O,%;I]2G!R7)N;V.WEVBRDR9![I93-\3:B ML)/+SL?`.F]`_H1@'W62%Y<61;2S>N/%JWB=DO54=%CF!L;K!Z\[T*FN46O2 MI!H&^"[Q83J/5',GX[6*E6DF"!(B>4:N,\-T>PS*+Q;8(\#XH,JND4 M?,F&(3_%'FD#OV8"#C1Q[(IC/<5YWPYJA56$M@S:#FO*"+Y9**P7XMW?GYY,J$?@/_/SP"I2*IS!;?YTPE]^OX,8+T#W*;!(PR?L9,_ M_O'L3W_^\]G%7]YG3O"_+R[>8\>3P@DZIDF*WY'U$[T].4-@_M(*`:RX[.VN MEV!:L8!X&\%;?1D94Z<1NL\`?7,&%A2C+[/^Y>%;"0".!&^:)"=9??!C.$NJ M&\J;4N;P7;=KJ?/'<*&(]8YF*\(WHS+IZ&5/W.G=,2N730)>37"I4%?@,*)K MTQU>S,JF5\:-KB2/'W5)TQRI;%OE2<>-%E=:VFR^5$F/PYQA5+J(-^S:D7"G M4A+RIVW;'0ZMJE111B*&*(]%#5'3-*H9MS13)G&GQ:>V.IM0]8S=74:Q$""B M%*>F))RJ:0E)U;%N&6@V\G>NHR$8Z^3UF=09J,F]+F3)L_Y!T!JY-W"(X0., M$MPKS\XY7\)TM=MX3]V`+9.LXC5?+;-;U:7^I+02*@];0@XWP;)KQOL MD;W/2"Y9,D\@.9AO7-MF629S(^:66'O:$`!$`A`15W8G*=0TTJZ2-IFX2DT* M26R[0YQKSAW+;6J"IEE3FK9*FK87+=>984Z%A&&61L2OI0Z M0KJT++O#E@\PVCZ0KG&(;\^DY9P]!=+FJ2O)95E-TCC!2MMVN=5VHT>KIC8_ MK2,BSE&I6\]"%C$K1$:@4DG,G99M=VBS(0-,THY078C;!\J$C'=_B%F[/9^: M![U.3ZG(3-[H:]=(T:Q*82>G_>%E_9MBJ%+%HCL$^/!<-FQJC0=3G-^"M,3- M-R,-!Y;;$I8OS0:E:T*2I[G9M+!1(&Y?N#4E;60:FI*6AN'%';;=P)@\\.YA M^[)6%5$>RQJBIAE6,VZ575T_6LQJJT^K!V12R=MNT;'8E8K2!QB#&&YA\$AB M,CV&"SP<(S^&?OHP_D(3!2B(J,:I,@G-:EI"BG6L6T:E70X0=3H\4-@56':,'N/@B$N)0PU55@F+5+ M!_5N`4^1304W^@"BJA320)KO,^3%%'`BMX\/"+=8<(FB-;PG9V]PEK9(Y$H: M<.4&,X%CV2P9Q$[$?!#I3LO7SJQ/D=4HTOSX;4)P5)J<$-H=D19)NMI]0LA/ MUBCL;D5BOBTIT'H[&/@->V;ASC(M!GE78TH>DDY"XH5D1;HC%T[R:@DI?=HV MF!N"30@S;+@`W%GDKV'\&&RA!,,&J%#89DA`+(? MP@LSS">YK`MP[U17!^*LC\Q"=E0;!_9)\VJ>QJ-;#/T@[QB$8*@Z%U)(;F.:;85/O"<#L M]6FP2ZC7HI.#!.KC,=8V57`W#%>DB9T+%;FNRD3B7`V]RR;%7 M(UB`&J^_;!!KH_:;CTF*RQ5?!TF:L#,@OD09IAD2@^G3L6DTQ^&:%].$K34M M7@#ZQI4D1E!Q2/E+MV'?$6YBG6-K-'Q?P3M,/=SM.)+!C@V,]RW`\07R7\X2 M&`CNKDF3V.9:%T&;HS3][*7'.$B?08H?D3YPA-*Q.\""*D.J'[D)ZZYL'=4\ M2XZ`>A'ANH%)>NNE,+L,H%KU)@2[BB*3!&)%H^00N;)'&@6OZF22&IL6$H`N M3L!=84HRMU9Z]H`.EXRJE2HBJ<@&G[QRSR.2>@=QINBOR10^.3HM2!+\P M6"A5TI4C-9B;3+MFB2AR(68=7W-:O`3;\H4;W6-9A2*MK]]F#%.A20^!S=&Y M<)L-N$MO^E66;_%#(&^(*5P/-C@C:@:"MQ3&N9DAZ$/(;E'MJLU,3N;;91$7FSV+:HNA:(XE1LCB] M?"`B"<"][9*8MTZL].B+)'Z&HU.]PGQ'9DB0_:B5P17RU\K*/?%21X5-:04**UM35 MB-KQYPQ3?3\@J];:2_-E8AP^5F*&*5@8MLFZE@\=HC54I^4__^H6<3J5*.`* MZX.+Z5%HB!C1M.H*";3[CMK=Q1/T$`UT"C7&XZ1.>XUIMWJ`[4%MI]C4KZ,W MI&^GUYU3[<'9@9WQ83ZYN^&(FS#2HDH4)T-8&%!IMS(BHU"4C!>:Q*)#8XGB M>"\.[J8II1NV#S`.D#^/?(W`K1^E6]V&XM@S+P60'+FW`UDQG"*&`@N4HZ\` MWC;BJG80S3[_.O7B5!,'FL&S'2EK2$@?(+B#]T$4D2L',2;(@Y>+"[50*`'& M\",[&48O+#6OA6U-.%QT&\Z76-\7)NK[PIU&3;QB@"W$;N),KQIHFM4^TT1V M"*C0C0:V&RL'KF&2_!5L\ZG2`XI)3]8IF"O,#O,_O!#S@@EBED5K*+'5K>BQ M?H"EV6T4W[X^P*BUBEJ(<:@C4!NTO>9<"*:A(9VVN#9V19B"C]-,6;3=]9NP M:%H1SRBZ1'?RR_ MZZPWJ!B9T&N!CEKVTP,[QL<)FN9MC1ATO?1,4X0Q4(J\%06JC##T0Y-#( M0VN-$N/H>'4%I95Y1HZ4E[LXW:H\Q:/F%8VHK,ASX!!Z#5`HK\83'TXOUU5? MB>?`H?6M`I;_V:+[*/@7;!]UK"K.IB!#W"P!.PZ4Z?=C1K\(WI.]Q!I)$,^E M!@?9)J;5OX&7%%F16PN$^/7/9YNPCH1&K9^6#DN3!>N?&>K@/O+@B#-("2S:%"V59PY\@:HAK3NL5U:B)_ M*DSCZUXP3!W;EVH.99+@/1QFXX;M0PRW`3TB%O\=0O+'+/)G>S(O^"_Z MO!.]U57*(*ZB,IAL[9@WY!KX)EAP7@E:\5L^0(RIGV]NI[4*OLMF/OW7@QN`^3* MP?I]:IX7\32J?MP856RL7.TNT9X<8YA=0@1#,O%)#V];/W@Q_.`ET+_QGFF8 MY>YR-V.MC((#K0UFU"#_-OH21DHDYNQP#]/U3[/;^=L/LS7N6URN/M_,E^O9 M9K%:CLUN,^!$5A#2#A^###?CC8$RCL\DQ&IP5V]^+R#W(T8TTT,.,9.%D(/^*:F^\/(7J& MW+5+8JDBEO"DA@8)MEVC[!>Z$-):H#G%+P$A!H#%ZY'I*:E'I/716X1B*S28 M(K(Y&@7F7DR.2$EN8%RD$,%V%OE707C$_%VE#S"N.,YKE0=:R;]E;RL#*=;3 MKTD*#BN"B*)#+$]_@<']`^D@>(\P)O=FD;LJ<+\A(982@(YIDGJ1C^V/2^VA M^$-&P=`,#3T-UD/'H#*Y&EKT0HA>J+`=$HSOJE;S-X#G&9_?@CORF"[5\;,7 M]!)!'X6A%R=D_-3@X=&AK@4?!@;PE+T-1!VD^^FA13` M8MDHTQGX4"(QEWV-D.,,#IG%W)B#.^WB\69TI'*IS-E(M:= M7J_6:W`SOR5C'Y]72T"'0]SBC'"H5>G[BVG"'!V5V'6&&8I=)\6^D;7.SREZ M-P.Z+\W^"9,3SHP'2JM6P`[]?H5*QT'8,S")'+-+1F2>^@)H0LX<2K*TM]ZS M?1VP4XO;&E8:?-?V/EX(R,?/URE.\59T)2]S7:Q4KB`W M7VXHDWF6C=)6XD3(4:'NE#X&V7-75E;*:Q5I5D"+0#R5!EO$=L>G!HP?@RVL MEH34)V:7*'J$20K]V33^FJ&VZ9.8' MEBV75"F^6/$]_1+%U;DI^'??;^@>++8Y*B/8RO M.=<*:&H5V9JJUM"@JN;':"=+RZ4PW&E8FI:'YE$A4$@Y=,N`+E+0H&IL108U M`PV>Z_@#F5:PYQ10K$L"WG359BN-ZO+__YI=7TU MOUW_`D(J7[>%\X9<`\X,"Z.A]J,7Q#][X1'.D@2FR2SR M:T>??88>69GFKR+<-A[C&/?*L`!N4>/BGV190T*O)>>M(+#G(/_>-AP,9*#Y M(IEDL;72B2*!):?3S!PH+)`;1X@K0'V-&TLL(A^="FO-F&;>5STNVOHEX\?6 M#\_EGS\%,,;8>7B^QJE,R+C70$^I'0,E2J;BFM"-E5BEXE$I_L@-3:L`<@9* M&2?N-]`$!RM,*%<=A_I"?2:=%3R.3]&A,<=6UF,KV7$GQW$RM3EE1M,..D4R M0R<[R-'[N09=/E$W`;Y2?5=BDC&HV\AN3I#46,EE7D%\Y(U76K%M,$Z:&_LT M6AK7XJ7..*IY?XUD+>\,DCA9LUMU#NG1*=QH2JT[-$IKAQ^&@ZO"B*]1-Z:# MK"NCQ^5OD>_:5A%MAT$;^Z]%QJT$J7X[J:7JTX^SQ2WX>7;]90X^SV?K+[?9 MZ!J%JTA@GJTDY=-RE>8AQUMB9P]B8:]W*PBVBPS%-Z,3`!7-K MD()D.U:S)$W1J6O;2J[%=:-$)([V=!W<1\$NV'I1"N@Y1&!UE\#XD8YC9DK@ M#54#%]\[LHE(I?Y9M!)7%(=3724FHWBVG:+31)E.$V4Z32S2:7(:.DT&T:FN M/?W;$9$%Z#=Q0+:[XN1YMDV#1P@^>_&O9$1RAV*P\''6C!D7%L.4.;\F+O.K M#0@)OQ@U)^?71(U?$V?Y]5Z97^^5^?7>(K_>GX9?[P?QZSVON?H2(5Y3]=YE M*K7K7D(E1B7)J?1>C4KOW:!2$`4IO,9QTE]$*<9&@&N4QL8O"=P=P^M@UUE6 MH:%2D$M)92C+%)P8WR.JX51(/E4ST^S?(,0/R'D/02D-/-JBC76N2@S(F@3H79[U3HT_FSQP5'.X9+V%E"JR0L;P*IL#W^8_/:HX;D M?)N>#5OEKB>U"P/3&G&]G+@13)WE:+W.U?C8JAEEZF$]19J5'JS#ZQ1-2T8!IC794.;=+9,=)"F\_I):24J?.W!Y))3R M4FS>PFR"DD,1&14,T#NQ8`+>W&/9Y'MRV(%/9;V0K-;:!4]D]L"!A5J*2$!] MZJO).[%>G6\J'JR#SMA`C)JK87B;?#*=0X(S$FL3;F M2,PGA/QO01BVPW?K<1&HR\=#V9$;,ID*M6P*\5X7G7Y:K:Y^65Q?CPS>]B=' MXL_5PF,NT4!>0\M@C6E%K@.,`^3/(W&+V;*N6GDD+.7_/`/81W:P#U;=0O#F M&'E''^=5_LCWI*O6+"_42*K60()4LW:A7[?KU(M3U=J]T*C=BWKM?H#W0135 M*OAE5.I%OTJ]<*!-F$6=WDBUI9AWR$(_Y5;[HJIL"/=J[BRGEVBRF:UD!/?>O.^)<*3ITE,088)?D'*=`NPO=GTWL14E(5S;-_'\ MP45Y#;&IQ]9C44WDP3K,C#<<8E?#$-;H+M;$0$WN]>%,$N--`,V%&'Z+PA`' M$'+O'R=P,R1:T;HA88@[-9LVAKNZYE4XTM::7M(KYR!4=29=8M>8R?0BVJ(]7*=>2H]]YF0.$JG\1W.E!J*5 M8]=DNR]V(<*P2'-ZN5I>S9?K^17`?ZU7UXNKV0;_8[W!_\DN(5A]!*N;^>UL ML\`"M,F_7'V^N9W_A-46/\_!]6J]KL]L.M/^RR"!M.JO21N.0IU"0ILCLXFL M_OB(/](EBM(@.N*NU>H`8]J-3C[`'8IA)K?QGF`R?\(%1[$?1%[\3`\E6.*/ MCC5Q!>#RW>/NSD##67;$JDV3]I2ICC2M&MA&8;8DQ)%&)I%&XTS=/`&9N^_ MQ^TQE7"$(YR*9?PL<;C05F+Q@V;2'&L/9)=='3\!461U^#?+WX$TN,?)R M>S.($>8_?2'C6-[!6\.M(LK//,RMSQ89M[`:6\&=9@[26FE=3T(T%ZUQGG; M#KS%6U,4R>Q9Z=HU3"O1H*91RU%A`@[XL2,X;U4/"]K=;\H!_)#H`,F[F"$R>[V,8FOY-A!9PC=SI:9;PZ0C++=@OI M*>\W7IP&,,G++&TU5)2Y[8=8V3B!1>Y.TJ8H%$"/V5*#TUNXA0&]/34!_A%F M\^]Q)H^S0:K@&K>5,"5DN6I-R^@NLB,FOKP$)X>WQ99*Q;599$]^A[:DEL?# MMEO-&VV"R5J0K(#7@7<7A`$ILEJ72*@J[AIQ5.UDIDQG=D.BHV1QY83Z^..;'_:HXXL,]/\.PBAD M2ULZ!LGTYA`QK^`.XNCA7SYX\;T"*SGR_+YC6]Y\/MWT<)H>(M.G9NK,L#$M M'H(MVN^#)"&GGN3,=(V"/"2(TV)^94D3X::J)/=E^3D%]&SVWMC>!J../\)8 MHC&7?JT05.^,#<2@TUTNG0DHGI9J1\ON-%3;S^EFHCB>!W6PNO-1#L]#<8&A MTX_J.1O5-J#5>[(_)\7R97M:BN?3$"!EDU.5CLOS4X8QJS=+90BT;K4LQ>*+ M6>33$M?&@)57'0ETI8N/F+K6UB`QO)VDQ9'[[[O6I]4C1'$E8QKW%8! MDM*B)4G]JJY=8IA16\+$]7]J1%MLK10\&P4SO^5J@#QKQFY_NR!7;LQLH=RM MAJWHT]W"1Q@=Y4MH.?+2X;)2WMJ81>[!S@8=)9_]!B[J-JKALCA[ZAH[>=6O M-$#!J"'5\8E<56U\HN'G%'@[P1A9R]M@J"F,D=V^;@AJCY'UQ:!;`3\_RB*Z MO_0.0>J%_$,@-!7Y(V5<1?/#$AQ7)VD4),XU1RA$QO)3LQ-"5U0(YH-H-,NK M373^U37^2G$D'J10J&'I,`7'AF2D0NCYI%"V.<@F<6L.Q8*AMA+2N9I+)Z>< M#,WJHV[&X>Q8BT4Z4?/](43/$.:+_[17T\GUQ3,](GT[H^M\CR=87"=UWF.\ M76*S7+A3K11P;G!"%4KR<7:UVE4:<.>;4AAZEY7#H3BPB'!*C;VI<)XAR^5W M0]8XEVO63S*&WO6G1]6V_K3VX`Q$Z-'"K*',CN5C9 M.`U%[NSF:`J>]6@J-3A=>W3BPWMR]2P')>0(::M:GS(:B^R(>2TOP8@\S\ZQ M+8JVH`?$=/@L$BIYRQ8:S$^66;,\%'@0\XVK."V/(:Z6(`3TM1/)EK`ZD<[' M;Y.&)=\D!]_BZ"1@'IO5?=4"O*$#LRIC-L"M?%162[P"L@MG9#'J@H%6V>E8 ME10+F4ZKM=ON&UN^%N=:D:UBG:B^J MJGT^`\N75K$7PRKVPH4FY6,0!"!1,D9+KPFQG6M&;$B'%1J;X-=@7[QUAG+SF6813JAL.W;BZ3+9) M/(W/-97;,N2B;7[9N2V#;]SF@$#?VS(DZM/%\N?YGS@*EXY*)?G)C,$=)5S;5LC3\])1L78G@W%H M^;R\DL4MCLIV#ZZ2I+EQYN+1O&2_H/A7NB2$Q#^E_K9-2)A^]("9- M*:R"`X-R/2A3X22!Q2GV=G,0>5A]/M@E2""^E1DEXI\O38+91Y&(^`UBNY) M'5[!NW2#G@G9+)Q+)OPE;9"#%6$9-$DM@7T0GKMKTNCRLG+P[`^0M3@/Q M^Y%30&$-(O4OWF0`2[J.>[XU9]!^A?9>$$GPWA3B(+X0,HSYS*Q-U#<\Z."^ MILA!?B;A&/9;M2E`?_?;B_&?R8L84+=Y@?3J^5!P%Y:, MXKEE5`CAANR4_$5'NT+R')"$.-B./7_>K08D^8(M5!8B#2`V]<;#7K73E7WG M&%^@0"-#8"@L.R:UURC)%EUR70C1RE::;HBW\C9)9ZY7$%0=4OW8+2AW9!N8 MYEBR@@9C4V!\\_I0F."&MWIQ5ESB^')AP)G-ZH.#,6>N:B6:1?XZ1=M?'U#H MPSB9__,8I,_\F"<4[T9`CK@Y!C`=V(R.(H>*!.&;R"-G+6+2":ZD)OT'`*F\ M,QP2(X+-*&FM<>G%U.203>#E!`"T$9"%SH:BKQFL*?#FKQAJ\E!N!&N.A/GJ M+'5^;._*=`-Z7<8A1U"^:H3OHZX?^C(FA,F M;>4DXO5\M/;S?SVLY.L$52TK#71XDY73=JX MN,<@9@]!3B8E-<6!%QL4$SJRQ#85GT-ZPRT.5LP#L^456&]6E__]T^KZ:GZ[ M_@.8_^W+8O-W9RBI!A>-KK(64846='K.KM`7>1$.*BE,-K'G0\;5+?(-68-L ME'/YO6P,GNKOX=7"WJXAY1"O%^AK=SJ[O%Q]66ZR@+#:_#2_!;?SR_GBY]F' M:RI=G+#J8&ZH84@(K3"!#'427#'*D9*R#ZK.O M%'-SO]OX1.$-JHS&E#$'93Y[_T#QY3%)T1XG`XRUGGR!_/.Q!`8ROVO29&++ MM2YB+$=I2I^#\H43BSL%5894/W*3&UW9.O!YEL8#-7J$9'5UYQZH6Q2&'U'\ MS8O;YT;JJ!3`5U(92@4%)T;)H>Y/2!=5,_4[E/S6K7O@*Y$&N?C8I-(!".I? M@2WB*6@WJ*CL;31R+KT]7.T:,8.YZ%HJEW\I@=Q`[G$MFR2VLC"]0LJ(K,)@. M;9,6QAZX3L0\8"I-5[>?9LO%_SO;+%9+.G)PN=72%(X3NV M0%H7:^"SJV^Z9LV%*I9EK6J=O-QZY44?Y8H=?I)VQZ364=K2DX69YK6J]Z*J M7N"E:1S<'5-(NW"?8/0-XN[N(DK2^$@WAX-+]`Y=$VB.YGVS1XS*92V:L)^ANHVC%M`\.) MH^G2:">XKW<)]_H8G1(EL`O1MP00_(-=H0"\4F-T0O8%&#)5Y1UF:]IJT;]7 M25P+$>5ESE6!+U&$'QSQ,WY?WH@Q<>A0-F8GC"BZMY%D#R].CQBCXX#F`UL2 MP.QY^=`$K#T4]8*,4EA3M*H0HK1*.SBV3W1P# M1;%+K+PC15OSFSJSOA3,*HV!RMH9J.S5QH=^)QP72^XR;N0A+,64IG^&H&E, MNW-QR@Q!T?VI,@2]XICIA2AD"'E2\**[)`-#5`^@].VJ](Q06B4CTZ(4(!0/:`XBV M0X3`Y0E"A-R[F>$+<8AXR8-_/4*$8I7W'7+0"!'2DK@6(A@QK?_(@J8Q[>SB ME",+BNY/-;*@5QPS:8C&R,)+SDD&=G1Z`*5OKM*SGZ-5PM'99'MD0;,H=JDD M'UDHC;W0D851":6`[R*%>VX(T]4K`I6ZWM!PI.K):-#1="H,+5JVINLO-S?7-$3,KL'Z M\J?YU9?K.=F/M5PMWU[.UC\!4.MM_WD,DH!,/SG`C';-M*'/^*(,;.=2 M'?`VM,=#YY&T?JO=.O5(F:)?'H+MPSS"O^,YFPGL7*"LH5%@645C*,3E/HPB M7]F=D!"*5J:9(#G=:4LF:N^/Z)B`A&J1]2W?B![XV4O03]`+TX>M%T/PX"7@ M#L((>(<#"B+2Y,"G;7A,@D>(&Z$#_J`X..*.!OXGX=ZG.:AI7P7>?822--B" MQ=Z[)T,BAQCYQVTZ]D2^!OQ0;WRT>"Q7;M!;U=?HK"\7!*[A/9T]XW"=*]=B M.$/.$*\[EK4'I:7'X$@\J1"9K5NC[QVF7P033-YN702%A5;")TU%A MT85CUR:`S`U,R[ST1L^D#I_7AAK>:/1@V(PZ&IT7[$/.=9C,2%H;P_;QW'+! M5GAE"1JB1]>TM0#+=:7"$8YRC2.7#T0`UG89;-'^X$4!N8XXUW&#/X)Z9Q!( M7$-L`G5U6`SB6;8*+>.AE^^F/ZX:P;<2`;-7AR-))!X"I#%C\6JW"[8P9DY. M,-_E/[_U;B`3&M9,=D-9AD5H[\I/\T>.3!ZPZP0I?,HF;AMB=:@R],<#9]%" MY5-\O#5_4KD"M'RYH0#F6=8%L\)AZ3)?0GP+=:?5V4CY3/3(B;2\8I%F';18 MP%-I,$)LUR9RC.4`4B^]03.IHZ80<&8IN#D`<=K_X0@:M?5O%TP66&4!U3P= MC*^MY'G08D!C+:7K05,)ZQI!4@AM.T'1;C#L%02YP>^EUKYJA)-6OQ,1C7N5 MA$"B'=4,7BO!L&DOLFE=,<'3JB%[_&L)1)7&PK7*U1,,82:T#5]#P;%K/KKI M74G!5:OAX`T!PO?Y:M67#`A9J--"A!/AKAC;9P_DB*7:8:\M90KP3;M&AWF$ M+I1@S]"L(;^<7W%D%$A2H2P&\+\^AP1-!2816#;'XT)\[T7!O^C>_$L4)2@, M?/J/6>3?E(LY4+3:Y?O@O)`N0,AVQ7)&EDS:+'AFQN905IHHA5$.&RR0D/'& M_*C<-.C.2(A1)".+0&J%(Q/F&\'+7'G'"W5D??XEVA]B^("[7<$CK%*2CRB& MP7V4K>W=/F]B+TK(J4[T!])_A=G/]?]Q3%+RJY8P7>TVWE,[]EEU4@1#2TZ& M1DYOI@FQL`::4#[LDUOED79.10:I<8Z)0P;`5;*_X: MT=?B+QHW',^2!*8).76!N0U)*%,/AET9$[&L;=5X*.(XD$82IMYTM?EI?@MF MZ_5\LW;@?`)QY;4)*_K6#+ZUQ3MT8=MS`>WL'7=\@2[.3>V?ZYJT,?/.MVSG=U'G'A5P!N6"36WB+\W%-V.+&L^2%2B8&U_EFM='P:2`0?;F#.3O M7BX.>".K/8`PZKBJ($TIDHX;&`?(Q\]CZ"7P"F;_Y0TD&3.HT'%2-6BQDZ16 MA%-UB+1*T[?SH^&D"/YU0R[,LID#J6(G1A\FZAT6-=NJG1.=DHX;MJX#[RX( MZ:FUXMZ(4+`>9CB")L('T[2MU$WD3,IZOG+.YA!%]V]3&.]!6(DZ0&AQ-;>) M*JT0!@&9.AUB"2Q;19+9S$_HIC^(RDRP)G$&*IG7@R-1AC@02&-FC#=>RIU_ M9[[+?W[KW4`F-*P9WZ#&LBZ"?%=^FC\"7N2##=P^1"A$]\^.3*NSZPDI?-XF MEAMB=?@R]$U7N+%HQ[2L5=N3JKI?:OUR@I5Z!8\;DI[II.5'%-_"`P;1`\Y4 M5SN#$H+5N-;/YK6*%Q71U M[R=&M?&&2,>Q24#7&R=<`?FKVB$39^0B,-I0$>"[<>+$J<$M:;ULH]O1%NU3 MW-WVI2HN;[ER<7N\I@Y.VT+57?8D<65B.JM.*7T)S4ZS_M78V*DC90)23472 MU;R<`&ZG:#H:SH8B3:&)H+*O$WGZL;\7])R*\3 M//(^TQY`$M%8J8HE?.;:$#);XOFD6+;7T$C=FH,QI_&Y*>%,M0;(0_`U>SSV*A-VU2"5#]K"=4.N`6"&A=&!.GL*.JD-XU4+I-DK0Q`EQFP` MM&97!9ZE>!VQ?00 M!_]G+SS"&QBO'[RX#28]I0+&BDI#`:[DQBCT=3P*2:%N:%K*9@N@SL@E@."1 MR($W.`+Z*`R].`&X[X=S=*PU\DD`FHA!0^JSQ4$E_08[-3PZPEM:,B%)&Q), M1N821NE';9I?7S[\S-`:C0;[;J"V_SQA#Y^ M[Q))FXCA,K)3Q2+Z46$^UVJV[,#07/>6;[\'!B=U$*XS$-*79R"[V_$EXX+7 M%>T%C%&[F8TBT48@OWI3&'E9@LP`W!0T2H"Z:7NI#\.+.ADZRMVXW(RS),W) MGCB5VS"KF\L27L6(N%+7X5.F:]DIXLS*)E2!/%UA`8'JPA9(5)FW3:2.)UTR MM0QP"56E,VZ3B@$#";'8E24G5Z4G(UC;@U,D6U5IJ`++&-("FC6D+?"L9M\V MT;JN=)G6ML"E6KUCX#376&"0D(U38W*VU11E=.OX&)%O`8JS,RYNX3;TDB38 M!=O6L7M7,-G&P8$\[!"PGWK)2%WUP135R>$5+J>2YFM)@=JNXL7#:C)9C M,:&5#6$:^W!_*!;=.[F$10\K:$A-MEFLHM_DKKK'D\'4X$"?CDLS"*7#@9DP M('@`1)Q`U`*G<(T1Y6QQUHY*S97,+.\GT%T:HI$8@.9R;7N(7Y'ZDS M"1'%ZM.;6W(OQ>;O]*J*^=^^+&X^SY<;>KPRH:&WW1[WQY!,"0(?'F*X#;RB M-?FWR=G[/UTT)GVR&1\ZX8/?7OQE0MXZ-_6C@".D7]\=PG*U6C256+<,5Y/- MA]31$*QF345]'7US&3W=^ONZH,5O#(Q@:\S`C_L^,'CT[D+N!=X"B?QS,"4& MTH5ATV3_GF]>1`V>UG1V>;GZLMRL:?3.SL>_G5_.%S_//ES/UY@1\XTSEPV) MZA,I5T"3"0SA.@&XMD:$/6U+;SQ,R]I=%LE5D&Q#E!QCN(%/Z8>P>PY7#\V2 M)AJ:@^FC[,M"%UO?NYAU>M:FM_/KV69^]?9F1A*JS>ULN9Y=TAN_QF:>/G30 MX#IM,U792)/!FKY/BU]CR5,/OP:A.R$#15F23U5`70=42N`K40-4;_36Y)28 MYB1BIP'UN&D:LZC70007N,O7'OA5%1>W3#5Q.W0N'9A-[91\]:!MTP2?JN`K MD014U$UZ=H$@YR2SLI1X6&HJD*_EQ37")1^>ZV\8NVKT%27I(4O14NO:=74" M8O*]]FE9.<9:9'5AOT\/H"@TG.(J5&LVNS946DV>9RG M:&^T!OP43`C&&QP:]%/$@4(3HS(<*-94:4Z<&2A,(/Z^#[/(OX*/,$1TX'[^ M=(!1T@:YDFS)-*'L8)H)K)OEF-R1F&`R_6DA0F>9_$IH;$*IU#7J425M*@G4 MFCR2VA^31&D<;--\72WS'AZA3$4:ELQPLG2M&B8)UX&$'!R]:?4JV[SGR"4N MXDI$&M^\PX*N>`O]/'LCHC[%^2+TYUXMQ).`)PSU]']C$RT)@Q0CCT+03>1WGD)],GEY;C- MR[:8Q3&N-4BZZ!^>*Y'\[,O9-R_V5W2[4/(S[ME`?WDD'1JR=X!L26W!S::+ M_#O;<3&07C8*99*J%LLGHKTUM]/LC3N[R*T"'YT.:,U@9L-;/3#:^S7C!5DO MA$D>\#\AY"?=;4LBD2+(,46&!BF&4:-!AF]?&"1X:M/JD/^$R(S,<%&M(?6O MW&(80[K!$*XU)Q`N!K<8UZ8AW6>S'4J]4#0DP;:OBN82R!OB!\1Y&N@.CA4@ MK(Q>`7!-;5QCV#36X>?8UJSJ6F?>2],XN#NFV2E*^>5V8!$E:7S,MN9>HG?@ M.O7?O40\H`8LQ_>*@YGT8I$BAW5C"U1X=BUL$U&[$F#!*WE*"Y&/-%" M$X4O+@0\:UF)T*8]A-B*C&T?/<%119`8M:>-1$BROA<@WCQV`+ M)3T;AA0C7#:D#)*A9M=6%Z?K0I4*;B84I%0*I]P0.V5L'B*-0ZVT"J54-@TA\Q0ZA9#[L0\QL>B+W-1!= MDP)>V8H!(@>P(,@EST`N^QHA)TIFC&%NU.1F^P#](SD0*Y\W_A?T%SXN6+`+ MH#]+$I@F^0UP/OX5UX%W%X1!&N#?E"2X,^]OR(_A+>VQ9+UH+4Q;'TI]L^4Q MFKQ9*9HPL%CP.)TG:;"G2P4_>D&<795!KR--'R#M2F5VBSL@1[X^PQ;ZT4D@ MUXIX9ATU(J2-W^!`0)WA7^`'X3$-'G'ZOCW&M,RX'0B//O3)281DYN^8THF_ MU:Y8SUG<,R6/J:8==,*J.0?&(JNI(AE?P6FMB&I!UJC3:=T:P(I[%.4['$AW M_1&G-&00O[">K66JV2<1^8JHXW>%)X!=99/JK@1EX_1AQF4;@.6%9E.^V-'9 M["]Q,B*8ZYE9*][IPP'I_^6&";$;L:&R+8X&W2@`OM)FVYW%O2\Y,/"ZJ2\P M,KC1&1[ZBPBTK>5M=>/&<[;,N#/1F13'3D?88,E.$Y-+AQ;#\:N)P0V.6(F_ M;63:"KVTE;02=JM?X$#$_1A$00JO\4_Q%U&*V13@TF6=?W$T557L1$JYHK$H M*'-E)\(I>E6+7DK&&I$ITWA+54"E4XS1.19PE&'$#"8Z%]"GG4%5M@$U?%JP.TE<47.8.U+6BWU#9XK>S3XDBR;AG, MM.0M]J_2!]Q)Z+3?KA!?'UV]&G"M<*!LK%^3;FLD5VK_$?5L]]4Z[J:IN+(*H.;23 M%&OY5HL<&B8;4:/0`W7%,W#W7'_@6@=8$VO,<*%?_[Q0H6:)'2=T2N%`C)A' M^",\_Q+X,%_K_>'YL_AMGA[:!974@VI&=_-^",)2/&W`E.]&)(6DLZG1LVXDF/#=J48*M/;U\((>) M)""(P*47Q\^$W+,].D9T"*]0_/IFTE98,3PZ=I38-./8=H`^.:E+DB^B M'8KW=(;OPW/^4DZM7E8ZM-.T8HR26GXM#L_U*8<:G_4M3]?'_=Z+G\F(A1=M M`X^91J/(19&\WJ5P1(]6J-Z MN4@MY:U9H,EP(>'N`-^8[)$.](U!'S<&_-3NY1)WWWO88.R(T[!A<-^;LE=; MN]MT"Z"ZATW/;JOCS;M--N]X-V[X+G/UIO:#!WX6F;(ZWUTRS/`X$ M%Z68*`PMVA;Z)?V&PXJR3SM!1=>]P22&'5!T\Q=GHHD^_/HG+*J11-G8@#S% MJ2@RVV[)$%"R1"E,KA$.?;/(S[N-T?TMW,+@46UE3V]+W5T+^I;,;5'0]6UI M/T+/8BAN/NAE?5JHT;,_LI5`E:PS(PG]<&3`$$-QM`+I&.6O^^Y7-@;!# M]QQ\$!QXG>0G7G]HGW@M26G,V.TF.D/MFDM_AI7$4E)DI%"*J9(!7\T$B@B_ MI4>K@[I)4+=)\ZB:8&X74,/.95:&6,#.M\P!D)N%#7/!R+Y2K;2XR-%H4$MHU1FFU/I@UT$$%RG<=V[KT5#A,(BM8IA- M+"XH@4/0 M9DAJ3]QD,)1%+0;7UVD0:6[AB;H_`V"JGL<]ZK?SJ!?FYE"H?IU MNPPA$Q?F=LR:7ZB.;*>%-E-#_(7<1XW;A M!L8!\B=*H7:8:6&`[FO:"DO[%<9HVF6^7/KQ8("[Z2TD`T4^C,G,[6,F``Y4 MPL4X,A#9TN@S'%$J(:N?%WF@&U+ZEQ<=\[O:/V'!-%E$V:_Y%*.D,QUES\/0 M6"GR,%;(Y)?)B<@I+9Z5`"KQ.J4O<"+V)HA`0BPDW[_0^*D`>A-A5`UEAJ(I MWYF1H"K[+2\OME[S9O:-&1P:.:_-K0H87`0GXF*[-%;"X'5KO8'"4C_)2K]K M9]8DF(.VB?C(!)>A<'C-7.U@J*0O+]@MC_L[&.$9(7B1Q33B&XJ M!"JZ&1H8I6[&"I>2@IUHC-980:W$5Q77TTR(=-BS3!-XA1P]BN*>2+Z"1%25 M+R:BK08V#<5@B4(IJS0V%II;*)^5<,KU-\T'X$%`W[V"Z"D$N8G(*<.6H:C)8E+U<9C>FF^Z(GI[K3O4[NX0?9 M"0BX?+/(O\'46WI[R-Z^:=&%:I[4RX7M`-RC4"?M@?8OWZ!@W-?M-)N()0*N M;)*UB7R=D#H0:9J!M8,&&51G&Y@O"?7>28I_1&=*,D7*:,<2V1P ME.H:-1MEN/;%48*C-J5OWJ;X%4Z9RG=C$UU0>4C]8[>)UI5N$H5G;3R@IUY* M.;K:77K)P\<0?4MX)Q(IB!;`%XH.)8#`N%$BR/T("2%3GUZNEE?SY7I.-[NO M5]>+J]D&_V.]P?\A.^+78/417,[6/X&/UZM?UN#-E\@[^D$*_>_=.;Q(!11( MO_):Q!)H-0@FM>X"T3K*(<.FI5*5;05.)M?+H6MTX6U^S,GH).)J@B MVR8H6]84,UG6K5!2X$B)BUS]XB".!',+/W.%5\(J9A%*5A,<)K'4F!3BVQ^? M.Y>AER2KW3I%VU]%O.')M3G3E3/%E[9E*USA.%'B"5-W2I_2Y5/DN5M,X58J MBR6B[\]A2%N%R0ZVW1&9@`F]B=!][^VK6/;O%L;/56D^K9(VB MUF`.*?DQRR@=EV)^J5N:9B2+2VEPR,3/ZNMG/*HQ-@?U`(,&U6:;GTH&FFS5 M\#DN=[.YH*MC7&YBKL\1?43Q&L:/P19VF[H^RG4F:RB;(+2R.^.\UO4LI;>> MP>DMQ!V08$NVU.:KX_*U'61%,B9=<@SI407>?0RS26-W%GWT0UF;_KWJGA$% ME.UT@H%F"<:-"?5)#S*)\1F2)76L`""6K+.=)VF"VFS;QGDL=",EK4`[;X<; M:SB("/B:"8V>`,MKNLTX>94PZ,56ZG!)9-O-QG0)O]%76HUH1TFE\:PIV6PT M2S?F=QKJN.W=4C8-92NIW%OQJ(<.U4:/67<:C5VIK]S(M3R>#)CFE@MJN32# MRDG1+.2+\S+Q?(%>L7+O#&"=3&+L^><3@)6WS,XB6D==&$=*F1^&4R_FSUYX MA+2L=^TE*LPCFP::J3<[OZ*QXCZSXT`H M&`*X=G`86/F,:-'#8B=^]"[5N`'E`84^3L+F_SP&Z?,BVH9'GY2?'&B.HEF: MQL'=,:4W,Z(EKF,4I;B^0WIE"T[>8))RY_9M&*\''X/&380D8\6QDT.;+IXT MAIEU.%UO5I?__=/J^FI^N_X#F/_MRV+S=P?BFGF$MZ.=%5PQ8J`Q/YW(:/@7 M.$=6L_T*XT4[+5,GOU/5,*I>+E='[RT-_C56DAHKR8PC<5$[>4&I%]I/7DZ6 MM&3)RH;\JJP/EEO\`X#4YFN(@_;BG^T4Q7RX/FUMP]8S',(XG&\>L M:/K6"T$JL6FU2)5V,PY32,@*@X>OOG MR4"LW("91O&HS=#Q+@G\P(N?5[M+M-^CZ,:+892R5W8I"1<-CD1X*'.%YLV/ MG*NX$])4;F#ZT<.9SJ<8?4L?P)SD*8I`93O$X$@3UW8/]+D#[Y-=3FT<5F;9I M$HG]6:67DFLMXBE89%+R&]8#=44"V4S5D4/S^J),1&7UJI>07&Q(2'^5,HP7 M&&+H)#D#'780N>8PQZ-,N;W?.2%%+40;$E6P]"6-$G$IFV[ MS0#3ES+S&-JMH'\&O!1L"<.5]DRE_5`+Z;XRSG_,R^%OEXOLU>?4@CV,S`Y/WM__I>S\[_\&7B1 M#WX\^_>_3,XFYY/R=K\4K#$^L]FZ]^=G@-03%;V"V_SIA#Y]?P:PP@%NT^`1 MAB.OQA:@0ICPZ_0]Q;F\I7ZEY5YDOSZCJ(?XX2Q=P\;ES:NCFF28C('T?T'+PFVL\B_"L)CVNG=#3.2?\"^1@:2J)];"VMI M!Q5$Q,@!AJ=OP1UY3$.ZG[UP)P4:"#MD$@3-*-#/7CU2#"G1:(PPUO0,*X(= M,N`FK%`&N7;WEOF:B3/PH:1.;N9WNG!:S3'YTJ_U??021-O4\Q_?G],6E3SY M'[(T+4@2,J]W"Q]A=(1+V%[V)93)OPM'IB>S^473;<=\M#W2!3UDZK)59JD7 M%B\E2M/9_7U,>T.X^T#?`#\[?RM]@."079F M#`_X^V2%?X2U4U;I1/BG.?@)>F'ZL,6(>3?CT`&]TA[&'IY M%L5H/(^13U;@O\C64X(/I%&7;9:P-6I$$9FT!3Q3C:G80R_(T28U2<%J!QA- MZRL`"K=Q'8"4P4TLW[3A5E;LJ!=B+G+$X$[UUITVUP!2N"WO`*08;7_G3RG$ M4=_/KT"X)*-LT86Y.51/.?ZI,>`C:Q;:-M\M*[KC`5]">S@#YT03_/MS! MF*P\*/J^=\_`JRZ_SEIPVAE&`.:609*9!MO"]LC-L2)0D'9U-FDDUBO)I&+> M+AK---9J?@;@$#?/0XC3FQK!E=*PQ=S.K`@([4DOEBHVE M?+DAC.":-1Z:99ZX;!`K]@S(11RNO1\[%,N1@'0JK;5!E*=2\D-BU!K(S$1< MJ8M^\")'`N1(J0LX$F$-(8:W_7\89"S-W.3I-3N8RL0Z\S=M,3-CITVK%F=Q MF(X4!E`9>CWC:-4)+*3'#J-2#'0'8?GUQ1N&;6HP1F)9)FV!R_1L#=M#+U@U MYFR*<257PJ<1I$BG;WI`Q6CH7$1%F([\3>P%$68N,WC*!?.?*!(<@G&^7>,A M5.J*BW:)9L\P&D1ORXPT\D&:&QXYE"H@`FG579,C?)V2)3*S]N!F)JC*??0$ M&@ZLBZCL^A/,%#*.!%=CV.$$V,'@,=O;)[-PM[5).!3-BCDXWOE2&BK%&("2 MRJ">FH('@YTV#6_\_INRD2D5!4U94`J#KX7XV-TZ'62@OC77ZNPIJ%?]/G5? MIP"CUJP9=VNPMLO!B+SX'9&"F3DLR=;J9DJRH*>?J<*C8TTLC.TML,$FK)39!A!4] M_(0XI4\@/5;?)PD_I$<'C9S'ZP,.#<%"D\?*)DHR:SH]&=;-)#W:+LV@'*<_ MN3S8Y+@6-SZ_"T!`H MM,>Y%$W4AKVTG)X,ZJ9&5#5=F@$Y'6_-',$[B81!B M`Y,,!0\&4PM%;T.`=E$"313?7AW0.'F"0:`9S0D^P6JC+W.1%U\@_X$L@2%$ MZ-HSWKYS77#QSM&8?O;^@6(Z`11'9"?V,4G1GFZT]E+@;;?H2!9_[[#,Y)R< M;[(EF2#^UQ[%=,E7U:C_(7%E/:R@QI%2'361WY4MP]T256Y.;8`XD#:WA/_L/>]RH4*O:[TRH*O:KB_+6L!L.QS+KYW:UJ#G76#/X>K,VL5!234PC^6=1.J"N4RS;D M"L/F`V7V+2S44'0IF`)4LE!;FK$]9=M!K*8/V!:62H/M,?1BK)*Q]T6V*QJH M1;UPU9Z'E.G6)B#5W-BGB*D%'JJ^!I*#+NFH(%M).M;.6(,>=_6&8>P-7J^A MXL3HT7GJ+@=BD"S.V/Q6\,9=Y"N$$K_)YN\+Z&7@*3[E'S-DR7.9-)T\/8:ZXD%O(P MXX43!`3#ONB:$WJ?-,GH@LH\.3Z@L$^H<\@]T&WBL/!!+A*KO!`Y5/@!(75$ M\K((QPDO>2A2,OR.&"'.$BKID2O#@C08?9K+"IF091"W`Z$Y+[60:;KH+D4# M4RFG^5*=+`[0--8X]\]`-/:]"B^*T=Q<^@50>G!^;K8XAC-Y\X4[&;4O?J>V M`]3F=EM>`+6-=H7H=5T?L'6?S$/!*,D6N$=^_0#(]JR@CDXQ-:BF,VC"1,6% M^4E"#:_\"11E([2#X)57='E[,J1+^@IY4G]&HT;Z_/:.6`/S_2%$SS`[36J) MHNI!#/?'B,(+1>_`AHSK[KUGW`O8AD9P&_\IG%G?DNF&,WBVYX:2A042Q>\__QS%)Z:`(&4I&NUVPA7'R!SIH7/SF M=V"65+^%#C?#,-]4F(UB^SZX\[#Q;P\P`ELO)`/1-!+B"`AHO^8>TA^6K5.C=B`Y].PJ53\F#Z_2\3DX8SO)U[MAW=4CMK&R0VQG>$!/Y M!^MG8@@]^W@TG@X.*`27O;UM3F=E>DARG>T1=SSP/_-+7.$3@21^C%%ZC\GN MW7M!1*Z!.N1I87)&U7"BEN#4*EM0@).P++TBF]+RPR'PW^B;AYE*\SH_+V&U MMX($CMJ9XE4>F.1K"B`X'.,#[O)G6:1_W&:+%+8P>"0](5R0+"^E:1Y*Z4;G MXN49*,Z:H+\UV]9QP!WIIV#O$5%L/XAI=AA#+\3Y*NE#9[GM&UK\3)%\CFU^ M.]\=N5[X\7I^`?XV)`,%L+2_Z5I\E!5-WZD%WCO/4.04HR29(TX[A`!CZ/89HEK]D- MSV2)[',VN4.&'YPFDHR:X2C*8Y`B"SHS0S\1RTG]G:[(`Q(MGM&3R.)$U`;8S0= MGY#)IM96:#LUQ6&Z,B(G<*$""AV0*X%<"U"UWPR$N>L5K&-X\&H#+6]J6>B/ M&8@C.E'F"Q83:/LVA65Z"&YS"JW6TD2D32'!/1^G^TP5#L&-V\>H.K$#]]SXRU M[)?%E%7KY:`1MH8M\]-,+//\0;&N-.T*DV>`O`3?O"2;-'FL3K+\4(3`JR($ M-M;MG%6A\0S`!O[SY,4C@SIY_"43H%XT]KF8G.I'TDIKC6XUY*IQ*X:Z60P9 MFHU@VM5`#YE!(*BA^'$CQFG7+&\T7[5JAX[`=PP:7#3"-JY1P;AG4L6&%UK! MO)%IU0HVNR8C,W\N:I3.18W2N<%&Z=QNHW2NU2B=,QJE\]]BH]2N?B2M-":P MS]G`/C?<*)U;:I3.]1JE*,E=",] M7)NAU;HV(-N.039V41$RG4@F_NJ;-`[>,]W@4%MH* MY+Y`X0QL$"#N`/$'J$-`/?X>5,QC^Q5&%3M;.XT5S^C"^5,4=K3HN'%%KCS]N3R/).N8/-;BA%=%[![59CB)(V& M0&7V-K%BOE>\S%:\MM;H@EK;JV@UE\[6I]IO8)QDVY(0\.C&I&P=K/>,RQ"V MELV2^?-O*/ZU.-4_(BZ,>_:HX)E:U?E-6PT5C$CXSIX^HRB]$$IF^P(B]+)FK#Q5KRT?9J$ MLNU.KS5O:BNGE$GP!/94[V7FE%VP"!,`9I4J)`"EGC@#:)FWBTB+B67'SP`L M"E/+"GZO#%LZV64?Z"L+@LZYX$_*@X`B#+8<<^]TD)0DBSJILT$VF5)).;MHE1,]%;Q4MO=.+( M78B`-D[=2)>-0HD3LHU@:>`LCLR\T5D8%6>],751P]3;WP*J.+,01E!E=!;@ MLMQ&P&SX>:_SG]5]/03O;6O&&W6.`RZLF?)T02R,[KU\70!NHZN]&/3PQB0) MDM2A'1G<2D0*'[X)X+9D"5JV"=-H,--\\BQKX6!"KKHNJ]V-$-:KHCD-H%9- M#VSH6"8-;M7@F=>J[XM&?7_V(N\^V\95:]CF_KT7@]L`N3*PV`L0G+9+"Q!& MVZ@-;@!7N]E]#&G$;2&(\S8O?.?M$)RVC!EOG]CVN3!EB4_+B[7I2<$`,V.? MWZ;L%8+UIHGT#F%,AV52-'([Q:M))/_\3:BV!$ND,@T8!H29)HIC6`<*N(': M%)5?/']Q]Q+!HL&7B6->IYHO74,V<)D>CFHTV.)]@]`V&X2)* MTIA&[.027:<^LX>D))O_+(GL$)P*31MOJ%2\<4$L5YXNO7UYU)6W_>-6$66FI5-RTQ]+N!7,94!-"&<_[P"6>^=(GFX8 M59Q6TQ"LC$Y"U<\L7-!4-$D7T2SG_)Q2OH5.'97\`ZBI#&&+B@?C85C#*9=! MRC:FMXW#H(- M34:K^S+'L0]>$B2KW4TVD%W<,ODE@:O=/$FS>_!N4!ALGS?P*?V`3?_:@O@` M"_G'ZF5A""%[.#3>H>A?!BYI^YJ<7@7)-D3),<[[$/3")'J1#96F"]VH85782N<,+#[>KK]_1\-4L>?DF%T<"8NO4^Q2R7@WV,0>4P#0? M+G3X\)O%/J=#.@+VC797U]7U>U7:09T&LARZCVIQ1I^6ZJ"3;C0\&4^7>SCG M'T2C:TLI0<9Y7^,&QK94`,O3PZN;(IV8:.V%/C00%:TS8S2L5&?`:+L^)?P- MG0?7PZLQX)/SVFJ(KG?`"D0[E].=%,R\<]%.@>:AYY9INC.8L/5Q;0S3%U), M_X;PRSO!ZQ3X-9I[?3@F0023Y!+M[X*(9A&W<(MPB?X%_85/FME=X-V%<)8D M,$V*B0N<(U[CQV0[)RXD?H>3$/_R&,=D&)9*8BLP>"2:]`(R,M;4>-\>#!V[ M',60ZGCE&-29'*O8YH=W1_XE_)[MJ`4CU];BR`#\(P0DWH'M,4G1/K]V?!L& M=&@UVUB-?/J0;-8.MF2DM[JU/(T]GZ31I<>S['Y.NDO[#D(R,!T&CW2U/3&! M0K]U`!$.4''6'[_+/TAV?;E'RY=4!:3WIC>U`H"J!*!>!)!CNB@$P(9!K1@@+P?('17RM:)0 ME7Q>L2'T>_!T`@^_1T_F5WFQX=/D9-#8O\/-&'J!,^^L4Y[4TF::6&:IY#:/ M<][O<;)OMMQSFSPT9>$FRQJZL@/.(>VS5*DAL8TU/A%M$5"D,O+A\P MEKWIJM;6NZFK#IV<5_5D986;IG/A?+R6+7ITS"%&@"ZA)/U\:H)&/#\S@OO, M";V!*CLUL5P4EI_=Z26D7TT/B"NRSVTM^R3#%=4_$_#@^=G(`SG6,X1IU06_ M@_=!1(^((W.';EQYU0N]:""JNM/]JE8:\_QZKD])'W/KNW2]&B-.O;,UJ\:. M$G`3HX^42E(>D9T5?F:Y>CKR!HN3XEVPMLLZX`VLYM)Q9W@9EZYK8[#/%V[] MCFNERAX!UV7:5__>U_@O_+!XA/^'G*R-G_S_4$L#!!0````(`&"%;467T-BC M"#L``.+T`P`5`!P`=F%S;RTR,#$T,#DS,%]P&UL550)``/C)654XR5E M5'5X"P`!!"4.```$.0$``.U]6W/C.)+N^XDX_\&G][GNTS-3$].[X6NM8EUE MA^WIWGGJH"7(9C=%N$G*5>I??P"0E$@0EP0("H#*+W41$XG,Q(?$+9'XYW]] M6V5'SZ@H4YS_],.[UV]_.$+Y'"_2_.&G'];EJZ26H2"JT.+K?')VEY3S#Y;I`1[$0WET?7-U,;L\/_KP^NWK]Z_?'IWB MITV1/CQ61^\^?OSQZ-71^[?O_G)T]XA7)[]JP_O7G\K%S\T(M+/@$I:\F\#^D8G M8KV/;]C7+2EAE"I8;]4FUCLZJNU7X`S=H.41_?M?-S-IZ8]O*,6;'%67R3W* M2)6L>+5Y0C_]4*:KIPRUOST6:"GFDQ7%E@VUSD=JG7=_I=;YCQWG-V/$>Z!8 MO,-5DKF1D_$;RCJH9KS07UR95B7R%Y=6)OT4[<'*G6K&"WV-BA0OSO/%](+S M5;D2_K9*BCU`95C9>`6FE]I`U.>DQ"NT2.=)]GJ.5S7WDW69YJ@L3_'J/LW9 MB'"&JB3-2KW8E.$K.IJ]_?CA+1-*QH M'"$JA*NUR#,R@5BAN^3;*!%%7*Q%NJWP_/='G"V(>SG_8YU6FQ&2*9A9"WB# M,@KH)]+_-G=%DI?)G$VH1HBI96DM[!E:HJ)`BQOTC/(U&B&CC).U:)\P7GQ- MLXR@^JIZ1,4L)Y.@A_0^&X5%"-<1W87H7N&"]#TR8(_J,4)&UH*163E>UQZ" M:7V#YBA]3JC6XP0%,K86_"))BY^3;(T^HX2N3YB?&R&OFI^UF)>X+,FX2WTQ MSF\?DV),3U(PL_>:E`U=GI`18O6$B`<9.4)J&-H+BAYHF]R@)US0D:P>T^;D MIX+54/;^=Y.6OX]1PKZRZ12<4I_QXE\5#TF>_LG8$?;769)?+:^>T'CAH9Q= M3A'OF*=R-$-LF;D:C.V%DS":8BBV%Q+`U-%`;"^CF,]$P["]F#"^;@=A>VF5 M[!P.P?82RGE-Y_;MI06SMO><29F65\MKNI%+>FGCH4^+M*)T#?I(S=AM/-##>[&!-L7[C>K!B1 M%$B?$742TVH*KMNM^B=)1N,I;A\1JG:U7!/?DY-!A/4"9^J"ZMJ'>A-K-&9. MA^=K"@B"@7/B>*K-+%_B8F4]BJCY=<5\ZKC`2_)#KS+TK4)$_:WAJ*PC%&'5 MMA5G>-ZK*Z-13+C0:49_^555R_%]20:A^78NE=%C]9]^,"E"/E,]847>F&O5 M&)`%")1H_OH!/[]9H/0-593^@VG\ZNV[)OSJ/\A/O]82W*"'E%:<5U^2%>)4 M5)$T*HE)^BIT$7%<]-5)BGG+D?RS!X=AT%9#\>:)]?17\\"58:-@ MD(9=Z?]Q!*G@J,)'8L:X(.O)GWYX2P,)"=]ZS719&UNJ-5,YZ\9R[`D;IVSV ME$IH>.`4UD\%#K.`8?`\X-0-Z%#I#3=4%M?)&6Q%G_&R7% M>;XX(P,9AQ$=66-".5DT2`%J:@<6.?,&+^]#QTNMWB\HR_XGQU_S6[)NQSE: ML.W20NA8-+0]!R.EC08^)CJ/<3C2&AH@?8@#2#_CC"RGDV)SD6:H*(4`DM#T M@#.@B0PP:AW'`&7`N0'(7^(`2.,QM]M)=(&\%N-$3=J?R$A((T,-2.-1TQI) M!0V&?HP#0PSYIV28?<"%>/(KI.@AAJ.(#"@J_<;@@^/;P.*O<<#B>GV?I?.+ M#"?\CH#T>P\2O>^1`4*NVQ@X]+@V8/A;'&!H#GOH83$[9RFOUA6]6$9O"(I' M&T"!_IBC+!`9?@RT'S7^**MI$/;WT!'6ZKQ;]EV07_A)C(:*VWD<4$4#()B> M=JB1\FZ@\C$NJ-2WU?1@$=`)X=*CBQ0P`FF';Z,'OW!X3F1<,N5G"3U&$WQHC<=^B:7>53G8-SW%L M6S[X/=A6O^U=;,&&O9*&>;@6DOR0_3G;V; MA"J,P_`R*>^9ZNORU4.2/-5`1EE5MK_PB&Y^_G4;^G*UO$AS(EE*AF-Y,B#1Y@149V9'LC')DI-*#QIA<-/*.! M6.0O&D?^G&2(QM96ITE1;,AZE,6Q\L>F)F7:,U18&6]>6MUVV$[IOIL65L'. M3V&L?4=GC'""C[BH[E"QHF'E9=4+K&Z=GH*D=7)"DG`1`U`)"!`Q)]_!&".< MJ3*$OS$`[UQ-RK3.%E8F7`C9*`W$%)"U?03',RKN,9<.RB/6=OHU5Y2NDZ+J M1--S,-.1`G5%0;>G>3;53_L4Z?Z$)V.(>"D#9F5),&B`T# MW7004;.RWQRH!DE\/<"ES8O`08/_N3'5[N<`FUPBLZYY=\5\7Z)P,D7Z@O.Y M;I8TI!E.E+HT`38V1!M=RTMX^+X",79R))P5":=#0;:L4%[8,#YF#1S$7,?H M1!)KCO3Z-H.PWEG2Q4PHD!7#99KODPW='%4?=HB)N+UGGLB;FP`T#`;JUG<2>8?0N M@BA6K-'B-LE0R3+BE?2A'REB]+0[X*AHP\EC0!IG+L`E*W01TZZL"Q9*:M":*T MG*,_1^6R$"ZF6!&QM#W[?CQ&"'XUXY<(%H.,1+:2(`# MT=0&/Q*^T9_9?L$5:M<)_;"4TRPA\[UEBA9B;%F4;.QO5#)PW-E;P02%1K7X MOIWO`('D%.W97"1\5ZK&R\OR>T*6CK%5J5V-*'<"C=T6IWTJ+? M=933#ONEB-;[9*J9'DK/Y+1TXFEW$&=SL'8:3KZ!QW5*]H(IN.`$+]X-278R M*;2`Z%!72=@]V940A@\AL)J&&%+QC7X?$H(?B$VC1S`.\XM9=``2\^-5<_]8\Y10(NN,[VT%+6$6\HV%#I63[/U@OV MYDC!VKNJBO1^7=%5_QVFW8KH3F0GHCS,\@H1B\KFYM,PW]ZM=\O<8PAN`QBF MD>ABMX)B&W`KH/`8ES1)NV.()?@P)I>2U.&]`@GL5Q!!1/5V$M\)\PI(/G?& MD?[G`P2>Q@93HVY8?>2!Y,>+!8LE3++K)%W,\M/D*:T2/JY<0]5&/,BH#A"' M,(M,#4>I%/%.A&[HH^8Y6IPG14ZT+H_G\_5JS0XYSM`RG:?\Y`9>H&D42($# M1*RQG:8&+T2@B(/Z=]JP[:K>4V[U4[GT0;B! MPMOW!->-F2;94)ED(^4@N\8D]IZZ.[D2VCZ")]I3BDDW+.WWGEV+93^[#6+O M0&68:_TMYS@8LSO+ZOENMLF"52?>&F$$ M:&XNLRHGNI-_9XBU5KXX7M&EP9_L=VE.*OGV MKQ.VPWWAD6Q#Q.*=R?4UK-^=/5Y7C[A(_]QM MCP@Q+2,68GE(?/`8UMAGO]@="A/O;0219K.R7(/PVB=48+4E_$YP*K2+#XRV M@L0;RR?22O[".I!:@=0PWE;?+URA3[#O![.BE]HC#-[KA'D#9[D&)8;A^M_5 M_-;<4GL,ZM?.;",,P.NHIYG6`BB'X/TN)K1PR^P1K-*IK$4"JN!`*IS':JAD MX#S@&2S,(GL')3=WC3#[U$`E^<050BJ#YJ%/60ULLW>0BB:K%GFQ`CDPZ$5O MUPJJ`NW[%*)(^Y;B`%&IM\1>8^U;"1H,_CV^$\"7(%]=D&^$L2`O@9;A!5IN MS5->+:^>4,$JJS.A=&Z0T;MCVRA,;X&7]3VVK<22HU<-U?9U8`F5WZSO;18[ M)#U85E-UL[R+J(+0CCZU5@[?(521"/3:D?AS:)K&P""E.'\EYKG-4#_@%>\1 M:5>?6U0\IW.D@86`2H",'E4LX)"K9H6/'CL?)Y)T"&(-__;CA[>LV>DOO^Y> M>NDH(5C_2FFZ2]L-&@5L6JSW<18',' M,(3+6+K9V]!RH%6`A*W`@@<4\GF*2[+J83,%NJ1I1H1;LJJ13"[A!;9>6%\@ M!/6I1')=NU^'BM5?O74(@S;!.JWZ?4+/N1YH.([QSC=K55I%A7C@/_;@L/L8 M%1HD.MF#8<!DP/_RIK/&$"SRKA7".-U#Y4X'+\KK`RT'V1L&7QG2]+R�JX" MN/5[+*9XE6"?CZ#4IQ+YP_FW)WI\(4LZH*5KGT"1T_G;]4#LL.\3RHEL&;WB MN5BE>4KEJM)GU$C*;X88%6KW2("%O'40?3-B2]7[O4=:#]L3`/*/=RUT0VQ! M&N.1Z'9&IF\99I>&Q4`#T6Z3X2IIPX:5B:(&:-*PC7<8'FBM<\DZ5QPZ0'0* M&8!"P"KRYX,`4QOH&`V>Z"@81O]<]U:W7?Y>6?\:4O`]K$L1!4*D*IECH\MJ MBEQU>WU0.<=]M1K@2R;%8/KMX\E:>F^Z;T/A\CK'=2W?(/I'1;0-_A$3>>L8 M\&;"0!7[O43+G_87&=]X)[E2M:&]!-H[8H$.5%$+]"A8CWC2)I)YC:F;!8]A M`,;QWM':CI@74(6/ M5YUJAE@3L+.X!Q;6@Q=?4"5=@`J_M9.E_K>0L:!2`SY4]YG8W[T*PC]`7A&Z M1D6*%^1W>O<,G:'Z;]GQC#.&W:?L1S(,TKP79$A*'_(ZJ^U\4FDK7-_ MLO]E=;]9_+8NV_IJT$T`QC*O&W$>P.J'A/;321XO+L) M`F-(.AZ`-04YY(%T`;HTI<*RL_?!W)IP/N_#M=P5DP2AXDI3IG)YPI]FZ&B3:`5)+U!U0>^MQVO;"IKKV^Y.,/^U0 M6KY3O%8?EC<#=A>PCY+S:T<&I\8,IWLRYWR6EO,,E^M"&E,WD@NL.\NY>+/> M+V1Z^TA$.WY&1?*`OJQ7]ZBX6C+I.UE^U#YO')/&=K9,@O&0II#!C@RG]JM` MJ:B/L)5FFNN#8?MC._]@[:[!U;7>_/!RMIPFY>-%AK\&D)ZEDVEG*Y7T>0P] MZ?`=/`&ISUUQ*LYU@9]3TJ(GFW^11IKEVYBCXWF5/M?9A"21.=8,=OOKQ@Q> M#A%LHRSL6\OH?,&\'OG10X1;;+L-P_(.WZ`YSN=IAGKJW>%Q_6[**MIGT2:I MPENC0)XAXXQL4J0Q&JR(OW?BIH0-MK)8WW-,(2#U+3#!HL^5\2E)HQS0.DE[0KO812TM*%L1) M.PH519(_(!'LC)8_$]5PD0(;?1XE&ON%GZ]>BS6I:&CC9OUZ7VDF%[N M%GGZZ)&GMH!CY\?79;&\#!V!=9AN[=#K?5#]#%Q:1#[W%A2)'HI:.[A%HZBZ M0UP84C7IK5MS3,I*J6$Y+'48R-188P)P#FNT2$X0.C[;-=UULF$/MA7)8IB$ MQJ20=DW>+Q0].`&VF&85WJ\PWJ=D);WO?/64X0U"S5JM\Z`=S'OJRZO]J*I\ M]*`UL]`$OE55M_U;L^%!F7368FV&7GD1E6L=%(D>HUH[.'>K@^H[@SXN(:T#1BQOL\`=R*HMR0W"CE MAIGQW3TQLTC[D5,;.KHX-TJ@R%]L`%W#-6HWD'=356O6*@,O%>&=1XFV-/*A M''.3&,!`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`!^%7 M_J7Y]FM_E>WJEBVBV.QS*%]O-FQDQ MCO34Q+1LMX[.)6M_^]#&2,&3FI7;C(9*5[M9EU)%_U[*%URA7R+J MT;L25\O.H9"D6A>H MU^2<&Y82M,Y80.#-?[AM8@Q0O^]1G-3/7(^@7K>C_=Y=#7UFM[Q:=LU`-_&* MM*)T378]XEFOB='F-"N$M^L&E.-8^4O"X@>"MBIG;CL'M+JJ3,95VWD;N<6/5#O>H.> MZ$N3;!)'//.<_.1[CC.03+*;KR%KM^^E9/Y.+SB1=H^JRQR)00F)VL(2_M8S MNK;#-CISJQA)'6S[$<([]@Y.WW2[3[@WW;SUZIV)683M5J`FX^HI+JMR)W(; MFBOI^VZ8M6\CCV3F[^EHJ.`G7<%E/L81-U.CRKAY\TV.L(5=6[3OW<9)R9Z> M'BM=Y/Z1)NRZ1D43[4\5]>8;SY,B)Z,0%8<)(O%Z.K(VJE5*YB^\EQ-)YH.T M=!(50_`;VM;!\>\2-*"A2I]1@EU3W4N!5_0W4JS M\Y>R60F$M&E@-:FW?BH22]970;0*=4/HLZ`6PV:Z]ONNJ@;:?S6<(Q]C%2]T MTH-:7S#OB"'IR@J*IIF%%-XZ[B5.\I*==M[1]U<$]M9O,HSBT5C%DHL:0M^&-!8V4I1/_"[EWPUI$O.-O.=^PGCQ-F MG3CU4WG:CFU5MD&%85EOG1\DI\P=V!4VL5`(+L,.!GBD>?INQ4@&ZFA,ZX[< M]?#/NWC;?>_+H74Q8/IV!UU/[^_D02:;]'`!7$"G?0AN`MZ4V$)U;J-?5Q?; MRP?4$7FW;XXE2*-4&Q8B3E3W&J;0"'3-"R3=48"1;[<7=.3>.K],-+T7L"BI M,4=8?@'XC_Y"E0;6I)M4@(`ETW)MV!*\G+^#/G'+87NMN>.^'G\6K@3G&WGO[5RW M];@=V,@`V`[44O)7JX.:Q@NDDF\'ZDGENH;0;2&-A8T4Y;<#I?Q[%\D/L=O2 M()JT?O2@CB.F094H]WI=02&3MF-;E6TSUIB5]9?#!R*GS!W8%3:Q4`@NPPX& M>*1Y^F[%2`:6!6\2)_JZX,*5'K,8N\,1=F-"/IOQ:`'KO5$KP2)WB^T#*F0TN$]SOU<_!++(G!N$ MM+T1J23U=WUT*)9^.F562&Z`L*9/H,;$EMKW?86J*G;5$UB%?:^O4.&]SQO> M)'^Y4:Y34Y+U2FSH?]''(\[+*ETE56/SLJ/@YMM\>VSRJ;%`P?C2'N88-.\*D?OAX278>4N\1HO??AY5N:/:+%F MKW-SPG52#9]LFH_2:=(X+JUY;+F$G:/%B6T,\K;8UA?UNGZ8J<"SYSCX?`4[ MG!V3@6R19NLJ?4:W:+XNV)-KY]_FV9JTX07I*31WQKI-7PA-=#!=!0-_XZZ" MH%,K3&Y1>$Z&*42)VH$),SIX]F'?9UZ'^EH0F8E>ILE]FC$X-HVRN,IO*$2+ M>JKZ!>=%^U^V4\;:2YL,PGD%O&$=5A!/VHFIK&J9J\*A.+$FJ5%GMO#LVPXO MOT5G2&T,SY(EL+0)W?3S.ZD!,R];3L,IECFG4#->N#,/*._%J.IB]1W]M!>> M?<7WD_QBA[6M?*=D9*(;!3"'`2LV\`ZZ8J$GR+`T@%&R#'@=L79Z1<8,SQ[@ M)6\&U&^T$NM=A91RX!T$E/&EOX`K/C+7A;*B>%_MW*E%9CQIA2[39S2P"'"4 M,N8P@*0!AYBA:FLH9Q`V$,!E.(COC"V>A[N7O"U;V4XVQT5!P^C9F;MI$A=H M:;%=]*6C3.]B:)3QN5[T%<8Z8Q;$;'MV'=_518;=.-7$D?U)AJD%:=]TF:)% MLP4\_V.=$C3UMX+)MS5I3>!\Q2GWP5S&$??@[U!,:T^SRQ;.98EW8M^:BJE; MUJ&8!;Z@H2J=B!7=M2##TIQ?`9<.'N3C[&%W8PAKE?WJ-BV?/[0!-$-'K[5T;67RN5T!_0,+M`8?=?C[C5<>?7>[BFY M12/3NYSEOSRF\\=S,H.H-K6R2(9+0`D.HCJ8LK=C-Z MA2;)[E"Q(D(G9`%Z@WI`>"@0TW)P7FI8;GMZ"BYW..BT-=9$(Q]M-*@E< MCU=L`F@,5^-R[95K>+G#@:NML2:"JX$X]K>I@IH8M,LSM-U)D,P'Y(3<-$!$ M>#B`!9MCXD%?5'\#R;^$XD%;67]YQ%FVN?J:H\7M^KY,%VE"8[8D0--0Y&"&F1AW4B$:\/T8YDZRN>'[ M/,#P`BL]!Y$>G!ESL+N*7'/PF(&^<>OMS*&%P?&WE.]D(-IMIGDEK3]]:S'. M\"I)^;05PF]]W]A^=5`Q&1;\?&V1,#U1&Z MLIH7>YE;PL.'\Y(ECQJN%%6-#"5O$:DE#Z_A#5740$#/+:AMSLZIYOPQQQE^ MV*C@`"^PW=C4%P@/$L9J:D`!X6>_IRA*/NO#FJ"1&*N'-,Z0*I:LM_59.?:S M^S3>B"D>-IL%<28VK[A^GD998;RS]=[.PXSH*)ITJHFV3QZ(B0)233CCU)%) MU1LQ#W44-\(O&X5CF(:JC>V047E\F4+3+ABJ6]\#R/C2;B[E%W,'+XB#(][K MBWKFJZ7;]@,I7=!0@>H'!XN"H^,YKU=3\M,9H+_4V;&=TLC9?;>S&]!PZV1: M(ZO)QYIMFMWXCOJ79.+&=-3LS*N*2';IQ45\IR;F%>5_[B<:#FG[7=D$6*J) M>N==Q+232CCJ:?QVXE*_P4?3*VUF9O*M)/,+#P*1,_S4279EX0&1A`TN, MP6IRE!KG<'=-_0O^-DJQZG!,W)-RKEA.T>=<$!/Y>H=7:%@-4ZOM$*4_J%$6\ MXMU,570X#`=NWWQ#GBP<4\XK7O.Y=/`8X/YDTRCKVFG+B&J-=[-N8(J>>K)M M:L-2;4`BM)3/8_I=-/]-6OY^C0KZ0_*`W@V/ZK6DN^-Z!:F_9SX,&Q$;*=WO M>\"ZFG,@11U37+2/UP/:]<-)W")8E'C/H\T6G*[6,#8+T!%U.]H/".]NUL"O MO%S6VO=H*EKTJXED(ZCOI?E`H)/-"=@?L5"6?7@PH.R-"B:#83/ZPQ;S=T3<,VW@T"@6YWI$[8(,=3RL>W M'64XFE*98*/:D%(Z<>E0^M.4@"^M!K*)8[$AM*VV:MJ`',.PO;"9JCK7L*V` M^0,^N4$]>4$ M]>4$-23G]G*".O'88'@H*A\2%.><$<8@#_0<'([(YO8#0MG4_C*``\R74&M) M/QFVHI,`:WD]YF'5L28/_ZX.S6'`LCXG5^,)=#0>X<&JQ8I'YI6M%SR7@Q-J M5]<<`CNA!AVXP0^=9>QB?0;M]I%8]SXIT>(4KYY07C+&OL^*=R_-72V[;+9T30J'']- MBH4F8Z0;OL,\DF/Y^IN>,B'$QP?";^UTL__-'V:L+;_3H'[SB:Y.Q4DG)ZRB M1=(D57C,,$!\23HGSN:VPG/Q*8:29IM[0$CC;S"?$@D89A-N'C"!1'76`Z$D M\1Z:,C6Z-J(ZBY-\ZBFW&705E`<+4KA]]@-5I3SQ'I2OV25H]L M!X(T=?F8/MWAO,JMDV% M-0KVG8=A+2SM"<<]7A]QM5RF98,X;F)HCGN).7Y&9846[2N4 MC%382R>JHMM-G5=Q2/UT6OM/UE&=BQW0^FVL)SK_]H3HX>L=IJI>/:/BCM2' M_HV2PO5`":G*T8BIKNJ0NN1^VB/$,50M_C3/^NT[C(#-$]#B;%VD^4,]6?@Y MR=9([-:$L]N1;+H!"%9L#J6SN;'C)!W)6K1X<[J++0<:L$!#S>'@%F*#_;GW M,:G@@[CP=@?U!+;B3-_F?P"Z[^ MC:H;-,?KG[@(G'X<^53U\'+O[>@ZDH^ZK):;HM1/*WG3AC]'GJ7<8=N(\ MJF'"&!47LL8;YN7HACB>`DBBIA\G+_=XVU@Y8\U\0)\3)E,0^F8CSIF&OK,> MG"=%3N9%5"HFCR2?@8ZL'9.T[\DXV8@2C!P?0UM=O&4]84 M6$M)$RE`R94V"R+!P?=P.1?<6M87;74UP"[-1AB9UPSHTMP8TN_;3&R#[U'` M1*>7.3P$'.W#P()8Y^UC3,+&OAC2,DYD9&=]6MD.X?:(TRF@M$6GF,S(%ODN M-)*WOR--XATU1IIEL&7C9A(LVPERQS96@Q^O:*I9M];N\W1CZI9GK$.>:U-ND92O6<5DBENC^ M,DWNTXS!L&F5Q55^0Z%9U*_R?L%YT?[W)"G34K1W[9PO;\;Q?/W;_&2S_>=_ MIZ@@+NYQD2BKDUDAWEJ:0OY-T74`0U&%^\-697G#P,KZM\\L)X-`R9KL MG7`3$$#)ZRZB]#9ZV[4F-E&\/SX;54@';65%\>X3B-1Z#X;8>S#$WA\6Q,2* M3P"Q]SX33DT'L0]@B'T`0^S#84%,K/@$$/L0?UXKP^D1'C=]D+2!LNZ>\6%U MQKM!XW[ZCRVGP)*F&BM7KS4U\AS`W&"$N60'"9/P=KA*#.%(X30I'XEL]*_S M/];IMH9BQ$?P5# M-XRX:1T=\>'AV,@\$X-7)TN\:YK:0GJP:NG:4UDYW>%!%&J4B=&I$,-^)531 M^T6^P\*FG7]/,&/;QS3=C=CQ'I""3JL9?;MJM1S"O5@!RK# MC7J:,L'BSD)EHW%0P]@^J^=P_;GW>2O=]=U&95#?)U\_$V11IDM$6N%K>D/8MG@<)^>$%>+T5!;QU:4CS80NE^_U: M44N[XZGC'O<^/=/N%US\/LNO"SQ')0QB^A(\QE0EH@$96&T[E*G8QSMIWJIW MD>9I^8@6GS!>P&"F+\'#3%4B&IB!U;:#F8K]B*WR$-;N6QV)6C)0=3[QZ&&? MHH')4!$[/#`^+N>H/AN>[C(WV:;4OD5*R(-"0!@-1'1*V@%&P-4^B;S?77GJ M`[^F6=:NX&:$=?Z0TA6<[Z5.1[2=5/7YB7;Q8U6VP81A66]=OI7S!F?9!2YH MSC>)%004G*X]"N\:2=20R.[1':D,C*6"]YV.@`=U-KNR]@NL)Y;"][9*BLKW M^-2J5D_C7N\^&W=A--(&EQ-S,%`1APZ.$!*&D%&QM%B"176=J_&/_SZ M/EH/,1#=SD=8+%MJ'W&>BQO7@Z7,AFP,&>7$Q@15U#5SKX)XM[UV]_7I0KA" ME^DS&EA"G<(36G"0GE-?T-_U`+EH)YO/R6^X.,V24I1*TZ)D&]IO4C)$R^QD ME&:^M"RMMY"XM#IQ<7)FE5#ORS&/ M/+CFE$S'R"J\N$Q+"584%.W%%A%%C+C1JSH:/<(JXCU+J//GH.(6+RLR#T&< M&6095>%E=EE6(66B!)V%.<;#$%9IQ%>6+>9`>.SD`-PLO`@L)-NTZG@O,%M, MW-5MHYG6RA+$Z6K7-,NPUG@780HU+V5WC`V*Z&?/EP'<"%:(]P55LC1E1H7T MAN@5"M$4HD?4H>1Z]7T_BF[8G&J_I'_@'%:=QA'U'RL_+.]S/)^O5VOV4-'Q M"A=5^B>S'!Q_&@9Z1$H9'`9&8?:9`+72BJ,_%U";QVC\,!HW#@62ND`:)_#K M1MDXO8F\S_L&G7YSM>0UY(`&(VYO&&B((P*:D=ZV0--58A_.Y7NQ9C3-U_9K MR7P8;/;+;HH!:%6'.#'Z5XF6Z^PR70Z2`QL4T8XJW2('@$"I!5SCKUM1Y(\@ M.=^LD6T.3+1+JWK6B'J#GE&^]OX>+"^. M+B853-_>G=?3^\L1T)>M]Q+U':E<%#YB5$9L`UF9`.U`I1/$BL`+:"VP*Q"H M^L)P$),B(!.,"/R@7H:I]O;CA[=,,?K+K^>-9[I%Q7,Z1Z1Q631@`*HJ1TFY,SCW2DTF$MBJXF7B:G;L!I8 M-?'&TIBM8K1VUT;/@.K3&S[V>!FY=H/M+>U"0[8A!BKAS0*?\3.3999SCS[$J%V&+D3I+R"\!>[B0*Z9\EUXL4BI672^@2>3 M.(0=6:S0D6GJ!$,=YO%&V/,:MW_-\4.>_HEX%PLE%R-*0!XKLG2:.T&8H)+H M\(',ZAI;D"/'=8LEG?!W(PVF'$`$$C]90&ET>VJ`TNSC(!UA-K"_$W"!V.8&T2;5A M.8R(VG0YZ3O0IY'KFI=+^E`,C'S[:HR./(!,,3(A3S:]+\JD,18\!OECC'AX MLQM,2D%TD'E!#8A$!8,PBS`V2$X@4--]W,]96J`Y(3Y+GM/%98KN4;%*16U9= M";6XB'F\(3?CEA!XQ+1:=D7*0`Z^.73UQ[M??K(NTQR5Y?'\CW5:LI-@P1)' M0]487DH5E';TGP42WW,`TRLTYNC=37<^H?PKRK)97E;%F@7(GN++:B$<\D"T M;<)E-:TW#P)O#&RF<-]!:*MAV835[.-UT[J>C/?S"? MZVBPDU86;TR0Q`*#`Q7U+MZ`7+UW=QE`S.DE>DBR"S1X1&CP>Z-*Y_?0IN-# MZV.Y'J"Y]V7W!++#*:"+:7>H6%TMCQ^(&UP-3Y\E7QL;#+Y&T:)JG! MTU$6,<>I:76.[^!YV!8XQ:O[-&MO1Q82NJ]PL)S,*5%:S=JF[.,^)13:*U8BNB&!%(B\2!:PL MM#>'$ZR2!D8_1GK,,=4NO&Q9/.W>>Z?6>!]=`$>:83=Q6+`C*7%:,J-:8XU@ M9//S1YP1Z_8Q5H*2:2B^&.;JXC[&$`4(EOGG)#YY(*^IX((ANI. MMLOS<;+9T5PG&_K;,;V'HHY,=,1W$*TXFJ^_Q\RR)*=OGP@.\$2?VJ?,>I^\ M"R\\EQ-_Y!1P?^)&.9-?WXJ?AQ-^[,C4_>AMM)%8#FOD[P\:?2;L?3>NL+<' MWM0M]T'52?-%#.(-T-5AB MY5`BF_V/K+W;*+''V]Q12]'<]XOT.5VLDTPP6"MIVH,>,4TX>OV25H]LD4#7 M"X_ITQVNE]3"\=VRM,P6NM(.LXZNGC*\0:@\SA=7RV4Z)SY1G'%42]C.X!6$ MWAR);?M@`\7[SL.P1I9[5%%3O`[C`*XIC$"/P1T&"\2XN^#@>Z17#QEXK(?5 M6+J=.1E7\C*U0LI&VN\<2U)]O"%@M7KBG.[";^V[3OUO_C;1K-MTIT&^4.ZL M3%E%N[4V217>&J6=9K!MXZLGJHMRQB>EXR9\`CI_WFU*5&"X;3AG-X%4W8FC M0)IX!RBQ?\-[Z?']9NM)PLZ7)I$@WJ::9"ZA&M\FG$-PU<8;RW9+S,-T9B^7 M$]M0YR"81VCIMI&44CIO.G9%$R<=/_?= MFT]06![K->EW\"&O-KD^QR-B%ZKMA1B`9LXORG@RZPEX16R^*48@J&><<#12 MB!!O]*K6+C*S7$JN/KEC"%WQ`1C&9]XO:^I%&]R6Q^OJ$1>"Y-.3\1]K?#G_ M<->A<&1"5CXC+6^X6M7*#EHKF>W? M7/5;%>^QG57,^WOOH0"+!]4MQ?+:W[@,)",LFS?3W=W2Z7B% MUWG%WP@V+-6=&T)*'4K?L++29+-#B"3V5S]]+W'NZ/W]=;%AJC9C9W.OE0^\ MU5.V0;8JR@,!*=P:4P!367L#QK]&.M'IZ?9SDJU1J]HI+JO/B'0^)30U1408 ME18Y1+#"[#,Y:J5B-/#]6Z2WC*8Y'W-][#+E09H#61UGY-AC\TNN7.,I@"%J MRG[]_2OZH^N-]=K^+"?_1'?)-^3]K:&M*/('IW9)KG24NXQ6M M<.??*.30"I_WZM$DW7TZW*=@+1#,JZ.X^]33)4DK5QMW>U630E M>IH4:?<^0$7<:37+TRI-LCHKJ*KR@;,V++=UW>!R_F:T)LV&[6W!S4D!M=:I M",&UA99YXGC%_)\QV(S+M7>5X.6B`9NM+>S`9E!;Y,DR[,8D;.7DN1!DDYK9 M`@=4H\O.O_>)CR"?I>\)CT`DV8.I$%)YXM.P'DH5O'Y`5LV=_ZDSD9D5'R0< M@Q;WGB[WY8V@ES>"7MX(>GDCB._9+V\$C3Y6,!Q"1C\/!*L/\C)0A"EU+G'^ M0.9_JS-T7TFR0ZA(VF=SA"3!*"4@:2MLJFG?%8BYLXA_'==X_:VR5V-@]U#;L1VW9*SB-=Z8 MP0K@3L>/5.)*XKVH(M#\4G*#$T(J7XYT2+TK^_(D"VP"/FQ>E\^QJ"JT?HHE MPIFB@9Z7:7*?9BE](6F6S^F1+1_0YH:9.7*%S`X)RWIK389N8=7Q#CETZ-SM M7]`3$0[#HF%/;//`; MY.8%A1A2%XP,6P96&(,Y=37QICX1>.:.09HWB6CE!8/'HK45 M1H^?TFI\/-/GZ/BP/J%^1OD:?4&2L"C^:S\":O.BH]3'#QX!7O#>MB/AU M7.8E+@=Y2T3?VFW'_K?@FU^EBUGCE'CF7BW M'#(!F:"R*5I-4)EW=S4]_,6SI>F:3.Q$)]-3,DUSJE]HD;F3&95P041M>D9& MGYZA9V:][_ORX5`YIO;M>CE>',@^&SIVWV*F^A0QVI'.2JX+_(2*:D-3Y5>- M>WX2W#W8:YT3>!]%G2^>9JH&C-RK*-2,=Z_>I8%FI&WSAW1+S'SMW6.2?\)X M\37-L@F="+CN"9P)H.X7IS)U@T;N7`#J'M0AC+6A)E\@3;[R>5G2.&V:R#L^ MMPB),-?-B+/$27>B1Q]!NI;./J55*`Z\8SPR&[[`Q2J9Y4OZ%\.9^@3"K+`\ M^%19."03E:VDS=.98YWA?WN$`@7]R,SFFB7[KU5MWEEDR`L``00E#@``!#D!``#M75]SHS@2 M?[^J^PZ<7VZN:AT[DYW==6JR5\0F&>H-&WVJ M*1=GP[.W9T-E[&^VC"Q77#D?C=XI?>7M\/Q[Q5[YZ\"GBHE##L]65,?!7AB< M*:KG*9(\4!@.,'O$[EF_+Y[^'%P&S@JOD<(16V(^0VL<;)"#KWHKSC>7@\$C M"OPU=HF#O#/'7P_$DX:C"Z&1A]>8\AN?K2=X@4*/7_5^#Y%'%@2[/06:@`:7 MS\&NIJ>GI[.GBS.?+:&2X?G@U[NI)9^=T(I'U7AN1`RMR+<;O*]^@8('67E2 M(EGZP_/^Q7G"Y!'Z.2//\P/S$HDN!J+X`05X)_P!?2P_M/IH($MWI%`1*:F: MT(`CZN`TO0]<8332GOK1A>7/6$O?03(_EMP_`9R)>0,-_# M)>"(XL%&N`:-))ON'YQ4@9AS4,N!-4`E_@8S3L#Z]L8T>#6UA#,T5`M8G-`[ M::U)6Z M&N6$;W7P4;:6QM13B'O5*Z78/3MY^AZUGX\K>&$NV.H'M7J--K656L;;^EV*9#%(8*6=BLZ3L74YH8I48H&39AIS>S.'X_@M8+YI@BH MY>P&1KU4!'RDK`*9[PN0^:":6A\\3(LF,3#N23@Z-')HB$GE'#-H[K5/9?-' M2!3:IUKT93?@Z*')0Q..Z"+T,B(B9B1U,'M&#AX,9YA$F M%305X/QX"$X\R$<1EV%_`'\QM;&F?U2OIYKUG3+3[`ZH'%`Z?00-?492P.3N M50#QTR$0^NPC>(5AZEVK%[?ZK>^[3\3S$M/705VZ),+T(PC*""KP&!WB<6L8 MDU_TZ33E&#I,DV>WNG",#IW\`@->8,:P:V+P@S`>Q_,WRU$X'QZB,-%N--.$ M>92I@7O<=^-WOMU-[(ETS08QOK49@DFKDXH[CI96(%$0_9O:5&1L^G/5M#\I M$&#`I';+\"AX+`W;*-\;\^&-.)9EI_ M5[1_W^OVIPZ!@Q$:+K&-GI.Q(7VCHLT+0FU]!C&$IMCJKUW/7Y!W7J\)E\%! ME-80"0Y,]]FL,H(*+`J":Q'-Z7:4,HX3'B+YH*\F;05D!9&X""AF]O23HEO6/8SEZ<2B:MR%A,7IXS`@%`?7\MLE[RL6 M]']\O64"Y4VB1K=XUWC%P$;[D+8N<9FQU%DGJ#"-G]JN/RAO(@$[,ZA.?:=Q M/UI:!G1APKL2V;J9\P[*1BGT-)IE!&6`'DF<5T):/P??@=HN&9]&MQ9E&\N#0R+LAH5,)8,S/20=ER M0^H$OM2$]HRD&ML1*W`?-1R?ZOR)I:OLX'&>8V,%=2F_L*9C5'[S$9G M"6TM(?//),'G9J9QE/TKV,K;-K;RG9(161$R=_;3<(]NUD9*24KMX,C>W$KL M&^SS[;!MD/;,X'J\^+43GZ,&B<\.S2:9SPR@I12OG_L<-]8@9T5"\#VF'7/`6:`;(&W1=+@H[:)$$[Q.ME M03,H'RE[Q3SHJ%X>M$.OX1;N#(Q51&5X'M^Z78ELHXW@'<8-MH1GX]FCQ:6Q M;,%6\$I$:VXI[["LL[D\-S$ZN%\^*]IO*J]$K6)3>H=6F^WI&?1JT)6A6;HM MO1+>IOO<.[R;+"MF<"XI?^6%Q5']A<7_`S3?#W*'@T8WLD>(B@-$R5HD_A5Z M<'YM^EC8)4*;S*FPT=FW4]^1E67/,2UD'&"/!\F=_KZJL^?`34Y;+!6G[(C4 M4G'R/.+BQ0(4'!];1X846WS=WU?13A*9#V+;QJ*D^9(_+Q#!-^=E:-9=DQR:L7RT`1<>21RN=-A-AS19?]?07MQ`B(TUB(A$=1S:$1DR;!YC&:Z^J*=__K9__L/+Y>"-9>!MGI]M5+YAS9%( MF.35:V"1/EF[3AM(%O&OG_")EK@0+?$"*;X?,'%<;TT!)+5X+#CD3_WS83,` M#DX)K_G4A$$\^%T[38O/`:_S_#3G+&)\L0<3)+V8I0?-=]^4B'K:M-3 M'_8,\9G1(*K#^_AYXR&8M?IL>P/_Z_<6Z5JT?24E;19_%$#*&(='@?@*0A!G M$G='GXAI^&]'RJ,SMN61^I=K'WHKQ+8ZQVLQ,03APX>`$RX_C7#+_'"3D!(@ MZ2F4>)Y82;KJ<2:.E$!`S4#^J]X">?)L?TF\`?!]UY9/ M]1P&@0(OTR_@QN)0BXR*QTA.1DL7/Y0IJ3US3%WL6I@]$@>+(%<\*;C#ZP?, M4JI6$48*1Q\:N'3]-2+T%?2-_I>I>TRQ6$Z5,01!NPSB#W0JH3DU=?8V%IO8 MH3;'24Y-&9TF+4]=FX$TA"X/U"DC.C6%+.1A\/UT]*TN&98D:EQ_VNYJD:>[ M$+@'ZG]3'=6U]'\;L[6Q*-,@I6@#GK2VB3!?I\,\;J6$$^0U4K@!S^DI#',W M\"YC\_YR>TR].L2GI^!NIX]<W)S+VK(@RYG?4ZOV<9E$W/2-,.48_^9/2OB#T`W4N/Y6XSEEM+%`F("5A"@EA"=6C#)CC;;20->Q9&A=-*7-$YS:3/;(&+`?`*ZW>Y(YVLHA\PDQ MU]C(W6':\P8[7`RN'W'`C4?,[!7$))\P8C6&FE=Z3":T%=4$W[1-Y>L($*]) M282\V-6I_>3G&Z6"[FOWISN]&J;\DH[R>!=ZJEY<"(!%GN]\RE>52*4(_R10 M30@#+X+I#7HD[I1@`&6-Z`%NY62G!J+XIE3HB>8H2&'FBTY-^"BS4Y3Z.2@Y MO03/+:9/V/-T,$8F/\89C/TI=PL2(J5TIX9)>E:KPQ`-+L]UJCHPDL/$4I/? M&DUI5X\\5A(T!&'$F[K?=(0J^Q1K08*Y'OF))9B+S\6\#Z`?UT`6D#X^"W-K MXV=^[?G.YY3*K;@SELR3^]_622VRI`3"%["'(V>!%NK?C.T4%2_8AFEBQP>U M_H#1VP5"T$\\50T"#"%^[+"`\A1N$X^(SR-#&5B^.Y:[LWA$F7H!,7FQ*5.> MMJ)O)\.?9$HB_,P!%2;$"Z$7C5_/EA,MG4Y\$(/M;N3"OCW/U!+`0(>`Q0````(`&"%;45,H=6DGZ@``(_8#``1`!@```````$` M``"D@0````!V87-O+3(P,30P.3,P+GAM;%54!0`#XR5E5'5X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`&"%;468@%[NW0\``!K8```5`!@```````$```"D M@>JH``!V87-O+3(P,30P.3,P7V-A;"YX;6Q55`4``^,E951U>`L``00E#@`` M!#D!``!02P$"'@,4````"`!@A6U%9ILW+#\>``"+W`$`%0`8```````!```` MI($6N0``=F%S;RTR,#$T,#DS,%]D968N>&UL550%``/C)654=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`8(5M10.]:RL%=P``RH0&`!4`&````````0`` M`*2!I-<``'9A`Q0````(`&"%;467T-BC"#L``.+T`P`5`!@```````$` M``"D@?A.`0!V87-O+3(P,30P.3,P7W!R92YX;6Q55`4``^,E951U>`L``00E M#@``!#D!``!02P$"'@,4````"`!@A6U%J_.R_#T-``#N@0``$0`8```````! M````I(%/B@$`=F%S;RTR,#$T,#DS,"YX`L``00E#@`` ;!#D!``!02P4&``````8`!@`:`@``UY XML 19 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
SHARE-BASED COMPENSATION
 9 Months Ended
Sep. 30, 2014
SHARE-BASED COMPENSATION [Abstract]  
SHARE-BASED COMPENSATION
NOTE D – SHARE-BASED COMPENSATION

The Company complies with ASC Topic 718 “Compensation – Stock Compensation” (“ASC 718”), which requires all share-based awards to employees, including grants of employee stock options, to be recognized in the condensed consolidated financial statements based on their estimated fair values.

During the nine months ended September 30, 2014, the Company granted 450,000 restricted shares of common stock valued at $157,500 to officers and 140,000 restricted shares of common stock valued at $31,100 to employees.  Of the 450,000 shares granted to officers, 100,000 shares vested immediately and the remainder vest at various times through February 2016.  Of the 140,000 shares granted to employees, 50,000 shares vested immediately and 90,000 shares vest over a three year period.  In the first nine months of 2014, the Company also granted 500,000 restricted shares of common stock to directors.  The shares were valued at $175,000 and vested immediately.

During the nine month period ended September 30, 2013, the Company granted 400,000 restricted shares of common stock valued at $74,000.  100,000 of such shares were granted to an officer and 300,000 shares were granted to employees.  Shares valued at $3,600 and $38,000 vested over six month and two year periods, respectively, with the remainder vesting immediately.

During the nine month periods ended September 30, 2014 and 2013, the Company did not grant any stock options.

Share-based compensation expense recognized for the three and nine month periods ended September 30, 2014 was $32,000 and $189,000, respectively, and $29,000 and $300,000 for the three and nine month periods ended September 30, 2013, respectively.  These expenses are included in selling, general, and administrative expenses in the condensed consolidated statements of operations in 2014, and in cost of revenues; selling, general, and administrative expenses; and research and development expenses in the condensed consolidated statements of operations in 2013.  Expense for share-based arrangements with directors and non-employees was $43,000 and $131,000 for the three and nine months ended September 30, 2014, respectively, and $0 and $87,000 for the three and nine months ended September 30, 2013, respectively.  Unrecognized expense related to share-based compensation and arrangements is approximately $130,000 at September 30, 2014 and will be recognized through September 2017.
EXCEL 20 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\Q,S,R8S,Q85\P-V4W7S0R8C1?8C%A-%\T83%A M,&8R86%A,60B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?4U1!5$5- M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9!25)?5D%,545?345!4U5214U%3E13/"]X.DYA;64^#0H@ M("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E)%3$%4141005)465]44D%.4T%#5$E/3E,\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I7 M;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D)!4TE37T]&7U!215-%3E1!5$E/3E]!3D1?0U))5#$\ M+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%#0T]53E137T%.1%]/5$A%4E]214-%259! M0DQ%4S$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-%1TU%3E1?4D503U)424Y'7T%.1%]#3TY#14Y44C(\ M+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I7 M;W)K#I7;W)K#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I7;W)K#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0 M#I%>&-E;%=O7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO2!296=I'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)TYO/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)UEE2!&:6QE3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)U-M86QL97(@4F5P;W)T:6YG M($-O;7!A;GD\'0^)SQS<&%N/CPO'0^)U$S M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO'0^)S$P+5$\'0^)V9A;'-E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q M,S,R8S,Q85\P-V4W7S0R8C1?8C%A-%\T83%A,&8R86%A,60-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,3,S,F,S,6%?,#=E-U\T,F(T7V(Q831? M-&$Q83!F,F%A83%D+U=O'0O:'1M;#L@8VAA'!E;G-E/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XR+#,X.#QS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@ M("`\=&0@8VQA'!E;G-E"!P87EA8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.#$\ M3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPOF5D.R`Q-C4L.3@U+#,W,"!A M;F0@,38T+#3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPOF5D("AI;B!S:&%R97,I M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-3`L,#`P+#`P,#QS M<&%N/CPO2!S=&]C:RP@870@ M8V]S="`H:6X@7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M/B@Y-RD\'!E;G-E*2!B96YE9FET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M/B@R-BD\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!T'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA M6%B;&4\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO2P@97%U:7!M96YT(&%N9"!S;V9T=V%R93PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N M/CPO&5S('!A M:60\+W1D/@T*("`@("`@("`\=&0@8VQA2!A;F0@97%U:7!M96YT+"!A='1R:6)U=&%B;&4@ M=&\@;W!E7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA3H@)U1I;65S($YE=R!2;VUA;B3H@)R=4:6UE3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY687-O;65D:6-A;"P@26YC+B!W M87,@:6YC;W)P;W)A=&5D(&EN($1E;&%W87)E(&EN($IU;'D@,3DX-RX@56YL M97-S('1H92!C;VYT97AT(')E<75I2`R,#$T(&AA9"!B965N(&]P97)A=&EN9R!I;B!T=V\@ M9&ES=&EN8W0@8G5S:6YE2`R,#$P+"!T:&4@0V]M<&%N>2P@=&AR;W5G:"!I=',@=VAO;&QY+6]W M;F5D('-U8G-I9&EA2`H M3EE313H@1T4I+"!T;R!B92!'14A#)B,X,C$W.W,@97AC;'5S:79E('-A;&5S M(')E<')E2`Q+"`R,#$P('1O M(&9I=F4@>65A7-T96US+"!W:&EC:"!A2P@86YD(&-U2!I;F1I8V%T960@:6X@=&AE(%5N:71E M9"!3=&%T97,@9F]R('1H92!T2!A;F=I M;F$@86YD('5S960@9F]R(&ES8VAE;6EC(&1I2!P871I96YT(&UO;FET;W)I;F<@ M7-IF4Z(#$P<'0[)SY);B!397!T96UB97(@,C`Q M,2P@=&AE($-O;7!A;GD@86-Q=6ER960@1F%S="!'"!);G-T2P@86YD('!R;V1U8W0@<&]R M=&9O;&EO+B8C,38P.R!!;'-O(&EN(%-E<'1E;6)E2!R97-T6QE/3-$)VQI;F4M:&5I9VAT.B`Q M.R!F;VYT+7-I>F4Z('-M86QL97([('9E3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SY);B!!<')I;"`R,#$T+"!T:&4@0V]M<&%N>2!A;FYO M=6YC960@=&AA="!I="!E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@)R=4:6UE2!E;G1E2!A8W%U:7)E9"!A;&P@;V8@=&AE(&]U='-T86YD:6YG('-H87)E M&DL($-H:6YA+"!T:')O=6=H M(&ET2!7=7AI($=E;G1O;F4@26YS M=')U;65N=',@0V\N($QT9"X@*"8C.#(R,#M'96YT;VYE)B,X,C(Q.RDN)B,Q M-C`[($=E;G=E;&P@=V%S(&9O2!R:6=H=',@9F]R('1H:7,@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@3H@)R=4:6UE2P@=&AE6EN9R!C;VYD96YS M960@8V]N2!I;G1E M'!E8W1E9"!F;W(@86YY(&]T:&5R(&EN=&5R:6T@ M<&5R:6]D(&]R('1H92!F=6QL('EE87(N/"]D:78^/&1I=CX\8G(@+SX\+V1I M=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@)R=4:6UE2!E=F%L=6%T M97,@:71S(&5S=&EM871E6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T M.R!F;VYT+69A;6EL>3H@)R=4:6UE2!O9B!T:&4@3L@9F]N="US='EL93H@:71A;&EC.R!F;VYT+69A;6EL>3H@)R=4 M:6UEF4Z(#$P M<'0[)SY2979E;G5E(&%N9"!%>'!E;G-E(%)E8V]G;FET:6]N(&9O&5D(&]R(&1E M=&5R;6EN86)L92!A;F0@8V]L;&5C=&%B:6QI='D@:7,@2!A MF5D M('=H96X@=&AE(&-O6QE.B!I=&%L:6,[(&9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SY296-L87-S:69I8V%T:6]N'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD M:78@6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B2!A;F0@:7,@8W5R28C.#(Q M-SMS(')E3H@)R=4:6UEF4Z(#$P<'0[)SX@96YH86YC960@97AT97)N86P@8V]U M;G1E7-T96US(&)O=&@@9&]M97-T:6-A;&QY(&%N9"!I M;G1E28C.#(Q-SMS(&YE=R!S=6)S M:61I87)Y+"!687-O2&5A;'1H8V%R92!)5"!#;W)P+BP@9F]R;65D('1O(&-O M;F1U8W0@:71S(&AE86QT:&-AF5D(&%N9"!R96QA=&5D M(&5X<&5N6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@ M)U1I;65S($YE=R!2;VUA;B6QE/3-$)W!A M9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&-O;'-P86X],T0Q."!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/"]T6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@ M=&5X="UA;&EG;CH@8V5N=&5R.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M17%U:7!M96YT(%-E9VUE;G0\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@3H@)R=4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8V]L6QE/3-$)V)OF4Z(#$P<'0[)SY#;W)P;W)A=&4\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X] M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C M,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD M:78@3H@ M)R=4:6UE6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('9E6QE/3-$)W9E3H@)R=4:6UEF4Z M(#$P<'0[)SY2979E;G5E3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXM/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXH-#`U/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXH.#(\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXQ,RPS-#$\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4 M:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXY+#`V-SPO9&EV/CPO=&0^ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXS,BPS,3D\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4 M:6UEF4Z(#$P<'0[)SY!8V-O M=6YT3H@)R=4:6UE3H@)R=4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXW M+#$V-SPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B3H@)R=4:6UE3H@)R=4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^ M/"]T9#X\=&0@;F]W6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SX\='(^/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V)OF4Z(#$P<'0[)SY!6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S M;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=4:6UE6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S M;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)OF4Z(#$P M<'0[)SY#;W)P;W)A=&4\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=4:6UE6QE/3-$)W9E M6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`W<'@[('9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)V)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T M:#H@.2XR-24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXU+#@V M,CPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)V)A M8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXQ+#6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXM/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@)R=4:6UE M3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@)R=4:6UEF4Z(#$P<'0[)SY/<&5R871I;F<@*&QO3H@)R=4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B`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`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXT+#6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B3H@)R=4:6UE3H@)R=4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^ M/"]T9#X\=&0@;F]W6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SX\='(^/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V)OF4Z(#$P<'0[)SY!6QE/3-$)W!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/CQD:78@3H@)R=4:6UE#L@=VED=&@Z(#$R<'@[('9E#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S M;VQI9#L@=VED=&@Z(#$P.7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY%<75I<&UE;G0@4V5G;65N=#PO M9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M#L@=VED=&@Z(#AP>#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8V]L6QE/3-$)V)O MF4Z(#$P<'0[)SY)5"!396=M M96YT/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)OF4Z(#$P<'0[)SY#;VYS;VQI9&%T960\+V1I=CX\+W1D M/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W=I9'1H.B`Q,#-P>#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CPO=&0^/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`X<'@[('9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@ M)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXR,BPU.3D\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UEF4Z(#$P<'0[)SY/<&5R871I;F<@*&QO M3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH.#(\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE M3H@ M)R=4:6UE3H@)R=4:6UE M6QE/3-$)V9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\ M+W1R/CQT6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4 M:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D M:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UEF4Z(#$P M<'0[)SY$969E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^ M/"]T9#X\=&0@;F]W6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@ M3H@)R=4 M:6UE6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)OF4Z(#$P<'0[)SY386QE6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P M,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@ M3H@)R=4 M:6UE6QE/3-$)W!A9&1I;F6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('9E'1E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXT+#4S,SPO9&EV M/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D M:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@.24[('9E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXH,2PW,#0\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXX+#,Y.#PO9&EV M/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXX+#,Y M.#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)V)A M8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXM/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SXS+#4Q,#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXQ+#(R.3PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4 M:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UEF4Z(#$P<'0[)SY$969E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@)R=4 M:6UE3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY&;W(@=&AE('1H2X\+V1I=CX\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!F M;VYT+69A;6EL>3H@)R=4:6UE2!A;F0@.3`L,#`P M('-H87)E2X\ M+V1I=CX\9&EV/CQB3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY$=7)I;F<@=&AE(&YI;F4@;6]N=&@@ M<&5R:6]D(&5N9&5D(%-E<'1E;6)E65E65A3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SY3:&%R92UB87-E9"!C;VUP96YS871I;VX@97AP M96YS92!R96-O9VYI>F5D(&9O65E2XF(S$V,#L@56YR M96-O9VYI>F5D(&5X<&5NF5D('1H3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,S,R8S,Q M85\P-V4W7S0R8C1?8C%A-%\T83%A,&8R86%A,60-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO,3,S,F,S,6%?,#=E-U\T,F(T7V(Q831?-&$Q83!F M,F%A83%D+U=O'0O:'1M;#L@8VAA6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SY.3U1%($4@)B,X,C$Q.R!,3U-3(%!%4B!#3TU-3TX@4TA!4D4\ M+V1I=CX\9&EV/CQB3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXF(S$V,#M"87-I8R!L;W-S('!E6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@)R=4:6UE6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@)U1I M;65S($YE=R!2;VUA;B6QE/3-$)W9EF4Z M(#$P<'0[)SY&;W(@=&AE('1H6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)OF4Z(#$P<'0[)SY397!T96UB97(@,S`L(#(P,30\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X] M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C M,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD M:78@3H@ M)R=4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)OF4Z(#$P<'0[)SY397!T96UB97(@,S`L(#(P,3,\ M+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXQ+#0P,CPO9&EV/CPO M=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXQ+#6QE/3-$)W!A9&1I M;F6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXT.3`\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA M;&EG;CH@#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG M;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXU.#4\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$ M)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG"!D;W5B;&4[ M('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXQ M+#@Y,CPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[ M('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXR+#,V-3PO9&EV/CPO=&0^/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W!A M9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M"!D;W5B;&4[('1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXQ+#@Y M,CPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXR+#,V-3PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,S,R8S,Q85\P-V4W7S0R8C1? M8C%A-%\T83%A,&8R86%A,60-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO,3,S,F,S,6%?,#=E-U\T,F(T7V(Q831?-&$Q83!F,F%A83%D+U=O'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO6QE M/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E MF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SY.3U1%($8@)B,X,C$Q.R!&04E2(%9!3%5%($U%05-54D5-14Y44SPO9&EV M/CQD:78^/&)R("\^/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J M=7-T:69Y.R!T97AT+6EN9&5N=#H@,S9P=#L@9F]N="UF86UI;'DZ("2`H:2YE+BP@=&AE("8C.#(R,#ME>&ET('!R:6-E)B,X,C(Q.RD@ M:6X@86X@;W)D97)L>2!T6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@)R=4:6UE28C.#(Q-SMS(&%S3H@)R=4:6UEF4Z(#$P<'0[)SXS,"P@,C`Q-"!A;F0@1&5C96UB M97(@,S$L(#(P,3,Z/"]F;VYT/CPO9&EV/CQD:78^/&)R("\^/"]D:78^/'1A M8FQE(&-E;&QP861D:6YG/3-$,"!C96QLF4Z(#$P<'0[)SX\='(^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('9E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9EF4Z(#$P<'0[ M)SY3:6=N:69I8V%N=#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@6QE M/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('9E6QE/3-$ M)W9EF4Z(#$P<'0[)SYI;B!!8W1I=F4\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`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`[/"]T9#X\=&0@ M8V]L6QE/3-$)V)OF4Z(#$P<'0[)SXH3&5V96P@,2D\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X] M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C M,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD M:78@3H@ M)R=4:6UE6QE/3-$)W!A9&1I;F6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)OF4Z M(#$P<'0[)SXR,#$T/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$ M)W9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9EF4Z(#$P<'0[)SXH M=6YA=61I=&5D*3PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@2!M87)K970@9G5N9',@*&EN8VQU9&5D(&EN(&-A6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXX+#,X-#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4 M:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@ M)R=4:6UE#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXQ,3$\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA M;&EG;CH@6QE M/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXQ,3$\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F6QE/3-$)W!A9&1I;F"!D M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$ M)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9EF4Z(#$P<'0[)SY3 M:6=N:69I8V%N=#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@6QE/3-$ M)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('9E6QE/3-$)W9E MF4Z(#$P<'0[)SYI;B!!8W1I=F4\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`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`[/"]T9#X\=&0@8V]L6QE/3-$)V)O6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S M;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=4:6UE6QE/3-$ M)W!A9&1I;F6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE M/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@)R=4 M:6UE3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M.24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A M8VMG"!S;VQI9#L@ M=&5X="UA;&EG;CH@#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O M#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)V)O M3H@)R=4:6UE"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^/"]T9#X\=&0@;F]W#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE"!D;W5B;&4[('1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^ M/"]T9#X\=&0@;F]W#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)V)O3H@)R=4:6UE"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXV+#DY-#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S M-G!T.R!F;VYT+69A;6EL>3H@)R=4:6UE2!M87)K970@9G5N9',@87)E(&1E M=&5R;6EN960@=&AR;W5G:"!M87)K970L(&]B7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA3H@)U1I;65S($YE=R!2;VUA;B3H@)R=4:6UEF4Z(#$P<'0[)SY4:&4@9F]L;&]W:6YG('1A8FQE('!R97-E;G1S M(&EN9F]R;6%T:6]N(')E9V%R9&EN9R!T:&4@0V]M<&%N>28C.#(Q-SMS(&%C M8V]U;G1S(&%N9"!O=&AEF4Z(#$P<'0[)SXF(S$V,#L\+V1I M=CX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL M93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ("=4:6UE6QE/3-$)W9E6QE/3-$)W!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&UI M9&1L93LG/CQD:78@3H@)R=4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9EF4Z M(#$P<'0[)SXH=6YA=61I=&5D*3PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXQ-RPQ-S,\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`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`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)V)O#L@8F%C:V=R;W5N M9"UC;VQO6QE M/3-$)V)O3H@)R=4:6UE"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXQ,RPU-S`\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F2!D=64@=6YD97(@=&AE($=%2$,@06=R965M96YT M(&%R92!S=6)J96-T('1O(&%D:G5S=&UE;G0@:6X@6EN9R!S86QE3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY!;&QO=V%N8V4@9F]R(&1O=6)T9G5L M(&%C8V]U;G1S(&%N9"!C;VUM:7-S:6]N(&%D:G5S=&UE;G1S(&EN8VQU9&4@ M97-T:6UA=&5D(&QO2!R961U8V4@=&AE M(&%M;W5N="!T:&4@0V]M<&%N>2!W:6QL('5L=&EM871E;'D@65E'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO'0^)SQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY);G9E;G1O6QE/3-$ M)W9E6QE M/3-$)W!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R M=&EC86PM86QI9VXZ(&UI9&1L93LG/CQD:78@3H@)R=4:6UE6QE/3-$ M)W!A9&1I;F6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W9E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E3H@)R=4:6UE M3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M M-RXR<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXV-S@\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXR.3$\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UEF4Z(#$P<'0[ M)SY&:6YI'0M86QI9VXZ M(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S M;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@ M)R=4:6UE#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)V)O#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE"!D;W5B;&4[('1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXQ+#8Q.#PO9&EV/CPO M=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@)R=4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,S,R8S,Q85\P M-V4W7S0R8C1?8C%A-%\T83%A,&8R86%A,60-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,3,S,F,S,6%?,#=E-U\T,F(T7V(Q831?-&$Q83!F,F%A M83%D+U=O'0O:'1M;#L@8VAA6QE/3-$)V9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z M(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY.3U1%($D@)B,X,C$Q M.R!'3T]$5TE,3"!!3D0@3U1(15(@24Y404Y'24),15,\+V1I=CX\9&EV/CQB M3L@ M=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SY';V]D=VEL;"!A9V=R96=A=&EN9R`D,RPR.#`L,#`P(&%N M9"`D,RPS,#,L,#`P('=A28C.#(Q M-SMS(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@8F%L86YC92!S:&5E=',@870@ M4V5P=&5M8F5R(#,P+"`R,#$T(&%N9"!$96-E;6)E6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@)U1I;65S($YE M=R!2;VUA;B6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('9E#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@ M8V]L6QE/3-$)V)OF4Z(#$P<'0[)SY#87)R>6EN9R!!;6]U M;G0\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W9E M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('9E3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@)R=4:6UE2!T'0M86QI9VXZ M(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@#L@8F%C:V=R;W5N9"UC;VQO3H@)R=4:6UEF4Z(#$P<'0[)SY"86QA;F-E(&%T(%-E<'1E;6)E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)OF4Z(#$P<'0[)SY4:&4@0V]M<&%N>28C M.#(Q-SMS(&]T:&5R(&EN=&%N9VEB;&4@87-S971S(&-O;G-I6QE/3-$)W!A9&1I M;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CPO=&0^/'1D M(&-O;'-P86X],T0V('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&UI M9&1L93LG/CQD:78@6QE.B!I=&%L:6,[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXH:6X@=&AO=7-A;F1S*3PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/CPO=&0^/"]T6QE/3-$ M)W!A9&1I;F6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)OF4Z(#$P M<'0[)SY$96-E;6)E#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/"]T6QE/3-$)W9E3H@ M)R=4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY! M8V-U;75L871E9"!A;6]R=&EZ871I;VX\+V1I=CX\+W1D/CQT9"!V86QI9VX] M,T1B;W1T;VT@#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXH-#8R/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXI/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A M9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE#L@8F%C:V=R;W5N9"UC;VQO3H@)R=4:6UE6QE/3-$)W!A9&1I;F"!S;VQI9#L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA M;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[ M('9E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMGF4Z(#$P<'0[)SY#=7-T;VUE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA M;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXH,C8W/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SXI/"]D:78^/"]T9#X\+W1R/CQT6QE/3-$)W!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXT-#@\ M+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SY!8V-U;75L M871E9"!A;6]R=&EZ871I;VX\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T M;VT@#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXH-#6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)V)O3H@)R=4:6UE#L@8F%C M:V=R;W5N9"UC;VQO3H@)R=4 M:6UE6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXR-S(\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@ M)R=4:6UE"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXR+#@X,3PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SY0871E;G1S(&%N9"!T96-H;F]L;V=Y+"!C=7-T;VUE M65A2XF(S$V,#L@06UOF%T:6]N(&5X<&5N2X\+V1I=CX\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO'0^ M)SQD:78@F4Z(#$P<'0[)SY4:&4@8VAA;F=E28C.#(Q M-SMS(&1E9F5RF4Z(#$P<'0[)SXF(S$V M,#L\+V1I=CX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$ M,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ("=4:6UE6QE/3-$)W9E6QE/3-$)W9E3H@)R=4:6UE6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)W!A M9&1I;F6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ('1O M<#LG/CQD:78@3H@)R=4:6UE#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)OF4Z(#$P<'0[)SXR,#$T/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$ M)W!A9&1I;F6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE M/3-$)W9E6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E3H@)R=4:6UE M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('9EF4Z(#$P<'0[)SXH=6YA=61I=&5D*3PO9&EV/CPO M=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXQ-RPW,3(\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@)R=4 M:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXQ-2PV,#(\+V1I=CX\+W1D M/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UEF4Z(#$P<'0[)SY!9&1I=&EO;G,Z M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG M6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE M/3-$)V)A8VMG6QE/3-$ M)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY$969E M'1E;F1E9"!S97)V:6-E(&-O;G1R86-T6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXR-#0\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXT,3`\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXW.3$\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXX-#@\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXX/"]D:78^ M/"]T9#X\=&0@;F]W6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXR,SPO9&EV/CPO=&0^/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SY$969E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXR.#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXV,#PO M9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M6QE M/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY$ M969E6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@)R=4:6UE M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXX+#@T,#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@ M.24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R!W:61T:#H@.24[('9E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@)R=4 M:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH,C0U/"]D:78^/"]T9#X\=&0@ M;F]W6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D:78^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D:78^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG3H@)R=4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH,C4\+V1I=CX\ M+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SXI/"]D:78^/"]T9#X\+W1R/CQT6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SY$969E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH,C8\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH-30\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@8F%C:V=R;W5N9"UC;VQO M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH M,BPY-S4\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH,BPW.38\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXH."PW-#D\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH."PS,S(\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SY,97-S.B!C=7)R96YT M('!O#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXY M+#$U.#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA M;&EG;CH@#L@8F%C:V=R;W5N M9"UC;VQO6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXW+#8X-#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A M9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXY+#`W.#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4 M:6UE"!D M;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SXU+#`T,SPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\Q,S,R8S,Q85\P-V4W7S0R8C1?8C%A-%\T83%A,&8R M86%A,60-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,3,S,F,S,6%? M,#=E-U\T,F(T7V(Q831?-&$Q83!F,F%A83%D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)SQS<&%N/CPO6QE/3-$ M)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&IUF4Z(#$P<'0[ M(&UA3L@=&5X="UI;F1E;G0Z M(#,V<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B2!A('-E;FEO&EM871E;'D@)#8P+#`P,"!A;F0@)#$X,"PP,#`@=V5R M92!B:6QL960@8GD@=&AE(&9I2P@870@=VAI8V@@9&%T97,@;F\@86UO=6YT3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B2!I28C.#(Q-SMS(&-O;G-U;'1I;F<@86=R965M96YT('=I=&@@161G87)Y($-O M;G-U;'1A;G1S+"!,3$,N)B,Q-C`[(%1H92!C;VYS=6QT:6YG(&%G6QE/3-$)VQI;F4M:&5I9VAT.B`Q.R!F M;VYT+7-I>F4Z('-M86QL97([('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B'!E8W1E9"!T;R!B92!P86ED(&EN(&-O;FIU;F-T:6]N('=I=&@@=&AE M(&%G3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY296-E:79A8FQE M2X\+V1I=CX\9&EV/CQB3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXF(S$V,#M/;B!!=6=U M2!A8W%U:7)E9"!A;&P@;V8@=&AE(&]U M='-T86YD:6YG('-H87)E&DL M($-H:6YA+"!T:')O=6=H(&ET2!7 M=7AI($=E;G1O;F4@26YS=')U;65N=',@0V\N($QT9"X@*"8C.#(R,#M'96YT M;VYE)B,X,C(Q.RD@9F]R(&-A6QE/3-$)VQI;F4M:&5I9VAT.B`Q.R!F M;VYT+7-I>F4Z('-M86QL97([('9E7-T M96TN)B,Q-C`[(%1H92!P"!);G-T'1087)T7S$S,S)C,S%A7S`W93=?-#)B-%]B,6$T M7S1A,6$P9C)A86$Q9`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Q M,S,R8S,Q85\P-V4W7S0R8C1?8C%A-%\T83%A,&8R86%A,60O5V]R:W-H965T M'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQD:78@3L@ M9F]N="UF86UI;'DZ("6QE/3-$)W1E>'0M86QI9VXZ(&IUF5D(&)U="!U M;FES&EM=6T@;G5M8F5R(&]F('-H87)E6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!F M;VYT+69A;6EL>3H@)R=4:6UE2XF(S$V,#L@5&AE(#(P,3`@4&QA;B!P M6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SX@,S`L(#(P,30@=&AE($-O;7!A;GD@:7-S M=65D+"!U;F1E3H@)R=4:6UEF5D(&)U="!U;FES M&EM=6T@;G5M8F5R(&]F('-H87)E6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!F;VYT M+69A;6EL>3H@)R=4:6UE2XF(S$V,#L@5&AE(#(P,3,@4&QA;B!P6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SX@,S`L(#(P,30@=&AE($-O;7!A;GD@ M:7-S=65D+"!U;F1E3H@)R=4:6UE M3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY.;R!O<'1I;VYS('=E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SX@,S`L(#(P,30N/"]F;VYT/CPO9&EV/CQD:78^/&)R("\^/"]D:78^/&1I M=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@ M,S9P=#L@9F]N="UF86UI;'DZ("28C.#(Q-SMS(&-O;6UO;B!S=&]C:RXF(S$V,#L@07,@;V8@/"]F;VYT/E-E M<'1E;6)E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SX@,S`L(#(P,30L(#$P+#,P."PP.#<@3H@)R=4:6UE'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQD M:78@6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`Q.'!T.R!F;VYT+69A;6EL>3H@)R=4:6UEF4Z(#$P<'0[)SY4:&4@0V]M<&%N>28C.#(Q M-SMS('!R;W9I&5S(&-O;G-I65A"!P'!E8W1S('1O(&%C:&EE=F4@9F]R M('1H92!F=6QL('EE87(N)B,Q-C`[($9O"!P2!O9B!S=&%T92!A;F0@;&]C86P@;6EN:6UU;2!T87AE"!A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,S,R M8S,Q85\P-V4W7S0R8C1?8C%A-%\T83%A,&8R86%A,60-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO,3,S,F,S,6%?,#=E-U\T,F(T7V(Q831?-&$Q M83!F,F%A83%D+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO6QE/3-$)V9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IUF4Z(#$P<'0[)SY.3U1%($X@ M)B,X,C$Q.R!#3TU-251-14Y44R!!3D0@0T].5$E.1T5.0TE%4SPO9&EV/CQD M:78^/&)R("\^/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T M:69Y.R!F;VYT+7-T>6QE.B!I=&%L:6,[(&9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SY386QE3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY);B!*=6YE(#(P,3(L('1H92!# M;VUP86YY(&-O;F-L=61E9"!A;B!A;65N9&UE;G0@;V8@=&AE($=%2$,@06=R M965M96YT('=I=&@@1T4@2&5A;'1H8V%R92P@;W)I9VEN86QL>2!S:6=N960@ M;VX@36%Y(#$Y+"`R,#$P+B8C,38P.R!4:&4@86UE;F1M96YT+"!E9F9E8W1I M=F4@2G5L>2`Q+"`R,#$R+"!E>'1E;F1E9"!T:&4@:6YI=&EA;"!T97)M(&]F M('1H2`Q+"`R,#$P('1O(&9I=F4@ M>65A3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT M.B`S-G!T.R!F;VYT+69A;6EL>3H@)R=4:6UE2!E;G1E'1087)T7S$S M,S)C,S%A7S`W93=?-#)B-%]B,6$T7S1A,6$P9C)A86$Q9`T*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\Q,S,R8S,Q85\P-V4W7S0R8C1?8C%A-%\T M83%A,&8R86%A,60O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^4W1A;F1A3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY);B!-87D@,C`Q-"P@=&AE($9! M4T(@:7-S=65D(&$@8V]M<')E:&5N&ES=&EN9R!R979E;G5E(')E8V]G;FET:6]N(&=U:61A;F-E+B!4:&4@&5R8VES M92!J=61G;65N="!W:&5N(&-O;G-I9&5R:6YG(&-O;G1R86-T('1E2!I7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA3H@)U1I;65S($YE=R!2;VUA;B3H@)R=4:6UE3L@=&5X="UI M;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SY/;B!!=6=U2!A8W%U:7)E9"!A M;&P@;V8@=&AE(&]U='-T86YD:6YG('-H87)E&DL($-H:6YA+"!T:')O=6=H(&ET2!7=7AI($=E;G1O;F4@26YS=')U;65N=',@0V\N($QT9"X@ M*"8C.#(R,#M'96YT;VYE)B,X,C(Q.RD@9F]R(&-A6QE/3-$)VQI;F4M:&5I M9VAT.B`Q.R!F;VYT+7-I>F4Z('-M86QL97([('9E7-T96TN)B,Q-C`[(%1H92!P6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@)R=4:6UE2!A=F%I;&%B;&4L(&%N9"!M87D@8F4@861J=7-T960@ M869T97(@;V)T86EN:6YG(&UOF4Z(#$P<'0[)SX\='(^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@.#@E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R!W:61T:#H@,24[('9E6QE.B!I=&%L:6,[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXH:6X@=&AO=7-A;F1S*3PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H M.B`X."4[('9E6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UEF4Z M(#$P<'0[)SY02!A;F0@97%U:7!M96YT/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@ M)R=4:6UEF4Z(#$P<'0[)SY) M;G1A;F=I8FQE(&%S'0M86QI9VXZ M(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)V)O3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY$=7)I;F<@=&AE('1H2!E>'!E;G-E9"`D."PP,#`@;V8@86-Q=6ES:71I;VXM M6EN9R!C;VYD M96YS960@8V]N"!S=6)S:61I87)Y+B8C,38P M.R!4:&4@9F]L;&]W:6YG('5N875D:71E9"!S=7!P;&5M96YT86P@<')O(&9O M2`Q+"`R,#$S.CPO9&EV/CQD:78^/&)R("\^/"]D:78^/'1A M8FQE(&-E;&QP861D:6YG/3-$,"!C96QLF4Z(#$P<'0[)SX\='(^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M)B,Q-C`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`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CQD:78@3H@)R=4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`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`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXH-34Q/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH,2PY,S`\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@.24[('9E6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@)R=4:6UEF4Z(#$P<'0[)SY"87-I8R!A;F0@9&EL=71E9"!L;W-S('!E3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D:78^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD)B,Q M-C`[/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH,"XP M,3PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@3H@)R=4:6UE3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY4:&4@86-C M;VUP86YY:6YG(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T M871E;65N=',@:&%V92!B965N('!R97!A&-H86YG92!#;VUM:7-S:6]N("AT:&4@(E-%0R(I+B!#97)T86EN(&EN9F]R M;6%T:6]N(&%N9"!D:7-C;&]S=7)E2!I;F-L=61E9"!I;B!T M:&4@8V]N9&5N2!F;W(@82!F86ER('!R97-E;G1A=&EO;B!O M9B!I;G1E6EN9R!N M;W1E'!E;G-E3H@)U1I;65S($YE=R!2;VUA;B3H@)R=4:6UE3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY.;W1E($(@;V8@=&AE($YO=&5S('1O($-O M;G-O;&ED871E9"!&:6YA;F-I86P@4W1A=&5M96YT65A6QE/3-$)V9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU M3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B"!R M96EM8G5R&ES=',L('-EF5D+CPO9&EV/CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;B6QE/3-$)V9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@)R=4:6UE7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO2!&:6YA;F-I86P@ M26YF;W)M871I;VX@9F]R(%-E9VUE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S M($YE=R!2;VUA;B6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)W!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0Q."!V86QI9VX],T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@ M8V5N=&5R.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^17%U:7!M96YT(%-E M9VUE;G0\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/CQD:78@3H@)R=4:6UE#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S M;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=4:6UE6QE/3-$)W9E6QE/3-$)W9E M6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E M6QE/3-$)W9E3H@)R=4 M:6UEF4Z(#$P<'0[)SY2979E M;G5E3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D M:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH-#`U M/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V)A M8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXH.#(\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A M8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXQ,RPS-#$\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@)R=4 M:6UE3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXY+#`V-SPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXS,BPS,3D\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UEF4Z(#$P<'0[)SY!8V-O=6YT3H@ M)R=4:6UE3H@)R=4:6UE M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@ M)R=4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[ M('9E6QE/3-$)V9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXW+#$V-SPO9&EV/CPO M=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;B3H@ M)R=4:6UE3H@)R=4:6UE M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@ M)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^/"]T9#X\=&0@;F]W M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SX\='(^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W!A9&1I;F6QE/3-$)V)OF4Z(#$P<'0[)SY!6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@8V]L6QE/3-$)V)O MF4Z(#$P<'0[)SY#;W)P;W)A M=&4\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CQD:78@3H@)R=4:6UE6QE/3-$)W9E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`W<'@[('9E6QE/3-$)W9E6QE M/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('9E6QE/3-$ M)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.2XR-24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXU+#@V,CPO9&EV/CPO=&0^ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXQ+#6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D M:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UEF4Z(#$P M<'0[)SY/<&5R871I;F<@*&QO3H@)R=4:6UE3H@)R=4:6UE6QE M/3-$)V9O;G0M9F%M:6QY.B`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`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXT+#6QE/3-$)V)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B3H@)R=4 M:6UE3H@)R=4:6UE M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@ M)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^/"]T9#X\=&0@;F]W M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[)SX\='(^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W!A9&1I;F6QE/3-$)V)OF4Z(#$P<'0[)SY!#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/"]T6QE M/3-$)W!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@ M3H@)R=4 M:6UE#L@=VED=&@Z(#$R<'@[('9E#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=VED=&@Z M(#$P.7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/&1I=B!S='EL93TS M1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SY%<75I<&UE;G0@4V5G;65N=#PO9&EV/CPO=&0^/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)OF4Z(#$P<'0[)SY)5"!396=M96YT/"]D:78^/"]T M9#X\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)OF4Z(#$P<'0[)SY#;VYS;VQI9&%T960\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F6QE/3-$)W=I9'1H.B`Q,#-P>#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`X<'@[('9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E'1E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@)R=4:6UE M3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXR,BPU.3D\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@)R=4:6UEF4Z(#$P<'0[)SY/<&5R871I;F<@*&QO3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@ M)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH.#(\+V1I=CX\+W1D/CQT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\+W1R/CQT6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M M-RXR<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@)R=4 M:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^/"]T9#X\=&0@ M;F]W6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE MF4Z(#$P<'0[)SY$969E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@ M)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^/"]T9#X\=&0@;F]W M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q,#`E M.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B#L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L"!S;VQI M9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V)OF4Z(#$P M<'0[)SY386QE6QE/3-$)W!A9&1I;F6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI M9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@6QE/3-$)W!A M9&1I;F6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/"]T6QE/3-$)W9E6QE/3-$)W9E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)W9E6QE M/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('9E'1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXT+#4S,SPO9&EV/CPO=&0^/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^/"]T9#X\=&0@ M;F]W6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[ M('9E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH M,2PW,#0\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXX+#,Y.#PO9&EV/CPO=&0^/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXX+#,Y.#PO9&EV/CPO=&0^ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^/"]T M9#X\=&0@;F]W6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD M/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXS+#4Q,#PO M9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXQ M+#(R.3PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@6QE/3-$ M)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SXM/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMGF4Z(#$P<'0[)SY$969E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$ M)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SXM/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY4:&4@9F]L;&]W:6YG('1A8FQE(')E M<')E&-L=61E9"!FF4Z(#$P<'0[)SX\='(^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E3H@)R=4:6UE6QE/3-$)W!A9&1I M;F6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D M:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@8V]L6QE M/3-$)V)OF4Z(#$P<'0[)SY3 M97!T96UB97(@,S`L(#(P,3,\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=4:6UE6QE/3-$)W!A M9&1I;F6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/"]T3H@)R=4:6UEF4Z(#$P<'0[ M)SY3=&]C:R!O<'1I;VYS/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SXQ+#0P,CPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG#L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG M"!S;VQI9#L@=&5X M="UA;&EG;CH@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E M6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXT.3`\+V1I=CX\+W1D/CQT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[ M(&)A8VMG"!S;VQI M9#L@=&5X="UA;&EG;CH@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)V)O#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)V)O#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)V)O#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE M/3-$)V)O'1087)T M7S$S,S)C,S%A7S`W93=?-#)B-%]B,6$T7S1A,6$P9C)A86$Q9`T*0V]N=&5N M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\Q,S,R8S,Q85\P-V4W7S0R8C1?8C%A M-%\T83%A,&8R86%A,60O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@F4Z(#$P<'0[)SY4:&4@9F]L;&]W:6YG('1A8FQE6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE.B!I=&%L:6,[(&9O;G0M9F%M:6QY.B`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`[/"]T9#X\=&0@8V]L6QE/3-$)V)OF4Z(#$P<'0[)SXH3&5V96P@,BD\+V1I=CX\+W1D M/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P M(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=4:6UE M6QE/3-$)W!A9&1I;F6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F6QE/3-$)W9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('9E6QE/3-$)W9E M6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY#87-H(&5Q=6EV86QE;G1S(&EN=F5S=&5D(&EN M(&UO;F5Y(&UA6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4 M:6UE6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXX+#,X-#PO9&EV/CPO=&0^/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SY);G9E'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W!A M9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)O#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI M9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I M;F#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE"!D;W5B;&4[('1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXX+#0Y-3PO9&EV M/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4 M:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;FF4Z(#$P<'0[)SX\='(^/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R<^)B,Q-C`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`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CQD:78@3H@)R=4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V)OF4Z(#$P<'0[)SXH3&5V96P@,RD\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/"]T3H@ M)R=4:6UEF4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^07-S971S/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W9E6QE/3-$)W9E6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE M/3-$)W9E2!M87)K970@9G5N9',@*&EN8VQU9&5D(&EN(&-A6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXV+#@X,SPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXM/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4 M:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@ M)R=4:6UE#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXQ,3$\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA M;&EG;CH@6QE M/3-$)W!A9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXQ,3$\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I M;F6QE/3-$)W!A9&1I;F"!D M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O'1087)T7S$S,S)C,S%A7S`W93=?-#)B M-%]B,6$T7S1A,6$P9C)A86$Q9`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO M+R]#.B\Q,S,R8S,Q85\P-V4W7S0R8C1?8C%A-%\T83%A,&8R86%A,60O5V]R M:W-H965T'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA6QE/3-$ M)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F;VYT+69A;6EL>3H@)R=4:6UE M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!F M;VYT+69A;6EL>3H@)R=4:6UEF4Z(#$P<'0[)SX\='(^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W9E6QE.B!I=&%L:6,[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXF(S$V,#LH:6X@=&AO=7-A;F1S*3PO9&EV/CPO=&0^/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O M;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\ M=&0@8V]L6QE/3-$)V)OF4Z(#$P<'0[)SY$96-E;6)E#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO M=&0^/"]T6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('9E6QE/3-$)V)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;B6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXQ,"PW,38\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG3H@)R=4 M:6UE3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W!A9&1I;F6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@8F%C:V=R;W5N M9"UC;VQO6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXH,RPV.#D\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH,RPW-C0\ M+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE"!D;W5B;&4[('1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXW+#$V-SPO M9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4 M:6UE'1087)T7S$S,S)C,S%A7S`W93=? M-#)B-%]B,6$T7S1A,6$P9C)A86$Q9`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL M93HO+R]#.B\Q,S,R8S,Q85\P-V4W7S0R8C1?8C%A-%\T83%A,&8R86%A,60O M5V]R:W-H965T'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQD:78@ MF4Z(#$P<'0[)SY);G9E;G1O6QE/3-$)W9E6QE/3-$)W!A M9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P M.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM M86QI9VXZ(&UI9&1L93LG/CQD:78@3H@)R=4:6UE6QE/3-$)W!A9&1I M;F6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE M/3-$)W9EF4Z(#$P<'0[)SXH=6YA=61I=&5D*3PO9&EV/CPO=&0^/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W9E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('9E3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXV-S@\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXR.3$\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@)R=4 M:6UEF4Z(#$P<'0[)SY&:6YI M'0M86QI9VXZ(&QE9G0[ M(&)A8VMG"!S;VQI M9#L@=&5X="UA;&EG;CH@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)V)O#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXQ+#8Q.#PO9&EV/CPO=&0^/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,S,R8S,Q85\P M-V4W7S0R8C1?8C%A-%\T83%A,&8R86%A,60-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,3,S,F,S,6%?,#=E-U\T,F(T7V(Q831?-&$Q83!F,F%A M83%D+U=O'0O:'1M;#L@8VAA'0^)SQD:78@6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL M>3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E M6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E3H@ M)R=4:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D M:6YG+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q M-C`[/"]T9#X\=&0@8V]L6QE M/3-$)V)OF4Z(#$P<'0[)SY# M87)R>6EN9R!!;6]U;G0\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F6QE/3-$)W9E6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('9E3H@ M)R=4:6UE3H@)R=4:6UE M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@ M)R=4:6UE2!T'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@#L@8F%C:V=R;W5N9"UC;VQO3H@)R=4:6UE3H@)R=4:6UEF4Z(#$P<'0[)SY"86QA;F-E(&%T(%-E<'1E;6)E M6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O3H@)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL M>3H@)U1I;65S($YE=R!2;VUA;B#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG M+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^/"]T9#X\ M=&0@8V]L6QE/3-$)V)O6QE/3-$)W!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@ M=F5R=&EC86PM86QI9VXZ(&UI9&1L93LG/CQD:78@3H@)R=4:6UE6QE M/3-$)W!A9&1I;F6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)W9EF4Z(#$P<'0[)SXH=6YA=61I=&5D*3PO9&EV/CPO M=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)W9E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)V)A8VMG6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY#;W-T3H@)R=4 M:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4 M:6UE#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[('!A9&1I;F#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH-#4T M/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\+W1R M/CQT6QE/3-$)W!A9&1I;F#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXR+#`S.#PO9&EV/CPO=&0^/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W!A M9&1I;F"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SY#;W-T6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXX,#`\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXX M,#`\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`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`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R!W:61T:#H@.24[('9E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE MF4Z(#$P<'0[)SY3;V9T=V%R M93PO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,24[('9E6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@.24[('9E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@)R=4:6UE M6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@)R=4:6UE#L@ M8F%C:V=R;W5N9"UC;VQO'0M86QI M9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@ M.24[('9E6QE/3-$)V9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH-#(T/"]D:78^ M/"]T9#X\=&0@;F]W6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\+W1R/CQT6QE/3-$)W!A9&1I;F#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)O'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXS.34\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@ M#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE"!D;W5B;&4[('1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T M:#H@.24[('9E6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXX,C`\+V1I M=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3H@)U1I;65S($YE M=R!2;VUA;B6QE/3-$)W=I9'1H.B`Q M,#`E.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9EF4Z(#$P<'0[)SY&;W(@=&AE('1H6QE/3-$)W9E3H@)R=4 M:6UE6QE/3-$)W!A9&1I;F#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M/CQD:78@3H@)R=4:6UE6QE/3-$)V)OF4Z(#$P<'0[)SXR,#$S/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W!A9&1I M;F6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CQD:78@3H@)R=4:6UE#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/"]T6QE/3-$)W9E M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9EF4Z(#$P<'0[)SXH M=6YA=61I=&5D*3PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@6QE/3-$ M)W9E6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)W9E3H@)R=4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('9E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W M:61T:#H@.24[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXQ,RPR M-S`\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE M/3-$)V)A8VMG6QE/3-$ M)V)A8VMG6QE/3-$)V)A M8VMG6QE M/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY$ M969E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXQ,SPO9&EV/CPO=&0^/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXR.#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXU.#PO9&EV/CPO=&0^/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXR M+#`W-CPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@6QE/3-$ M)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UEF4Z(#$P<'0[ M)SY296-O9VYI>F5D(&%S(')E=F5N=64Z/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG M6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M M-RXR<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SY$969E'1E;F1E9"!S97)V:6-E M(&-O;G1R86-T6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXH,C`W/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@)R=4:6UE3H@ M)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXH-S4U/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\+W1R M/CQT6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`M-RXR<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z(#$P<'0[)SY$969E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXH,3`\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@)R=4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXH,C`\+V1I=CX\+W1D/CQT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)V)A8VMG3H@)R=4:6UE M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXH,38\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)V9O;G0M9F%M:6QY M.B`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`C8V-E969F M.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXW M+#8X-#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9&1I;F"!S;VQI9#L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE M6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA M;&EG;CH@#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)V)O#L@8F%C:V=R;W5N M9"UC;VQO6QE M/3-$)V)O3H@)R=4:6UE"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXU+#`T,SPO9&EV/CPO=&0^/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W!A M9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$ M)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV/E1H92!F;VQL;W=I;F<@=&%B;&4@ M6QE/3-$)W=I9'1H.B`X M."4[('9E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[('=H:71E+7-P86-E.B!N;W=R87`[('9E6QE/3-$)W1E>'0M86QI9VXZ(&IU M3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@)R=4:6UE M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M M-RXR<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)W!A9&1I M;F6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W!A9&1I;F"!S;VQI9#L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3H@)R=4:6UE M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@)R=4:6UE MF4Z(#$P<'0[)SY.970@87-S M971S(&%C<75I6QE/3-$)W!A9&1I;F"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@ M3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\ M9&EV/E1H92!F;VQL;W=I;F<@=6YA=61I=&5D('-U<'!L96UE;G1A;"!P6QE/3-$)W9E6QE.B!I=&%L:6,[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SXH:6X@=&AO=7-A;F1S*3PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@3H@)R=4:6UE6QE/3-$)W!A9&1I;F3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0V('-T>6QE/3-$)V)OF4Z(#$P<'0[)SY.:6YE(&UO;G1H M6QE/3-$)W!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI M9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/B8C M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG M+6)O='1O;3H@,G!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[ M/"]T9#X\=&0@8V]L6QE/3-$ M)V)OF4Z(#$P<'0[)SXR,#$S M/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P M>"!S;VQI9#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/CQD:78@3H@)R=4:6UE#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/B8C,38P.SPO=&0^/"]T3H@)R=4:6UEF4Z(#$P<'0[ M)SY2979E;G5E/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXW+#8T,SPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[)SXW+#8P-CPO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXD/"]D:78^/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXR,BPV,C8\+V1I=CX\+W1D/CQT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UE3H@)R=4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T M:#H@.24[('9E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@.24[('9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)R=4:6UEF4Z M(#$P<'0[)SY.970@;&]S6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z M(#$P<'0[)SXH,3,V/"]D:78^/"]T9#X\=&0@;F]W6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG3H@)R=4:6UE M6QE/3-$)V9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)A8VMG3H@)R=4:6UE6QE/3-$)V)A8VMG6QE/3-$ M)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M-RXR<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V)A8VMG M6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SXD)B,Q-C`[/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[)SXH,"XP,#PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@3H@)R=4:6UE M3H@ M)R=4:6UE3H@ M)R=4:6UE6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[)SXI/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXD)B,Q-C`[/"]D:78^/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@.24[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[)SXH,"XP,3PO9&EV/CPO=&0^/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@3H@)R=4:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`@("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\Q,S,R8S,Q85\P-V4W7S0R8C1?8C%A-%\T83%A,&8R86%A M,60-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,3,S,F,S,6%?,#=E M-U\T,F(T7V(Q831?-&$Q83!F,F%A83%D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^ M)SQS<&%N/CPO'!E;G-E/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,R+#`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`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO&-L=61E9"!F'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO&-L=61E9"!F'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Q,S,R8S,Q85\P M-V4W7S0R8C1?8C%A-%\T83%A,&8R86%A,60-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,3,S,F,S,6%?,#=E-U\T,F(T7V(Q831?-&$Q83!F,F%A M83%D+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO65E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\Q,S,R8S,Q85\P-V4W7S0R8C1?8C%A-%\T83%A M,&8R86%A,60-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,3,S,F,S M,6%?,#=E-U\T,F(T7V(Q831?-&$Q83!F,F%A83%D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)SQS<&%N/CPO&-E3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\Q,S,R8S,Q85\P-V4W7S0R8C1?8C%A-%\T M83%A,&8R86%A,60-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,3,S M,F,S,6%?,#=E-U\T,F(T7V(Q831?-&$Q83!F,F%A83%D+U=O'0O:'1M;#L@8VAA6EN M9R!A;6]U;G0@;V8@9V]O9'=I;&P@6U)O;&P@1F]R=V%R9%T\+W-T'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!T'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XU,"PP,#`\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)S$P('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S<@>65A'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T M:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-S8L,#`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`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA2!$:7)E8W1O'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)S(@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO2`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`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!S=&]C:RP@870@ M8V]S="`H:6X@'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\Q,S,R8S,Q85\P-V4W7S0R8C1?8C%A-%\T83%A,&8R86%A,60-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,3,S,F,S,6%?,#=E-U\T,F(T7V(Q M831?-&$Q83!F,F%A83%D+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!E>'!E;G-E/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(V+#`P,#QS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N M/CPO'0^)S,@>65A M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`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htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAXES (Details) (USD $)
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
INCOME TAXES [Abstract]        
Income tax expense $ 26,000 $ 91,000 $ 50,000 $ 35,000
XML 22 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
DEFERRED REVENUE (Tables)
 9 Months Ended
Sep. 30, 2014
DEFERRED REVENUE [Abstract]  
Changes in Deferred Revenues
The changes in the Company’s deferred revenues are as follows:
 
 
(in thousands)
  
For the three months ended September 30,
  
For the nine months ended September 30,
 
  
2014
  
2013
  
2014
  
2013
 
  
(unaudited)
  
(unaudited)
  
(unaudited)
  
(unaudited)
 
Deferred revenue at the beginning of the period
 
$
17,712
  
$
13,270
  
$
18,019
  
$
15,602
 
Additions:
                
Deferred extended service contracts
  
244
   
410
   
791
   
848
 
Deferred in-service and training
  
13
   
8
   
28
   
23
 
Deferred service arrangements
  
28
   
30
   
58
   
60
 
Deferred commission revenues
  
3,457
   
2,076
   
8,840
   
5,355
 
Recognized as revenue:
                
Deferred extended service contracts
  
(207
)
  
(245
)
  
(654
)
  
(755
)
Deferred in-service and training
  
(10
)
  
(10
)
  
(25
)
  
(20
)
Deferred service arrangements
  
(26
)
  
(16
)
  
(72
)
  
(54
)
Deferred commission revenues
  
(2,975
)
  
(2,796
)
  
(8,749
)
  
(8,332
)
Deferred revenue at end of period
  
18,236
   
12,727
   
18,236
   
12,727
 
Less: current portion
  
9,158
   
7,684
   
9,158
   
7,684
 
Long-term deferred revenue at end of period
 
$
9,078
  
$
5,043
  
$
9,078
  
$
5,043
 
XML 23 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOODWILL AND OTHER INTANGIBLES (Tables)
 9 Months Ended
Sep. 30, 2014
GOODWILL AND OTHER INTANGIBLES [Abstract]  
Changes in Carrying Amount of Goodwill
The components of the change in goodwill are as follows:

 
(in thousands)
  
Carrying Amount
 
   
Balance at December 31, 2013
 
$
3,303
 
Foreign currency translation
  
(23
)
Balance at September 30, 2014 (unaudited)
 
$
3,280
 
Other Intangible Assets
The Company’s other intangible assets consist of capitalized patent and technology costs, customer lists and software costs, as follows:

 
(in thousands)
  
September 30, 2014
  
December 31, 2013
 
  
(unaudited)
   
Patents and Technology
    
Costs
 
$
2,500
  
$
469
 
Accumulated amortization
  
(462
)
  
(454
)
   
2,038
   
15
 
         
Customer lists
        
Costs
  
800
   
800
 
Accumulated amortization
  
(352
)
  
(267
)
   
448
   
533
 
         
Software
        
Costs
  
871
   
696
 
Accumulated amortization
  
(476
)
  
(424
)
   
395
   
272
 
         
  
$
2,881
  
$
820
 
XML 24 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMITMENTS AND CONTINGENCIES (Details)
 1 Months Ended 9 Months Ended
Jun. 30, 2012
Sep. 30, 2014
Sales Representation Agreement [Abstract]    
Initial term of sales representation agreement 3 years 3 years
Amended term of sales representation agreement   5 years
XML 25 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
BUSINESS COMBINATION (Tables)
 9 Months Ended
Sep. 30, 2014
BUSINESS COMBINATION [Abstract]  
Estimated Fair Values of the Net Assets Acquired
The following table summarizes the estimated fair values of the net assets acquired:


 
(in thousands)
Cash and cash equivalents
 
$
113
 
Accounts receivable and other current assets
  
2
 
Property and equipment
  
3
 
Intangible assets
  
2,033
 
Net assets acquired
 
$
2,151
 
Business Acquisition Proforma Information
The following unaudited supplemental pro forma information presents the financial results as if the acquisition of Genwell had occurred January 1, 2013:

 
(in thousands)
 
 
Three months ended September 30,
  
Nine months ended September 30,
 
  
2014
  
2013
  
2014
  
2013
 
Revenue
 
$
7,643
  
$
7,606
  
$
22,626
  
$
22,795
 
                 
Net loss
  
(136
)
  
(551
)
  
(1,420
)
  
(1,930
)
                 
Basic and diluted loss per share
 
$ 
(0.00
)
 
$ 
(0.00
)
 
$ 
(0.01
)
 
$ 
(0.01
)
XML 26 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
ORGANIZATION AND PLAN OF OPERATIONS (Details)
 1 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2012
Sep. 30, 2014
Company
Segment
Subsidiary
State
Dec. 31, 2010
Segment
ORGANIZATION AND PLAN OF OPERATIONS [Abstract]      
Number of business segments   3 2
Number of contiguous states in which VasoHealthcare has been appointed exclusive representative for GE Healthcare Diagnostic Imaging products   48  
Initial term of sales representation agreement 3 years 3 years  
Amended term of sales representation agreement   5 years  
Number of Chinese operating companies acquired   2  
Number of wholly-owned subsidiaries   3  
XML 27 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT REPORTING AND CONCENTRATIONS
 9 Months Ended
Sep. 30, 2014
SEGMENT REPORTING AND CONCENTRATIONS [Abstract]  
SEGMENT REPORTING AND CONCENTRATIONS
NOTE C – SEGMENT REPORTING AND CONCENTRATIONS

The Company views its business in three segments – the Sales Representation segment, the Equipment segment, and the IT segment. The Sales Representation segment operates through the VasoHealthcare subsidiary and is currently engaged solely in the fulfillment of the Company’s responsibilities under our agreement with GEHC. The Equipment segment is engaged in designing, manufacturing, marketing and supporting EECP® enhanced external counterpulsation systems both domestically and internationally, as well as the development, production, marketing and supporting of other medical devices. The Company’s new subsidiary, VasoHealthcare IT Corp., formed to conduct its healthcare IT operations, reports through the IT segment. Operations in the IT segment began in the third quarter of 2014. The Company evaluates segment performance based on operating income. Administrative functions such as finance, human resources, and information technology are centralized and related expenses allocated to each segment. Other costs not directly attributable to operating segments, such as audit, legal, director fees, investor relations, and others, as well as certain assets – primarily cash balances – are reported in the Corporate entity below.  There are no intersegment revenues.  Summary financial information for the segments is set forth below:

 
(in thousands)
  
As of or for the three months ended September 30, 2014
 
  
Sales Representation Segment
  Equipment Segment  
IT Segment
  
Corporate
  
Consolidated
 
           
Revenues from external customers
 
$
6,409
  
$
1,234
  
$
-
  
$
-
  
$
7,643
 
Operating (loss) income
 
$
723
 
 
$
(405
 ) 
$
(82
)
 
$
(385
)
 
$
(149
)
Total assets
 
$
13,341
  
$
9,909
  
$
2
  
$
9,067
  
$
32,319
 
Accounts and other receivables, net
 
$
6,376
  
$
791
  
$
-
  
$
-
  
$
7,167
 
Deferred commission expense
 
$
4,763
  
$
-
  
$
-
  
$
-
  
$
4,763
 
 
  
As of or for the three months ended September 30, 2013
 
  
Sales Representation Segment
  
Equipment Segment
  
IT Segment
  
Corporate
  
Consolidated
 
           
Revenues from external customers
 
$
5,862
  
$
1,744
  
$
-
  
$
-
  
$
7,606
 
Operating (loss) income
 
$
199
 
 
$
(364
) 
$
-
  
$
(327
)
 
$
(492
)
Total assets
 
$
8,040
  
$
8,398
  
$
-
  
$
8,972
  
$
25,410
 
Accounts and other receivables, net
 
$
3,510
  
$
1,229
  
$
-
  
$
-
  
$
4,739
 
Deferred commission expense
 
$
4,145
  
$
-
  
$
-
  
$
-
  
$
4,145
 
 
  
As of or for the nine months ended September 30, 2014
 
  
Sales Representation Segment
  
Equipment Segment
  
IT Segment
  
Corporate
  
Consolidated
 
           
Revenues from external customers
 
$
3,264
  
$
3,264
  
$
-
  
$
-
  
$
22,599
 
Operating (loss) income
 
$
2,267
 
 
$
(2,361
) 
$
(82
)
 
$
(1,267
)
 
$
(1,443
)
Total assets
 
$
13,341
  
$
9,909
  
$
2
  
$
9,067
  
$
32,319
 
Accounts and other receivables, net
 
$
6,376
  
$
791
  
$
-
  
$
-
  
$
7,167
 
Deferred commission expense
 
$
4,763
  
$
-  
$
-
  
$
-
  
$
4,763
 
 
  
As of or for the nine months ended September 30, 2013
 
  
Sales Repreesntation Segment
  
Equipment Segment
  
IT Segment
  
Corporate
  
Consolidated
 
           
Revenues from external customers
 
$
18,262
  
$
4,533
  
$
-
  
$
-
  
$
22,795
 
Operating (loss) income
 
$
870
 
 
$
(1,489)  
$
-
  
$
(1,085
)
 
$
(1,704
)
Total assets
 
$
8,398
  
$
8,398
  
$
-
  
$
8,972
  
$
25,410
 
Accounts and other receivables, net
 
$
3,510
  
$
1,229
  
$
-
  
$
-
  
$
4,739
 
Deferred commission expense
 
$
4,145
  
$
-
  
$
-
  
$
-
  
$
4,145
 

For the three months ended September 30, 2014 and 2013, GE Healthcare accounted for 84% and 77% of revenue, respectively.  For the nine months ended September 30, 2014 and 2013, GE Healthcare accounted for 86% and 80% of revenue, respectively.  Also, GE Healthcare accounted for $6.2 million, or 87%, and $8.1 million, or 89%, of accounts and other receivables at September 30, 2014 and December 31, 2013, respectively.
XML 28 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT REPORTING AND CONCENTRATIONS (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Segment
Sep. 30, 2013
Dec. 31, 2010
Segment
Dec. 31, 2013
SEGMENT REPORTING AND CONCENTRATIONS [Abstract]            
Number of segments     3   2  
Segment Reporting Information [Line Items]            
Revenues from external customers $ 7,643 $ 7,606 $ 22,599 $ 22,795    
Operating (loss) income (149) (492) (1,443) (1,704)    
Total assets 32,319 25,410 32,319 25,410   33,517
Accounts and other receivables, net 7,167 4,739 7,167 4,739   13,570
Deferred commission expense 4,763 4,145 4,763 4,145    
GE Healthcare [Member]
            
Revenue, Major Customer [Line Items]            
Percentage of revenue (in hundredths) 84.00% 77.00% 86.00% 80.00%    
Corporate [Member]
            
Segment Reporting Information [Line Items]            
Revenues from external customers 0 0 0 0    
Operating (loss) income (385) (327) (1,267) (1,085)    
Total assets 9,067 8,972 9,067 8,972    
Accounts and other receivables, net 0 0 0 0    
Deferred commission expense 0 0 0 0    
Equipment Segment [Member] | Operating Segments [Member]
            
Segment Reporting Information [Line Items]            
Revenues from external customers 1,234 1,744 3,264 4,533    
Operating (loss) income (405) (364) (2,361) (1,489)    
Total assets 9,909 8,398 9,909 8,398    
Accounts and other receivables, net 791 1,229 791 1,229    
Deferred commission expense 0 0 0 0    
Sales Representation Segment [Member] | Operating Segments [Member]
            
Segment Reporting Information [Line Items]            
Revenues from external customers 6,409 5,862 19,335 18,262    
Operating (loss) income 723 199 2,267 870    
Total assets 13,341 8,040 13,341 8,040    
Accounts and other receivables, net 6,376 3,510 6,376 3,510    
Deferred commission expense 4,763 4,145 4,763 4,145    
IT Segment [Member] | Operating Segments [Member]
            
Segment Reporting Information [Line Items]            
Revenues from external customers 0 0 0 0    
Operating (loss) income (82) 0 (82) 0    
Total assets 2 0 2 0    
Accounts and other receivables, net 0 0 0 0    
Deferred commission expense $ 0 $ 0 $ 0 $ 0    
XML 29 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
DEFERRED REVENUE (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2014
Jun. 30, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Dec. 31, 2012
Sep. 30, 2014
Extended Service Contracts [Member]
Sep. 30, 2013
Extended Service Contracts [Member]
Sep. 30, 2014
Extended Service Contracts [Member]
Sep. 30, 2013
Extended Service Contracts [Member]
Sep. 30, 2014
In Service and Training [Member]
Sep. 30, 2013
In Service and Training [Member]
Sep. 30, 2014
In Service and Training [Member]
Sep. 30, 2013
In Service and Training [Member]
Sep. 30, 2014
Service Arrangements [Member]
Sep. 30, 2013
Service Arrangements [Member]
Sep. 30, 2014
Service Arrangements [Member]
Sep. 30, 2013
Service Arrangements [Member]
Sep. 30, 2014
Commission Revenues [Member]
Sep. 30, 2013
Commission Revenues [Member]
Sep. 30, 2014
Commission Revenues [Member]
Sep. 30, 2013
Commission Revenues [Member]
Changes in deferred revenue [Roll Forward]                                            
Deferred revenue at the beginning of the period $ 18,236 $ 17,712 $ 18,019 $ 12,727 $ 13,270 $ 15,602                                
Additions:             244 410 791 848 13 8 28 23 28 30 58 60 3,457 2,076 8,840 5,355
Recognized as revenue:             (207) (245) (654) (755) (10) (10) (25) (20) (26) (16) (72) (54) (2,975) (2,796) (8,749) (8,332)
Deferred revenue at end of period 18,236 17,712 18,019 12,727 13,270 15,602                                
Less: current portion 9,158   10,541 7,684                                    
Long-term deferred revenue at end of period $ 9,078   $ 7,478 $ 5,043                                    
XML 30 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
CURRENT ASSETS    
Cash and cash equivalents $ 9,054 $ 7,961
Short-term investments 111 111
Accounts and other receivables, net of an allowance for doubtful accounts and commission adjustments of $3,689 at September 30, 2014 and $3,764 at December 31, 2013 7,167 13,570
Receivables due from related parties 21 21
Inventories, net 1,937 1,618
Deferred commission expense 2,388 2,312
Other current assets 504 338
Total current assets 21,182 25,931
PROPERTY AND EQUIPMENT, net of accumulated depreciation of $1,362 at September, 2014 and $1,281 at December 31, 2013 272 365
GOODWILL 3,280 3,303
OTHER ASSETS, net 7,585 3,918
Total Assets 32,319 33,517
CURRENT LIABILITIES    
Accounts payable 525 597
Accrued commissions 2,106 2,161
Accrued expenses and other liabilities 4,361 5,571
Sales tax payable 181 230
Deferred revenue - current portion 9,158 10,541
Deferred tax liability, net 112 112
Notes payable due to related party 1,019 3
Total current liabilities 17,462 19,215
LONG-TERM LIABILITIES    
Deferred revenue 9,078 7,478
Other long-term liabilities 573 359
Total long-term liabilities 9,651 7,837
COMMITMENTS AND CONTINGENCIES (NOTE N)      
STOCKHOLDERS' EQUITY    
Preferred stock, $.01 par value; 1,000,000 shares authorized; no shares issued and outstanding at September 30, 2014, and December 31, 2013 0 0
Common stock, $.001 par value; 250,000,000 shares authorized; 165,985,370 and 164,705,382 shares issued at September 30, 2014 and December 31, 2013, respectively; 155,677,283 and 155,223,981 shares outstanding at September 30, 2014 and December 31, 2013, respectively 166 165
Additional paid-in capital 61,864 61,508
Accumulated deficit (54,904) (53,561)
Accumulated other comprehensive income 80 108
Treasury stock, at cost, 10,308,087 and 9,481,101 shares at September 30, 2014 and December 31, 2013, respectively (2,000) (1,755)
Total stockholders' equity 5,206 6,465
Total liabilities and stockholders' equity $ 32,319 $ 33,517
XML 31 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8
BUSINESS COMBINATION (Details)
 3 Months Ended 9 Months Ended 0 Months Ended 3 Months Ended 9 Months Ended 0 Months Ended
Sep. 30, 2014
USD ($)
Sep. 30, 2013
USD ($)
Sep. 30, 2014
USD ($)
Sep. 30, 2013
USD ($)
Aug. 06, 2014
Genwell Instruments Co. Ltd. [Member]
USD ($)
Aug. 06, 2014
Genwell Instruments Co. Ltd. [Member]
CNY
Sep. 30, 2014
Genwell Instruments Co. Ltd. [Member]
USD ($)
Sep. 30, 2014
Genwell Instruments Co. Ltd. [Member]
CNY
Sep. 30, 2013
Genwell Instruments Co. Ltd. [Member]
USD ($)
Sep. 30, 2014
Genwell Instruments Co. Ltd. [Member]
USD ($)
Sep. 30, 2013
Genwell Instruments Co. Ltd. [Member]
USD ($)
Aug. 06, 2014
Genwell Instruments Co. Ltd. [Member]
Notes Payable [Member]
USD ($)
Aug. 06, 2014
Genwell Instruments Co. Ltd. [Member]
Notes Payable [Member]
CNY
Aug. 06, 2014
Genwell Instruments Co. Ltd. [Member]
Notes Payable [Member]
Business Combination [Line Items]                            
Consideration for acquisition         $ 2,151,000 13,250,000 $ 2,151,000 13,250,000            
Notes paid as a part of consideration                       1,015,000 6,250,000  
Maturity term of notes                       1 year 1 year  
Interest rate on notes (in hundredths)                           5.00%
Acquisition-related legal costs             8,000     8,000        
Revenue attributed to Genwell Instruments Co. Ltd. 7,643,000 7,606,000 22,599,000 22,795,000     0              
Net loss attributed to Genwell Instruments Co. Ltd. (123,000) (464,000) (1,343,000) (1,649,000)     (10,000)              
Estimated fair values of the net assets acquired [Abstract]                            
Cash and cash equivalents             113,000     113,000        
Accounts receivable and other current assets             2,000     2,000        
Property and equipment             3,000     3,000        
Intangible assets             2,033,000     2,033,000        
Net assets acquired             2,151,000     2,151,000        
Business acquisition proforma information [Abstract]                            
Revenue             7,643,000   7,606,000 22,626,000 22,795,000      
Net loss             $ (136,000)   $ (551,000) $ (1,420,000) $ (1,930,000)      
Basic and diluted loss per share (in dollars per share)             $ 0   $ 0 $ (0.01) $ (0.01)      
XML 32 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
ORGANIZATION AND PLAN OF OPERATIONS
 9 Months Ended
Sep. 30, 2014
ORGANIZATION AND PLAN OF OPERATIONS [Abstract]  
ORGANIZATION AND PLAN OF OPERATIONS
NOTE A - ORGANIZATION AND PLAN OF OPERATIONS

Vasomedical, Inc. was incorporated in Delaware in July 1987. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Vasomedical” or “management” refer to Vasomedical, Inc. and its subsidiaries. The Company until July 2014 had been operating in two distinct business segments, the Sales Representation segment and the Equipment segment. In May 2010, the Company, through its wholly-owned subsidiary Vaso Diagnostics, Inc. d/b/a VasoHealthcare, expanded into the sales representation business via its agreement with GE Healthcare (“GEHC”), the healthcare business unit of General Electric Company (NYSE: GE), to be GEHC’s exclusive sales representative for the sale of select GEHC diagnostic imaging products in specific market segments in the 48 contiguous states of the United States and the District of Columbia.   In June 2012, the Company entered into an amendment, effective July 1, 2012, of the sales representative agreement (“GEHC Agreement”) extending the initial term of three years commencing July 1, 2010 to five years through June 30, 2015, subject to earlier termination under certain circumstances.  In the Equipment segment we design, manufacture, market and support certain medical devices.  Our principal products in this segment are Enhanced External Counterpulsation (EECP®) systems, which are non-invasive therapy devices based on our proprietary technology, and currently indicated in the United States for the treatment of refractory angina and used for ischemic diseases overseas.  In addition we develop, manufacture and market certain ambulatory patient monitoring systems including recorders and analysis software.

In September 2011, the Company acquired Fast Growth Enterprises Limited (FGE), a British Virgin Islands company which owns and controls two Chinese operating companies - Life Enhancement Technologies Ltd. (“LET”) and Biox Instruments Co. Ltd. (“Biox”), respectively – to expand its technical and manufacturing capabilities and to enhance its distribution network, technology, and product portfolio.  Also in September 2011, the Company restructured to further align its business management structure and long-term growth strategy and started to operate through three wholly-owned subsidiaries.  Vaso Diagnostics d/b/a VasoHealthcare continues as the operating subsidiary for the sales representation of GE Healthcare diagnostic imaging products; Vasomedical Global Corp. operates the Company’s Chinese companies; and Vasomedical Solutions, Inc. manages and coordinates our EECP® therapy business as well as other medical equipment operations.

In April 2014, the Company announced that it entered into an agreement with Chongqing PSK-Health Sci-Tech Development Co., Ltd. ("PSK") of Chongqing, China, the leading manufacturer of ECP therapy systems in China, to form a joint venture company, VSK Medical Limited ("VSK"), for the global marketing, sale and advancement of ECP therapy technology.  The joint venture is in the early implementation phase and had not begun operations as of September 30, 2014.

In June 2014, the Company entered into a Value Added Reseller Agreement (“VAR Agreement”) with GEHC to become a national value added reseller of GE Healthcare IT's Radiology PACS (Picture Archiving and Communication System) software solutions and related services, including implementation, management and support.  This multiyear VAR Agreement focuses primarily on existing customer segments currently served by Vaso Diagnostics on behalf of GEHC.  A new wholly owned subsidiary, VasoHealthcare IT Corp., was formed to conduct the healthcare IT business.

In August 2014, the Company acquired all of the outstanding shares of Genwell Instruments Co. Ltd. (“Genwell”), located in Wuxi, China, through its wholly owned subsidiary Wuxi Gentone Instruments Co. Ltd. (“Gentone”).  Genwell was formed in China in 2010 with the assistance of a government grant to develop the MobiCareTM  wireless multi-parameter patient monitoring system and holds the patents and intellectual property rights for this system.  See Note K.

We report the operations of Vasomedical Global Corp. and Vasomedical Solutions, Inc. under our Equipment segment.  Vaso Diagnostics activities are included under our Sales Representation segment.  VasoHealthcare IT operations report under the IT segment (See Note C).
XML 33 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
LOSS PER COMMON SHARE (Details)
In Thousands, unless otherwise specified
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of diluted earnings per share (in shares) 1,892 2,365 1,892 2,365
Stock Options [Member]
        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of diluted earnings per share (in shares) 1,402 1,780 1,402 1,780
Common Stock Grants [Member]
        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of diluted earnings per share (in shares) 490 585 490 585
XML 34 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Policies)
 9 Months Ended
Sep. 30, 2014
BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES [Abstract]  
Basis of Presentation and Use of Estimates
Basis of Presentation and Use of Estimates

The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and disclosures normally included in the condensed consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in connection with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013, as filed with the SEC. These condensed consolidated financial statements include the accounts of the companies over which we exercise control. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of interim results for the Company. The results of operations for any interim period are not necessarily indicative of results to be expected for any other interim period or the full year.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company's management. The Company evaluates its estimates and assumptions on an ongoing basis.
Significant Accounting Policies
Significant Accounting Policies

Note B of the Notes to Consolidated Financial Statements, included in the Annual Report on Form 10-K for the year ended December 31, 2013, includes a summary of the significant accounting policies used in the preparation of the condensed consolidated financial statements.
Revenue and Expense Recognition for VasoHealthcare
Revenue and Expense Recognition for VasoHealthcare

The Company recognizes commission revenue, net of the medical device tax reimbursement to GEHC, in its Sales Representation segment (see Note C) when persuasive evidence of an arrangement exists, service has been rendered, the price is fixed or determinable and collectability is reasonably assured.  These conditions are deemed to be met when the underlying equipment has been accepted at the customer site in accordance with the specific terms of the sales agreement.  Consequently, amounts billable under the agreement with GE Healthcare in advance of the customer acceptance of the equipment are recorded as accounts receivable and deferred revenue in the condensed consolidated balance sheets.  Similarly, commissions payable to our sales force related to such billings are recorded as deferred commission expense when the associated deferred revenue is recorded.  Commission expense is recognized when the corresponding commission revenue is recognized.
 
Reclassifications
Reclassifications

Certain reclassifications have been made to prior period amounts to conform with current period presentation.
XML 35 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE MEASUREMENTS (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents invested in money market funds (included in cash and cash equivalents) $ 8,384 $ 6,883
Investment in certificates of deposit (included in short-term investments) 111 111
Assets 8,495 6,994
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents invested in money market funds (included in cash and cash equivalents) 8,384 6,883
Investment in certificates of deposit (included in short-term investments) 111 111
Assets 8,495 6,994
Significant Other Observable Inputs (Level 2) [Member]
    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents invested in money market funds (included in cash and cash equivalents) 0 0
Assets 0 0
Significant Unobservable Inputs (Level 3) [Member]
    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents invested in money market funds (included in cash and cash equivalents) 0 0
Assets $ 0 $ 0
XML 36 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
LOSS PER COMMON SHARE (Tables)
 9 Months Ended
Sep. 30, 2014
LOSS PER COMMON SHARE [Abstract]  
Antidilutive Common Stock Equivalents Excluded from Computation of Diluted Earnings Per Share
The following table represents common stock equivalents that were excluded from the computation of diluted earnings per share for the three and nine months ended September 30, 2014 and 2013, because the effect of their inclusion would be anti-dilutive.

 
(in thousands)
  
For the three months ended
  
For the nine months ended
 
  
September 30, 2014
  
September 30, 2013
  
September 30, 2014
  
September 30, 2013
 
Stock options
  
1,402
   
1,780
   
1,402
   
1,780
 
Common stock grants
  
490
   
585
   
490
   
585
 
   
1,892
   
2,365
   
1,892
   
2,365
 
XML 37 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 38 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES
 9 Months Ended
Sep. 30, 2014
BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES [Abstract]  
BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES
NOTE B - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES

Basis of Presentation and Use of Estimates

The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and disclosures normally included in the condensed consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in connection with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013, as filed with the SEC. These condensed consolidated financial statements include the accounts of the companies over which we exercise control. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of interim results for the Company. The results of operations for any interim period are not necessarily indicative of results to be expected for any other interim period or the full year.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company's management. The Company evaluates its estimates and assumptions on an ongoing basis.

Significant Accounting Policies

Note B of the Notes to Consolidated Financial Statements, included in the Annual Report on Form 10-K for the year ended December 31, 2013, includes a summary of the significant accounting policies used in the preparation of the condensed consolidated financial statements.

Revenue and Expense Recognition for VasoHealthcare

The Company recognizes commission revenue, net of the medical device tax reimbursement to GEHC, in its Sales Representation segment (see Note C) when persuasive evidence of an arrangement exists, service has been rendered, the price is fixed or determinable and collectability is reasonably assured.  These conditions are deemed to be met when the underlying equipment has been accepted at the customer site in accordance with the specific terms of the sales agreement.  Consequently, amounts billable under the agreement with GE Healthcare in advance of the customer acceptance of the equipment are recorded as accounts receivable and deferred revenue in the condensed consolidated balance sheets.  Similarly, commissions payable to our sales force related to such billings are recorded as deferred commission expense when the associated deferred revenue is recorded.  Commission expense is recognized when the corresponding commission revenue is recognized.
 
Reclassifications

Certain reclassifications have been made to prior period amounts to conform with current period presentation.
XML 39 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
CURRENT ASSETS    
Accounts and other receivables, allowance for doubtful accounts and commission adjustments $ 3,689 $ 3,764
PROPERTY AND EQUIPMENT, accumulated depreciation $ 1,362 $ 1,281
STOCKHOLDERS' EQUITY    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 1,000,000 1,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 250,000,000 250,000,000
Common stock, shares issued (in shares) 165,985,370 164,705,382
Common stock, shares outstanding (in shares) 155,677,283 155,223,981
Treasury stock, at cost (in shares) 10,308,087 9,481,101
XML 40 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY
 9 Months Ended
Sep. 30, 2014
STOCKHOLDERS' EQUITY [Abstract]  
STOCKHOLDERS' EQUITY
NOTE L – STOCKHOLDERS’ EQUITY

Common Stock

On June 17, 2010 the Board of Directors approved the 2010 Stock Plan (the “2010 Plan”) for officers, directors, employees and consultants of the Company.  The stock issuable under the 2010 Plan shall be shares of the Company’s authorized but unissued or reacquired common stock.  The maximum number of shares of common stock which may be issued under the 2010 Plan is 5,000,000 shares.

The 2010 Plan is comprised of two separate equity programs, the Options Grant Program, under which eligible persons may be granted options to purchase shares of common stock, and the Stock Issuance Program, under which eligible persons may be issued shares of common stock directly, either through the immediate purchase of such shares or as compensation for services rendered to the Company.  The 2010 Plan provides that the Board of Directors, or a committee of the Board of Directors, will administer it with full authority to determine the identity of the recipients of the options or shares and the number of options or shares.

During the nine months ended September 30, 2014 the Company issued, under the 2010 Plan, 710,000 shares of common stock to employees and officers, and 500,000 shares of common stock to directors.  As of September 30, 2014, 1,222 shares were available for grant under the 2010 Plan.

On October 30, 2013 the Board of Directors approved the 2013 Stock Plan (the “2013 Plan”) for officers, directors, employees and consultants of the Company.  The stock issuable under the 2013 Plan shall be shares of the Company’s authorized but unissued or reacquired common stock.  The maximum number of shares of common stock which may be issued under the 2013 Plan is 7,500,000 shares.

The 2013 Plan is comprised of two separate equity programs, the Options Grant Program, under which eligible persons may be granted options to purchase shares of common stock, and the Stock Issuance Program, under which eligible persons may be issued shares of common stock directly, either through the immediate purchase of such shares or as compensation for services rendered to the Company.  The 2013 Plan provides that the Board of Directors, or a committee of the Board of Directors, will administer the Plan with full authority to determine the identity of the recipients of the options or shares and the number of options or shares.

During the nine months ended September 30, 2014 the Company issued, under the 2013 Plan, 69,988 shares of common stock to employees.  As of September 30, 2014, 7,330,012 shares were available for grant under the 2013 Plan.

No options were issued under the 2010 Plan or 2013 Plan during the nine-month period ended September 30, 2014.

In April 2013, the Company’s Board of Directors authorized a share repurchase program of up to $1.5 million, which was subsequently increased in July 2013 to $2.0 million, of the Company’s common stock.  As of September 30, 2014, 10,308,087 shares had been repurchased at a cost of $2,000,000, which cost has been recorded as treasury stock in the accompanying condensed consolidated balance sheet as of September 30, 2014.
XML 41 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
 9 Months Ended
Sep. 30, 2014
Nov. 09, 2014
Document and Entity Information [Abstract]    
Entity Registrant Name VASOMEDICAL, INC  
Entity Central Index Key 0000839087  
Current Fiscal Year End Date --12-31  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   155,677,283
Document Fiscal Year Focus 2014  
Document Fiscal Period Focus Q3  
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2014  
XML 42 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAXES
 9 Months Ended
Sep. 30, 2014
INCOME TAXES [Abstract]  
INCOME TAXES
NOTE M – INCOME TAXES

The Company’s provision for income taxes consists of state and local, and foreign taxes, as applicable, in amounts necessary to align the Company’s year-to-date tax provision with the effective rate that it expects to achieve for the full year.  For the three and nine months ended September 30, 2014, the Company recorded an income tax provision of $26,000 and $50,000, respectively, consisting primarily of state and local minimum taxes and foreign taxes related to the Chinese subsidiary.  For the three and nine months ended September 30, 2013, the Company recorded a tax benefit of $91,000 and $35,000, respectively, consisting of a tax refund on a previous period return, partially offset by state and local minimum taxes and foreign taxes related to the Chinese subsidiary.  Our domestic deferred tax assets are not realizable on a more-likely-than-not basis and, therefore, we have recorded a full valuation allowance against our domestic deferred tax assets.
XML 43 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Revenues        
Equipment sales $ 903 $ 1,353 $ 2,157 $ 3,320
Equipment rentals and services 331 391 1,107 1,213
Commissions 6,409 5,862 19,335 18,262
Total revenues 7,643 7,606 22,599 22,795
Cost of revenues        
Cost of sales, equipment 251 381 745 1,015
Cost of equipment rentals and services 189 207 549 665
Cost of commissions 1,828 1,831 5,282 5,502
Total cost of revenues 2,268 2,419 6,576 7,182
Gross profit 5,375 5,187 16,023 15,613
Operating expenses        
Selling, general and administrative 5,344 5,507 16,867 16,843
Research and development 180 172 599 474
Total operating expenses 5,524 5,679 17,466 17,317
Operating loss (149) (492) (1,443) (1,704)
Other income (expense)        
Interest and other income, net 52 (63) 150 20
Total other income, net 52 (63) 150 20
Loss before income taxes (97) (555) (1,293) (1,684)
Income tax (expense) benefit (26) 91 (50) 35
Net loss (123) (464) (1,343) (1,649)
Other comprehensive loss        
Foreign currency translation gain (loss) 2 29 (28) 64
Comprehensive loss $ (121) $ (435) $ (1,371) $ (1,585)
Loss per common share        
- basic and diluted (in dollars per share) $ 0 $ 0 $ (0.01) $ (0.01)
Weighted average common shares outstanding        
- basic and diluted (in shares) 155,186 157,864 155,319 160,796
XML 44 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
ACCOUNTS AND OTHER RECEIVABLES, NET
 9 Months Ended
Sep. 30, 2014
ACCOUNTS AND OTHER RECEIVABLES, NET [Abstract]  
ACCOUNTS AND OTHER RECEIVABLES, NET
NOTE G – ACCOUNTS AND OTHER RECEIVABLES, NET

The following table presents information regarding the Company’s accounts and other receivables as of September 30, 2014 and December 31, 2013:
 
 
 (in thousands)
  
September 30, 2014
  
December 31, 2013
 
  
(unaudited)
   
Trade receivables
 
$
10,716
  
$
17,173
 
Due from employees
  
140
   
161
 
Allowance for doubtful accounts and commission adjustments
  
(3,689
)
  
(3,764
)
Accounts and other receivables, net
 
$
7,167
  
$
13,570
 

Trade receivables include amounts due for shipped products and services rendered.  Amounts currently due under the GEHC Agreement are subject to adjustment in subsequent periods should the underlying sales order amount, upon which the receivable is based, change.

Allowance for doubtful accounts and commission adjustments include estimated losses resulting from the inability of our customers to make required payments, and adjustments arising from subsequent changes in sales order amounts that may reduce the amount the Company will ultimately receive under the GEHC Agreement.  Due from employees is primarily commission advances made to sales personnel.
XML 45 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE MEASUREMENTS
 9 Months Ended
Sep. 30, 2014
FAIR VALUE MEASUREMENTS [Abstract]  
FAIR VALUE MEASUREMENTS
NOTE F – FAIR VALUE MEASUREMENTS

The Company complies with the provisions of ASC 820 “Fair Value Measurements and Disclosures” (“ASC 820”).  Under ASC 820, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.

The following tables present information about the Company’s assets measured at fair value as of September 30, 2014 and December 31, 2013:

 
(in thousands)
  
Quoted Prices
  
Significant
     
  
in Active
  
Other
  
Significant
  
Balance
 
  
Markets for
  
Observable
  
Unobservable
  
as of
 
  
Identical Assets
  
Inputs
  
Inputs
  
September 30,
 
  
(Level 1)
  
(Level 2)
  
(Level 3)
  
2014
 
Assets
       
(unaudited)
 
Cash equivalents invested in money market funds (included in cash and cash equivalents)
 
$
8,384
  
$
-
  
$
-
  
$
8,384
 
Investment in certificates of deposit (included in short-term investments)
  
111
           
111
 
  
$
8,495
  
$
-
  
$
-
  
$
8,495
 
 
  
Quoted Prices
  
Significant
     
  
in Active
  
Other
  
Significant
  
Balance
 
  
Markets for
  
Observable
  
Unobservable
  
as of
 
  
Identical Assets
  
Inputs
  
Inputs
  
December 31,
 
  
(Level 1)
  
(Level 2)
  
(Level 3)
  
2013
 
Assets
        
Cash equivalents invested in money market funds (included in cash and cash equivalents)
 
$
6,883
  
$
-
  
$
-
  
$
6,883
 
Investment in certificates of deposit (included in short-term investments)
  
111
           
111
 
  
$
6,994
  
$
-
  
$
-
  
$
6,994
 

The fair values of the Company’s cash equivalents invested in money market funds are determined through market, observable and corroborated sources.
XML 46 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT REPORTING AND CONCENTRATIONS (Tables)
 9 Months Ended
Sep. 30, 2014
SEGMENT REPORTING AND CONCENTRATIONS [Abstract]  
Summary Financial Information for Segments
Summary financial information for the segments is set forth below:

 
(in thousands)
  
As of or for the three months ended September 30, 2014
 
  
Sales Representation Segment
  Equipment Segment  
IT Segment
  
Corporate
  
Consolidated
 
           
Revenues from external customers
 
$
6,409
  
$
1,234
  
$
-
  
$
-
  
$
7,643
 
Operating (loss) income
 
$
723
 
 
$
(405
 ) 
$
(82
)
 
$
(385
)
 
$
(149
)
Total assets
 
$
13,341
  
$
9,909
  
$
2
  
$
9,067
  
$
32,319
 
Accounts and other receivables, net
 
$
6,376
  
$
791
  
$
-
  
$
-
  
$
7,167
 
Deferred commission expense
 
$
4,763
  
$
-
  
$
-
  
$
-
  
$
4,763
 
 
  
As of or for the three months ended September 30, 2013
 
  
Sales Representation Segment
  
Equipment Segment
  
IT Segment
  
Corporate
  
Consolidated
 
           
Revenues from external customers
 
$
5,862
  
$
1,744
  
$
-
  
$
-
  
$
7,606
 
Operating (loss) income
 
$
199
 
 
$
(364
) 
$
-
  
$
(327
)
 
$
(492
)
Total assets
 
$
8,040
  
$
8,398
  
$
-
  
$
8,972
  
$
25,410
 
Accounts and other receivables, net
 
$
3,510
  
$
1,229
  
$
-
  
$
-
  
$
4,739
 
Deferred commission expense
 
$
4,145
  
$
-
  
$
-
  
$
-
  
$
4,145
 
 
  
As of or for the nine months ended September 30, 2014
 
  
Sales Representation Segment
  
Equipment Segment
  
IT Segment
  
Corporate
  
Consolidated
 
           
Revenues from external customers
 
$
3,264
  
$
3,264
  
$
-
  
$
-
  
$
22,599
 
Operating (loss) income
 
$
2,267
 
 
$
(2,361
) 
$
(82
)
 
$
(1,267
)
 
$
(1,443
)
Total assets
 
$
13,341
  
$
9,909
  
$
2
  
$
9,067
  
$
32,319
 
Accounts and other receivables, net
 
$
6,376
  
$
791
  
$
-
  
$
-
  
$
7,167
 
Deferred commission expense
 
$
4,763
  
$
-  
$
-
  
$
-
  
$
4,763
 
 
  
As of or for the nine months ended September 30, 2013
 
  
Sales Repreesntation Segment
  
Equipment Segment
  
IT Segment
  
Corporate
  
Consolidated
 
           
Revenues from external customers
 
$
18,262
  
$
4,533
  
$
-
  
$
-
  
$
22,795
 
Operating (loss) income
 
$
870
 
 
$
(1,489)  
$
-
  
$
(1,085
)
 
$
(1,704
)
Total assets
 
$
8,398
  
$
8,398
  
$
-
  
$
8,972
  
$
25,410
 
Accounts and other receivables, net
 
$
3,510
  
$
1,229
  
$
-
  
$
-
  
$
4,739
 
Deferred commission expense
 
$
4,145
  
$
-
  
$
-
  
$
-
  
$
4,145
 
XML 47 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMITMENTS AND CONTINGENCIES
 9 Months Ended
Sep. 30, 2014
COMMITMENTS AND CONTINGENCIES [Abstract]  
COMMITMENTS AND CONTINGENCIES
NOTE N – COMMITMENTS AND CONTINGENCIES

Sales representation agreement

In June 2012, the Company concluded an amendment of the GEHC Agreement with GE Healthcare, originally signed on May 19, 2010.  The amendment, effective July 1, 2012, extended the initial term of three years commencing July 1, 2010 to five years through June 30, 2015, subject to earlier termination under certain circumstances.  These circumstances include not materially achieving certain sales goals, not maintaining a minimum number of sales representatives, and various legal and GEHC policy requirements.  Under the terms of the agreement, the Company is required to lease dedicated computer equipment from GEHC for connectivity to their network.

Value Added Reseller agreement

In June 2014, the Company entered into an agreement with GE Healthcare for the purchase of certain GEHC IT professional services in conjunction with the execution of its VAR Agreement, as described in Note A. 
XML 48 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
DEFERRED REVENUE
 9 Months Ended
Sep. 30, 2014
DEFERRED REVENUE [Abstract]  
DEFERRED REVENUE
NOTE J - DEFERRED REVENUE

The changes in the Company’s deferred revenues are as follows:
 
 
(in thousands)
  
For the three months ended September 30,
  
For the nine months ended September 30,
 
  
2014
  
2013
  
2014
  
2013
 
  
(unaudited)
  
(unaudited)
  
(unaudited)
  
(unaudited)
 
Deferred revenue at the beginning of the period
 
$
17,712
  
$
13,270
  
$
18,019
  
$
15,602
 
Additions:
                
Deferred extended service contracts
  
244
   
410
   
791
   
848
 
Deferred in-service and training
  
13
   
8
   
28
   
23
 
Deferred service arrangements
  
28
   
30
   
58
   
60
 
Deferred commission revenues
  
3,457
   
2,076
   
8,840
   
5,355
 
Recognized as revenue:
                
Deferred extended service contracts
  
(207
)
  
(245
)
  
(654
)
  
(755
)
Deferred in-service and training
  
(10
)
  
(10
)
  
(25
)
  
(20
)
Deferred service arrangements
  
(26
)
  
(16
)
  
(72
)
  
(54
)
Deferred commission revenues
  
(2,975
)
  
(2,796
)
  
(8,749
)
  
(8,332
)
Deferred revenue at end of period
  
18,236
   
12,727
   
18,236
   
12,727
 
Less: current portion
  
9,158
   
7,684
   
9,158
   
7,684
 
Long-term deferred revenue at end of period
 
$
9,078
  
$
5,043
  
$
9,078
  
$
5,043
 
XML 49 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
INVENTORIES, NET
 9 Months Ended
Sep. 30, 2014
INVENTORIES, NET [Abstract]  
INVENTORIES, NET
NOTE H – INVENTORIES, NET

Inventories, net of reserves, consist of the following:

 
(in thousands)
  
September 30, 2014
  
December 31, 2013
 
  
(unaudited)
   
Raw materials
 
$
651
  
$
790
 
Work in process
  
678
   
291
 
Finished goods
  
608
   
537
 
  
$
1,937
  
$
1,618
 
 
At September 30, 2014 and December 31, 2013, the Company maintained reserves for excess and obsolete inventory of $829,000 and $803,000, respectively.
XML 50 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOODWILL AND OTHER INTANGIBLES
 9 Months Ended
Sep. 30, 2014
GOODWILL AND OTHER INTANGIBLES [Abstract]  
GOODWILL AND OTHER INTANGIBLES
NOTE I – GOODWILL AND OTHER INTANGIBLES

Goodwill aggregating $3,280,000 and $3,303,000 was recorded on the Company’s condensed consolidated balance sheets at September 30, 2014 and December 31, 2013, respectively, pursuant to the acquisition of FGE in September 2011.  All of the goodwill was allocated to the Company’s Equipment segment.  The components of the change in goodwill are as follows:

 
(in thousands)
  
Carrying Amount
 
   
Balance at December 31, 2013
 
$
3,303
 
Foreign currency translation
  
(23
)
Balance at September 30, 2014 (unaudited)
 
$
3,280
 

The Company’s other intangible assets consist of capitalized patent and technology costs, customer lists and software costs, as follows:

 
(in thousands)
  
September 30, 2014
  
December 31, 2013
 
  
(unaudited)
   
Patents and Technology
    
Costs
 
$
2,500
  
$
469
 
Accumulated amortization
  
(462
)
  
(454
)
   
2,038
   
15
 
         
Customer lists
        
Costs
  
800
   
800
 
Accumulated amortization
  
(352
)
  
(267
)
   
448
   
533
 
         
Software
        
Costs
  
871
   
696
 
Accumulated amortization
  
(476
)
  
(424
)
   
395
   
272
 
         
  
$
2,881
  
$
820
 

Patents and technology, customer lists, and software are included in other assets in the accompanying condensed consolidated balance sheets and are amortized on a straight line basis over their estimated useful lives of ten, seven, and five years, respectively.  Amortization expense amounted to $50,000 and $146,000 for the three and nine months ended September 30, 2014, respectively, and $41,000 and $126,000 for the three and nine months ended September 30, 2013, respectively.
XML 51 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED-PARTY TRANSACTIONS
 9 Months Ended
Sep. 30, 2014
RELATED-PARTY TRANSACTIONS [Abstract]  
RELATED-PARTY TRANSACTIONS
NOTE K – RELATED-PARTY TRANSACTIONS

On February 28, 2011, David Lieberman and Edgar Rios were appointed by the Board of Directors as directors of the Company.  Mr. Lieberman, a practicing attorney in the State of New York, was also appointed to serve as the Vice Chairman of the Board.  He is currently a senior partner at the law firm of Beckman, Lieberman & Barandes, LLP, which performs certain legal services for the Company.  Fees of approximately $60,000 and $180,000 were billed by the firm through the three and nine months ended September 30, 2014, respectively, and fees of approximately $66,000 and $187,000 were billed through the three and nine months ended September 30, 2013, respectively, at which dates no amounts were outstanding.

Mr. Rios currently is President of Edgary Consultants, LLC, and was appointed a director in conjunction with the Company’s consulting agreement with Edgary Consultants, LLC.  The consulting agreement (the “Agreement”) between the Company and Edgary Consultants, LLC (“Consultant”) commenced on March 1, 2011 and was for a two-year term and expired on February 28, 2013.  The Agreement provided for the engagement of Consultant to assist the Company in seeking broader reimbursement coverage of EECP® therapy.

In consideration for the services to be provided by Consultant under the Agreement, the Company agreed to issue to Consultant or its designees, up to 18,500,000 shares of restricted common stock of the Company, 3,000,000 of which were issued in March 2011 and the balance was to be earned on performance. Mr. Lieberman received 600,000 of these restricted shares.  The Company recorded the fair value of the shares issued to Consultant as a prepaid expense and amortized the cost ratably over the two year agreement.  No performance-based shares were issued and no further compensation is expected to be paid in conjunction with the agreement.

Receivables due from FGE management aggregating $8,000 and $6,000 were collected during the three and nine months ended September 30, 2013, respectively.

 On August 6, 2014 the Company acquired all of the outstanding shares of Genwell Instruments Co. Ltd. (“Genwell”), located in Wuxi, China, through its wholly owned subsidiary Wuxi Gentone Instruments Co. Ltd. (“Gentone”) for cash and notes of Chinese Yuan RMB13,250,000 (approximately $2,151,000 at the acquisition date – see Note P).  Genwell was formed in China in 2010 with the assistance of a government grant to develop the MobiCareTM  wireless multi-parameter patient monitoring system and holds the patents and intellectual property rights for this system.  The president of our subsidiary Life Enhancement Technologies Ltd. and the president and vice-president of our subsidiary Biox Instruments Company Ltd. together owned 80.9% of Genwell at the time of acquisition.  The President and CEO of the Company was appointed the nominee Chairman of Genwell at its formation for the sole purpose of applying for the government grant available only to overseas Chinese persons.  He has never received any compensation from Genwell nor held any ownership interest in Genwell.  The Company has received a fairness opinion for this transaction from an independent certified appraisal firm and a legal opinion from Chinese counsel.
XML 52 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
SHARE-BASED COMPENSATION (Details) (USD $)
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation expense $ 32,000 $ 29,000 $ 189,000 $ 300,000
Remainder of vesting period       2 years
Unrecognized expense related to existing share-based arrangements 130,000   130,000  
Restricted Stock [Member]
        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares)       400,000
Value of stock granted       74,000
Value of shares vested in six months   3,600   3,600
Value of shares vested in two years   38,000   38,000
Restricted Stock [Member] | Director [Member]
        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares)     500,000  
Value of stock granted     175,000  
Restricted Stock [Member] | Officer [Member]
        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares)     450,000 100,000
Vested (in shares)     100,000  
Value of stock granted     157,500  
Restricted Stock [Member] | Employees [Member]
        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares)     140,000 300,000
Vested (in shares)     50,000  
Vested over three years (in shares) 90,000   90,000  
Value of stock granted     31,100  
Remainder of vesting period     3 years  
Stock Compensation Plan [Member]
        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Allocated share-based arrangements $ 43,000 $ 0 $ 131,000 $ 87,000
Stock Options [Member]
        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares)     0 0
XML 53 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
BUSINESS COMBINATION
 9 Months Ended
Sep. 30, 2014
BUSINESS COMBINATION [Abstract]  
BUSINESS COMBINATION
NOTE P – BUSINESS COMBINATION

On August 6, 2014 the Company acquired all of the outstanding shares of Genwell Instruments Co. Ltd. (“Genwell”), located in Wuxi, China, through its wholly owned subsidiary Wuxi Gentone Instruments Co. Ltd. (“Gentone”) for cash and notes of Chinese Yuan RMB13,250,000 (approximately $2,151,000 at the acquisition date).  The notes totaling RMB6,250,000 (approximately $1,015,000) are payable one year from the closing date with interest at the rate of 5% per annum.  Genwell was formed in China in 2010 with the assistance of a government grant to develop the MobiCareTM  wireless multi-parameter patient monitoring system and holds the patents and intellectual property rights for this system.  The primary purpose of the acquisition was to acquire ownership of these patents and intellectual property.

The operating results of Genwell from August 6, 2014 to September 30, 2014 are included in the accompanying condensed consolidated statements of operations and comprehensive loss for the three and nine month periods ended September 30, 2014.  The accompanying condensed consolidated balance sheet at September 30, 2014 reflects the acquisition of Genwell effective August 6, 2014.

In accordance with Accounting Standards Codification 805, Business Combinations, the total purchase consideration is allocated to the net tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at August 6, 2014 (the acquisition date).  The purchase price was allocated based on the information currently available, and may be adjusted after obtaining more information regarding, among other things, asset valuations, liabilities assumed, and revisions of preliminary estimates.  The following table summarizes the estimated fair values of the net assets acquired:


 
(in thousands)
Cash and cash equivalents
 
$
113
 
Accounts receivable and other current assets
  
2
 
Property and equipment
  
3
 
Intangible assets
  
2,033
 
Net assets acquired
 
$
2,151
 

During the three and nine month periods ended September 30, 2014, the Company expensed $8,000 of acquisition-related legal costs.  The costs are included in the line item Selling, General & Administrative costs in the accompanying condensed consolidated statements of operations and comprehensive loss.  The amounts of revenue and net loss of Genwell included in the Company's condensed consolidated statements of operations and comperhensive loss for the three months ended September 30, 2014 was $0 and $10,000, respectively.  Genwell is not expected to report future revenue as the sales of its principal product, MobiCare™, will be through the Biox subsidiary.  The following unaudited supplemental pro forma information presents the financial results as if the acquisition of Genwell had occurred January 1, 2013:

 
(in thousands)
 
 
Three months ended September 30,
  
Nine months ended September 30,
 
  
2014
  
2013
  
2014
  
2013
 
Revenue
 
$
7,643
  
$
7,606
  
$
22,626
  
$
22,795
 
                 
Net loss
  
(136
)
  
(551
)
  
(1,420
)
  
(1,930
)
                 
Basic and diluted loss per share
 
$ 
(0.00
)
 
$ 
(0.00
)
 
$ 
(0.01
)
 
$ 
(0.01
)

An adjustment was made to the unaudited pro forma financial information to reflect the acquisition-related costs in the nine months ended September 30, 2013.
XML 54 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
ACCOUNTS AND OTHER RECEIVABLES, NET (Tables)
 9 Months Ended
Sep. 30, 2014
ACCOUNTS AND OTHER RECEIVABLES, NET [Abstract]  
Accounts and Other Receivables
The following table presents information regarding the Company’s accounts and other receivables as of September 30, 2014 and December 31, 2013:
 
 
 (in thousands)
  
September 30, 2014
  
December 31, 2013
 
  
(unaudited)
   
Trade receivables
 
$
10,716
  
$
17,173
 
Due from employees
  
140
   
161
 
Allowance for doubtful accounts and commission adjustments
  
(3,689
)
  
(3,764
)
Accounts and other receivables, net
 
$
7,167
  
$
13,570
 
XML 55 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED-PARTY TRANSACTIONS (Details)
 3 Months Ended 9 Months Ended 0 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Mar. 31, 2011
Sep. 30, 2014
USD ($)
Sep. 30, 2013
USD ($)
Aug. 06, 2014
Genwell Instruments Co. Ltd. [Member]
USD ($)
Aug. 06, 2014
Genwell Instruments Co. Ltd. [Member]
CNY
Sep. 30, 2014
Genwell Instruments Co. Ltd. [Member]
USD ($)
Sep. 30, 2014
Genwell Instruments Co. Ltd. [Member]
CNY
Sep. 30, 2014
Director - David Lieberman [Member]
USD ($)
Sep. 30, 2013
Director - David Lieberman [Member]
USD ($)
Mar. 31, 2011
Director - David Lieberman [Member]
Sep. 30, 2014
Director - David Lieberman [Member]
USD ($)
Sep. 30, 2013
Director - David Lieberman [Member]
USD ($)
Sep. 30, 2014
Director - Edgar Rios [Member]
Mar. 31, 2011
Consultant Managed by Director - Edgar Rios [Member]
Sep. 30, 2013
Fast Growth Enterprises Limited (FGE) [Member]
USD ($)
Sep. 30, 2013
Fast Growth Enterprises Limited (FGE) [Member]
USD ($)
Related Party Transaction [Line Items]                                
Fees for legal services               $ 60,000 $ 66,000   $ 180,000 $ 187,000        
Term of agreement                         2 years      
Restricted shares issued for consulting agreement (in shares) 18,500,000                 600,000       3,000,000    
Receivables due from related parties   0 (6,000)                       8,000 6,000
Consideration for acquisition       $ 2,151,000 13,250,000 $ 2,151,000 13,250,000                  
Related party interest in acquired entity (in hundredths)           80.90% 80.90%                  
XML 56 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities    
Net loss $ (1,343) $ (1,649)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities    
Depreciation and amortization 290 266
Losses (gains) on disposal of fixed assets 39 0
Provision for doubtful accounts and commission adjustments (1) 23
Share-based compensation and arrangements 320 300
Amortization of deferred consulting expense 0 87
Changes in operating assets and liabilities:    
Accounts and other receivables 6,396 4,304
Receivables due from related parties 0 6
Inventories, net (332) 71
Deferred commission expense (75) 521
Other current assets (123) (138)
Other assets (1,639) (349)
Accounts payable (72) 99
Accrued commissions (55) (746)
Accrued expenses and other liabilities (1,203) (678)
Sales tax payable (48) (13)
Deferred revenue 218 (2,875)
Other long-term liabilities 214 195
Net cash provided by (used in) operating activities 2,586 (576)
Cash flows from investing activities    
Purchases of property, equipment and software (227) (126)
Purchases of short-term investments (40) (111)
Redemption of short-term investments 40 111
Acquisition of Genwell (1,136)  
Cash acquired through purchase of Genwell 113 0
Net cash used in investing activities (1,250) (126)
Cash flows from financing activities    
Repurchase of common stock (244) (1,602)
Net cash used in financing activities (244) (1,602)
Effect of exchange rate differences on cash and cash equivalents 1 (18)
NET INCREASE IN CASH AND CASH EQUIVALENTS 1,093 (2,322)
Cash and cash equivalents - beginning of period 7,961 11,469
Cash and cash equivalents - end of period 9,054 9,147
SUPPLEMENTAL DISCLOSURE OF CASH INFORMATION    
Interest paid 0 0
Income taxes paid 48 61
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES    
Inventories transferred to property and equipment, attributable to operating leases, net 5 57
Note issued for acquisition $ 1,017 $ 0
XML 57 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
LOSS PER COMMON SHARE
 9 Months Ended
Sep. 30, 2014
LOSS PER COMMON SHARE [Abstract]  
LOSS PER COMMON SHARE
NOTE E – LOSS PER COMMON SHARE

 Basic loss per common share is computed as earnings applicable to common stockholders divided by the weighted-average number of common shares outstanding for the period.  Diluted loss per common share reflects the potential dilution that could occur if securities or other contracts to issue common shares were exercised or converted to common stock.

The following table represents common stock equivalents that were excluded from the computation of diluted earnings per share for the three and nine months ended September 30, 2014 and 2013, because the effect of their inclusion would be anti-dilutive.

 
(in thousands)
  
For the three months ended
  
For the nine months ended
 
  
September 30, 2014
  
September 30, 2013
  
September 30, 2014
  
September 30, 2013
 
Stock options
  
1,402
   
1,780
   
1,402
   
1,780
 
Common stock grants
  
490
   
585
   
490
   
585
 
   
1,892
   
2,365
   
1,892
   
2,365
 
XML 58 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
INVENTORIES, NET (Tables)
 9 Months Ended
Sep. 30, 2014
INVENTORIES, NET [Abstract]  
Inventories, Net of Reserves
Inventories, net of reserves, consist of the following:

 
(in thousands)
  
September 30, 2014
  
December 31, 2013
 
  
(unaudited)
   
Raw materials
 
$
651
  
$
790
 
Work in process
  
678
   
291
 
Finished goods
  
608
   
537
 
  
$
1,937
  
$
1,618
 
XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 127 204 1 false 36 0 false 10 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://vasomedical.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://vasomedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) false false R3.htm 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) Sheet http://vasomedical.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) false false R4.htm 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) Sheet http://vasomedical.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) false false R5.htm 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://vasomedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) false false R6.htm 060100 - Disclosure - ORGANIZATION AND PLAN OF OPERATIONS Sheet http://vasomedical.com/role/OrganizationAndPlanOfOperations ORGANIZATION AND PLAN OF OPERATIONS false false R7.htm 060200 - Disclosure - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES Sheet http://vasomedical.com/role/BasisOfPresentationAndCriticalAccountingPolicies BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES false false R8.htm 060300 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS Sheet http://vasomedical.com/role/SegmentReportingAndConcentrations SEGMENT REPORTING AND CONCENTRATIONS false false R9.htm 060400 - Disclosure - SHARE-BASED COMPENSATION Sheet http://vasomedical.com/role/SharebasedCompensation SHARE-BASED COMPENSATION false false R10.htm 060500 - Disclosure - LOSS PER COMMON SHARE Sheet http://vasomedical.com/role/LossPerCommonShare LOSS PER COMMON SHARE false false R11.htm 060600 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://vasomedical.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS false false R12.htm 060700 - Disclosure - ACCOUNTS AND OTHER RECEIVABLES, NET Sheet http://vasomedical.com/role/AccountsAndOtherReceivablesNet ACCOUNTS AND OTHER RECEIVABLES, NET false false R13.htm 060800 - Disclosure - INVENTORIES, NET Sheet http://vasomedical.com/role/InventoriesNet INVENTORIES, NET false false R14.htm 060900 - Disclosure - GOODWILL AND OTHER INTANGIBLES Sheet http://vasomedical.com/role/GoodwillAndOtherIntangibles GOODWILL AND OTHER INTANGIBLES false false R15.htm 061000 - Disclosure - DEFERRED REVENUE Sheet http://vasomedical.com/role/DeferredRevenue DEFERRED REVENUE false false R16.htm 061100 - Disclosure - RELATED-PARTY TRANSACTIONS Sheet http://vasomedical.com/role/RelatedpartyTransactions RELATED-PARTY TRANSACTIONS false false R17.htm 061200 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://vasomedical.com/role/StockholdersEquity STOCKHOLDERS' EQUITY false false R18.htm 061300 - Disclosure - INCOME TAXES Sheet http://vasomedical.com/role/IncomeTaxes INCOME TAXES false false R19.htm 061400 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://vasomedical.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES false false R20.htm 061500 - Disclosure - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS Sheet http://vasomedical.com/role/RecentlyIssuedAccountingPronouncements RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS false false R21.htm 061600 - Disclosure - BUSINESS COMBINATION Sheet http://vasomedical.com/role/BusinessCombination BUSINESS COMBINATION false false R22.htm 070200 - Disclosure - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Policies) Sheet http://vasomedical.com/role/BasisOfPresentationAndCriticalAccountingPoliciesPolicies BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Policies) false false R23.htm 080300 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS (Tables) Sheet http://vasomedical.com/role/SegmentReportingAndConcentrationsTables SEGMENT REPORTING AND CONCENTRATIONS (Tables) false false R24.htm 080500 - Disclosure - LOSS PER COMMON SHARE (Tables) Sheet http://vasomedical.com/role/LossPerCommonShareTables LOSS PER COMMON SHARE (Tables) false false R25.htm 080600 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://vasomedical.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) false false R26.htm 080700 - Disclosure - ACCOUNTS AND OTHER RECEIVABLES, NET (Tables) Sheet http://vasomedical.com/role/AccountsAndOtherReceivablesNetTables ACCOUNTS AND OTHER RECEIVABLES, NET (Tables) false false R27.htm 080800 - Disclosure - INVENTORIES, NET (Tables) Sheet http://vasomedical.com/role/InventoriesNetTables INVENTORIES, NET (Tables) false false R28.htm 080900 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Tables) Sheet http://vasomedical.com/role/GoodwillAndOtherIntangiblesTables GOODWILL AND OTHER INTANGIBLES (Tables) false false R29.htm 081000 - Disclosure - DEFERRED REVENUE (Tables) Sheet http://vasomedical.com/role/DeferredRevenueTables DEFERRED REVENUE (Tables) false false R30.htm 081600 - Disclosure - BUSINESS COMBINATION (Tables) Sheet http://vasomedical.com/role/BusinessCombinationTables BUSINESS COMBINATION (Tables) false false R31.htm 090100 - Disclosure - ORGANIZATION AND PLAN OF OPERATIONS (Details) Sheet http://vasomedical.com/role/OrganizationAndPlanOfOperationsDetails ORGANIZATION AND PLAN OF OPERATIONS (Details) false false R32.htm 090300 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS (Details) Sheet http://vasomedical.com/role/SegmentReportingAndConcentrationsDetails SEGMENT REPORTING AND CONCENTRATIONS (Details) false false R33.htm 090302 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS, Concentration Risk (Details) Sheet http://vasomedical.com/role/SegmentReportingAndConcentrationsConcentrationRiskDetails SEGMENT REPORTING AND CONCENTRATIONS, Concentration Risk (Details) false false R34.htm 090400 - Disclosure - SHARE-BASED COMPENSATION (Details) Sheet http://vasomedical.com/role/SharebasedCompensationDetails SHARE-BASED COMPENSATION (Details) false false R35.htm 090500 - Disclosure - LOSS PER COMMON SHARE (Details) Sheet http://vasomedical.com/role/LossPerCommonShareDetails LOSS PER COMMON SHARE (Details) false false R36.htm 090600 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://vasomedical.com/role/FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) false false R37.htm 090700 - Disclosure - ACCOUNTS AND OTHER RECEIVABLES, NET (Details) Sheet http://vasomedical.com/role/AccountsAndOtherReceivablesNetDetails ACCOUNTS AND OTHER RECEIVABLES, NET (Details) false false R38.htm 090800 - Disclosure - INVENTORIES, NET (Details) Sheet http://vasomedical.com/role/InventoriesNetDetails INVENTORIES, NET (Details) false false R39.htm 090900 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details) Sheet http://vasomedical.com/role/GoodwillAndOtherIntangiblesDetails GOODWILL AND OTHER INTANGIBLES (Details) false false R40.htm 091000 - Disclosure - DEFERRED REVENUE (Details) Sheet http://vasomedical.com/role/DeferredRevenueDetails DEFERRED REVENUE (Details) false false R41.htm 091100 - Disclosure - RELATED-PARTY TRANSACTIONS (Details) Sheet http://vasomedical.com/role/RelatedpartyTransactionsDetails RELATED-PARTY TRANSACTIONS (Details) false false R42.htm 091200 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://vasomedical.com/role/StockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) false false R43.htm 091300 - Disclosure - INCOME TAXES (Details) Sheet http://vasomedical.com/role/IncomeTaxesDetails INCOME TAXES (Details) false false R44.htm 091400 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://vasomedical.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) false false R45.htm 091600 - Disclosure - BUSINESS COMBINATION (Details) Sheet http://vasomedical.com/role/BusinessCombinationDetails BUSINESS COMBINATION (Details) false false All Reports Book All Reports Element us-gaap_ConcentrationRiskPercentage1 had a mix of decimals attribute values: 1 2. Element us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent had a mix of decimals attribute values: -3 0. Element us-gaap_NetIncomeLoss had a mix of decimals attribute values: -3 0. Element us-gaap_SalesRevenueNet had a mix of decimals attribute values: -3 0. 'Monetary' elements on report '090800 - Disclosure - INVENTORIES, NET (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '090900 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '091200 - Disclosure - STOCKHOLDERS' EQUITY (Details)' had a mix of different decimal attribute values. Process Flow-Through: 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Process Flow-Through: Removing column 'Sep. 30, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) Process Flow-Through: 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) Process Flow-Through: 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) vaso-20140930.xml vaso-20140930.xsd vaso-20140930_cal.xml vaso-20140930_def.xml vaso-20140930_lab.xml vaso-20140930_pre.xml true true XML 60 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
INVENTORIES, NET (Details) (USD $)
Sep. 30, 2014
Dec. 31, 2013
INVENTORIES, NET [Abstract]    
Raw materials $ 651,000 $ 790,000
Work in process 678,000 291,000
Finished goods 608,000 537,000
Inventories, net 1,937,000 1,618,000
Reserves for excess and obsolete inventory $ 829,000 $ 803,000
XML 61 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
 9 Months Ended
Sep. 30, 2014
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS [Abstract]  
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
NOTE O - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

Standards issued but not yet effective

In May 2014, the FASB issued a comprehensive new revenue recognition standard which will supersede previous existing revenue recognition guidance. The standard creates a five-step model for revenue recognition that requires companies to exercise judgment when considering contract terms and relevant facts and circumstances. The five-step model includes (1) identifying the contract, (2) identifying the separate performance obligations in the contract, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations and (5) recognizing revenue when each performance obligation has been satisfied. The standard also requires expanded disclosures surrounding revenue recognition. The standard is effective for fiscal periods beginning after December 15, 2016 and allows for either full retrospective or modified retrospective adoption. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements.